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Abstract 
Abstract 
Electroporation is a phenomenon, which occurs when short high voltage pulses are applied to cells and tissues 
resulting in a transient increase in membrane permeability or cell death, presumably due to pore formation. If 
cells recover after pulse application, this is reversible electroporation. If cells die, this is irreversible 
electroporation. Electroporation is used in biotechnology for biocompound extraction and cryopreservation, in 
food processing for sterilization and pasteurization of liquid food and in medicine for treating tumors by 
electrochemotherapy or irreversible electroporation as an ablation technique, for gene electrotransfer, 
transdermal drug delivery, DNA vaccination, and cell fusion.  
In electroporation-based medical treatments, we can treat tumors with predefined electrode geometry and 
parameters of electric pulses. When we treat larger tumors of irregular shape treatment plan of the position of the 
electrodes and parameters of the electric pulses has to be calculated before each treatment to assure coverage of 
the tumor with a sufficient electric field. In treatment plans, currently, 1) we assume that above an 
experimentally determined critical electric field all cells are affected and below not, although, in reality, the 
transition between non-electroporated and electroporated state is continuous. 2) We do not take into account the 
excitability of some tissues. 3) The increase in tissues’ conductivity is described phenomenologically and does 
not include mechanisms of electroporation. 4) Transport of chemotherapeutics into the tumor cells in 
electrochemotherapy treatments is not included in the treatment plan although it is vital for a successful 
treatment. We focused on the mathematical and numerical models of electroporation with the aim of including 
them in the treatment planning of electroporation-based medical treatments. 
We aimed to model processes happening during electroporation of tissues, relevant in the clinical procedures, by 
taking into account processes happening at the single cell level. First, we used mathematical models of cell 
membrane permeability and cell death which are phenomenological descriptions of experimental data. The 
models were chosen on the basis of the best fit with the experimental data. However, they did not include 
mechanisms of electroporation, and their transferability to tissues was questionable. We modeled time dynamics 
of dye uptake due to increased cell membrane permeability in several electroporation buffers with regard to the 
electrosensitization, i.e., delayed hypersensitivity to electric pulses caused by pretreating cells with electric 
pulses. We also modeled the strength-duration depolarization curve and cell membrane permeability curve of 
excitable and non-excitable cell lines which could be used to optimize pulse parameters to achieve maximal drug 
uptake at minimal tissue excitation. 
Second, we modeled change in dielectric properties of tissues during electroporation. Model of change in 
dielectric properties of tissues was built for skin and validated with current-voltage measurements. Dielectric 
properties of separate layers of skin before electroporation were determined by taking into account geometric 
and dielectric properties of single cells, i.e., keratinocytes, corneocytes. Dielectric properties of separate layers 
during electroporation were obtained from cell-level models of pore formation on single cells of lower skin 
layers (keratinocytes in epidermis and lipid spheres in papillary dermis) and local transport region formation in 
the stratum corneum. Current-voltage measurements of long low-voltage pulses were accurately described taking 
into account local transport region formation, pore formation in the cells of lower layers and electrode 
polarization. Voltage measurements of short high-voltage pulses were also accurately described in a similar way 
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as with long low-voltage pulses; however, the model underestimated the current, probably due to 
electrochemical reactions taking place at the electrode-electrolyte interface. 
Third, we modeled the transport of chemotherapeutics during electrochemotherapy in vivo. In 
electrochemotherapy treatments, transport of chemotherapeutics in sufficient amounts into the cell is vital for a 
successful treatment. We performed experiments in vitro and measured the intracellular platinum mass as a 
function of pulse number and electric field by inductively coupled plasma – mass spectrometry. Using the dual-
porosity model, we calculated the in vitro permeability coefficient as a function of electric field and number of 
applied pulses. The in vitro determined permeability coefficient was then used in the numerical model of mouse 
melanoma tumor to describe the transport of cisplatin to the tumor cells. We took into account the differences in 
the transport of cisplatin in vitro and in vivo caused by the decreased mobility of molecules and decreased 
membrane area available for the uptake in vivo due to the high volume fraction of cells, the presence of cell 
matrix and close cell connections. Our model accurately described the experimental results obtained in 
electrochemotherapy of tumors and could be used to predict the efficiency of electrochemotherapy in vitro thus 
reducing the number of needed animal experiments. 
In the thesis, we connected the models at the cell level to the models at the tissue level with respect to cell 
membrane permeability and depolarization, cell death, change in dielectric properties and transport. Our models 
offer a step forward in modeling and understanding electroporation at the tissue level. In future, our models 
could be used to improve treatment planning of electroporation-based medical treatments.  
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Razširjen povzetek v slovenskem jeziku 
Uvod 
Elektroporacija  
Visokonapetostni električni pulzi povečajo prepustnost celične membrane (Tsong 1991; Weaver 1993; 
Kotnik et al. 2012) skozi pore (Abidor et al. 1979), ki nastanejo na tistih njenih delih, kjer vsiljena 
transmembranska napetost preseže kritično vrednost (Towhidi et al. 2008; Kotnik et al. 2010). 
Elektroporacija je reverzibilna, če si celica po pulzih opomore, in ireverzibilna, če je škoda preobsežna in 
celica odmre (Pakhomova et al. 2013b; Jiang et al. 2015a). Trenutne optične metode por ne morejo zaznati, 
zato njihov nastanek zaznavamo posredno, bodisi z meritvami vnosa različnih molekul v celice ali z 
meritvami električnih lastnosti celic (Napotnik in Miklavčič 2017). 
Uporaba elektroporacije 
V živilski industriji (Toepfl 2012; Toepfl et al. 2014) uporabljamo elektroporacijo oziroma pulzirajoča 
električna polja (angl. pulsed electric fields), kar je uveljavljen izraz v tej industriji, za uničevanje patogenih 
organizmov in njihovih produktov (encimov in toksinov). V nasprotju s termično obdelavo hrane električni 
pulzi ne vplivajo na okus, barvo ali hranilno vrednost. V biotehnologiji uporabljamo elektroporacijo za 
ekstrakcijo molekul iz mikroorganizmov in rastlin, s čimer se izognemo uporabi kemičnih sredstev in ne 
uničimo celičnih organelov, torej se izognemo tudi dodatnemu čiščenju končnega produkta (Sack et al. 
2010; Haberl et al. 2013a; Mahnič-Kalamiza et al. 2014b; Kotnik et al. 2015). Primeri: ekstrakcija DNK iz 
bakterij; sladkorja iz sladkorne pese (Haberl et al. 2013b), sokov iz sadja; polifenolov iz grozdja za 
izboljšanje kvalitete vina (Puértolas et al. 2010); vode pri sušenju zelene biomase, ki služi kot vir za 
biogorivo (Golberg et al. 2016). Elektroporacija je tudi nova metoda pri zamrzovanju celic in tkiv, angl. 
cryopreservation (Galindo in Dymek 2016; Dovgan et al. 2017).  
Elektroporacijo uporabljamo tudi v medicini (Miklavčič et al. 2010; Yarmush et al. 2014), in sicer pri 
elektrokemoterapiji (Miklavčič et al. 2012; Mali et al. 2013; Cadossi et al. 2014; Miklavčič et al. 2014; 
Campana et al. 2014; Serša et al. 2015), netermičnem odstranjevanju tkiva z ireverzibilno elektroporacijo 
(Davalos et al. 2005; Garcia et al. 2010; José et al. 2012; Cannon et al. 2013; Scheffer et al. 2014b; Jiang et 
al. 2015a; Rossmeisl et al. 2015), genski terapiji (Golzio et al. 2002; Vasan et al. 2011; Gothelf in Gehl 
2012; Calvet et al. 2014; Heller in Heller 2015; Trimble et al. 2015) in vnosu učinkovin v kožo in skoznjo 
(Denet et al. 2004; Zorec et al. 2013b). Pri genski terapiji vnesemo v celice plazmide, v katerih je zapisana 
sinteza določenega proteina, ki lahko spremeni biološko funkcijo celice (Aihara in Miyazaki 1998; Heller in 
Heller 2015). Z elektroporacijo povišamo varnost genske terapije, saj se izognemo uporabi virusov in 
kemikalij. Mehanizmi genske terapije z elektroporacijo še niso popolnoma pojasnjeni, osnovni koraki so 
opisani v literaturi (Rosazza et al. 2016). Z elektroporacijo lahko zlivamo različne celice, s čimer 
pridobivamo celice, ki proizvajajo monoklonska protitelesa ali inzulin (Ramos in Teissié 2000; Trontelj et 
al. 2008; Rems et al. 2013).  
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V doktorski disertaciji sem se osredotočila na uporabo elektroporacije v medicini, predvsem pri 
elektrokemoterapiji, netermičnem odstranjevanju tkiva z ireverzibilno elektroporacijo in pri vnosu 
učinkovin v kožo in skoznjo je, zato so ti trije posegi podrobneje opisani v naslednjem poglavju.  
Medicinski posegi z elektroporacijo – elektrokemoterapija, netermično odstranjevanje tkiva z 
ireverzibilno elektroporacijo in vnos učinkovin v kožo in skoznjo 
Elektrokemoterapija je kombinacija kemoterapije in električnih pulzov, dovedenih neposredno na tarčno 
tkivo. Električni pulzi povečajo prepustnost celične membrane za kemoterapevtike, zato povečamo 
učinkovitost zdravljenja, obenem pa zmanjšamo dovedeno dozo kemoterapevtika in omilimo stranske 
učinke. Celoten tumor mora biti pokrit z dovolj visokim električnim poljem, da povečamo prepustnost vseh 
tumorskih celic (Miklavčič et al. 2006a), zagotoviti pa moramo tudi dovolj visoko koncentracijo 
kemoterapevtika znotraj tumorja (Miklavčič et al. 2014). Okoliško tkivo ne sme biti uničeno, torej mora biti 
električno polje okoli tumorja pod mejo za ireverzibilno elektroporacijo. Pri elektrokemoterapiji običajno 
dovajamo osem pulzov dolžine 100 μs s ponavljalno frekvenco 1 Hz. S poskusi določena meja za povišanje 
prepustnosti tumorskega tkiva je 0,4 kV/cm (Miklavčič et al. 2010). Osem pulzov je bilo določenih kot 
optimalno število pulzov (Marty et al. 2006; Mir et al. 2006), večje število dovedenih pulzov namreč že 
zmanjšuje preživetje (Dermol in Miklavčič 2015). Za zdravljenje tumorjev z elektrokemoterapijo so bili 
definirani standardni postopki (angl. standard operating procedures) (Marty et al. 2006; Mir et al. 2006), 
kjer so glede na število tumorjev, njihovo velikost in lokacijo (na koži ali pod kožo) določeni tip elektrod, 
kemoterapevtik, anestezija in način dovajanja kemoterapevtika. Kemoterapevtik lahko dovedemo lokalno 
ali sistemsko. V elektrokemoterapiji oz. terapiji z električnimi pulzi sta najbolj razširjena kemoterapevtika 
cisplatin in bleomicin. Z elektrokemoterapijo je možno zdraviti tudi globlje ležeče tumorje (Miklavčič et al. 
2010; Pavliha et al. 2013; Edhemović et al. 2014; Miklavčič in Davalos 2015). V zadnjem času se 
uveljavlja tudi uničevanje tumorskih celic z visokimi koncentracijami kalcija in električnimi pulzi 
(Frandsen et al. 2015; Frandsen et al. 2016; Frandsen et al. 2017). Pri elektrokemoterapiji se pojavijo še 
dodatni učinki, ki povišajo učinkovitost elektroporacije. Vazokonstrikcija zmanjša spiranje kemoterapevtika 
iz tumorja in s tem ohranja visoko koncentracijo kemoterapevtika v tumorju, obenem se zmanjša pretok 
krvi skozi tumor, kar povzroči hipoksijo in pomanjkanje hranilnih snovi (Mir 2006; Serša et al. 2008). 
Elektrokemoterapija sproži tudi odziv imunskega sistema, ki nato odstrani preostale tumorske celice (Serša 
et al. 2015). 
Z ireverzibilno elektroporacijo netermično odstranjujemo tumorje brez uporabe kemoterapevtika (Jiang et 
al. 2015a). Tako se popolnoma izognemo stranskim učinkom kemoterapevtikov, vendar na račun več 
dovedene energije in posledično Joulovega gretja. Pri ireverzibilni elektroporaciji dovajamo več (okoli 90) 
električnih pulzov, dolgih od 50 μs do 100 μs, s ponavljalno frekvenco 1 Hz. Dovedeno električno polje je v 
rangu nekaj kV/cm, kar je dosti več kot pri elektrokemoterapiji. Pri ireverzibilni elektroporaciji lahko z 
visoko natančnostjo odstranimo želeno tkivo – območje med uničenim in nepoškodovanim tkivom je široko 
le nekaj premerov celic (Rubinsky et al. 2007). Za odstranjevanje tumorjev tradicionalno uporabljamo 
termične metode (Hall et al. 2014) – radiofrekvenčno odstranjevanje in odstranjevanje s tekočim dušikom, 
kjer tkivo uničujemo z visoko oz. z nizko temperaturo. Prednost ireverzibilne elektroporacije pred 
uveljavljenimi termičnimi metodami je krajši čas zdravljenja, izognemo se učinkom hlajenja oz. gretja tkiva 
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zaradi bližine žil (Golberg et al. 2015), pri čemer ostanejo okoliške pomembne strukture (žile, živci) 
nedotaknjene (Jiang et al. 2015a). Tudi pri ireverzibilni elektroporaciji je v dokončno odstranitev tumorskih 
celic vpleten imunski sistem (Neal et al. 2013).  
Pri elektrokemoterapiji in ireverzibilni elektroporaciji se zaradi daljših pulzov in ponavljalne frekvence 
1 Hz pojavljajo težave zaradi krčenja mišic (Miklavčič et al. 2005), bolečine med dovajanjem pulzov, 
heterogenosti električnih lastnosti tkiv v tem frekvenčnem področju ter zaradi možnosti srčnih aritmij (Ball 
et al. 2010). Bolečini in krčenju mišic se lahko izognemo, če pulze dovajamo z višjo frekvenco, npr. 5 kHz 
(Županič et al. 2007; Serša et al. 2010). Srčnim aritmijam se izognemo tako, da s sinhroniziramo dovedene 
električne pulze z električno aktivnostjo srčne mišice (Mali et al. 2008; Deodhar et al. 2011a; Mali et al. 
2015). Bolečini, krčenju mišic in heterogenosti električnih lastnosti tkiv se lahko izognemo z dovajanjem 
1 μs bipolarnih pulzov (Arena et al. 2011; Arena in Davalos 2012; Sano et al. 2015). V zadnjem času so se 
pojavile tudi metode, s katerimi so vnos barvil v celico dosegli brezkontaktno s t. i. magnetoporacijo (Chen 
et al. 2010; Towhidi et al. 2012; Kardos in Rabussay 2012; Novickij et al. 2015; Kranjc et al. 2016; 
Novickij et al. 2017b; Novickij et al. 2017a).  
Elektroporacijo lahko uporabljamo ne le za zdravljenje tumorjev, temveč tudi za vnos učinkovin v kožo in 
skoznjo. Vnos učinkovin skozi kožo je neinvaziven, poleg tega pa se izognemo degradaciji učinkovin pri 
prehodu skozi prebavni trakt. Skozi kožo lahko preide le malo molekul, zato uporabljamo različne metode 
za povečanje prehoda učinkovin – iontoforezo, radiofrekvenčno mikroablacijo, laser, mikroigle, ultrazvok 
in elektroporacijo (Zorec et al. 2013b). Proces elektroporacije kože je slabo razumljen. Predpostavljamo, da 
pri dovajanju visokonapetostnih električnih pulzov v roženi plasti nastanejo lokalna transportna območja, 
kjer sta povišani električna prevodnost in prepustnost (Pliquett et al. 1996; Pliquett et al. 1998; Pliquett et 
al. 1998; Pavšelj in Miklavčič 2008a). Skozi lokalna transportna območja lahko nato učinkovine še nekaj ur 
po dovedenih pulzih vstopajo skozi kožo v krvni obtok (Zorec et al. 2013a). Gostota teh območij je odvisna 
od električnega polja v koži – višje električno polje jih povzroči več. Velikost lokalnih transportnih območij 
je odvisna od trajanja pulza. Med samim pulzom se zaradi Joulovega gretja topijo lipidi v roženi plasti, kar 
povzroči njihovo širjenje (Pliquett et al. 1996; Prausnitz et al. 1996; Pliquett et al. 1998; Weaver et al. 1999; 
Vanbever et al. 1999; Gowrishankar et al. 1999b). 
Načrtovanje posegov elektrokemoterapije in netermičnega odstranjevanja tkiva z ireverzibilno 
elektroporacijo 
Pri zdravljenju tumorjev z elektroporacijo lahko uporabimo standardne oblike in postavitve elektrod z že 
določenimi parametri električnih pulzov (Marty et al. 2006; Mir et al. 2006; Campana et al. 2014). Če 
zdravimo velike tumorje ali tumorje nepravilnih oblik, ki pogosto ležijo globlje, s standardno postavitvijo 
elektrod ne moremo zagotoviti ustrezne pokritosti tumorja z dovolj visokim električnim poljem. V tem 
primeru lahko elektrode med samim posegom večkrat premaknemo ali pa prilagodimo njihovo število in 
postavitev. Pri tem moramo prej pripraviti načrt posega (Kos et al. 2010; Miklavčič et al. 2010; Pavliha et 
al. 2012; Linnert et al. 2012; Edhemović et al. 2014). V njem zagotovimo, da bo cel tumor izpostavljen 
dovolj visokemu električnemu polju (Miklavčič et al. 2006a), obenem pa škoda na okoliškem tkivu 
minimalna. 
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Načrtovanje posega poteka v več korakih: 1. zajem medicinskih slik (računalniška tomografija, magnetna 
resonanca) tumorja in okoliškega tkiva; 2. obdelava slik; 3. razgradnja slik in določitev geometrije tkiva; 4. 
vzpostavitev tridimenzionalnega modela; 5. optimizacija postavitve elektrod glede na obliko in velikost 
tumorja; 6. izdelava modela elektroporacije (izračun električnega polja in spremembe električne 
prevodnosti tkiva); 7. optimizacija napetosti med elektrodami in položaja elektrod (Pavliha et al. 2012). Na 
sliki 1 lahko vidimo izračunano električno polje v tumorju in okoliškem tkivu pri eni izmed možnih 
postavitev elektrod. 
Med načrtovanjem posega privzamemo naslednje predpostavke. 
1. Pri določanju elektroporiranega in neelektroporiranega območja uporabljamo s poskusi določeno
vrednost kritičnega električnega polja (Miklavčič et al. 2000; Šel et al. 2005; Čorović et al. 2012). Za vsako
tkivo privzamemo dve kritični vrednosti električnega polja – eno za reverzibilno in drugo za ireverzibilno
elektroporacijo. Predpostavljamo, da so celične membrane vseh celic, ki so izpostavljene električnemu
polju pod kritično vrednostjo za reverzibilno elektroporacijo, neprepustne. Vse celice, ki so izpostavljene
električnemu polju nad kritično vrednostjo za reverzibilno elektroporacijo, imajo prepustne membrane.
Tiste, ki so izpostavljene električnemu polju nad kritično vrednostjo za ireverzibilno elektroporacijo, pa so
mrtve. Vendar v resnici kritično električne polje za elektroporacijo ni enako za vse celice v tkivu, temveč je
statistično porazdeljeno. Če pri načrtovanju posegov predpostavljamo, da imajo vse celice enak prag za
reverzibilno in ireverzibilno elektroporacijo, je lahko tumor izpostavljen prenizkemu električnemu polju in
tumorske celice preživijo. Če tkivo izpostavimo previsokemu električnemu polju, lahko poškodujemo
pomembne bližnje strukture.
2. Z elektroporacijo lahko vplivamo tudi na vzdražna tkiva, kot so nevroni in mišice. Zdravimo jih pri
netermičnem odstranjevanju tumorjev v možganih z ireverzibilno elektroporacijo (Garcia et al. 2012;
Rossmeisl et al. 2015; Sharabi et al. 2016), pri genski terapiji (Hargrave et al. 2013; Hargrave et al. 2014;
Bulysheva et al. 2016) ali netermičnem odstranjevanju tkiva srčne mišice z ireverzibilno elektroporacijo
(Neven et al. 2014b; Neven et al. 2014a) in pri genski terapiji skeletnih mišic (Aihara in Miyazaki 1998).
Lahko pa vzdražna tkiva električnemu polju izpostavimo nenamerno, ko so v bližini tarčnega območja.
Vplivamo na živčno-žilni snop pri zdravljenju raka na prostati (Neal et al. 2014; Ting et al. 2016), na
nevrone pri zdravljenju kostnih metastaz (Tschon et al. 2015; Gasbarrini et al. 2015) ali na hrbtenjačo pri
zdravljenju tumorjev v hrbtenici (Tschon et al. 2015). Električna stimulacija živcev in mišic povzroči
nelagodje in bolečino (Miklavčič et al. 2005; Županič et al. 2007; Arena in Davalos 2012; Golberg in
Rubinsky 2012). Pokazali so, da lahko električni pulzi povzročijo stimulacijo receptorjev za bolečino
(nociceptorjev) (Nene et al. 2006; Jiang in Cooper 2011). Pomemben napredek pri zdravljenju vzdražnih
tkiv ali tkiv v njihovi bližini bi bila določitev optimalnih parametrov električnega polja, kjer dosežemo
najvišjo prepustnost celične membrane, obenem pa ne vzdražimo tkiva.
3. Elektroporacija poviša električno prevodnost tkiva zaradi povišane električne prevodnosti celičnih
membran in zaradi Joulovega gretja (Šel et al. 2005; Ivorra et al. 2009; Essone Mezeme et al. 2012a; Neal
et al. 2012). Spremenjena električna prevodnost vpliva na porazdelitev električnega polja (Šel et al. 2005).
Pri načrtovanju posegov predpostavljamo, da se prevodnost tkiva poviša za približno štirikrat (Neal et al.
2012). Tkiva imajo različne električne lastnosti, ki se spremenijo in vplivajo na porazdelitev električnega
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polja. Vrednosti električnih lastnosti tkiv po elektroporaciji lahko izračunamo z ekvivalentnim vezjem 
(Neal et al. 2012), lahko pa bi v izračune vključili tudi mehanizme elektroporacije.  
4. Pri elektrokemoterapiji je za učinkovitost zdravljenja najpomembnejši zadosten vnos
kemoterapevtika v celice (Miklavčič et al. 2014). Pri nizki znotrajcelični koncentraciji kemoterapevtika
bleomicina pride do mitotske smrti, pri visoki pa do procesa, podobnega apoptozi (programirani celični
smrti) (Tounekti et al. 1993; Tounekti et al. 2001). V načrtovanju zdravljenja predpostavljamo, da je
električno polje nad kritično vrednostjo za reverzibilno elektroporacijo tkiva dovolj za zadosten vnos
kemoterapevtika v celice. Lahko se zgodi, da kemoterapevtika kljub dovolj visokemu električnemu polju v
celice ne pride dovolj, če je njegova začetna prostorska porazdelitev v tumorju nehomogena in ga v
zunajceličnem prostoru zmanjka.
Slika 1: Primer izračunanega električnega polja v različnih tkivih (tumorju, mišicah, maščobnem tkivu) pri 
zdravljenju tumorja z elektroporacijo. Tumor je označen z modro barvo in je cel izpostavljen električnemu 
polju nad kritično vrednostjo za reverzibilno elektroporacijo. Povzeto po (Županič et al. 2012). 
Električne lastnosti celic in tkiv 
Elektroporacija poveča električno prevodnost celične membrane, kar so merili v več raziskavah z 
dielektrično impedančno spektroskopijo (Abidor et al. 1993; Schmeer et al. 2004), s tokovnonapetostnimi 
meritvami (Pliquett in Wunderlich 1983; Pavlin et al. 2005; Pavlin in Miklavčič 2008; Suzuki et al. 2011), z 
optičnimi metodami (Hibino et al. 1991; Griese et al. 2002) ali z metodo vpete krpice, angl. patch clamp 
(Pakhomov et al. 2007; Wegner 2015; Yoon et al. 2016; Napotnik in Miklavčič 2017). Zaradi 
elektroporacije se poveča tudi električna prevodnost sloja celic (Ghosh et al. 1993; Müller et al. 2003; 
Stolwijk et al. 2011; García-Sánchez et al. 2015). Elektroporacija spremeni električne lastnosti človeških, 
živalskih in rastlinskih tkiv, kar lahko merimo s podobnimi metodami kot pri celicah – z dielektrično 
impedančno spektroskopijo (Barnes in Greenebaum 2006; Ivorra in Rubinsky 2007; Grimnes in Martinsen 
2008; Dean et al. 2008; Zhuang et al. 2012; Dymek et al. 2014; Trainito et al. 2015; Zhuang in Kolb 2015), 
s tokovnonapetostnimi meritvami (Pavlin et al. 2005; Cukjati et al. 2007; Ivorra in Rubinsky 2007; Pavlin 
in Miklavčič 2008; Ivorra et al. 2009; Chalermchat et al. 2010; Neal et al. 2012; Becker et al. 2014; Dymek 
et al. 2015), z električno impedančno tomografijo (Davalos et al. 2002; Davalos et al. 2004; Granot in 
Rubinsky 2007; Meir in Rubinsky 2014) ali z magnetno resonančno električno impedančno tomografijo 
(Kranjc et al. 2014; Kranjc et al. 2015; Kranjc et al. 2017). Elektroporacija spremeni specifično prevodnost 
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tkiva predvsem v območju β-disperzije (Pliquett et al. 1995; Ivorra in Rubinsky 2007; Garner et al. 2007; 
Oblak et al. 2007; Ivorra et al. 2009; Neal et al. 2012; Zhuang et al. 2012; Salimi et al. 2013). Ta nastane 
zaradi polarizacije celične membrane, na katero elektroporacija najbolj vpliva zaradi por v njej in 
posledično povečane prevodnosti. Iz spremembe elektičnih lastnosti tkiv lahko sklepamo na odziv tkiva na 
zdravljenje (Cukjati et al. 2007; Ivorra et al. 2009; Neal et al. 2012). Pri meritvah električnih lastnosti po 
elektroporaciji moramo biti pozorni na sekundarne učinke elektroporacije, ki lahko vplivajo na rezultate 
meritev: spremembo velikosti celic (Serša et al. 2008; Sano et al. 2010; Deodhar et al. 2011b; Calmels et al. 
2012), nastanek edema (Ivorra et al. 2009), izpust ionov iz celic (Pavlin et al. 2005) in vaskularno okluzijo 
(Ivorra in Rubinsky 2007; Serša et al. 2008).  
Specifična prevodnost tkiv s frekvenco narašča, dielektričnost pa pada. Obe lahko razdelimo na več 
značilnih disperzijskih območij (Pethig 1984; Pethig in Kell 1987; Gabriel et al. 1996a; Miklavčič et al. 
2006b; Barnes in Greenebaum 2006; Grimnes in Martinsen 2008), kar lahko vidimo na sliki 2. Pri nizkih 
frekvencah (pod 100 kHz) je prisotna α disperzija zaradi interakcij v bližini celične membrane, 
znotrajceličnih struktur, ionske difuzije in polarizacije elektrod. β disperzija je prisotna v območju 
megahertzov in nastane zaradi polarizacije celičnih membran in odzivov proteinov. γ disperzija nastane nad 
1 GHz zaradi dipolarnih mehanizmov v polarnih medijih, kot je voda. Obstaja tudi manjša δ disperzija pri 
nekaj 100 MHz, ki nastane zaradi sprostitve vezane vode in manjših polarnih delov bioloških molekul ter 
zaradi ionske difuzije ob nabiti površini (Barnes in Greenebaum 2006). Električne lastnosti tkiv so 
prikazane na sliki 2, vendar so absolutne vrednosti različne od tkiva do tkiva (Gabriel et al. 1996a; Gabriel 
et al. 1996b; Gabriel et al. 1996c; Grimnes in Martinsen 2008). Obenem so lahko tkiva tudi anizotropna, kar 
pomeni, da je tkivo različno električno prevodno v različne smeri. Tipičen primer anizotropnega tkiva so 
mišice (Čorović et al. 2010). 
Slika 2: Frekvenčna odvisnost električne prevodnosti (σ) in relativne dielektričnosti (εr). Vidimo lahko, da 
dielektričnost s frekvenco pada, specifična prevodnost pa narašča. Povzeto po (Miklavčič et al. 2006b). 
Transport majhnih molekul v celice in v tkivo 
Transport molekul skozi celično membrano zaradi elektroporacije je posledica treh različnih mehanizmov – 
difuzije, elektroforeze in endocitoze. Med samimi pulzi je transport elektroforetski in difuzijski (Li in Lin 
2011; Sadik et al. 2013), po pulzih pa predvsem difuzijski (Pucihar et al. 2008). Endocitozo so opazili po 
dovajanju daljših pulzov pri nižjih električnih poljih (Rols et al. 1995; Antov et al. 2005). 
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In vitro lahko transport določamo z različnimi tehnikami (Napotnik in Miklavčič 2017), kot so 
fluorescentna mikroskopija, pretočna citometrija, vnos citotoksičnih molekul (Maček Lebar in Miklavčič 
2001), vnos plazmidov (Golzio et al. 2002), vnos magnetnih nanodelcev, masna spektrometrija (Čemažar et 
al. 2001) ali barvanje z barvili. Pri tehnikah in vivo je merjenje transporta zahtevnejše, saj je treba tkivo 
pred analizo večinoma izrezati in razgraditi. Uporabljamo metode, kot so radioaktivno označevanje z 
molekulami 57Co-bleomicin (Belehradek et al. 1994), 111In-bleomicin (Engström et al. 1998), 99mTc-DTPA 
(Grafström et al. 2006), 51Cr-EDTA (Batiuškaitė et al. 2003), magnetna resonanca z gadolinijem (Garcia et 
al. 2012; Kranjc et al. 2015), masna spektrometrija (Melvik et al. 1986; Čemažar et al. 1998; Čemažar et al. 
1999; Ogihara in Yamaguchi 2000; Čemažar et al. 2001; Serša et al. 2010; Hudej et al. 2014; Čemažar et al. 
2015) in barvanje z barvilom lucifer rumeno (Kranjc et al. 2015). 
Pri elektrokemoterapiji je transport ključen za učinkovitost zdravljenja (Miklavčič et al. 2014). Primerjava 
transporta in vitro ter in vivo je težavna. Celice v celični suspenziji so obdane s topljencem, ki lahko vanje 
vstopi z vseh strani. Transport poteka večinoma z difuzijo. Če je topljenca dovolj, se transport ustavi, ko je 
membrana zaceljena. Difuzija po zunajcelični tekočini ni omejena in transport topljenca skozi celično 
membrano lahko neposredno povežemo z njeno prepustnostjo (Mahnič-Kalamiza et al. 2014a). In vivo je 
začetna koncentracija topljenca prostorsko nehomogena, celice imajo na voljo različno začetno 
koncentracijo topljenca, ki ga lahko zmanjka, še preden je membrana zaceljena. Transport topljenca z 
difuzijo in konvekcijo (Canatella et al. 2004; Pucihar et al. 2008) poteka z določeno časovno konstanto. 
Električni pulzi povzročijo vazokonstrikcijo (Serša et al. 2008), ki omeji izpiranje in pritok topljenca. Tesen 
stik med celicami zmanjšuje površino membrane, skozi katero lahko poteka transport. Zunajcelični matriks 
ovira transport topljenca. Že pri elektroporaciji sferoidov (preprost približek tkiva) v fluorescentnem barvilu 
so ugotovili, da je transport majhnih molekul po sferoidu nehomogen – najvišji vnos so dosegli na robu 
sferoida, nato pa se je zmanjševal proti njegovemu središču (Canatella et al. 2004; Gibot et al. 2013). 
Vazokonstrikcija po električnih pulzih zmanjša pretok krvi v tumor in iz njega, kar podaljša izpostavljenost 
kemoterapevtiku. V tumorju je transport še dodatno otežen zaradi povišanega intersticijskega tlaka, 
heterogene prekrvavitve, vezave aktivnih molekul na netarčne molekule v tumorju, okvarjenega limfnega 
sistema in metabolizma (Baxter in Jain 1989; Baxter in Jain 1990; Baxter in Jain 1991; Jain 1999). 
Modeliranje elektroporacije 
Z uporabo matematičnih in fizikalnih zakonov pri modeliranju strnjeno opišemo biološke pojave ter 
omogočimo razumevanje in napovedovanje odziva ter zmanjšamo število poskusov. Elektroporacijo 
modeliramo na različnih prostorskih ravneh: molekule lipidov, lipidni dvosloj, celice in tkiva. Trenutno so 
modeli večinoma omejeni na eno prostorsko raven, povezovalnih modelov med njimi pa je malo. 
Modeli na ravni molekul 
Osnovni gradniki celične membrane so fosfolipidi. Obnašanje lipidov in drugih molekul pod vplivom 
električnega polja lahko ugotavljamo s simulacijami molekularne dinamike (Tieleman 2006; Böckmann et 
al. 2008; Delemotte in Tarek 2012; Reigada 2014; Casciola et al. 2014; Kirsch in Böckmann 2015), ki so 
zaradi računske zahtevnosti časovno omejene nekaj 100 do 1000 nanosekund. Raziskave molekularne 
dinamike predvidevajo, da zaradi električnega polja v lipidnem dvosloju nastanejo hidrofobne pore, ki se 
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razvijejo v hidrofilne pore. Simulacije numerične dinamike so primerjali s poskusi. Ugotovili so, da lahko 
mala interferenčna RNA (siRNA) v nekaj nanosekundah prečka celično membrano (Breton et al. 2012). 
Modeli na ravni lipidnih dvoslojev 
V polarnem topilu, kot je voda, se lipidi spontano uredijo v lipidni dvosloj. Modele elektroporacije lipidnih 
dvoslojev lahko razdelimo v dve skupini (Chen et al. 2006a; Pavlin et al. 2008; Rems in Miklavčič 2014). V 
prvi so deterministični elektromehanski (hidrodinamični, elastični, hidroelastični, viskoelastični) modeli, 
kjer dvosloj obravnavamo kot elastično telo in ga opisujemo z zakoni elektrostatike. Druga skupina so 
stohastični modeli nastanka por. Temeljijo na energijskih enačbah (Abidor et al. 1979), združuje pa jih 
enačba Smoluchowskega, ki opiše nastanek in dinamiko razvoja por. Neu in Krassowska sta jo poenostavila 
in omogočila njen relativno preprost numerični izračun (Neu in Krassowska 1999; Neu in Neu 2009), 
vendar pa v njej predvidevata, da se velikost por med pulzom ne spreminja. Asimptotski model 
elektroporacije je torej primeren le za kratke nanosekundne pulze, pri daljših pulzih namreč že pride do 
širjenja por v celični membrani. Tudi širjenje por med elektroporacijo lahko modeliramo, a je računsko bolj 
zahtevno, ker za vsako poro posebej rešujemo diferencialno enačbo spremembe premera v vsaki časovni 
točki (Smith et al. 2004). Med energijske modele spada tudi model, ki nastanek por opiše s kinetično shemo 
prehajanja membrane (Neumann et al. 1998; Miklavčič in Towhidi 2010) med prepustnimi in 
neprepustnimi stanji (Böckmann et al. 2008). Transport majhnih molekul skozi poro lahko opišemo z 
elektrodifuzijsko enačbo (Granot in Rubinsky 2008; Li in Lin 2011; Smith in Weaver 2011; Movahed in Li 
2012; Movahed in Li 2013). Pri primerjavi zveznih modelov elektroporacije lipidnih dvoslojev in modelov 
molekularne dinamike so ugotovili, da se rezultati obojih dobro ujemajo (Casciola et al. 2016; Rems et al. 
2016).  
Modeli na ravni posameznih celic 
Lipidni dvosloj je skupaj z membranskimi proteini osnova za nastanek biološke celice. Biološka celica je v 
približku električno slabo prevodna membrana (dielektrik), ki je na obeh straneh obdana z elektrolitom 
(prevodnik). Na ravni celic obstajajo modeli različnih pojavov: vsiljene transmembranske napetosti, 
nastanka por, transporta, prepustnosti celične membrane, smrti, spremembe prevodnosti. Časovna in 
prostorska dinamika vsiljene transmembranske napetosti sta analitično rešljivi za preproste oblike 
osamljenih celic (Kotnik et al. 1998; Kotnik in Miklavčič 2000a; Kotnik in Miklavčič 2000b; Valič et al. 
2003; Kotnik in Miklavčič 2006), v splošnem pa zahtevata numerični izračun (Pucihar et al. 2006). Ko je 
vsiljena transmembranska napetost znana, lahko opišemo nastanek por (Neu in Krassowska 1999; Smith et 
al. 2004; Neu in Neu 2009). Celice lahko modeliramo tudi z ekvivalentnim električnim vezjem (Pethig 
1984; Gowrishankar in Weaver 2003). Smrt in prepustnost celic v suspenziji lahko opišemo s statističnimi 
modeli (Peleg 1995; Huang et al. 2012; Dermol 2014; Dermol in Miklavčič 2014; Dermol in Miklavčič 
2015; Dermol in Miklavčič 2016). V literaturi se pojavljajo štirje modeli prepustnosti celične membrane – 
simetrična in asimetrična sigmoida, Gompertzova krivulja in hiperbolični tangens (Laird 1964; Puc et al. 
2003; Essone Mezeme et al. 2012b; Dermol in Miklavčič 2014). Modelov celične smrti je več (Hülsheger in 
Niemann 1980; Hülsheger et al. 1981; Geeraerd et al. 2000; Peleg in Penchina 2000; Huang et al. 2012), 
večinoma izhajajo iz živilske industrije, kjer z njimi napovedujejo učinkovitost uničevanja patogenih 
organizmov v živilih z namenom pasterizacije in sterilizacije (Peleg 2006; Huang et al. 2012; Dermol in 
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Miklavčič 2016). Električno prevodnost in prepustnost celične membrane lahko modeliramo ločeno 
(Miklavčič in Towhidi 2010; Leguèbe et al. 2014). Transport molekul v posamezno celico lahko opišemo z 
elektrodifuzijsko enačbo skozi prepustno membrano (Zaharoff et al. 2008; Pucihar et al. 2008; Leguèbe et 
al. 2014; Blumrosen et al. 2016).  
Modeli na ravni tkiv in skupkov celic 
Skupek po obliki in funkciji podobnih celic tvori tkivo (Alberts et al. 2009). Modele tkiv delimo v dve 
skupini – tkivo jemljejo kot homogeno enoto (Šel et al. 2005; Čorović et al. 2007; Pavšelj et al. 2007; 
Pavšelj in Miklavčič 2008b; Golberg in Rubinsky 2010; Neal et al. 2012; Čorović et al. 2012; Garcia et al. 
2014) ali pa vključujejo tudi mikrostrukturo tkiva (Gowrishankar in Weaver 2003; Stewart Jr. et al. 2005; 
Gowrishankar in Weaver 2006; Esser et al. 2007; Joshi et al. 2008; Esser et al. 2009; Essone Mezeme et al. 
2012b; Dymek et al. 2015). 
Modeli homogenega tkiva obravnavajo električno polje v odvisnosti od oblike in števila elektrod, 
parametrov električnih pulzov ter lastnosti tkiva in sprememb njegove prevodnosti (Šel et al. 2005; Čorović 
et al. 2007; Pavšelj et al. 2007; Pavšelj in Miklavčič 2008b). Za vsak tip tkiva privzamemo s poskusi 
določeno kritično vrednost električnega polja, kjer pride do povišane prepustnosti membrane ali do smrti 
(Šel et al. 2005; Čorović et al. 2012), kar uporabimo za optimizacijo parametrov električnega polja. Z 
matematičnimi modeli lahko napovemo verjetnost za povišano prepustnosti celične membrane ali celično 
smrt (Golberg in Rubinsky 2010; Garcia et al. 2014; Garcia et al. 2014; Sharabi et al. 2016; Kranjc et al. 
2017). S fenomenološkimi modeli, ki temeljijo na različnih porazdelitvah relaksacijskih časov molekul v 
tkivu, opišemo frekvenčno odvisnost električnih lastnosti različnih tkiv (Debyev, Cole-Colejev, Cole-
Davidsonov, Havriliak-Negamijev, Raicujev model (Barnes in Greenebaum 2006)).  
Pri elektroporaciji kože modeli opisujejo električno polje ali transport v koži kot organu iz posameznih 
homogenih slojev (Chizmadzhev et al. 1998; Weaver et al. 1999; Becker in Kuznetsov 2007; Pavšelj et al. 
2007; Pavšelj in Miklavčič 2008a; Becker 2012; Becker et al. 2014). Električne lastnosti slojev pred 
elektroporacijo in po njej so večinoma približki, obenem lahko več slojem pripišemo enake lastnosti 
(Pavšelj et al. 2007). Nekaj modelov vključuje tudi nastanek lokalnih transportnih območij (Becker in 
Kuznetsov 2007; Pavšelj in Miklavčič 2008a; Becker 2012), ampak so omejeni le na procese v roženi plasti 
in ne zajemajo elektroporacije celic v spodnjih slojih kože. 
Transport snovi po tkivu (Becker in Kuznetsov 2013) lahko dobro opišemo s statističnimi modeli, ki pa ne 
vključujejo mehanizmov transporta (Canatella in Prausnitz 2001), s kinetično shemo elektroporacije 
(Neumann et al. 1998; Miklavčič in Towhidi 2010), s farmakološkim modelom (Puc et al. 2003; Agarwal et 
al. 2009), z elektrodifuzijsko enačbo ali z modelom dvojne poroznosti (Mahnič-Kalamiza et al. 2014a; 
Mahnič-Kalamiza et al. 2015). Model dvojne poroznosti temelji na difuzijski enačbi, povezuje nastanek por 
s prepustnostjo celične membrane in omogoča modeliranje transporta med več razdelki, npr. celicami, 
intersticijsko tekočino in sosednjimi tkivi. V ta model lahko vključimo termične procese (Mahnič-Kalamiza 
et al. 2017) ali pa ga povežemo z enačbami za stopnjo elektroporacije, spremembo električne prevodnosti 
tkiv in celjenje por (Boyd in Becker 2015; Argus et al. 2017) ter celostno opišemo proces elektroporacije in 
transporta.  
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Druga večja skupina modelov tkiv upošteva mikrostrukturo tkiv. Iz električnih lastnosti posameznih 
okroglih celic v nizkih prostorninskih deležih lahko izračunamo ekvivalentne lastnosti z enačbami mešanja, 
kjer upoštevamo električne lastnosti in prostorninske deleže celic (Asami 2002). Uporabimo enačbe 
Maxwell-Wagnerja, Hanaija, Böttcherja, Bruggemana, Looyenge (Pavlin in Miklavčič 2009). V dveh 
dimenzijah lahko presek tkiva vzorčimo s kartezijskimi transportnimi mrežami in s Kirchoffovimi zakoni 
izračunamo tok, napetost in električni naboj po celi mreži (Gowrishankar in Weaver 2003; Stewart ml. et al. 
2005; Gowrishankar in Weaver 2006; Esser et al. 2007; Esser et al. 2009). Podobno metodo ekvivalentnega 
vezja so uporabili v literaturi (Ramos et al. 2003; Ramos 2005), kjer so najprej analizirali učinke 
elektroporacije na ravni celic, nato pa preko ekvivalentnih električnih lastnosti celic prešli na tkiva. V dveh 
dimenzijah odziv tkiva ponazorimo z modeliranjem celic z Voronojevim diagramom in izračunom vsiljene 
transmembranske napetosti znotraj vsakega poligona oz. celice (Joshi et al. 2008). Slabost zgornjih 
modelov je, da so v dveh dimenzijah, kjer je obnašanje celic drugačno kot v tridimenzionalnih pogojih in 
vivo. V tkivu so celice namreč gosto skupaj, so povezane, pride do zastiranja električnega polja in nižanja 
vsiljene transmembranske napetosti (Susil et al. 1998; Pucihar et al. 2007; Pavlin in Miklavčič 2009), 
prisotna sta krvni obtok in imunski sistem. Povezavo med celicami in tkivom lahko ponazorimo s 
tridimenzionalnimi numeričnimi modeli mrež okroglih celic (Pavlin et al. 2002; Ramos 2010). Simulacije 
so bile narejene za enako velike, popolnoma okrogle, pravilno razporejene in električno nepovezane celice, 
kar ni v skladu z dejanskimi razmerami v tkivu (Pucihar in Miklavčič 2009), obenem pa je bil največji 
prostorninski delež celic omejen na vrednosti, nižje od tistih v tkivih. Z numeričnim modeliranjem 
tridimenzionalnih okroglih različno velikih celic, naključno razporejenih po prostoru, lahko opišemo 
spremembo električne prevodnosti celične membrane in delež prepustnih celic (Essone Mezeme et al. 
2012b). S tridimenzionalnim modelom skupka posameznih celic različnih oblik lahko opišemo obnašanje 
lista špinače pri elektroporaciji (Dymek et al. 2015). V literaturi (Huclova et al. 2010; Huclova et al. 2011; 
Huclova et al. 2012) so celice in tkivo tudi modelirali v treh dimenzijah, model pa je opisal celice različnih 
oblik, velikosti in prostorninskih deležev. Lastnosti posameznih celic so nato posplošili na tkiva. V okviru 
doktorske disertacije smo model nadgradili z elektroporacijo, ki je že v nelinearnem območju odziva celic 
(Dermol-Černe in Miklavčič 2018).  
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Namen 
Namen doktorske disertacije lahko povzamemo v dveh točkah: 
1. optimizacija (fenomenoloških) matematičnih modelov, ki opisujejo prepustnost celične membrane, 
depolarizacijo in celično smrt;  
2. vključitev mehanizmov elektroporacije v modele sprememb električnih lastnosti tkiv in transporta 
v tkivih pri elektrokemoterapiji. 
V prvi točki smo prilegali različne obstoječe matematične modele povišane prepustnosti celične membrane 
in celične smrti na rezultate poskusov in vitro. Najprej smo se osredotočili na vprašanje, ali lahko iz deleža 
celic s prepustnimi membranami v homogenem električnem polju napovemo delež celic s prepustnimi 
membranami v nehomogenem električnem polju. Modelirali smo časovno dinamiko vnosa barvila v celice 
in ovrednotili povezavo med celjenjem celične membrane in vnosom barvila. Nato smo prešli na modele 
celične smrti. Naredili smo pregled obstoječih modelov celične smrti, pri čemer večina izhaja iz živilske 
industrije. Obstoječe modele celične smrti smo nato prilegali na rezultate poskusov, ki smo jih pridobili pri 
ireverzibilni elektroporaciji celic. Primerjali smo prepustnost in depolarizacijo vzdražnih in nevzdražnih 
celic ter oba pojava modelirali. 
V drugi točki smo se osredotočili na spremembe električnih lastnosti celic in tkiv ter povečanje vnosa snovi 
v celice. Modelirali smo spremembe električnih lastnosti kože pri elektroporaciji z dolgimi 
nizkonapetostnimi pulzi ali s kratkimi visokonapetostnimi pulzi. Ovrednotili smo prispevek nastanka in 
širjenja lokalnih transportnih območij v roženi plasti in nastanka por v membranah celic spodnjih plasti 
kože k povišanju električne prevodnosti kože. Preverili smo, ali lahko nastanek por na membranah celic v 
spodnjih plasteh kože izračunamo z asimptotskim modelom nastanka por in ali lahko nastanek lokalnih 
transportnih območij povežemo z obliko tokovnonapetostnih meritev. Modelirali smo transport cisplatina v 
podkožne tumorje na miših. Poskusi na živalih so zamudni, dragi, zaradi etičnih pomislekov pa lahko 
preizkusimo le omejeno število parametrov. Preverili smo, ali bi lahko rezultate poskusov in vitro uporabili 
za napoved odziva tkiv ter možnosti kasnejše uporabe pri načrtovanju posegov elektrokemoterapije. Ocenili 
smo, kako bližina celic, prisotnost celičnega matriksa in zmanjšana površina celične membrane, ki je na 
voljo za transport, vplivajo na vnos cisplatina v celice.  
  
15
Razširjen povzetek v slovenskem jeziku - Rezultati in razprava 
 
Rezultati in razprava 
V tem podpoglavju so na kratko povzeti vsi rezultati, pridobljeni v okviru doktorske disertacije. Razdeljeni 
so skladno s tremi izvirnimi znanstvenimi prispevki: 1. Matematično modeliranje prepustnosti celične  
membrane in celične smrti; 2. Prehod modeliranja z nivoja ene same celice na nivo tkiv, pri čemer je 
predstavljen realističen tridimenzionalen model kože nadgrajen z modelom elektroporacije vseh sestavnih 
delov in bistvenih plasti in 3. Matematično modeliranje transporta molekul (kemoterapevtika) skozi celično 
membrano na osnovi modela dvojne poroznosti. O rezultatih tudi razpravljam, na kratko pa so pri vsakem 
prispevku opisane še metode. 
Želimo si, da bi lahko celostno predstavili pojav elektroporacije ter z modeli opisali dogajanje na več 
ravneh (lipidni dvosloj, celice, tkiva) pri več procesih (spremembi električnih lastnost, transportu). Začeli 
smo z matematičnimi modeli prepustnosti celične membrane in celične smrti, časovne dinamike vnosa 
barvila v celice in intenzivnostno-časovne krivulje vzdražnih tkiv. Modeli so sicer dobro opisali rezultate, 
niso pa vključevali mehanizmov elektroporacije. Zato smo se namesto na fenomenološke modele 
osredotočili na vključevanje mehanizmov elektroporacije v modele tkiv pri spremembi njihovih električnih 
lastnosti ter pri transportu majhnih molekul v tkivu in skozi celične membrane po elektroporaciji.  
Matematični modeli prepustnosti celične membrane, celične smrti in depolarizacije 
V okviru doktorske disertacije smo se ukvarjali z matematičnimi modeli prepustnosti celične membrane 
(Dermol 2014; Dermol in Miklavčič 2014; Dermol et al. 2016), celične smrti (Dermol in Miklavčič 2015; 
Dermol in Miklavčič 2016) in depolarizacije (Dermol-Černe et al. 2018). V literaturi smo poiskali že 
obstoječe matematične modele in jih prilegali na rezultate poskusov. 
Matematični modeli prepustnosti celične membrane 
Povišanje prepustnosti celične membrane smo modelirali s štirimi različnimi modeli. Simetrična sigmoida 
(Puc et al. 2003) in hiperbolični tangens (Essone Mezeme et al. 2012b) sta bila v literaturi že uporabljena, 
na podlagi primerne sigmoidne oblike pa smo dodali asimetrično sigmoido in Gompertzovo krivuljo (Laird 
1964; Dermol in Miklavčič 2014). Matematične modele prepustnosti celične membrane smo optimizirali in 
primerjali z rezultati poskusov. Poskuse smo izvajali na celični liniji CHO-K1 (jajčne celice samice 
kitajskega hrčka). Uporabili smo dva tipa elektrod – paralelne žične (slika 3a) pri poskusih v homogenem 
električnem polju in igelne (slika 3b) pri poskusih v nehomogenem električnem polju. Električno polje med 
paralelnimi žičnimi elektrodami smo v približku izračunali kot dovedeno napetost, deljeno z razdaljo med 
elektrodami (Sweeney et al. 2016), električno polje okoli igelnih elektrod pa smo izračunali numerično. 
Pritrjene celice različnih gostot smo v rastnem mediju v prisotnosti fluorescentnega barvila propidijev jodid 
izpostavili enemu 1 ms pulzu pri različnih napetostih. Pet minut po dovedenih električnih pulzih smo rastni 
medij s propidijevim jodidom zamenjali z rastnim medijem brez propidijevega jodida, s tem zaustavili vnos 
barvila v celice in zajeli slike pod mikroskopom.  
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Slika 3: a) Paralelne žične elektrode, med katerimi je električno polje približno homogeno in b) igelne 
elektrode, okoli katerih smo električno polje izračunali numerično. Povzeto po (Dermol in Miklavčič 2014). 
Najprej smo določili delež celic s prepustnimi membranami, izpostavljenih homogenemu električnemu 
polju. Na rezultate poskusov smo z metodo najmanjših kvadratov prilegali štiri matematične modele 
prepustnosti celične membrane v odvisnosti od električnega polja. Optimizirane modele smo vstavili v 
numerični model igelnih elektrod in z numerično izračunanim električnim poljem okoli igelnih elektrod 
določili deleže prepustnih celic v posameznih območjih (slika 4). Predvidene deleže prepustnih celic v 
posameznih območjih smo primerjali s preštetimi deleži. Ugotovili smo, da se mora za pravilno napoved 
deleža prepustnih celic gostota celic v nehomogenem in v homogenem električnem polju ujemati - gostota 
celic mora biti torej enaka v poskusih, na katerih model optimiziramo, in v poskusih, kjer odziv 
napovedujemo. Primer prostorsko odvisne verjetnosti za prepustnost celic okoli igelnih elektrod lahko 
vidimo na sliki 5. Matematične modele prepustnosti celične membrane bi torej lahko uporabili v 
načrtovanju posegov, kjer bi namesto električnega polja v tkivu predstavili verjetnost za prepustnost tkiva v 
odvisnosti od geometrije elektrod in parametrov električnih pulzov.  
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Slika 4: a) Fazno-kontrastna in b) fluorescentna slika območja okoli igelnih elektrod, kjer so bile celice 
izpostavljene nehomogenemu električnemu polju. Območje okoli elektrod smo primerjali z c in d) 
numerično izračunanim električnim poljem in določili število prepustnih celic znotraj določenih območij 
električnega polja. Povzeto po (Dermol in Miklavčič 2014). 
 
Slika 5: Verjetnost za prepustnost (p) okoli igelnih elektrod pri izpostavitvi celice enemu 1 ms pulzu pri 
napetosti 120 V. Prehod iz numerično izračunanega električnega polja v verjetnost za prepustnost celične 
membrane je bil narejen z Gompertzovo krivuljo. Povzeto po (Dermol in Miklavčič 2014). 
V drugi študiji (Dermol et al. 2016) smo se ukvarjali z modeliranjem vnosa barvila v celice v odvisnosti od 
časa. Osredotočili smo se na pojav povišanja občutljivosti celic na električne pulze (angl. 
electrosensitization). V literaturi lahko zasledimo opažanja, da obstaja razlika v celični smrti, če dovedemo 
električne pulze v enem vlaku ali če vlak razdelimo na več delov, med njimi pa počakamo več minut 
(Pakhomova et al. 2011; Pakhomova et al. 2013a; Jiang et al. 2014; Jiang et al. 2015b; Muratori et al. 2016; 
Muratori et al. 2017). Shema dovajanja pulzov v obliki enotnega ali razdeljenega vlaka je prikazana na sliki 
6. Premor med posameznimi vlaki pulzov je po poročilih v literaturi bistveno povišal celično smrt pri enaki 
dovedeni energiji. S tem se je povišala učinkovitost zdravljenja, kar bi lahko imelo pozitivne učinke tudi pri 
medicinskih posegih z elektroporacijo. 
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Slika 6: Shema dovajanja pulzov. Levo je enotni vlak, kjer so bili naenkrat dovedeni vsi pulzi. Desno je 
razdeljeni vlak, kjer so bili najprej dovedeni štirje pulzi, po 1 do 3 minutnem premoru pa še štirje pulzi. 
Povzeto po (Dermol et al. 2016). 
Preverjali smo, če je pojav povišanja občutljivosti celic odvisen tudi od sestave elektroporacijskega pufra, 
t. j. tekočine, v kateri so elektroporirane celice. Poskuse smo izvajali na suspenziji celic CHO-K1. Pod 
mikroskopom smo zajemali slike pred dovedenimi električnimi pulzi in 8 minut za njimi. Uporabili smo 
paralelne žične elektrode, prikazane na sliki 3a. Celice smo električnim pulzom izpostavili v štirih različnih 
elektroporacijskih pufrih, ki so se razlikovali v električni prevodnosti, osmolalnosti, koncentraciji saharoze 
in kalcija. Dovedli smo enotni ali razdeljeni vlak električnih pulzov ter analizirali prispevek prvega in 
drugega vlaka električnih pulzov. Časovno dinamiko smo modelirali s fenomenološkim modelom prvega 
reda. Časovni potek vnosa barvila je shematično prikazan na sliki 7, kjer so napisane tudi enačbe, ki smo jih 
uporabljali za opis dinamike vnosa barvila v celice, obenem pa so na sliki razloženi tudi parametri enačb. 
Ugotovili smo, da lahko iz rezultatov vnosa barvil v molekule sklepamo tudi na celjenje celične membrane. 
S pomočjo merjenja časovne dinamike vstopa fluorescentnega barvila propidijev jodid smo ugotovili, da 
ima pufer, v katerem celice izpostavimo električnim pulzom, velik vpliv. Sklepali smo, da je povišanje 
občutljivosti celic posledica skupnega delovanja več procesov ter ni splošno prisoten pojav. Za točno 
določitev mehanizmov povišanja občutljivosti celic so potrebne nadaljnje študije. 
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Slika 7: Dinamika zapiranja por je bila modelirana s kinetičnim modelom prvega reda. Na sliki lahko 
vidimo, kako sta bila posebej analizirana prispevek prvega in drugega vlaka pulzov. Povzeto po (Dermol et 
al. 2016).  
Matematični modeli preživetja celic 
Ukvarjali smo se tudi z matematičnimi modeli celične smrti. Matematičnih modelov celične smrti poznamo 
veliko, saj jih rutinsko uporabljajo za napoved učinkovitosti pasterizacije in sterilizacije v živilski industriji. 
Pri načrtovanju medicinskih posegov elektroporacije matematični modeli niso razširjeni – trenutno 
uporabljamo deterministično kritično vrednost za določanje meje med uničenim in nedotaknjenim tkivom.  
Modele smo prilegali na rezultate poskusov. Naredili smo poskuse na celični suspenziji CHO-K1 v nizko 
prevodnem kalijevem pufru. Kapljico celične suspenzije smo prenesli med jeklene paralelne elektrode 
(slika 8) in jih izpostavili električnim pulzom podobnih parametrov, kot jih uporabljajo pri zdravljenju tkiv 
z ireverzibilno elektroporacijo (do 90 pulzov dolžine 100 μs, dovedenih s ponavljalno frekvenco 1 Hz pri 
električnih poljih do 4 kV/cm). Celično smrt smo ovrednotili s testom klonogenosti (Franken et al. 2006), 
kjer smo po elektroporaciji v petrijevke nasadili celice v nizki gostoti. V šestih dneh so celice ustvarile 
kolonije, ki smo jih nato fiksirali, obarvali, prešteli ter določili delež preživelih celic. 
Slika 8: Jeklene paralelne elektrode, ki so bile uporabljene v poskusih. Med elektrode smo prenesli kapljico 
celične suspenzije ter jo izpostavili električnim pulzom. 
Ovrednotili smo več modelov celične smrti – kinetični model prvega reda, Hülshgerjev, Peleg-Fermijev, 
Weibullov, logistični, prilagojen Gompertzov in Geeraerdov model. Ugotovili smo, da je najbolj primeren 
Peleg-Fermijev model, ki je dobro opisal rezultate poskusov in vključeval dve neodvisni spremenljivki – 
električno polje in število pulzov. V nasprotju z njim so ostali modeli vključevali le eno neodvisno 
spremenljivko – ali čas izpostavitve (število pulzov zmnoženo z njihovim trajanjem) ali električno polje 
med elektrodami. Na sliki 9 lahko vidimo rezultate poskusov in modele, ki smo jih prilegali na te podatke. 
Vidimo lahko, da se uporabljeni modeli različno približajo rezultatom poskusov, parameter R2, napisan 
poleg modela, pa nam pove še, kako dober je model v opisu podatkov. Bolj kot se vrednost R2 približa 1, 
boljše je prileganje. 
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Slika 9: Modeli celične smrti (Weibullov, Peleg-Fermijev, prilagojen Gompertzov, logistični, kinetični 
model prvega reda, Geeraerdov), s katerimi smo opisali rezultate poskusov celične smrti. Na sliki a so 
modeli v odvisnosti od dovedenega električnega polja, na sliki b pa od zmnožka števila pulzov in njihovega 
trajanja. Povzeto po (Dermol in Miklavčič 2015). 
Ugotovili smo, da bi bili matematični modeli prepustnosti celične membrane in celične smrti lahko 
uporabni v načrtovanju posegov. Dobra lastnost teh modelov je, da jih hitro prilegamo na rezultate 
poskusov, vrednosti med točkami lahko interpoliramo. Slabost modelov je, da jih je potrebno optimizirati 
za vsak tip celic posebej, prenosljivost na tkiva pa je vprašljiva. 
Modeliranje depolarizacije celic 
Pri načrtovanju medicinskih posegov z elektroporacijo je smiselno upoštevali tudi vzdražnost tkiv. V 
primeru proženja akcijskega potenciala mišic in živcev pride do neželenega krčenja mišic in bolečine. 
Ugotavljali smo: 1. ali se vzdražna in nevzdražna tkiva na elektroporacijo odzivajo enako, 2. ali lahko z 
elektroporacijo zdravimo tumorje osrednjega živčnega sistema in 3. ali so lastnosti vzdražnih tkiv po 
elektroporaciji spremenjene. Več študij je sicer pokazalo, da so bili učinki elektroporacije na vzdražna tkiva 
le kratkoročni – tkiva so si opomogla fiziološko, histološko in funkcionalno (Onik et al. 2007; Li et al. 
2011; Schoellnast et al. 2011; Jiang et al. 2014; Tschon et al. 2015; Casciola et al. 2017).  
S poskusi in modeliranjem smo ovrednotili depolarizacijo in elektroporacijo štirih različnih celičnih linij – 
nevzdražne celične linije CHO-K1, nevzdražne celične linije U-87 MG (človeški glioblastom), nevzdražne 
nediferencirane celične linije HT22 (mišji nevroni iz hipokampusa) in vzdražne diferencirane celične linije 
HT22. Depolarizacija pomeni povišanje transmembranske napetosti, do katere lahko pride tako na 
vzdražnih kot na nevzdražnih celicah, ko jih izpostavimo zunanjemu električnemu polju. Če presežemo 
pragovno vrednost transmembranske napetosti, pri vzdražnih celicah pride do proženja akcijskega 
potenciala. 
Najprej smo s poskusi določili depolarizacijsko (za nevzdražne) oz. vzdražnostno (za vzdražne celice) 
intenzivnostno-časovno krivuljo za en pulz dolžine od 10 ns do 10 ms. Za določanje depolarizacije smo 
uporabljali fluorescentno barvilo (Baxter et al. 2002). Barvilo je v začetku v zunajceličnem prostoru, po 
povišanju transmembranske napetosti pa lahko preide v notranjost celice in povzroči v njej dvig signala. 
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Intenzivnostno-časovno krivuljo vzdražnih celic smo opisali z dvema modeloma – s fenomenološko 
Lapicquevo krivuljo (Boinagrov et al. 2010) in Hodgkin-Huxleyjevim modelom (Santamaria in Bower 
2009; Boinagrov et al. 2010). Hodgkin-Huxleyjev model je sistem diferencialnih enačb, ki opisuje 
dinamiko odpiranja in zapiranja napetostno odvisnih kanalov. Akcijski potencial, modeliran s Hodgkin-
Huxleyjevim modelom, lahko vidimo na sliki 10. Ugotovili smo, da je primernejši Hodgkin-Huxleyjev 
model, čeprav bi morali za najboljši opis naših rezultatov njegove parametre optimizirati, kar bi bilo zaradi 
njihovega visokega števila težavno.  
Intenzivnostno-časovno krivuljo (slika 11) smo primerjali z rezultati poskusov elektroporacije po enem 
pulzu različnih dolžin (Pucihar et al. 2011). V isti študiji so rezultate poskusov modelirali s Saulisovim 
modelom (Pucihar et al. 2011). Dodali smo še modeliranje s časovno odvisno Schwannovo enačbo za 
eliptične celice v električnem polju (Kotnik et al. 1998; Kotnik in Miklavčič 2000b; Valič et al. 2003). Pri 
Schwannovi enačbi smo predpostavljali, da je kritična vsiljena transmembranska napetost enaka pri vseh 
dolžinah pulzov, kar ni nujno pravilno. Ugotovili smo, da elektroporacijo boljše opiše Saulisov model. 
 
Slika 10: Primer depolarizacije z akcijskim potencialom in brez njega pri modeliranju s Hodgkin-
Huxleyjevim modelom (Boinagrov et al. 2010). Modre in oranžne črte opisujejo napetost na katodnem in na 
anodnem polu celice. Po dovedenem pulzu se vidi le še oranžna črta, saj se z modro prekrivata. V primeru 
na sliki smo simulirali en 1 ms pulz tik pod pragom za proženje akcijskega potenciala in nad njim. 
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Slika 11: Intenzivnostno-časovna krivulja CHO, U-87 MG, nediferenciranih in diferenciranih HT22 celic. 
Intenzivnostno-časovno krivuljo smo modelirali z Lapicqueovo krivuljo in s Hodgkin-Huxleyjevim 
modelom. Prikazana je tudi prepustnostna krivulja CHO celic, pridobljena v okviru študije (Pucihar et al. 
2011) in modelirana s Saulisovim modelom in Schwannovo enačbo. Črne črte in y-os kažejo prepustnost 
celične membrane po enem pulzu. Sive črte in desna y-os kažejo depolarizacijo oz. akcijski potencial po 
enem pulzu. 
Zanimala nas je tudi elektroporacija nevzdražnih in vzdražnih celičnih linij, zato smo vse štiri celične linije 
izpostavili pulzom podobnih parametrov, kot se običajno uporabljajo pri elektrokemoterapiji – osem pulzov 
dolžine 100 μs, dovedenih s ponavljalno frekvenco 1 Hz. Vnos smo določali s fluorescentnim barvilom Yo-
Pro-1®. Merili smo časovno dinamiko vnosa barvila v celice, kot lahko vidimo na sliki 12. Iz časovne 
dinamike smo nato določili prepustnostno krivuljo, ki je prikazana na sliki 13a. S poskusi določene 
prepustnostne krivulje smo modelirali s simetrično sigmoido (Dermol in Miklavčič 2014), kar je prikazano 
na sliki 13b. 
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Slika 12: Časovna dinamika vnosa barvila Yo-Pro-1® v celice štirih celičnih linij. Dinamiko smo lahko 
opisali z modelom prvega reda. 
Slika 13: Povišanje prepustnosti membran štirih celičnih linij po dovedenih pulzih podobnih parametrov, 
kot se uporabljajo pri elektrokemoterapiji. S poskusi določene točke so na sliki a, optimizirana simetrična 
sigmoida pa na sliki b. 
Ugotovili smo, da je prag za depolarizacijo nevzdražnih celic nižji kot prag za depolarizacijo vzdražnih 
celic, kar lahko pojasnimo s tem, da imajo diferencirane celice, ki se ne delijo, nižjo mirovno 
transmembransko napetost (Levin in Stevenson 2012). Vse štiri celične linije so se podobno odzvale na 
elektroporacijo s pulzi podobnih parametrov, kot so uporabljeni pri elektrokemoterapiji. To nakazuje, da je 
elektroporacija primerna za zdravljenje vzdražnih tkiv. Naši rezultati kažejo, da je možno optimizirati 
parametre električnih pulzov tako, da dobimo čim višji vnos molekul v celice, obenem pa se izognemo 
proženju akcijskega potenciala. V prihodnosti bo potrebno določiti, če depolarizacija in vitro in vzdražnost 
korelirata s krčenjem mišic in bolečino in vivo. 
Prehod modeliranja z ravni ene same celice na raven tkiv z upoštevanjem njegove strukture  
Zaradi elektroporacije se spremenijo električne lastnosti celic in posledično tudi tkiv. Zgradili smo model 
kože, ki temelji na geometriji celic (keratinocitov, korneocitov) in lahko opiše spremembe električnih 
lastnosti kože med elektroporacijo. Elektroporacijo smo modelirali s spremembo prevodnosti kože z 
nastankom lokalnih transportnih območij v roženi plasti ter nastankom por na membranah celic spodnjih 
plasti kože. 
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Model je temeljil na rezultatih poskusov, pridobljenih v okviru že objavljene študije (Zorec et al. 2013a). 
Na kratko: v Franzevih difuzijskih celicah so pulzom izpostavili 350 μm debele kose prašičje kože z ušes. 
Elektrode so bile postavljene 0,2 cm nad kožo in 0,5 cm pod njo. Dovedli so dva različna protokola: dolge 
nizkonapetostne pulze (3x45 V dolžine 250 ms in 100 ms pavze med njimi) ali kratke visokonapetostne 
pulze (3x500 V dolžine 500 μs, 500 μs pavze med njimi). 350 μm debela koža je glede na model (Huclova 
et al. 2012) sestavljena iz štirih slojev – rožene plasti, epidermisa, papilarnega dermisa in žilne plasti.  
Naš model smo osnovali na že obstoječem modelu (Huclova et al. 2012), kjer so lastnosti posameznih 
slojev kože izračunane s pomočjo električnih in geometrijskih lastnosti posameznih celic. Tako kot v študiji 
(Huclova et al. 2012) smo električne lastnosti slojev z nizkim prostorninskim deležem celic izračunali s 
Hanai-Bruggemanovo formulo, ki sicer spada med t. i. enačbe mešanja. Lastnosti slojev z višjim 
prostorninskim deležem celic (nad 80%) smo izračunali z modelom enotske celice. Enotska celica je s 
kvadrom zunajcelične tekočine obdana biološka celica. Tri enotske celice, ki smo jih zgradili v okviru naše 
študije, so prikazane na sliki 14. Oblika biološke celice je bila opisana s pomočjo t. i. 'superformule' (Gielis 
2003). Biološki celici smo pripisali ustrezne električne lastnosti. Z velikostjo enotske celice smo spreminjali 
prostorninski delež celic v tkivu. Enotsko celico smo izpostavili sinusni napetosti različnih frekvenc v vseh 
treh smereh (x, y, z) in preko admitance izračunali frekvenčno odvisen kompleksni tenzor električnih 
lastnosti enotske celice (𝜀𝜀*̿). Posameznim plastem v homogenemu modelu kože smo pripisali izračunane 
električne lastnosti enotske celice in numerične izračune poenostavili na raven homogenih modelov tkiva. V 
primeru rožene plasti smo električne lastnosti izračunali preko korneocitov v enotski celici, pri epidermisu 
pa preko keratinocitov v enotski celici. Z izbranim modelom lahko modeliramo realistične oblike celic v 
visokih prostorninskih deležih, anizotropijo in heterogenost tkiv. V naši študiji smo v model vključili 
spremembe električnih lastnosti kože med elektroporacijo in model primerjali s tokovnonapetostnimi 
meritvami.  
Slika 14: Enotske celice, s katerimi smo predstavili (a) keratinocit, iz katerega smo nato izračunali lastnosti 
rožene plasti, (b) korneocit, iz katerega smo izračunali lastnosti epidermisa in (c) krogle lipidov v 
zunajcelični tekočini, iz katerih smo nato izračunali lastnosti papilarnega dermisa. Geometrija keratinocita 
in korneocita je bila zgrajena s 'superformulo' (Gielis 2003; Huclova et al. 2012), zaradi simetrije pa smo 
modelirali le eno osmino celice. Geometrija papilarnega dermisa so krogle v ploskovno centrirani mreži. 
Povzeto po (Dermol-Černe in Miklavčič 2018). 
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Pri elektroporaciji kože pride do dveh pojavov – v roženi plasti nastanejo lokalna transportna območja, na 
membranah celic spodnjih plasti pa pride do elektroporacije oz. nastanka por. Pri elektroporaciji kože z 
dolgimi nizkonapetostnimi pulzi se spreminja velikost lokalnih transportnih območij, saj okoli njih prihaja 
do topljenja lipidov zaradi Joulovega gretja. Spremembo velikosti lokalnih transportnih območij med 
nizkonapetostnimi pulzi smo prevzeli iz literature (Zorec et al. 2013a). Pri elektroporaciji s kratkimi 
visokonapetostnimi pulzi se poviša gostota lokalnih transportnih območij, njihova velikost pa se ne 
spreminja. Spremembo gostote lokalnih transportnih območij smo določili na podlagi najboljšega ujemanja 
s poskusi. Obenem smo z asimptotsko enačbo (Neu in Krassowska 1999; Neu in Neu 2009) izračunali 
gostoto por na membranah celic spodnjih plasti kože, pri čemer smo predpostavljali, da padec napetosti na 
koži lahko določimo, če kožo razumemo kot napetostni delilnik. Ekvivalentno vezje Franzeve difuzijske 
celice in kože v njej je prikazano na sliki 15. 
 
Slika 15: Shema, ekvivalentno vezje in fotografija Franzeve difuzijske celice. Na sliki (a) lahko vidimo, da 
je bila koža na obeh straneh obdana z elektroporacijskim pufrom, v katerega so bile vstavljene platinaste 
elektrode. V (b) ekvivalentnem vezju  so z upori so predstavljeni upornost stika kovina-elektrolit (Relektrode), 
elektroporacijski pufer (RPBS) in posamezne plasti kože (RSC – rožena plast, RE – epidermis, RPD – papilarni 
dermis, RUVP – žilna plast). Na sliki (c) lahko vidimo fotografijo Franzeve celice.  
Spremenjene električne lastnosti posameznih tkiv smo nato vstavili v numerični model Franzeve difuzijske 
celice ter modelirali tok skozi kožo in napetost na njej, če na elektrode dovedemo napetost, izmerjeno med 
poskusom na izhodu pulznega generatorja. Spreminjali smo gostoto transportnih območij, električno 
prevodnost transportnih območij in električno prevodnost spodnjih plasti kože, dokler nismo dosegli 
dobrega ujemanja s poskusi. Določili smo (lokalni) optimum parametrov. Zaradi visokega števila 
parametrov, ki jih v modelu lahko spreminjamo, in pomanjkanja meritev pri elektroporaciji kože, 
globalnega optimuma nismo mogli določiti. Za točno določitev vrednosti parametrov bi potrebovali več 
meritev, npr. električne lastnosti posameznih slojev pred elektroporacijo in po njej ter električno prevodnost 
lokalnih transportnih območij. 
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Ugotovili smo, da lahko dobro opišemo elektroporacijo z dolgimi nizkonapetostnimi pulzi, če upoštevamo 
širitev lokalnih transportnih območij, spremembo električne prevodnosti spodnjih plasti in polarizacijo 
elektrod. Izmerjeni in modelirani tok in napetost lahko vidimo na slikah 16a in 16b. Ujemanje modela in 
meritev pri elektroporaciji s kratkimi visokonapetostnimi pulzi je bilo slabše – napetost se je sicer dobro 
ujemala, a je model tok podcenjeval za približno 50%, kar lahko vidimo na slikah 16c in 16d. Razlog bi 
lahko bil v elektrokemijskih reakcijah, ki se dogajajo med elektroporacijo. Kemija pri visokonapetostnih 
pulzih je relativno neraziskano področje, obstaja le nekaj študij, ki se ukvarjajo z izpustom kovin iz elektrod 
(Kotnik et al. 2001; Roodenburg et al. 2005; Pataro et al. 2014) in z možnimi kemijskimi reakcijami, ki se 
dogajajo na elektrodah ali ob njih (Pataro et al. 2015a; Pataro et al. 2015b). Le redki modeli elektroporacije 
vključujejo elektrokemijo, npr. polarizacijo elektrod (Šel et al. 2003), čeprav je, kot se je izkazalo pri našem 
modelu, polarizacija elektrod bistveno zmanjšala napetost, dovedeno na kožo. 
 
Slika 16: Z modelom električnih lastnosti elektroporirane kože smo opisali tokovnonapetostne meritve pri 
dovajanju dolgih nizkonapetostnih pulzov in kratkih visokonapetostnih pulzov. Pri nizkonapetostnih pulzih 
smo dobro opisali meritve, pri visokonapetostnih pa je model podcenjeval izmerjeni električni tok. Pri 
visokonapetostnih pulzih so bili prisotni še drugi mehanizmi, kot so npr. elektrokemijske reakcije, ki jih v 
model nismo vključili. Povzeto po (Dermol-Černe in Miklavčič 2018). 
Naš model povezuje procese, ki se med elektroporacijo dogajajo na posamezni celici (nastanek por v celični 
membrani) in na plasti kože (nastanek lokalnih transportnih območij v roženi plasti), s tkivi (plasti kože) in 
celo z organi (koža). Z modelom lahko opišemo spremembe električnih lastnosti tkiv, pri čemer izhajamo iz 
mikrostrukture tkiva, obenem pa ostajajo numerični izračuni relativno hitri in preprosti. V prihodnosti bi v 
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model lahko vključili še termične pojave ali elektrokemijo. S tem lahko opišemo katero koli tkivo, če 
poznamo električne in geometrijske lastnosti osnovnih gradnikov tkiva.  
Modeliranje transporta molekul skozi celično membrano 
Pri zdravljenju tumorjev z elektrokemoterapijo je pomembno, da je v celotnem tumorju vzpostavljeno 
dovolj visoko električno polje (Miklavčič et al. 2006a), obenem pa mora biti v celicah dovolj molekul 
kemoterapevtika, da zagotovimo celično smrt (Tounekti et al. 1993; Tounekti et al. 2001; Miklavčič et al. 
2014). Pri načrtovanju posegov bi bilo torej smiselno modelirati tudi transport kemoterapevtika v tumorske 
celice. Modelirali smo transport cisplatina v tumorske celice pri elektrokemoterapiji tumorjev. Za to smo 
uporabili model dvojne poroznosti. Za postavitev modela smo izvedli poskuse in vitro, v sodelovanju z 
Onkološkim inštitutom pa tudi poskuse in vivo. Meritve mase platine so potekale v sodelovanju z 
Inštitutom Jožef Štefan. 
V študiji transporta majhnih molekul smo rezultate vnosa cisplatina v celice in vitro uporabili za opis 
transporta cisplatina v tumorjih in vivo. Celično suspenzijo mišjih melanomskih celic B16-F1 smo v 
rastnem mediju s serumom izpostavili 100 μs dolgim električnim pulzom s ponavljalno frekvenco 1 Hz. Z 
induktivno sklopljeno plazmo z masnim spektrometrom smo izmerili znotrajcelično maso platine. Najprej 
smo izvedli poskuse, pri katerih smo optimizirali protokol elektroporacije in vitro. Celice smo 
elektroporirali pri različnih zunajceličnih koncentracijah cisplatina in ugotovili, da je znotrajcelična masa 
platine linearno odvisna od zunajcelične koncentracije cisplatina (slika 17a). Zato smo nadaljnje poskuse 
izvedli pri 100 μM zunajcelični koncentraciji cisplatina, kar je dovolj visoka koncentracija, da smo lahko 
pri meritvah mase platine razlikovali med pulzi podobnih parametrov. Izmerili smo tudi dinamiko vnosa 
cisplatina v celice pri 100 μM zunajceličnem cisplatinu in ugotovili, da že 5 minut po pulzih dosežemo 
plato, zato smo vse nadaljnje poskuse izvajali z 10 minutno inkubacijo (slika 17b). Cisplatin se lahko veže 
na proteine v serumu in s tem postane biološko neaktiven (Takahashi et al. 1985). Celice smo 
elektroporirali s serumom ali brez njega in ugotovili, da v naših poskusih serum ni vplival na vnos 
cisplatina (slika 17c). Izmerili smo tudi celjenje membrane, tako da smo cisplatin dodali do 20 minut po 
pulzih. Celjenje por smo opisali z dinamiko prvega reda in izračunali, da je bila časovna konstanta celjenja 
por 2,29 minute. Po optimizaciji osnovnega protokola smo spreminjali število pulzov od 1 do 64 in 
električno polje od 0,4 kV/cm do 1,2 kV/cm. Maso znotrajcelične platine pri teh parametrih lahko vidimo 
na sliki 18. 
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Slika 17: Rezultati poskusov in vitro elektroporacije celic s cisplatinom. a) Znotrajcelična masa platine je 
bila linearno odvisna od zunajcelične koncentracije cisplatina. b) Vpliv časa inkubacije na znotrajcelično 
maso platine. Plato smo dosegli že 5 minut po dovedenih pulzih. c) Vpliv seruma na znotrajcelično maso 
platine. Ugotovili smo, da v 10 minutah po pulzih serum ne vpliva na vnos cisplatina. d) Po dovedenih 
električnih pulzih se je celična membrana celila z dinamiko prvega reda. 
Z modelom dvojne poroznosti (Mahnič-Kalamiza et al. 2014a; Mahnič-Kalamiza in Vorobiev 2014; 
Mahnič-Kalamiza et al. 2015; Mahnič-Kalamiza et al. 2017) smo izračunali koeficient prepustnosti celične 
membrane v odvisnosti od parametrov električnega polja. Obenem smo naredili poskuse in vivo, kjer smo v 
podkožni tumor B16-F10 intratumorsko vbrizgali cisplatin ter izmerili maso platine v serumu, celicah in 
intersticijski frakciji tik pred dovajanjem pulzov ter eno uro po končani terapiji. Zgradili smo numerični 
model tumorja ter z in vitro izračunanim koeficientom prepustnosti in difuzijsko konstanto cisplatina v 
intersticijski frakciji tumorja opisali maso platine v tumorjih in vivo. Opis je bil mogoč, če smo transport 
cisplatina po intersticijski frakciji zmanjšali s pomočjo transformacijskega koeficienta, s katerim smo 
upoštevali razlike v transportu in vitro ter in vivo. Pri transportu in vivo je zaradi bližine celic, visokega 
prostorninskega deleža celic ter prisotnosti celičnega matriksa na voljo manjša površina membrane, skozi 
katero lahko v celice pride cisplatin, otežena pa je tudi difuzija molekul po intersticijski frakciji. Obenem je 
zaradi visokega prostorninskega deleža in bližine celic zmanjšana tudi vsiljena transmembranska napetost 
na celicah. Prostorsko porazdelitev cisplatina eno uro po dovedenih pulzih, kar ustreza časovni točki, ko je 
bil tumor in vivo izrezan, lahko vidimo na sliki 19. Očitno je, da je prostorska porazdelitev koncentracije 
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cisplatina v tumorju nehomogena in se niža, ko se bližamo zunanjemu robu tumorja. V prihodnosti je 
potrebno še preveriti vpliv tipa tumorja in gostote celic v njem ter preveriti delovanje modela pri drugačnih 
parametrih električnega polja. Naš model ponuja korak naprej pri modeliranju transporta pri elektroporaciji 
na ravni tkiv, upoštevajoč transport na ravni ene celice. Z našim modelom bi lahko zmanjšali število 
poskusov in vivo ter bolj točno napovedali učinkovitost zdravljenja pri načrtih medicinskih posegov z 
elektroporacijo. 
Slika 18: Izmerjene znotrajcelične mase platine pri elektroporaciji celične suspenzije celic mišjega 
melanoma B16-F1. Vidimo lahko, da najvišji vnos dosežemo pri 8x100 μs pulzih pri 1,2 kV/cm.  
Slika 19: Modelirana porazdelitev a) znotrajcelične in b) zunajcelične koncentracije cisplatina v tumorju v 
mol/m3. Koncentracija obeh je najvišja v sredini tumorja, nato pa postopoma upada do roba tumorja, kjer 
je koncentracija 0 mol/m3. 
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Zaključek 
V doktorski disertaciji sem se ukvarjala z modeliranjem procesov pri elektroporaciji na ravni celic ter na 
ravni tkiv. Na ravni celičnih suspenzij ali posameznih celic in vitro je poskuse relativno lahko izvajati, 
preizkusimo lahko več parametrov brez etičnih pomislekov, ki se pojavijo pri izvajanju poskusov in vivo 
(Workman et al. 2010). Naš cilj je bil, da z rezultati poskusov in vitro modeliramo dogajanje med 
elektroporacijo in vivo in po njej . Modele, ki smo jih zgradili, bi lahko v prihodnosti vključili v načrtovanje 
medicinskih posegov z elektroporacijo. 
V prvem delu doktorske disertacije so opisani matematični modeli prepustnosti celične membrane in 
celične smrti. Ugotovili smo, da lahko s temi modeli dobro opišemo rezultate poskusov in vitro. Naše 
optimizirane modele celične smrti in vitro so že uporabili pri opisu ireverzibilne elektroporacije tkiv 
(Kranjc et al. 2017) in dosegli dobro ujemanje. V modelih celične smrti se z napovedjo približujemo 
preživetju 0, a ga nikoli ne dosežemo. Vprašanje je, kako nizko preživetje je potrebno zagotoviti, da 
uničimo tumor v celoti. Pri elektrokemoterapiji in pri netermičnem odstranjevanju tkiva z elektroporacijo 
preostale celice uniči imunski sistem (Neal et al. 2013; Serša et al. 2015). 
Analizirali smo časovni potek vnosa barvila v celice pri elektroporaciji, kar lahko modeliramo z modelom 
prvega reda, ki tudi ustreza dinamiki celjenja por v celični membrani. V več študijah so določali hitrost 
celjenja celične membrane po elektroporaciji in izmerili, da je v območju minut tako in vitro kot tudi in 
vivo (Kinosita in Tsong 1977; Saulis et al. 1991; Čemažar et al. 1998; Shirakashi et al. 2004; Kandušer et 
al. 2006; Demiryurek et al. 2015), kar se sklada z našimi rezultati.  
Pri elektroporaciji vzdražnih tkiv lahko pride do proženja akcijskega potenciala in krčenja mišic ter 
bolečine. S poskusi smo določili intenzivnostno-časovno krivuljo vzdražnih in nevzdražnih celičnih linij ter 
jo modelirali. V prihodnosti je potrebno ugotoviti, do kolikšne mere lahko iz in vitro depolarizacije in 
akcijskega potenciala napovemo krčenje mišic in bolečino in vivo. Pri uporabi intenzivnostno-časovnih 
krivulj za napovedovanje akcijskega potenciala v tkivih je potrebno upoštevati tudi, da nekaj časa po 
dovedenih pulzih tkivo ne zmore prožiti akcijskega potenciala. Izkazalo se je, da lahko elektroporacijski 
pulzi povzročijo škodo na membranskih proteinih, kot so napetostno odvisni kanali v celični membrani 
(Chen et al. 2006b; Azan et al. 2017). Čas odziva napetostno odvisnih kanalov je v okvirju milisekund 
(Gadsby 2009), kar je bistveno daljše kot nanosekundni pulzi. Vprašanje je torej, kako je sploh možno, da z 
nanosekundnimi pulzi prožimo akcijski potencial vzdražnih celic (Pakhomov et al. 2017).  
V okviru študije o vzdražnih tkivih smo opazili, da pri pulzih dolžine 1 μs depolarizacijska intenzivnostno-
časovna krivulja in krivulja prepustnosti po y-osi prideta zelo blizu skupaj. To opažanje je pomembno pri 
razlagi, zakaj s kratkimi bipolarnimi pulzi povzročimo prepustnost tkiv, obenem pa ne pride do vzdraženja. 
Pri 1 μs dosežemo namreč plato pri obeh intenzivnostno-časovnih krivuljah. Do podobnega zaključka so 
prišli v literaturi (Mercadal et al. 2017). Naši rezultati nakazujejo, da bi namesto s kratkimi bipolarnimi 
pulzi enak učinek dosegli s kratkimi monopolarnimi pulzi.  
V drugem delu doktorske disertacije smo modelirali spremembe električnih lastnosti kože med 
elektroporacijo z nastankom por v celičnih membranah ter z nastankom lokalnih transportnih območij v 
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roženi plasti. V prihodnosti je potrebno podoben model zgraditi še za druga tkiva (npr. jetra ali mišice) in ga 
primerjati s tokovnonapetostnimi meritvami med elektroporacijo. Nadgradnja modela bi lahko bila, da 
namesto asimptotske oblike enačbe por uporabimo enačbe, ki predvidevajo spremembe v premeru por 
(Smith et al. 2004), s čimer bi prevodnost posamezne plasti kože določili z mehanizmi elektroporacije in ne 
le z najboljšim ujemanjem z meritvami. Z modelom smo sicer dosegli dobro ujemanje z meritvami pri 
dolgih nizkonapetostnih pulzih, pri kratkih visokonapetostnih pulzih pa ne. Pri kratkih visokonapetostnih 
pulzih se je pojavila dodatna komponenta električnega toka, ki je nismo mogli pojasniti z nastankom 
lokalnih transportnih območij. Tudi če smo predpostavili, da je cela rožena plast eno samo veliko 
transportno območje, je bil tok skozi kožo prenizek, obenem pa je bil v tem primeru padec napetosti na koži 
zelo majhen zaradi nizke upornosti kože. Pri meritvah napetosti na koži so uporabljali tanke bakrene žice. 
Na vsako stran kože je bila dana ena žica, pri tem se je ustvarila visoko prevodna pot za električni tok, saj je 
baker bolj prevoden kot koža ali pufer, v katerem je bila koža. S tem bi se lahko električni tok lokalno 
povišal, obenem pa ne bi vplival na padec napetosti na celotni koži. Vsekakor je v prihodnosti potrebno 
ovrednotiti elektrokemijske reakcije, ki se odvijajo med dovajanjem visokonapetostnih pulzov. Vemo 
namreč, da pride do izhajanja kovin iz elektrod, spremeni se pH tekočine, opazen je nastanek mehurčkov, ki 
so lahko ali posledica lokalnega izparevanja vode ali kemijskih reakcij, kjer nastajajo plini.  
V model kože bi lahko vključili tudi termične vplive električnih pulzov. Zaradi Joulovega gretja se namreč 
poviša temperatura, z njo pa tudi električna prevodnost. Gretje je bilo v našem modelu vključeno posredno, 
z večanjem premera lokalnih transportnih območij, kar temelji na taljenju lipidov v roženi plasti. Morda bi 
v prihodnosti lahko v naš model vključili še model taljenja lipidov in nastanka lokalnih transportnih 
območij (Becker in Kuznetsov 2007; Becker 2012; Becker et al. 2014) – v našem modelu smo namreč 
velikosti lokalnih transportnih območij privzeli iz literature (Zorec et al. 2013a). 
V modelu smo vsiljeno transmembransko napetost na celicah v spodnjih plasteh kože ocenili tako, da smo 
kožo obravnavali kot napetostni delilnik. Upoštevali smo debelino posamezne plasti in geometrijo celice. 
Pri tem smo zanemarili vpliv bližine celic, ki zmanjšuje vsiljeno transmembransko napetost. Možno je, da 
smo precenili spremembo v električni prevodnosti spodnjih plasti kože, obenem pa podcenili prevodnost 
lokalnih transportnih območij, njihovo gostoto in velikost. Električna prevodnost posameznih plasti kože 
vpliva na porazdelitev električnega polja in obratno – s pomočjo te odvisnosti bi v model lahko vključili 
tudi napake. 
V tretjem delu doktorske disertacije smo se ukvarjali s transportom snovi po tkivih pri elektroporaciji. Naš 
model je veljaven za majhne molekule, podobne velikosti kot cisplatin (300 g/mol), kot so propidijev jodid, 
bleomicin, lucifer rumeno. Pokazalo se je, da večje molekule težje vstopajo preko celične membrane kot 
majhne molekule pri enakih parametrih električnih pulzov (Maček Lebar et al. 1998) že zaradi bistveno 
manjše difuzijske konstante večjih molekul po intersticijski frakciji tumorja. Pokazalo se je tudi, da večje 
molekule v celice vstopajo s pomočjo elektroforeze, manjše pa s pomočjo difuzije. Večje molekule (DNK) 
celično membrano prečkajo v več korakih, ki so opisani v literaturi (Rosazza et al. 2016). Predpostavili 
smo, da je ves transport difuzijski, kar pa ni nujno pravilno. Zaradi povišanega intersticijskega tlaka v 
tumorju (Baxter in Jain 1989; Boucher et al. 1990; Pušenjak in Miklavčič 2000) je povišan konvekcijski 
transport molekul iz njega, kar pomeni, da kemoterapevtik v tumor težko vstopi, ko je doveden sistemsko, 
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oziroma da ga iz tumorja hitro odnaša, ko je doveden intratumorsko. Obstoječe meritve konvekcijske 
hitrosti v tumorju se niso skladale z našimi meritvami mase platine v celicah pred pulzi in eno uro po njih – 
izračunali smo namreč, da bi iz tumorja ves cisplatin izginil v nekaj minutah. V prihodnosti bi bilo smiselno 
ovrednotiti konvekcijski transport v tumorjih, ki jih uporabljamo v okviru naše študije. Model smo trenutno 
preizkusili le na eni vrsti tumorja. Znano je, da se tumorji bistveno razlikujejo v prostorninskem deležu 
celic in matriksa (Mesojednik et al. 2007), kar seveda vpliva na difuzijsko konstanto molekul po tumorju ter 
na površino celičnih membran, skozi katere lahko poteka transport. V prihodnosti bi lahko ovrednotili naš 
model še na drugih tipih tumorjev in ugotovili, ali obstaja določena preslikava med morfologijo tumorja, 
koeficientom transformacije in transportom po tumorju. Možno je, da takšna transformacija obstaja – višji 
kot je prostorninski delež celic v tumorju, nižji je transport kemoterapevtika v celice in nižji je 
transformacijski koeficient. Obenem se zastavlja vprašanje, če je transformacijski koeficient odvisen tudi od 
parametrov električnega polja. Trenutno smo model preizkusili le pri osmih pulzih in eni dovedeni 
napetosti. Smiselno bi bilo poskuse in vivo narediti še pri drugačnih parametrih električnih pulzov. 
Pri intratumorskem dovajanju kemoterapevtika se izognemo običajni poti do celic v tumorju, ki jo mora 
kemoterapevtik preiti, če ga dovedemo sistemsko. Po sistemski administraciji mora namreč iz krvnih žil 
skozi žilne stene priti v okoliška tkiva (ali neposredno v tumorsko tkivo) in nato skozi intersticijsko frakcijo 
tumorja, kjer transport ovira višji intersticijski tlak v tumorju kot v okoliškem tkivu (Jain 1999; Jang et al. 
2003), prečkati celično membrano in priti v celice. Če bi naš model želeli uporabljati tudi pri sistemski 
administraciji kemoterapevtika, bi morali dodati še izračun začetne koncentracije kemoterapevtika v 
tumorju. Pri intratumorski injekciji smo namreč lahko utemeljeno predpostavili, da je v tumorju začetna 
koncentracija kemoterapevtika enaka vbrizgani koncentraciji in je homogeno porazdeljena po celem 
tumorju.  
V poskusih in vitro je bil cisplatin ali v celicah ali v zunajcelični tekočini. V poskusih in vivo smo vbrizgali 
80 μl cisplatina oz. 26 µg platine v 35 mm3 velike tumorje. Volumen injekcije je bil dvakrat večji kot 
volumen tumorja, ker smo uporabili že obstoječe rezultate iz literature (Uršič et al. 2018). V poskusih in 
vivo smo ugotovili, da je bilo 2 minuti po vbrizganju v tumorju in serumu le še 27% vbrizgane mase 
platine. Del cisplatina smo izgubili zaradi manjšega volumna tumorja od injiciranega volumna in zaradi 
izpiranja cisplatina iz tumorja. Če smo tumor izrezali eno uro po terapiji, je bilo vbrizgane mase platine v 
tumorju in v serumu 2% v kontrolnih vzorcih in 7% v elektroporiranih vzorcih. Del cisplatina smo izgubili 
pri mehanskem uničenju tumorja ter pri zbiranju krvi. Del cisplatina pa se je verjetno nabral v različnih 
organih, kar bi kasneje lahko povzročilo stranske učinke (Sancho-Martínez et al. 2012). V prihodnosti bi 
lahko ovrednotili, ali bi z vbrizganjem manjšega volumna cisplatina lahko ohranili enak učinek 
elektroporacije, obenem pa bi zmanjšali stranske učinke. Opaženo je bilo, da volumen vbrizganega kalcija 
ali virusov ni vplival na učinkovitost zdravljenja (Wang 2006; Frandsen et al. 2017). To lahko pojasnimo z 
našimi poskusi, pri katerih smo določali začetno koncentracijo cisplatina v tumorju. Čeprav se je pri 
vbrizganju izgubilo 70% vbrizganega cisplatina, je v tumorju ostal koncentrirani cisplatin, posledično pa je 
bil visok tudi koncentracijski gradient.  
V literaturi lahko najdemo podatke, koliko molekul bleomicina potrebujemo, da pride do celične smrti 
(Tounekti et al. 1993; Tounekti et al. 2001). Podobno analizo bi bilo potrebno narediti tudi s cisplatinom, 
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kar bi nam omogočilo optimizacijo parametrov zdravljenja za čim višjo znotrajcelično koncentracijo 
cisplatina. Z induktivno sklopljeno plazmo z masno spektrometrijo lahko zelo natančno izmerimo maso in 
posledično število molekul v celicah. Če obenem pod enakimi pogoji s testom klonogenosti določimo še 
preživetje celic, lahko sklepamo na število molekul cisplatina, potrebnih za celično smrt.  
Pri elektroporaciji lahko povišanje prevodnosti celične membrane in povišanje njene prepustnosti 
razumemo kot dva različna pojava (Miklavčič in Towhidi 2010; Leguèbe et al. 2014). Začetna ideja je bila, 
da bi ta pojava poskušali povezati in s spremembo električne prevodnosti celice napovedati prepustnost 
membrane, kar pa se je izkazalo za težko dosegljivo. Že pri začetnih poskusih smo namreč ugotovili, da pri 
isti prevodnosti zunajcelične tekočine, ki torej povzroči enako vsiljeno transmembransko napetost in enako 
gostoto por, dobimo bistveno drugačen vnos barvila v celico (Dermol et al. 2016). To torej nakazuje, da je 
elektroporacija bolj kompleksna in da samo nastanek por ne določa transporta v celice. Vseeno bi bilo v 
prihodnosti zanimivo ugotoviti, ali je povezava električne prevodnosti ter prepustnosti celične membrane 
možna in ali je prepustnost v večji meri določena z biološkimi procesi na celični membrani. Električna 
prevodnost celične membrane se namreč relativno hitro zmanjša, medtem ko transport poteka še več minut 
po dovedenih pulzih. Pri nanosekundnih pulzih so sicer ugotovili, da še nekaj časa po pulzih električna 
prevodnost celične membrane ostaja rahlo povišana (Pakhomov et al. 2007) in da trajanje povišane 
prevodnosti korelira s trajanjem transporta preko celične membrane. Druga razlaga podaljšanega transporta 
je, da električni pulzi povzročijo oksidacijo membrane, kar poruši urejenost lipidnega dvosloja in poveča 
prepustnost celične membrane (Benov et al. 1994; Gabriel in Teissié 1995; Maccarrone et al. 1995; 
Pakhomova et al. 2012). 
Eden izmed problemov obstoječih modelov elektroporacije je pomanjkanje meritev, npr. nastanka in 
širjenja lokalnih transportnih območij v koži, električnih lastnosti posameznih tkiv med elektroporacijo v 
odvisnosti od parametrov električnih pulzov, prevodnosti lokalnih transportnih območij, konvekcijskega 
transporta v tumorjih, prostorske porazdelitve cisplatina v tumorjih pred elektroporacijo in po njej, vezavo 
cisplatina in vivo. Obstoječi modeli so namreč zelo kompleksni in vsebujejo veliko število parametrov, 
katerih vrednosti so v večini primerov le ocenjene na velikostni razred. Z optimizacijo parametrov modelov 
lahko torej najdemo več lokalnih minimumov, ne pa nujno globalnega, kot smo ugotovili v naši študiji 
(Dermol-Černe in Miklavčič 2018). Že pri sami geometriji lokalnih transportnih območij, ki nastanejo pri 
elektroporaciji, se vrednosti iz literature razlikujejo. Velikosti lokalnih transportnih območij se razlikujejo 
za več velikostnih razredov – od 10 μm do več sto mikrometrov (Pliquett et al. 1996; Pliquett et al. 1998; 
Gowrishankar et al. 1999a; Vanbever et al. 1999; Pavšelj in Miklavčič 2008a), primanjkuje pa meritev 
časovne dinamike širjenja por. 
V prihodnosti bi modele, ki smo jih predstavili v tej disertaciji, lahko vpeljali v načrtovanje medicinskih 
posegov elektroporacije. Trenutno parametre zdravljenja optimiziramo tako, da zagotovimo, da je celoten 
tumor pokrit z dovolj visokim električnim poljem, okoliško tkivo pa je nepoškodovano. V začetku bi lahko 
najprej vpeljali matematične modele prepustnosti celične membrane in celične smrti, nato bi vključili 
modele transporta, s katerimi bi izračunali doseženo znotrajcelično koncentracijo kemoterapevtika oziroma 
točno število molekul znotraj posameznih celic. Lahko bi tudi zmanjšali krčenje mišic in bolečino, kar bi 
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skrajšalo in poenostavilo zdravljenje. Z vključitvijo meritev električnega polja v tkivu (Kranjc et al. 2014; 
Kranjc et al. 2015) pa bi se dalo odziv zdravljenja napovedati še bolj točno. 
Matematično modeliranje procesov med elektroporacijo ima vsekakor prihodnost. Menim, da opis procesa z 
modelom olajša naše razumevanje. Uporaba modelov nam omogoča, da rezultate interpoliramo, saj 
izvajanje nešteto poskusov vseh možnih kombinacij ni smiselno tako s časovnega kot tudi s finančnega 
vidika. V okviru doktorske disertacije sem odgovorila na večino vprašanj, ki sem si jih postavila na začetku 
dela. Med delom pa so se porodila številna nova vprašanja, na katera je v prihodnosti vredno poiskati 
odgovor. 
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Izvirni prispevki k znanosti 
V doktorski disertaciji so naslovljeni trije izvirni prispevki k znanosti. 
Matematično modeliranje prepustnosti celične membrane in celične smrti  
Z matematičnim modeliranjem lahko opišemo verjetnost za prepustnost ali celično smrti na ravni tkiv. 
Naredili smo pregled modelov prepustnosti celične membrane s področja elektroporacije evkariontskih 
celic in modelov celične smrti s področja elektroporacije evkariontskih in prokariontskih celic. Obstoječi 
modeli so večinoma izbrani na podlagi najboljšega ujemanja z rezultati poskusov in ne izhajajo iz 
mehanizmov elektroporacije. Parametre naših izbranih modelov smo določili s pomočjo rezultatov 
poskusov in vitro. Enostaven prenos optimiziranih modelov z ravni celic na tkiva ni mogoč. Ker moramo za 
vsako vrsto tkiva in vsako skupino električnih parametrov posebej optimizirati matematične modele, je 
njihova napovedna moč omejena.  
Prehod modeliranja z nivoja ene same celice na nivo tkiv, pri čemer je predstavljen realističen 
tridimenzionalen model kože nadgrajen z modelom elektroporacije vseh bistvenih delov in sestavnih 
plasti 
Elektroporacija celic in tkiv spremeni njihove električne lastnosti. V okviru doktorske disertacije smo 
modelirali časovno odvisno spremembo električne prevodnosti posameznih celic v koži – korneocitov, 
keratinocitov, papilarnega dermisa. Modelirali smo nastanek lokalnih transportnih območij v roženi plasti in 
nastanek por na celicah v spodnjih plasteh kože. Iz električnih lastnosti celic smo izračunali enakovredne 
električne lastnosti plasti kože – rožene plasti, epidermisa, papilarnega dermisa in žilne plasti. Naše 
izračune smo primerjali s tokovnonapetostnimi meritvami med elektroporacijo kože. Z našo metodo lahko 
modeliramo električne lastnosti med elektroporacijo katerih koli celic in tkiv. Edini pogoj je, da poznamo 
geometrijo celice ter električne lastnosti znotrajcelične tekočine, celične membrane in zunajceličnega 
prostora.  
Matematično modeliranje transporta molekul (kemoterapevtika) skozi celično membrano na osnovi 
modela dvojne poroznosti 
Za učinkovito elektrokemoterapijo je nujen vnos zadostne količine kemoterapevtika v celice. V načrtovanju 
posegov ob uporabi kritičnega električnega polja izračunamo, ali bo določeno območje uničeno ali ne, pri 
tem pa ne upoštevamo transporta kemoterapevtika v tumorske celice. V okviru tretjega izvirnega prispevka 
smo modelirali transport pri elektroporaciji tumorjev. Z modelom dvojne poroznosti smo izračunali in vitro 
koeficiente prepustnosti celične membrane v odvisnosti od parametrov električnega polja. Model dvojne 
poroznosti z diferencialnimi enačbami opiše difuzijo majhnih molekul topljenca skozi celično membrano in 
v tkivu. V numeričnem modelu tumorja smo s koeficientom prepustnosti izračunali transport po tumorju pri 
elektrokemoterapiji in model primerjali z rezultati vnosa cisplatina v podkožne tumorje na miših. Model je 
dobro opisal rezultate poskusov, če smo vanj vključili še koeficient transformacije, s katerim smo 
upoštevali razlike v mobilnosti majhnih molekul in vitro ter in vivo. V prihodnosti bi model lahko uporabili 
v načrtovanju posegov elektroporacije, kjer bi tako povišali natančnost napovedi celične smrti. 
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Introduction 
Electroporation – mechanisms, and use 
When short high voltage pulses are applied to cells and tissues, plasma membrane becomes transiently 
permeable to molecules which otherwise cannot freely pass in or out of the cell (Tsong 1991; Weaver 1993; 
Kotnik et al. 2012; Rems and Miklavčič 2016; Rems and Miklavčič 2016). The phenomenon is called 
electroporation as pores are presumably formed in the cell membrane (Abidor et al. 1979). After 
electroporation, pores can reseal, and cells recover – we consider this reversible electroporation. If the 
damage to the cell membrane is too extensive or if the homeostasis is severely altered, cells die - we 
consider this irreversible electroporation (Jiang et al. 2015a). Electroporation or pulsed electric field 
treatment is used in biotechnology (Haberl et al. 2013a; Haberl et al. 2013b; Mahnič-Kalamiza et al. 2014b; 
Kotnik et al. 2015), food-processing (Toepfl et al. 2014; Mahnič-Kalamiza et al. 2014b; Blahovec et al. 
2017) and medicine (Yarmush et al. 2014). In medicine, it is used in gene electrotransfer (Daud et al. 2008; 
Heller and Heller 2015), DNA vaccination (Vasan et al. 2011; Gothelf and Gehl 2012; Calvet et al. 2014; 
Trimble et al. 2015), transdermal drug delivery (Denet et al. 2004; Zorec et al. 2013b), irreversible 
electroporation as a soft tissue ablation technique (Davalos et al. 2005; Garcia et al. 2010; Deodhar et al. 
2011b; José et al. 2012; Cannon et al. 2013; Scheffer et al. 2014a; Jiang et al. 2015a; Ting et al. 2016; Lyu 
et al. 2017) and electrochemotherapy (Mali et al. 2013; Miklavčič et al. 2014; Edhemović et al. 2014; 
Campana et al. 2014; Mali et al. 2015; Gasbarrini et al. 2015; Bianchi et al. 2016).  
Treatment planning of electrochemotherapy and ablation with irreversible 
electroporation 
When treating tissues with electroporation-based medical treatments, we can use predefined electrode 
geometries and pulse parameters (Marty et al. 2006; Mir et al. 2006). When tumors are outside the target 
parameters, variable electrode geometry can be used. In this case, electrode geometry and pulse parameters 
have to be defined for each treatment separately (Kos et al. 2010; Miklavčič et al. 2010; Pavliha et al. 2012; 
Linnert et al. 2012; Edhemović et al. 2014). This is done in the process called treatment planning, when 
tumour geometry is extracted from medical images (Pavliha et al. 2013), and position and number of 
electrodes and electric pulse parameters are optimized to cover a tumour with a sufficiently high electric 
field for reversible or irreversible electroporation (Miklavčič et al. 2006a), depending on the chosen 
treatment. Simplifications done in the process and addressed in this thesis are the following.  
1) For each tissue type, the critical electric field for permeabilization or cell death used in the 
treatment planning was experimentally determined (Šel et al. 2005; Čorović et al. 2012). However, in 
reality, the transition from non-permeable to permeable cells and from alive to dead is continuous and 
should be described with appropriate continuous function.  
2) A possible upgrade of treatment plans is also taking into account excitability of tissues. In 
electroporation-based medical treatments, also excitable tissues are treated, either intentionally for example 
in irreversible electroporation of brain cancer (Salford et al. 1993; Agerholm-Larsen et al. 2011; Linnert et 
al. 2012; Garcia et al. 2012), gene electrotransfer (Hargrave et al. 2013; Hargrave et al. 2014; Bulysheva et 
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al. 2016) or ablation of the heart muscle (Lavee et al. 2007; Neven et al. 2014b; Neven et al. 2014a), and 
gene electrotransfer of skeletal muscles (Aihara and Miyazaki 1998; Heller and Heller 2015), or 
unintentionally when excitable tissues are in the vicinity of the target treated area. Unintentionally, we can 
affect the neurovascular bundle (Neal et al. 2014; Ting et al. 2016) when treating prostate cancer, neurons 
when treating bone metastases (Tschon et al. 2015; Gasbarrini et al. 2015) or spinal cord when treating 
tumors in the spine (Tschon et al. 2015). One of the main drawbacks to the treatment of tissues with pulsed 
electric fields is the discomfort and pain associated with repeated electrical stimulation (Miklavčič et al. 
2005; Županič et al. 2007; Arena and Davalos 2012; Golberg and Rubinsky 2012), the need to administer 
muscle relaxants and anaesthesia (Ball et al. 2010) and synchronization with the electrocardiogram (Mali et 
al. 2008; Deodhar et al. 2011a; Mali et al. 2015). The neurons responsible for pain sensation (nociceptors) 
can be stimulated by electric pulses (Nene et al. 2006; Jiang and Cooper 2011). An important advance of 
the treatment would be to determine a point at which maximum permeability of the membrane could be 
achieved while minimizing excitation of the exposed excitable tissues. 
3) During the delivery of electric pulses, the electric conductivity of tissues increases, which is in 
treatment planning described by a phenomenological sigmoid function (Šel et al. 2005; Ivorra et al. 2009; 
Essone Mezeme et al. 2012a; Neal et al. 2012). Another possibility to model change in electric conductivity 
is to model change in tissues’ dielectric properties by including the electroporation mechanisms, for 
example, pore formation. When electric pulses are delivered to the skin, also local transport region 
formation could be included in the model. In this way, instead of an experimentally determined change in 
conductivity of tissues, we could model and predict it based on the parameters of the delivered pulses. 
4) In the treatment planning of electrochemotherapy, we assume that in tumors electric field above 
0.4 kV/cm has to be achieved to permeabilize cells. The treatment plan does not take into account transport 
of chemotherapeutics. However, the above-critical electric field does not guarantee transport. In 
electrochemotherapy with bleomycin, cell death occurs due to the influx of bleomycin in the cell and 
consequent DNA breakage (Tounekti et al. 1993; Tounekti et al. 2001).  
Dielectric properties of electroporated cells 
Electroporation changes dielectric properties of cell membranes of single cells. We can assess this change 
with dielectric impedance spectroscopy (Abidor et al. 1993; Schmeer et al. 2004), current-voltage 
measurements (Pliquett and Wunderlich 1983; Pavlin et al. 2005; Pavlin and Miklavčič 2008; Suzuki et al. 
2011), optical methods (Hibino et al. 1991; Griese et al. 2002) or patch clamp (Pakhomov et al. 2007; 
Wegner 2015; Yoon et al. 2016; Napotnik and Miklavčič 2017). Electroporation also increases electric 
conductivity of cell monolayers (Ghosh et al. 1993; Müller et al. 2003; Stolwijk et al. 2011; García-Sánchez 
et al. 2015). Similar measurements were employed in electroporation of tissues. Dielectric properties of 
human, animal and plant tissues can be measured by dielectric spectroscopy (Barnes and Greenebaum 
2006; Ivorra and Rubinsky 2007; Grimnes and Martinsen 2008; Dean et al. 2008; Zhuang et al. 2012; 
Dymek et al. 2014; Dymek et al. 2014; Trainito et al. 2015; Zhuang and Kolb 2015), current-voltage 
measurements during electroporation (Pavlin et al. 2005; Cukjati et al. 2007; Ivorra and Rubinsky 2007; 
Pavlin and Miklavčič 2008; Ivorra et al. 2009; Chalermchat et al. 2010; Neal et al. 2012; Becker et al. 2014; 
Dymek et al. 2015; Dymek et al. 2015), electric impedance tomography (Davalos et al. 2002; Davalos et al. 
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2004; Granot and Rubinsky 2007; Meir and Rubinsky 2014), and magnetic resonance electric impedance 
tomography (Kranjc et al. 2014; Kranjc et al. 2015; Kranjc et al. 2017). The efficiency of electroporation 
can be predicted by the change in electric conductivity of tissues (Cukjati et al. 2007; Ivorra et al. 2009; 
Neal et al. 2012). When measuring dielectric properties of tissues, secondary effects can affect 
measurements – such as change of cell radii (Serša et al. 2008; Sano et al. 2010; Deodhar et al. 2011b; 
Calmels et al. 2012), forming of edema (Ivorra et al. 2009), loss of ions from the cells (Pavlin et al. 2005), 
vascular lock (Ivorra and Rubinsky 2007; Serša et al. 2008). Electroporation changes specific conductivity 
of tissues mostly in the range of the β dispersion (Pliquett et al. 1995; Ivorra and Rubinsky 2007; Garner et 
al. 2007; Oblak et al. 2007; Ivorra et al. 2009; Neal et al. 2012; Zhuang et al. 2012; Salimi et al. 2013) 
because pore formation in the cell membrane affects cell membrane polarization due to increase in its 
electric conductivity. 
Transport during and after electroporation 
Transport during and after electroporation can occur via three different mechanisms: diffusion, 
electrophoresis, and endocytosis. During pulses the transport is electrodiffusive (Li and Lin 2011; Sadik et 
al. 2013), and after the pulses, it is diffusive (Pucihar et al. 2008). Endocytosis was observed after 
application of longer low-voltage pulses (Rols et al. 1995; Antov et al. 2005). 
In vitro, transport due to electroporation is relatively easy to determine using fluorescent dyes and 
techniques like fluorescent microscopy, flow cytometry, spectrofluorometric measurements (Napotnik and 
Miklavčič 2017). In vivo, the transport due to electroporation is challenging to assess. 57Co-bleomycin 
(Belehradek et al. 1994), 111In-bleomycin (Engström et al. 1998), 99mTc-DTPA (Grafström et al. 2006), 
51Cr-EDTA (Batiuškaitė et al. 2003), gadolinium (Garcia et al. 2012), lucifer yellow (Kranjc et al. 2015) 
and cisplatin (Melvik et al. 1986; Čemažar et al. 1998; Čemažar et al. 1999; Ogihara and Yamaguchi 2000; 
Čemažar et al. 2001; Serša et al. 2010; Hudej et al. 2014; Čemažar et al. 2015) were already described in 
the literature. 
When modeling transport, we have to keep in mind that the conditions in vitro and in vivo are different. In 
vitro, at a single cell level, the solute surrounds the cells. Solute can pass cell membrane anywhere as long 
as the membrane is permeable. The transport in the extracellular space is not limited. If there is enough of 
solute in the extracellular space, the transport stops when the cell membrane reseals. The transport through 
the membrane can be directly linked to the cell membrane permeability (Mahnič-Kalamiza et al. 2015). In 
vivo, the initial solute concentration varies spatially. All the solute available can enter cells before the 
membrane reseals, i.e., the extracellular compartment can be locally depleted. The transport of solute occurs 
via diffusion and convection (Canatella et al. 2004). Cells are close together which decreases the possible 
area for the uptake and decreases the induced transmembrane voltage due to electric field shielding. 
Already in spheroids, it was shown that transport of small molecules was spatially heterogeneous (Canatella 
et al. 2004; Gibot et al. 2013). Electric pulses cause vasoconstriction (Serša et al. 2008) which limits the 
transport of solute in or out of a tumor. Increased interstitial pressure, heterogeneous perfusion, defective 
lymphatic system, binding of drugs to non-target molecules and metabolism additionally affect transport in 
a tumor (Baxter and Jain 1989; Baxter and Jain 1990; Baxter and Jain 1991; Jain 1999). 
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It should be kept in mind that an increase in cell membrane conductivity is not the same as the increase in 
its permeability (Wegner et al. 2015). An increase in cell membrane conductivity starts immediately after 
pulse application (Pavlin and Miklavčič 2008) while the transport due to increased cell membrane 
permeability lasts for minutes or even hours after the application of electric pulses (Saulis et al. 1991; 
Golzio et al. 2002). Sufficiently high increase in conductivity indicates that the transport will occur (Cukjati 
et al. 2007; Ivorra and Rubinsky 2007; Pavlin and Miklavčič 2008; Ivorra et al. 2009; Neal et al. 2012) 
Models of electroporation
Mathematical modeling offers a concise description of biological phenomena using mathematical and 
physical laws; it improves our understanding, our predictions, and decreases the number of needed 
experiments. In the clinical setting, modeling can help predict the treatment outcome and optimize the 
treatment to achieve the best results. In the field of electroporation, different spatial scales of biological 
systems are modeled separately: level of molecules (phospholipids), lipid bilayers, cells, and tissues. If in 
the process of modeling we do not achieve good agreement with experimental data, this indicates that we 
have not modeled all the relevant processes. 
Models at the level of molecules 
With molecular dynamics simulations, we can model how different molecules and ions behave when 
exposed to an electric field (Tieleman 2006; Böckmann et al. 2008; Delemotte and Tarek 2012; Casciola 
and Tarek 2016), but we are restrained to the time scale of 100 to 1000 nanoseconds. Molecular dynamics 
studies propose that during electroporation water fingers are formed in the cell membrane. Water fingers 
then evolve to hydrophilic pores. Molecular dynamics simulations were compared with experimental data – 
in simulations it was predicted that siRNA could cross the cell membrane in a few nanoseconds, which was 
also shown experimentally (Breton et al. 2012). 
Models at the level of lipid bilayers 
In polar solvent like water lipids spontaneously form a lipid bilayer. Models of electroporation of lipids 
bilayers are of three main groups (Chen et al. 2006a; Pavlin et al. 2008; Rems and Miklavčič 2014). In the 
first group are deterministic electromechanical models - hydrodynamic, elastic, hydroelastic, viscoelastic, 
where membranes are treated as elastic bodies, and their behavior is described with laws of electrostatic. 
This first group of models does not describe electroporation well. In the second group are models of pore 
formation which are stochastic and are derived from energy equations (Abidor et al. 1979). Pore formation 
and development during pulse application can be described by the Smoluchowski equation. The 
Smoluchowski equation is computationally demanding and was simplified by Neu and Krassowska to its 
asymptotic form (Neu and Krassowska 1999; Neu and Neu 2009). In the asymptotic form, we assume that 
all pores in the cell membrane are of fixed radii. The asymptotic model can be upgraded to include also 
increase in pore radii, but it is computationally demanding (Neu et al. 2003; Smith et al. 2004). In the third 
group is a kinetic scheme (Neumann et al. 1998; Miklavčič and Towhidi 2010), where lipid bilayer changes 
between permeable and non-permeable state (Böckmann et al. 2008). Transport of small molecules through 
a single pore can be modeled with the electrodiffusion equation (Granot and Rubinsky 2008; Li and Lin 
2011; Smith and Weaver 2011; Movahed and Li 2012; Movahed and Li 2013). It was determined that 
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continuum models of electroporation of lipid bilayers correspond well to molecular dynamics simulations 
(Casciola et al. 2016; Rems et al. 2016). 
Models at the level of single cells 
Lipid bilayer together with proteins forms cell membrane. Cell membrane can be approximated by a 
dielectric surrounded by a conductor. At the cell level, there are several models existing – models of 
induced transmembrane voltage, pore formation, transport, permeability, cell death, and change in electric 
conductivity of cell. Time and spatial change of induced transmembrane voltage can be analytically 
calculated for isolated cells of simple shapes (Kotnik and Miklavčič 2000a; Kotnik and Miklavčič 2000b; 
Valič et al. 2003) but requires a numerical calculation for other more complicated shapes (Pucihar et al. 
2006). When the induced transmembrane voltage is known, pore formation can be described either with 
asymptotic equation (Neu and Krassowska 1999; Neu and Neu 2009) or by also including the change in 
pore radii (Smith et al. 2004; Smith et al. 2014). Transport of molecules into a single cell can be described 
with the Neumann’s kinetic scheme (Neumann et al. 1998; Miklavčič and Towhidi 2010), the 
pharmacokinetic model (Puc et al. 2003) or with the electrodiffusion equation (Pucihar et al. 2008; Li and 
Lin 2011; Li et al. 2013; Sadik et al. 2013; Sadik et al. 2014; Blumrosen et al. 2016). Electrical properties 
of cells can be calculated with an equivalent circuit (Pethig 1984; Gowrishankar and Weaver 2003). Cell 
permeability and cell survival can be modeled with mathematical models (Schoenbach et al. 2009; Dermol 
2014; Dermol and Miklavčič 2014; Dermol and Miklavčič 2015; Dermol and Miklavčič 2016) which 
accurately describe the shape of the permeability and survival curves but are phenomenological and are not 
based on any mechanisms of electroporation. Cell permeability and conductivity can be modeled separately 
as two phenomena (Miklavčič and Towhidi 2010; Leguèbe et al. 2014). 
Models at the level of cell clusters and tissues 
Several cells together form either a monolayer or a tissue. Current tissue models are of two types – they 
either model the tissue as a bulk (Šel et al. 2005; Čorović et al. 2007; Pavšelj et al. 2007; Pavšelj and 
Miklavčič 2008b; Golberg and Rubinsky 2010; Neal et al. 2012; Čorović et al. 2012; Garcia et al. 2014) or 
also model the tissues' microscopic structure (Gowrishankar and Weaver 2003; Stewart Jr. et al. 2005; 
Gowrishankar and Weaver 2006; Esser et al. 2007; Joshi et al. 2008; Esser et al. 2009; Essone Mezeme et 
al. 2012b; Dymek et al. 2015).  
The bulk tissue models describe the electric field distribution as a function of tissue properties, applied 
voltage and the geometry of the electrodes. Transport to cell clusters or tissues was modelled by statistical 
models which describe the data well but do not include specific transport mechanisms (Canatella and 
Prausnitz 2001), the kinetic scheme of electroporation (Neumann et al. 1998; Miklavčič and Towhidi 2010), 
the pharmacokinetic model (Puc et al. 2003; Agarwal et al. 2009), the electrodiffusion equation or the dual-
porosity model (Mahnič-Kalamiza et al. 2014a; Mahnič-Kalamiza et al. 2015). The dual porosity model 
(Mahnič-Kalamiza et al. 2014a; Mahnič-Kalamiza et al. 2015) is based on the diffusion equation, connects 
pore formation with membrane permeability, and includes transport between several compartments - in our 
case between tumor cells, interstitial fraction and peritumoral environment and has the possibility to include 
also thermal relations (Mahnič-Kalamiza et al. 2017). Boyd and Becker also used the dual porosity model 
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by combining it with equations for the degree of electroporation, change of electrical conductivity, and 
membrane resealing (Boyd and Becker 2015; Argus et al. 2017). 
The models in the second group include properties of single cells and thus local inhomogeneities. If tissues 
are made of spheroidal cells in low-volume fractions, their effective dielectric properties can be calculated 
using the Maxwell-Wagner, the Hanai-Bruggeman, and other approximations (Asami 2002). Tissue was 
sampled using Cartesian transport lattices and current, voltage, and electric charge through the lattice were 
calculated using the Kirchhoff’s laws (Gowrishankar and Weaver 2003; Stewart Jr. et al. 2005; 
Gowrishankar and Weaver 2006; Esser et al. 2007; Esser et al. 2009). The equivalent circuit was used to 
analyze the effects of electroporation on cells and then averaged to obtain results for tissues (Ramos et al. 
2003; Ramos 2005). Tissue was modeled with the two-dimensional Voronoi network, and the induced 
transmembrane voltage was calculated in each region (i.e., cell) (Joshi et al. 2008) The weakness of these 
models is, however, that they are in two-dimensions. Besides, in tissues, cells are packed close together, the 
local electric field decreases due to electric field shielding, and consequently, the induced transmembrane 
voltage is lower than in isolated cells (Susil et al. 1998), there are the blood flow (Serša et al. 2008), and the 
immune system (Serša et al. 1997; Neal et al. 2013; Serša et al. 2015) present. In 3-dimensions, tissue was 
numerically modeled as an infinite lattice of spherical cells (Pavlin et al. 2002; Ramos 2010). The cells 
were all of the same size, electrically unconnected and in an iterative arrangement which is not in 
agreement with the circumstances in tissues. Besides, maximal volume fraction was lower than the ones we 
encounter in most tissues. The model was upgraded using randomly distributed spheres of different sizes to 
model change in electric conductivity of the cell membrane and the fraction of permeabilized cells (Essone 
Mezeme et al. 2012b). A similar model was built for the description of electroporation of spinach leaves. 
The authors adapted the shapes and sizes of cells to the morphology of a spinach leaf; however, they 
modeled only a small part of a leaf (Dymek et al. 2015). The model by Huclova et al. (Huclova et al. 2010; 
Huclova et al. 2011; Huclova et al. 2012) offers a more realistic description since cells can be of different 
shapes, sizes, and distances between them can be adapted. The dielectric properties of cells are then 
averaged to obtain properties on the tissue level. The model by Huclova et al. describes the behavior of cells 
in the linear range, but we have added electroporation to it (Dermol-Černe and Miklavčič 2018). Instead of 
numerical calculations, the properties of tissues can be calculated analytically. The frequency dependent 
dielectric properties of tissues can be described using phenomenological models – the Debye, the Cole-
Cole, and other models (Gabriel et al. 1996a; Gabriel et al. 1996b; Gabriel et al. 1996c; Asami 2002). 
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Aim 
The aim of this thesis can be summarized in two points: 
1) Use mathematical models to model cell membrane permeability and depolarization and cell death; 
2) Include mechanisms of electroporation in models of change in dielectric properties of tissues and 
transport due to electroporation. 
In the scope of the first aim, we fitted several mathematical models to experimental data of cell membrane 
permeability and cell death. We predicted the percentage of permeable cells, exposed to the inhomogeneous 
electric field, from the experiments on cells, exposed to the homogeneous electric field. We used optimized 
mathematical models of cell membrane permeability. We compared permeability and depolarization of cell 
membranes of excitable and non-excitable cells and modeled both phenomena. We made a review of the 
existing cell death models, usually employed in prediction of liquid food pasteurization and sterilization, 
and fitted the existing models to our experimental data of cell death caused by irreversible electroporation. 
We focused on time dynamics of dye uptake due to increased cell membrane permeability and the 
correlation between the membrane resealing and the transport of dye to cells.  
In the scope of the second aim, we focused on two important phenomena present during electroporation – 
change in dielectric properties of cells and tissues and increased transport of molecules in and out of the 
cells. We studied the change in dielectric properties of skin when either long low-voltage or short high-
voltage pulses were applied. We determined the contribution of local transport regions in the stratum 
corneum and the pore formation in the lower layers to the overall increase in electric conductivity. We 
modeled the pore formation with the asymptotic pore model and correlated the pore formation and local 
transport region formation to the shape of the current-voltage measurements in the Franz diffusion cell.  
We also studied the transport of small molecules (e.g., cisplatin) in the tumor tissue after electroporation. 
We modeled cisplatin uptake by tumor cells in mouse melanoma tumors. Animal experiments take a long 
time, a limited number of parameters can be tested due to ethical issues, and they are expensive. Thus, we 
aimed to determine if experiments on cell level can be used to predict the treatment outcome in animal 
experiments with a possibility of later translation to medical treatments. We investigated the contribution of 
close cell contacts, high cell volume fraction and smaller available area of cell membrane for transport in 
vivo. We determined that cisplatin uptake in vivo can be determined from the cisplatin uptake in vitro, 
provided we take into account reduced mobility of the molecules. 
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Results and Discussion 
In the present thesis, the aim was to link experiments on cell level (in vitro) to experiments on tissue level 
(in vivo) by using models describing electroporation-related processes at a single cell level and processes at 
the tissue level. Three original scientific contributions were made: 
1. Mathematical modeling of cell membrane permeability and cell death; 
2. The transition between single-cell models and the tissue models, where the realistic three-
dimensional skin model is presented with the model of electroporation of all components and 
essential layers of the skin. 
3. Mathematical modeling of transport of small molecules (chemotherapeutic) across the cell 
membrane using the dual porosity model. 
The work presented in this thesis consists of two parts – experimental in a cell culture laboratory and 
modeling. I believe that only by using modeling we can understand experimental results and vice versa – 
models are only relevant when they are based on experimental measurements. Models based on a good 
experimental data facilitate our understanding of the modeled phenomena, enable us to make predictions 
about the behavior of biological systems and decrease number of needed experiments.  
The work done in the scope of this thesis was presented in six papers and a book chapter. There, the results 
are presented and thoroughly discussed. Thus, the Results and Discussion section consist of the published 
papers, and the thesis will continue with a Conclusion and Future Work section. A summary of the work is 
the following.  
The first contribution was addressed in four papers and one book chapter. 
Paper 1 (Dermol and Miklavčič 2014) entitled Predicting electroporation of cells in an inhomogeneous 
electric field based on mathematical modeling and experimental CHO-cell permeabilization to 
propidium iodide determination described mathematical models of cell membrane permeability. We 
focused on four models – the symmetric and asymmetric sigmoid, the hyperbolic tangent and the Gompertz 
curve. From experimental data of the cell membrane permeability obtained on attached cell monolayers 
exposed to the homogeneous electric field, we predicted cell membrane permeability in the inhomogeneous 
electric field. Prediction of permeability was possible if the density of the cells in the homogeneous field 
was comparable to the density of cells in the inhomogeneous field. We conclude that models describing cell 
electroporation probability could be useful for development and presentation of treatment planning for 
electrochemotherapy and non-thermal irreversible electroporation. 
Paper 2 (Dermol and Miklavčič 2015) entitled Mathematical Models Describing Chinese Hamster 
Ovary Cell Death Due to Electroporation In Vitro focused on mathematical models of cell survival. We 
exposed cell suspension to pulses of parameters similar to irreversible electroporation parameters - several 
tens of 100 μs long pulses of up to 4 kV/cm, delivered at the repetition frequency 1 Hz. Cell survival was 
evaluated with the clonogenic assay. Several models of survival previously used in the literature were fitted 
to our experimental results. The models were: the first-order kinetics, the Hülsheger, the Peleg-Fermi, the 
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Weibull, the Logistic, the adapted Gompertz, and the Geeraerd model. The most appropriate models of cell 
survival as a function of the treatment time were the adapted Gompertz and the Geeraerd models and, as a 
function of the electric field, the logistic, the adapted Gompertz, and the Peleg-Fermi models. The next 
steps to be performed are a validation of the most appropriate models on tissues and determination of the 
models’ predictive power. A review of cell death models of the eukaryotic and prokaryotic cells is written 
in the book chapter (Dermol and Miklavčič 2016) entitled Mathematical Models Describing Cell Death 
Due to Electroporation. 
Paper 3 (Dermol-Černe et al. 2018) entitled Plasma membrane depolarization and permeabilization due 
to electric pulses in cell lines of different excitability consists of the experimental part and modeling part 
regarding the cell depolarization and cell membrane permeability. The aspect of excitability is important 
when treating excitable tissues with electroporation or when excitable tissues are in the vicinity of the 
treated area. The experimental strength-duration curve to one pulse of length 10 ns – 10 ms was determined 
for excitable and non-excitable cells and then modeled with the Lapicque curve and the Hodgkin-Huxley 
model. The Hodgkin-Huxley model gave insight into the ability of the short bipolar to permeabilize but not 
excite the tissue. The permeability curve to one pulse of length 100 ns – 100 ms was obtained from the 
literature along with the Saulis model, and was additionally modeled with the Schwann equation. The 
depolarization threshold was higher for the excitable cells than for the non-excitable cells. All four cell lines 
responded similarly to pulses of standard electrochemotherapy parameters, and their permeability curves 
were modeled with the symmetric sigmoid. Thus, electroporation is a feasible means of treating excitable 
and non-excitable cells with pulses of similar parameters. Our results show the potential of achieving cell 
membrane permeability and minimizing or avoiding excitation/pain sensation which needs to be explored in 
more detail. In future studies, it should be established, to what extent the in vitro depolarization and 
excitability correlate to the actual excitation and pain sensation in vivo. 
Paper 4 (Dermol et al. 2016) entitled Cell Electrosensitization Exists Only in Certain Electroporation 
Buffers consists of experimental work on the effect of pulse delivery in one or several trains on the uptake. 
Electroporation-induced cell sensitization was described as the occurrence of delayed hypersensitivity to 
electric pulses caused by pretreating cells with electric pulses. It was achieved by increasing the duration of 
the electroporation treatment at the same cumulative energy input. It could be exploited in electroporation-
based treatments such as electrochemotherapy and tissue ablation with irreversible electroporation. The 
mechanisms responsible for cell sensitization, however, have not yet been identified. We investigated cell 
sensitization dynamics in five different electroporation buffers. We split a pulse train into two trains varying 
the delay between them and measured the time dynamics of propidium uptake by fluorescence microscopy. 
By fitting the first-order model to the experimental results, we determined the uptake due to each train (i.e., 
the first and the second) and the corresponding resealing constant. Cell sensitization was observed in the 
growth medium but not in other tested buffers. The effect of pulse repetition frequency, cell size change, 
cytoskeleton disruption and calcium influx do not adequately explain cell sensitization. Based on our 
results, we can conclude that cell sensitization is a sum of several processes and is buffer dependent. 
Further research is needed to determine its generality and to identify underlying mechanisms. 
The second contribution was addressed in one paper. 
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Paper 5 (Dermol-Černe and Miklavčič 2018) entitled From cell to tissue properties – modeling skin 
electroporation with pore and local transport region formation modeled skin electroporation by pore 
formation and local transport region formation at the level of single cells and skin layers. We showed that it 
is possible to model electroporation at the level of single cell and then generalize the results to the bulk 
tissue where calculations are considerably faster. Current models of tissue electroporation either describe 
tissue with its bulk properties or include cell level properties, but model only a few cells of simple shapes in 
low-volume fractions or are in two dimensions. We constructed a 3-dimensional model of realistically 
shaped cells in realistic volume fractions. By using a ‘unit cell’ model, the equivalent dielectric properties 
of whole tissue could be calculated. We calculated the dielectric properties of electroporated skin. We 
modeled electroporation of single cells by pore formation on keratinocytes and on the papillary dermis 
which gave dielectric properties of the electroporated epidermis and papillary dermis. During skin 
electroporation, local transport regions were formed in the stratum corneum. We modeled local transport 
regions and increase in their radii or density which affected the dielectric properties of the stratum corneum. 
The final model of skin electroporation accurately described measured electric current and voltage drop on 
the skin during electroporation with long low-voltage pulses. The model also accurately described voltage 
drop on the skin during electroporation with short high-voltage pulses. However, our results indicated that 
during application of short high-voltage pulses additional processes might occur which increased the 
electric current. Our model connects the processes occurring at the level of cell membranes (pore 
formation), at the level of a skin layer (formation of local transport region in the stratum corneum) with the 
tissue (skin layers) and even level of organs (skin). Using a similar approach, electroporation of any tissue 
can be modeled, if the morphology of the tissue is known. 
The third contribution was addressed in one paper. 
Paper 6 (Dermol-Černe et al. 2018, submitted) entitled Connecting the in vitro and in vivo experiments 
in electrochemotherapy: Modeling cisplatin transport in mouse melanoma by the dual-porosity 
model was a modeling study where transport of chemotherapeutic in the tumor cells was modeled by the 
dual-porosity model based on experimental results obtained on cell suspension. In electrochemotherapy two 
conditions have to be met to be successful – the electric field of sufficient amplitude and sufficient uptake 
of chemotherapeutics. Current treatment plans only take into account the critical electric field to achieve 
cell membrane permeability. However, increased permeability of cell membrane alone does not guarantee 
uptake of chemotherapeutics and consequently successful treatment. In our study, we described the 
transport of cisplatin in vivo based on experiments performed in vitro. In vitro, a spectrum of parameters 
can be explored without ethical issues. In the experimental part of our study, we performed in vitro and in 
vivo experiments. Mouse melanoma B16-F1 cell suspension and inoculated B16-F10 tumors were exposed 
to electric pulses in the presence of the chemotherapeutic cisplatin. The uptake of cisplatin was measured 
by the inductively coupled plasma mass spectrometry. In modeling part of our study, we modeled the 
transport with the dual-porosity model which is based on the diffusion equation, connects pore formation 
with membrane permeability, and includes transport between several compartments. In our case, there were 
three compartments - tumor cells, interstitial fraction and peritumoral region. Our hypothesis was that in 
vitro permeability coefficient can be introduced in vivo, as long as tumor physiology is taken into account. 
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A transformation from in vitro to in vivo was possible by introducing a coefficient of transformation which 
takes into account in vivo characteristics, i.e., the smaller available area of the plasma membrane for 
transport due to high cell density, and presence of cell-matrix in vivo, thus reducing drug mobility. Our 
model offers a step forward to linking transport models at the cell level (in vitro) to the tissue level (in 
vivo). 
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Electric field distributionHigh voltage electric pulses cause electroporation of the cell membrane. Consequently, flow of the molecules
across the membrane increases. In our study we investigated possibility to predict the percentage of the
electroporated cells in an inhomogeneous electric field on the basis of the experimental results obtained when
cells were exposed to a homogeneous electric field. We compared and evaluated different mathematical models
previously suggested by other authors for interpolation of the results (symmetric sigmoid, asymmetric sigmoid,
hyperbolic tangent and Gompertz curve). We investigated the density of the cells and observed that it has the
most significant effect on the electroporation of the cells while all four of the mathematical models yielded
similar results. We were able to predict electroporation of cells exposed to an inhomogeneous electric field
based on mathematical modeling and using mathematical formulations of electroporation probability obtained
experimentally using exposure to the homogeneous field of the same density of cells. Models describing cell
electroporation probability can be useful for development and presentation of treatment planning for
electrochemotherapy and non-thermal irreversible electroporation.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
High voltage electric pulses affect membrane's selective permeabili-
ty. According to the theory electroporation of the membrane occurs as
pores are formed in the membrane. Cell membrane thus becomes per-
meable for different molecules which otherwise cannot pass through
the membrane in or out of the cell [1–3]. Increased membrane perme-
ability occurs in the regions of the membrane where the transmem-
brane voltage exceeds a certain threshold, which is characteristic of
each cell line, but also depends on pulse parameters [4,5]. If the cell is
able to recover after the exposure to electric pulses we call this revers-
ible electroporation. If the cell cannot recover and it does not survive
electroporation we call it irreversible [6]. Electroporation is widely
used in different areas—gene transfer [7–9], cancer treatment [10–12],
biotechnology [13,14] and food processing [15–17].
When predicting the electroporation of cells, for example in a tissue,
it is usually (implicitly) assumed that cells are electroporated if the in-
duced transmembrane voltage exceeds the characteristic threshold
[18,19]. If the induced transmembrane voltage is below the characteris-
tic threshold the cells are not electroporated. In reality the transition
from non-electroporated to reversibly and irreversibly electroporatedlavčič).state is continuous. So far differentmathematicalmodels of electropora-
tion have been proposed in the literature [20–22]. With the appropri-
ately chosen mathematical model we could predict percentage of cells
affected if a certain voltage is applied using specific electrode geometry.
In recent years electroporation based treatments have paved their
way to clinical use. Electrochemotherapy for solid cutaneous, subcuta-
neous tumors and metastasis [11,23], as well as for deep seated tumors
[24,25] is being used in clinics. Minimally invasive non-thermal irre-
versible electroporation as soft tissue ablation has also been proposed
[6] and used in animal [26] and human clinics [27]. In all these cases
treating deep seated tumors or soft tissue using minimally invasive
procedures a need for pretreatment planning was clearly established
[28–30]. Until now visualization of electric field distribution is used
as being the most important predictor of tissue permeabilization and
ablation [25,29,31,32].
There is a considerable number of studies of electroporation in dense
cell suspensions available [33–36], but there aremuch less studies avail-
able on tissues [37–39]. In these latter studies besides the density of the
cells, applied electric field, cell line, and cells' mutual electric shielding,
the connections between the cells and their irregular shape could play
an important role as well [4]. In our present study the experiments
were performed on monolayers of cells of different densities.
When defining the duration and the voltage of the applied pulses we
model the geometry of the electrodes and of the cells as a bulk 2D “tissue”
layer. Electric field (E field) distribution is numerically calculated and
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sues and electrodes analytical calculations are usually in most cases not
possible. There is no conventional or easy way to measure E field in vivo.
We have recently proposed a method based on current density imaging
(CDI) and magnetic resonance electrical impedance tomography
(MREIT) to measure E field in biological tissues [41,42]. However, the
most reliable or eveneasyway is numericalmodelingwhichweemployed.
Until now, the calculated electric field is thresholded with two dif-
ferent thresholds to obtain three areas—the area where irreversible
electroporation occurs, the areawhere reversible electroporation occurs
and the area where electroporation does not occur. The cell response
can be approximated with a step function. Electroporation is 100% if
the applied electric field is above the characteristic electroporation
threshold and 0% if it is below. In the same way area where irreversible
electroporation occurs can be modeled. Irreversible electroporation is
100% if the applied electric field is above the characteristic threshold
for irreversible electroporation and 0% if it is below.
The aim of our study was to predict a percentage of electroporated
cells grown as a dense monolayer exposed to an inhomogeneous field.
We performed experiments in a homogeneous electric field and deter-
mined the percentage of cell electroporation for a certain applied E.
We used these results in four different mathematical models, which
interpolated and extrapolated the percentage of electroporated cells to
other values of E. We used homogeneous E for calculating parameters
of the mathematical models because it is possible to determine the
percentage of electroporated cells at a certain E. We validated the
mathematical models by exposing cells to the inhomogeneous field
and comparing predicted and experimentally determined values of per-
centage of electroporation. We used the inhomogeneous electric field
for validation because in tumors and tissues the electric field around
the electrodes is in almost all cases inhomogeneous. The predicted
values were obtained by using the numerically calculated inhomoge-
neous E in mathematical models. We obtained the percentage of elec-
troporation in the dependence on E for the area around the electrodes.
The advantage of this approach is that simple electrode geometry
configurations can be used to calculate the parameters of the mathe-
matical models. Mathematical models predicting cell electroporation
can then be applied to arbitrary electrode geometry. This kind of math-
ematical relationship could allow us to present treatment plans in a
clearer and more understandable way. At the moment, the treatment
plans present the E field applied to a certain area of a tissue/tumor.
Using this method the percentage of the electroporated area of a tis-
sue/tumor could be shown. Eventually also the number and duration
of pulses could be taken into account [43].
The block scheme on Fig. 1 shows the procedure used in our study.
First, we exposed cells to the homogeneous field (block 1). Based on
these results we determined the parameters of a mathematical model
of cell electroporation (block 2). We used this mathematical model
and inhomogeneous E field distribution to predict the percentage of
electroporation (block 3). We then validated the model by exposing
cells to the inhomogeneous field (block 4) by comparing predictedelectric field
cell exposed to
homogeneous E
E field
distributi
mathematica
model of cel
electroporati
1 2
Fig. 1. A block scheme showing the layout of the article. Numbeand experimental values. If the results were not in good agreement,
we adjusted themathematicalmodel (block 2) and repeated the predic-
tion of electroporation and the validation of the mathematical model.
2. Methods
2.1. Cell line and cell culture
A series of experiments were performed on Chinese hamster ovary
cells (CHO). Cells were grown in monolayers of different densities in
Petri dishes 40 mm in diameter (TPP, Switzerland) in 2 mL of culture
medium (Ham's Nutrient Mixtures HAM-F12, Sigma-Aldrich, Steinheim,
Germany) supplemented with 10% FBS, antibiotics and L-glutamine for
2 days at 37 °C and 5% CO2 (Kambič, Slovenia).
2.2. Pulse generator and pulse exposure
For the experiments electric pulse generator Cliniporator (IGEA,
Italy) was used. For each experiment one rectangular pulse in the dura-
tion of 1mswas applied. The voltages were chosen so that themaximal
electric field in the homogeneous field was 1.6 kV/cm and in the inho-
mogeneous field it was 2.3 kV/cm. Therefore, for the homogeneous
field the applied voltages were between 200 V and 800 V with a step
of 200 V while for the inhomogeneous field the applied voltages were
between 80 V and 140 V with a step of 20 V. Two different electrode
configurations were used. For the homogeneous field two parallel Pt/Ir
wire electrodes with 0.75 mm diameter and distance between the
inner edges of the electrodes set at 5 mm [44] were positioned at the
bottom of the Petri dish (Fig. 2a). For the inhomogeneous field we
used one needle electrode pair with diameter 0.5 mm and distance be-
tween the inner edges of the electrodes set at 1.0 mm (Fig. 2b) [45].
Cells were exposed to the electric pulses in a medium of 1 mL HAM-
F12 and 100 μL of 1.5 mM propidium iodide (PI). PI is a non-permeant
fluorescent dye, which emits strong fluorescence after entering the cell
and thus allows easy determination of cell electroporation and discrim-
ination between electroporated and non-electroporated cells by
thresholding fluorescent images (see 2.3 Fluorescence microscopy).
After the exposure to an electric pulse the cells were incubated for 5
min at room temperature and then washed with HAM-F12.
2.3. Fluorescence microscopy
The cells were observed by an inverted microscope AxioVert 200
(Zeiss, Germany) under 10× magnification. In each experiment in the
homogeneous field up to five phase contrast and five corresponding
fluorescent images were acquired from randomly selected fields of
view between the electrodes. In the experiments in the inhomogeneous
field four imageswere acquiredwhen 80Vwas applied and nine images
when more than 80 V was applied to obtain the area around the elec-
trodes. The number of experiments and images acquired in each exper-
iment for each E for homogeneous field is shown in Table 1. The numberpercentage of 
permeabilization
cell exposed to
inhomogeneous E
on
l 
l 
on as f(E)
model
validation
4
3
rs in the blocks show the temporal sequence of our study.
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Fig. 2. Photos of electrodes, used in the experiments. a—Two parallel Pt/Ir wire electrodes
with 0.75 mm diameter and distance between their inner edges set at 5 mm. b—One nee-
dle Pt/Ir electrode pairwith diameter 0.5mm and distance between the inner edges of the
electrodes set at 1.0 mm.
Table 2
Number of experiments (one petri dish and one composed image for one
experiment) in the inhomogeneous field.
Voltage applied (V) Number of experiments
80 9
100 12
120 6
140 8
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the inhomogeneous field the number of experiments is reported in
Table 2. In each experiment one pair of composed images was acquired
(one fluorescent and one phase-contrast image). Fluorescent and
phase-contrast images were then stacked together in Adobe Photoshop
CS5 (Adobe Systems Inc., San Jose, CA, USA) to get one image of the
whole area around the electrodes (Fig. 3a,b). For acquisition we used
the VisiCam 1280 camera (Visitron, Germany) and MetaMorph PC soft-
ware (Molecular Devices, USA).2.4. Fitting of the mathematical models
First, the acquired fluorescent images from experiments in the
homogeneous electric field were thresholded and electroporated cells
were manually counted. Cells in the phase contrast images were manu-
ally counted as well. The percentage of the electroporated cells and
standard deviation were calculated. The results were classified into
three groups on the basis of the density of the cells i.e. on the number
of the cells on the phase contrast images. The first groupwas the images
with less than 300 cells, second was the images with density in the
range from 300 to 600 cells and the third was the images with more
than 600 cells per image. In Fig. 4 we can see how different groups of
cell densities look like under the microscope. Fig. 4a shows a typical
example of a least dense monolayer (less than 300 cells per image),
Fig. 4b shows the typical example of a medium dense cell monolayer
(from 300 to 600 cells per image) and Fig. 4c shows the densest mono-
layer (more than 600 cells per image).
Differentmathematicalmodels (symmetric sigmoid (Eq. (1)), asym-
metric sigmoid (Eq. (2)), Gompertz curve (Eq. (3)) and hyperbolic tan-
gent (Eq. (4))) suggested previously by other authors [20,46,47] were
fitted in Matlab (R2010a, Mathworks, USA) to the experimental data
of the percentage of electroporated cells in the homogeneous field
using themethod of non-linear least squares. We obtained an analyticalTable 1
Number of experiments for each voltage in the applied homogeneousfield. In each experiment a
pairs (phase-contrast and fluorescent) for each density of the cells is reported in the 3rd, 4th a
Applied voltage (V) Number of experiments Number of images (N600 cells/image)
200 6 14
300 4 4
400 8 11
500 9 6
600 6 10
700 6 9
800 8 7
52expression with optimized parameters for each of the equations
(Eqs. (1)–(4).
p Eð Þ ¼ 1= 1þ exp − E−E50%ð Þ=bÞð Þ100%
 ð1Þ
p Eð Þ ¼ 1þ v exp − E−E50%ð Þ=bð Þ
 ∧ −1=vð Þ100% ð2Þ
p Eð Þ ¼ exp − exp − E−E50%ð Þ=bð Þð Þ100% ð3Þ
p Eð Þ ¼ 1þ tanh B E−E50%ð Þ
  
=2100% ð4Þ
E50% represents the electric field at which 50% of the cells are
electroporated and p denotes the percentage of electroporated cells in
the dependence of the applied electric field. Parameters b and B define
the width of the curve, e.g. how quickly the cells go from the non-
electroporated state to the electroporated state when the electric field
is increasing. Parameter v defines the slope of the Eq. (2). E in all four
equations means the applied electric field.
2.5. Modeling of the inhomogeneous electric field
Numerical calculations of the distribution of the inhomogeneous
electric field were performed in COMSOL Multiphysics (version 3.5,
COMSOL, Sweden). Themodel wasmade in the AC/DCmodule. Theme-
dium around the electrodes had its electrical conductivity set at 1.0 S/m
which is the conductivity of the pulsing buffer. Since the pulse duration
(1 ms) was much longer than a typical constant for polarization of the
cell membrane (around 1 μs) [48] steady-state analysis was made. The
calculated distribution of the electric field around the electrodes is
shown in Fig. 5a.
The area around the electrodes in the inhomogeneous electric field
was divided using contours into subareas where the electric field was
within a certain range. An example of these contours is presented in
Fig. 5b. When 80 V was applied the area was divided into 4 subareas,
when 100 V was applied the area was divided into 5 subareas and
when 120 V or 140 V was applied the area was divided into 6 subareas.
The minimal electric field still analyzed was 0.30–0.39 kV/cm. The
limits of the analyzed ranges of electric field for all of the applied volt-
ages are presented in Table 3. Table 3 shows also the percentage oft least three imageswere acquired from randomly chosen points of view. Number of image
nd 5th columns.
Number of images (300–600 cells/image) Number of images (b600 cells/image)
10 5
6 3
8 16
25 20
8 10
7 6
22 7
Fig. 3. a—Phase contrast composed image from under the microscope, 10×magnification,
approximate position of the electrodes is marked with black circles, polarity of the elec-
trodes ismarkedwith+ and− signs. b—Composed fluorescent image from under themi-
croscope, 10×magnification, averaged 6 images, applied one pulse of 120 V, approximate
position of the electrodes ismarkedwithwhite circles, polarity of the electrodes ismarked
with + and− signs.
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the ranges of electric field when different voltages are applied. Up to
0.8 kV/cm the limits are the same for all the applied voltages. The closer
we get to the electrodes, the faster the electric field is increasing. Limits
of electric field values in the inhomogeneous field were based on theFig. 4. Phase contrastmicroscopic imageswith different numbers of cells. a—Image belongs to th
to 600 cells per image. c—Image belongs to the density group of more than 600 cells per imagesize of the area between two contours. The upper and lower limits of
the area were set so that the areas between two contours were approx-
imately the same in size. Therefore, the limits of the areas are not the
same for different voltages applied (Table 3). For each of the applied
voltages the corresponding contours (limits of the ranges of electric
field) were superimposed to the microscopic images. An example of
contours superimposed to the fluorescent image can be seen in Fig. 5c.
The maximal values from Table 3 are based on a numerical calculation
where this was the highest electric field value achieved when corre-
sponding voltage was applied.
For each subarea from Table 3 cells on phase contrast images and on
thresholded fluorescent images (Fig. 6a) were manually counted. The
percentage of the electroporation and standard deviation in each area
were determined.
In Comsol we transformed the calculated inhomogeneous electric
field into the predicted percentage of the electroporated cells in the
dependence on the geometry (Fig. 6b). We achieved transformation
by using the numerically calculated inhomogeneous electric field values
(Fig. 5a) in mathematical models (Eqs. (1)–(4)) with optimized coeffi-
cients to determine the predicted percentage of electroporated cells.
From the continuous distribution of the expected percentage of the
electroporated cells (Fig. 6b) we determined areas with ranges of pre-
dicted percentage of electroporated cells. These areas had the same
size and shape as the subareas of electric field around the electrodes
(Fig. 5b). The values of the borders of these subareas were determined
empirically. We put the image of areas with ranges of predicted per-
centage of electroporation on top of the image with areas with ranges
of the electric field. We determined at which values of the borders the
overlapping was complete. This allowed us to compare the predicted
percentage of electroporation and the experimentally determined per-
centage of electroporation in the same subarea. The comparison was
made for each of the mathematical models (Eqs. (1)–(4)) with opti-
mized coefficients.
3. Results
We first determined the percentage of the electroporated cells ex-
posed to a homogeneous electric field, and determined the influence
of the cell density by fitting different mathematical models to the exper-
imental data. Then we used the model with the best fit (highest R2) to
predict cell electroporation in the inhomogeneous field. Predicted values
were compared to experimentally determined cell permeabilization in
the inhomogeneous field.
3.1. Cell electroporation in a homogeneous electric field
Each of the four proposed mathematical models of electroporation
(Eqs. (1)–(4)) was fitted to the experimental data from all three cell
density groups, i.e. less than 300 cells per image, 300 to 600 cells pere density group of under 300 cells per image. b—Image belongs to the density group of 300
.
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54image and more than 600 cells per image. R2 value and optimized pa-
rameters for all four mathematical models (Eqs. (1)–(2)) and all three
density groups can be seen in Table 4. R2 measures how successful the
fit is in explaining the variation of the data i.e. R2 is the correlation
between predicted and observed values. The parameter R2 was 0.990
or higher in all fits. Based on the experimental data which can be seen
in Fig. 7 (triangles) we can see that the percentage of electroporated
cells depends significantly on the cell density. In Fig. 7 data is presented
only with Gompertz curve—the reason is explained later in this section.
Somewhat surprising, the mathematical models of electroporation are
not shifting to the higher values of E but are changing their slopes
with different densities of the monolayer. All of the curves start to
increase at approximately the same point (0.4 kV/cm) but reach their
plateaus at different values of the electric field (1.2 kV/cm or more).
At lower values of the electric field (less than 0.4 kV/cm) there was no
electroporation detected. At the middle values of the electric field
(0.4 kV/cm–1.2 kV/cm) where the curves are approximately linear,
the slopes of thefittedmodels are different for each of the ranges of den-
sities. When the density of the cells was lower the curve was steeper.
We can see the change in the slope in Fig. 7 where the Gompertz
curve (Eq. (3)) was fitted to all three density groups.
For further analysis images with the density of the cells in the range
from 300 to 600 cells per image were chosen. In the experiments in the
inhomogeneous electric field the actual density of the cells was higher
in some areas of the composed image (more than 600 cells per image)
but lower in the others. Therefore, 300 to 600 cells per image were
selected as an approximation for an average cell density and further
analysis was based only on density from 300 to 600 cells per image.
Fig. 8 presents the influence of the chosen mathematical model on
the predicted percentage of electroporated cells. It seems as if there
were only two different models shown instead of four. Namely, hyper-
bolic tangent and symmetric sigmoid are completely overlapping and
therefore there is no visible difference on the graph. The same is true
for the Gompertz curve and asymmetric sigmoid. All the mathematical
models were used with parameters fitted to data from experiments in
the homogeneous field. From the R2 coefficients in Table 4 we can
observe that the Gompertz curve and asymmetric sigmoid when the
density of the cells is 300–600 cells per image offer the best fit to the ex-
perimental data of the four curves used. Although Gompertz curve and
asymmetric sigmoid are overlapping and both offer almost equally good
fit to the experimental datawe have chosen the Gompertz curve (Eq. (3))
for further analysis.
In Fig. 7 we can observe the influence of the density of themonolay-
er, whereas in Fig. 8 we can see the influence of the chosen mathemat-
ical model on the percentage of electroporation. Fig. 9 is based on Figs. 7
and 8, as it combines the appropriate density of the monolayer (Fig. 7)
and the best fit based on the R2 value (Fig. 8). The appropriate density
is the density of the monolayer exposed to an inhomogeneous field,
i.e. 300–600 cells per image.3.2. Cell electroporation in an inhomogeneous electric field
On the basis of the results acquired in experiments in the homoge-
neous electric field and the model of geometry of the two needle
electrodes different mathematical models of cell electroporation as a
function of electric field (Eqs. (1)–(4)) were applied to the numerically
calculated inhomogeneous electric field.
We transformed a numerically calculated electric field (Fig. 5a) into
the predicted percentage of the electroporated cells (Fig. 6b). In Fig. 9Fig. 5.Distribution of the electric field strength in the plane of cell monolayer. a—Continuous
distribution of the electric field strengthwhen 120 V is applied. b—Contours whichmark the
borders between different ranges of the electric fieldwhen 120 V is applied. Range of electric
field in a certain area is written in the corresponding area. c—Fluorescent microscopic com-
posed image with superimposed contours of ranges of electric field, one 1 ms pulse of 120
V applied.
p(%)
b
a
Fig. 6. a—Thresholded fluorescent microscopic image, averaged 6 images, approximate
position of the electrodes is marked with gray circles; signs + and− in the circles mark
the polarity of the electrodes. b—Predicted percentage of the electroporated cells (p) in
the plane of cell monolayer when 120 V is applied; transformation from the electric
field strength to the predicted percentage is made by the Gompertz curve for densities
from 300 to 600 cells per image.
Table 3
Ranges of E-field vector when different voltages are applied and the size of the area in percents of the whole analyzed area without the electrodes. If a certain range is not analyzed when
that voltage is applied there is a sign – in the corresponding cell. When the sum of percentages is not 100% it is so because of rounding of the numbers.
E-field strength range (kV/cm) 80 V area (%) 100 V area (%) 120 V area (%) 140 V area (%)
0.3–0.4 33 30 29 28
0.4–0.6 47 33 29 28
0.6–0.8 12 19 16 15
0.8–1.0 – 12 13 10
0.8–1.5 8 – – –
1.0–1.2 – – 7 10
1.0–1.6 – 6 – –
1.2–2.0 – – 5 –
1.2–2.3 – – – 9
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mined values. With the variation of the different models used for
modeling the phenomena the difference in predicted ranges was mini-
mal. This can be seen from comparing black vertical bars (Gompertz
curve (Eq. (3)), 300 to 600 cells per image) and dark gray vertical bars
(symmetric sigmoid (Eq. (1)), 300 to 600 cells per image) in Fig. 9.
The predicted ranges of the percentage of the electroporated cells are
almost the same. The difference in ranges was maximally 4% at lower
electric field strengths. If we compare ranges predicted by these two
curves (Eqs. (1) and (3)) based on the same density (300 to 600 cells
per image) with the light gray bars, which represent a densermonolay-
er (more than 600 cells per image), we can observe that the predicted
ranges are quite different at lower as well as at higher electric field
strengths. Other combinations of the interpolation curve and the densi-
ty of the cells were made as well (Table 4) but for the sake of stressing
the influence of the density and of the mathematical model only the
Gompertz curve for 300–600 and more than 600 cells per image and
symmetric sigmoid for 300–600 cells per image are shown. Aside from
the symmetric sigmoid (Eq. (1)) also the hyperbolic tangent (Eq. (4))
could be shown.
4. Discussion
The aim of our studywas to compare differentmathematical models
that would allow transformation of the numerically calculated values of
the electric field into the predicted percentage of electroporated cells.
This kind of transformation and prediction would simplify presentation
of treatment plans for electrochemotherapy and non-thermal irrevers-
ible electroporation. We upgraded the usual assumption that the per-
centage of the electroporated cells is 100% if the electric field is above
the characteristic threshold and 0% if it is below [49]. Here the predic-
tion was continuous and all the values between 0% and 100% were pre-
dicted.We investigated and compared the effects of the cell density and
of the used mathematical model (Eqs. (1)–(4)). We started our study
with the model of continuous electric field distribution presented in
Fig. 5a, transforming it into the predicted percentage of electroporated
cells as shown in Fig. 6b. In Fig. 6a we can see that the pattern of the
electroporated and non-electroporated cells is in good agreement
with the predicted shape in Fig. 6b.
Ifwe look at Fig. 6a it appears as if thereweremore cells electroporated
around the positive electrode. However, the analysis of the percentages of
electroporated cells around each of the electrode (data not shown)
showed that there was no significant difference between the percentages
around the positive and around the negative electrode.
In the course of the transformation from the electric field strength in
the homogeneous field to the percentage of electroporated cells in the
inhomogeneous electric field we reached two main conclusions. The
first one was about the changing of the slope of the mathematical
model of electroporation in the homogeneous field and the second
one was about the choice of the mathematical model, fitted to the55
Table 4
Results for the goodness of thefit (R2) and the curves' parameters for all of the four proposed curves for all three density groups. The fit is based on the percentage of electroporated cells in
the homogenous field. The parameters are explained in 2.4 Fitting of the mathematical models.
Type of the curve R-square a Parameters
b300 cells/image 300–600 cells/image N600 cells/image b300 cells/image 300–600 cells/image N600 cells/image
Symmetric sigmoid 0.992 0.990 0.964 E50% = 0.659 E50% = 0.6879 E50% = 0.9231
b = 0.1090 b = 0.1242 b = 0.2353
Asymmetric sigmoid 0.997 0.998 0.965 E50% = 0.5869 E50% = 0.6061 E50% = 1.057
v = 5e−8 (fixed at bound) v = 2e−8 (fixed at bound) v = 2.557
b = 0.1529 b = 0.1772 b = 0.1494
Gompertz curve 0.997 0.998 0.958 E50% = 0.5869 E50% = 0.6061 E50% = 0.7567
b = 0.1529 b = 0.1772 b = 0.343
Hyperbolic tangent 0.992 0.990 0.964 E50% = 0.659 E50% = 0.6879 E50% = 0.9231
B = 4.587 B = 4.027 B = 0.9231
a Goodness-of-fit.
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with the results found in the literature, describing experiments with
suspensions. Nevertheless, the change of the models' slopes with re-
spect to cell density seems rather surprising and contradictory to theo-
retical considerations [47].
First, we will discuss the change of models' slope. Experimental ob-
servationwhere the slope of themodel changes can be observed in [35].
There we can see that the curve of detected fluorescence shifted with a
change of pulse parameters (when longer pulses were used the slope
was steeper). No curve which would show the dependence on the cell
density is shown; we can only see that with the same pulse protocol
and higher density of the suspension fewer cells are electroporated.
As it can be observed from Fig. 7, the model of electroporation did
not shift but changed its slope when monolayers of cells with different
densities were used for experiments. In previous studies it has been ob-
served that with increasing densities of cell suspensions the base point
of the curves and the pointwhere the curves reach their plateaus shifted
to the higher electric field with the slope of the curve being the same
[47]. In our study one part of the observation was similar—the points
where the curves reach their plateau values shifted to the higher electric
field valueswhenwe increased the density of the cellmonolayer. On the
other hand, the base point where a minimal fluorescence of the cells0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
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Up to 300 cells per image
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Above 600 cells per image
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Above 600 cells per image
Fig. 7. Percentage (p) of electroporated cells determined by propidium iodide staining in
the dependence on the applied electric field. The Gompertz curve is fitted to all three
groups of different densities of the cells. Mean experimental values from experiments,
made in the homogeneous field are marked with triangles; vertical bar denotes one stan-
dard deviation. Black triangle and gray solid line represent density up to 300 cells per
image, hollow triangle and dotted black line represent density from 300 to 600 cells per
image, and gray triangle and dashed black line represent density above 600 cells per
image.
56was detected was the same for all of the densities. Therefore, the slope
of the curves changed.
It is known that with denser suspensions we get lower induced
transmembrane voltage due to the mutual electrical shielding
[33–36]. In the monolayers the situation is the same—with denser
monolayers we get lower induced transmembrane voltage and
lower percentage of the electroporated cells. However, we should
not neglect the effect of the cells' geometry [50,51] which is deviato-
ry from spheres and the electrical connections between the cells, e.g.
gap junctions [52]. It seems that the cell's geometry and connections
between the cells are related to the curves' slopes, whichmight be an
area of further research.
The standard deviation in Figs. 7 and 8 is relatively high; the reason is
counting of the cells. Allmeans of cell counting are subjected to errors be-
cause of noise and artifacts, various cell shapes, and cells in close contact
without clear boundaries between them. Considering that we hadmono-
layers of very high density the calculated standard deviation is within the
expected values as reported in the literature [53]. The error would be
lower if using cells in suspension; however the cells in suspension and
in tissues behave very differently. In a suspension there are no connec-
tions between the cells and they are all approximately spherical.0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
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Fig. 8. Percentage (p) of electroporated cells determined by propidium iodide staining in
dependence on the applied electric field. Four different models of electroporation were
fitted to the experimental data of the percentage of electroporated cells in the homoge-
neous field. Triangles represent the mean experimental values for the percentage of
electroporated cells in the homogeneous electric field; vertical bar denotes one standard
deviation. Black solid line represents Gompertz line, black dashed line represents asym-
metric sigmoid, gray solid line represents hyperbolic tangent and gray dashed line repre-
sents symmetric sigmoid.
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scribing the dependence between the percentage of the electroporated
cells and the electric field. For example, a hyperbolic tangent law for
permeabilization as a function of the electric field has been proposed
[47]. In statistical physics the hyperbolic tangent is commonly used for
describing two-state systems, for example the polarized light. Simi-
larly, electroporated and non-electroporated cells can also be viewed
as two states in a system and hyperbolic tangent law describes the
crossover from the non-electroporated to the electroporated state.
In [20] two different ways of describing the cell electroporation frac-
tion have been used. The first one was sigmoid function which is often
fitted to the experimental data. The secondonewas a curvewhichderived
from a hypothetical normal distribution of cell radii. In this case the curve
was obtained from a step function (electroporation is 0% when the ap-
plied electric field is under the threshold for electroporation and 100%
when the applied electric field is above the threshold). Cell radius was
varied according to the normal distribution with empirically determined
values formean cell radius and its standard deviation. Goodness-of-fit be-
tween the normal distribution curve on one side and the experiments on
the other showed that experimental resultswere in good agreementwith
the theoretically predicted values. Nevertheless, the authors could not de-
cide which of the two curves was more appropriate.
The Gompertz curve is used for describing the systems which satu-
rate in a long period of time, for example the growth of the tumors
[46]. The growth is slower at the beginning. Then the size starts to in-
crease faster. The growth is limited after a certain time period when
the size of the tumor reaches a plateau value. The growth can be com-
pared to the percentage of cell electroporation as a function of the elec-
tric field where we obtain high percentage of cells being electroporated,
butwith an increasing electric field the increase e.g. from 97% to 100% of
electroporated cells is difficult to obtain.
Up to a certain electric field reached there are almost no cells
electroporated. From 0.4 kV/cm to 1.0 kV/cm the percentage of the
electroporated cells quickly increases and then it reaches the plateau
value. The described logic is the reason that we proposed the Gompertz
curve for describing the electroporation of the cells. It is not necessarythat the Gompertz curve is symmetric. The asymmetry in the model is
appropriate because in reality the percentage of the electroporated
cells depends also on the cell radius, and according to the literature
the cell radii are not symmetrically distributed [20] which was also
the case in our study (data not shown).
Therefore, we can expect that themathematical model of electropo-
ration is asymmetric as well. This asymmetry was also the reason why
we chose the asymmetric sigmoid curve for analysis.
So far not many studies of a statistical evaluation of electroporation
are available. For evaluating the area of irreversible electroporation a
statistical model based on the Peleg–Fermi model combined with a
numerical solution of the multidimensional electric field equation cast
in a dimensionless formwas used [21]. This model directly incorporates
the dependence of cell death on pulse number (n) and on electric field
(E). It is expressed by Eqs. (5)–(7), where Smeans the survival ratio and
Ec marks the intersection of the curve with the y-axis. Coefficients k1
and k2 are cell type and pulse type specific.
S ¼ 1= 1þ exp E−Ec nð Þð Þ=A nð Þð Þ ð5Þ
Ec nð Þ ¼ Ec0 exp −k1n
  ð6ÞA nð Þ ¼ A0 exp −k2n
  ð7Þ
The problemwith this model is that it was not validated since it was
tested only on extrapolated data reported in the literature for prostate
cancer cell death caused by irreversible electroporation [54]. Authors
stated that real curves and parameters should be developed for each
specific tissue. Also the Fermi–Peleg model should be validated first
in vitro and then in vivo.
Severalmicrobial inactivation curves have been effectively described
by Weibull distribution. In this model parameters were dependent on
the media type and treatment parameters (electric field and treatment
time) [22,55] but not on pulse number and pulse length like the
Peleg–Fermi statisticalmodel. Therefore, thismodel is not as interesting57
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activation by pulsed electric fieldsmanymathematicalmodels exist [22,
56], but they all describe survival of the cells in dependence on applied
electric field and treatment time, with treatment time most often
reported as the sum of duration of all of the applied pulses. All these
models (Weibull, Peleg–Fermi, log-linear etc.) describe the survival
of the cells. In our study on the other hand, survival of the cells has
not been determined. Therefore, these models were not used in our
study.
In our study four mathematical models (Eqs. (1)–(4)) were chosen,
used and evaluated.We achieved good agreementwith all of them since
R2 was 0.990 or higher in all four cases (see Table 4); therefore, for the
analysis of the effect of the cell density on electroporation any of them
might be used. For further analysis of the effect of cell density we con-
sidered the two curves with the highest R2—Gompertz curve and asym-
metric sigmoid. If parameter v in the asymmetric sigmoid model
(Eq. (2)) was negative, no fit could be achieved because complex values
were computed by model function. Therefore, we set a lower limit for
this parameter at 0. Although we managed to complete the fitting, the
parameter v was fixed at bound, which meant that the best fit was not
achieved. The asymmetric sigmoid model was thus not used in the
next step of the analysis.
For the analysis of the effect of the interpolation curve on the predic-
tion of the percentage of electroporation we used only the Gompertz
curve (Eq. (3)) and symmetric sigmoid (Eq. (1)). There was no need
to do the analysis bothwith hyperbolic tangent (Eq. (4)) and symmetric
sigmoid (Eq. (1)) since they can be seen as equivalent (see their over-
lapping in Fig. 8).
If we look at Fig. 9 we can see that under our experimental condi-
tions the percentage of the affected cells depends more on the density
of the cells than on a type of the curve. When different curve was
used for the same density (compare dark gray bars for the symmetric
sigmoid (Eq. (1)) and black bars for the Gompertz curve (Eq. (3)) in
Fig. 9) the difference between predicted ranges was 4% at lower electric
field strengths (0.30–0.39 kV/cm) and even less for the higher ones. The
reason for the 4% difference can be observed from Fig. 8. There we can
see that at lower electric field values Eqs. (1) and (3) deviate the most
one from another.
At lower electric field values the symmetric sigmoid overestimates
the experimental results while the Gompertz curve offers better fit.
This means that the percentage predicted by the symmetric sigmoid
(Eq. (1)) is higher than the one predicted by the Gompertz curve
(Eq. (3)) which is not in very good agreement with experimental
results. But since the predicted ranges of electroporation are still quite
similar (0–4% for Eq. (3) and 4–8% for Eq. (1)) and they both underesti-
mate experimental results we can conclude that the choice of the curve
is not of highest importance.
The reason for discrepancy at the higher electric field could be the
fact that mathematical models for electroporation allow 100% electro-
poration although in reality there are always some cells which do not
respond to electric pulses and stay unaffected at least to very high
values of electric field. This is particularly true with single pulse applied
at very high electric fields (data not shown) as was the case in our
experiments. This could be the reason why the predicted ranges in
Fig. 9 are above the experimentally measured values.
In vitro a small fraction of dead cells is always detected, which ex-
plains the deviation of experimental data at the lowest electric field
strength from theoretical prediction by mathematical models for
electroporation.
If we look at the light gray bars at Fig. 9 (Gompertz curve (Eq. (3)) for
densities above 600 cells) per image, we can see that they do not repro-
duce the experimental results (triangles) properly. The mathematical
model of electroporation is underestimating the experimental results
at all of the applied electric field strengths for at least 10%. The reason
is in the density of the cells. Prediction was made on monolayers of
more than 600 cells per image. The experiments were performed58on monolayers of less than 600 cells per image. This means that the
density of the cells is a very important factor. It must be the same
in experiments used for prediction and in experiments where we
predict the percentage of electroporated cells. The prediction offered
better agreement only at the higher values of the electric field be-
cause the electric field was already strong enough for all of the curves
to reach their plateau values. Therefore, we can say that the density
of the cell monolayer is very important for predicting the percentage
of electroporation.
In previously published works a strong dependence between the
cells' electroporation and the density of the cells was already shown
[33,34]. In our study we went one step further and showed that the
cell density not only has a strong influence on the cells' electroporation
but is under our experimental conditions the most important factor
influencing the prediction of electroporation. We eliminated the effect
of the size of the cells since the experiments in homogeneous and inho-
mogeneous field were made on monolayers of similar density. Our
experiments have been performed in vitro on CHO cells. Our results
were obtained using single pulse of 1 ms duration; however we need
to establish how the parameters of curves depend on duration and
number of pulses, and different cells. In addition, there might be other
parameters besides the density of the cells which have an important in-
fluence on the prediction of electroporation.How this translates into tis-
sue remains to be determined; tissue level determination and validation
are still needed [38,39].Acknowledgments
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Abstract Electroporation is a phenomenon used in the
treatment of tumors by electrochemotherapy, non-thermal
ablation with irreversible electroporation, and gene therapy.
When treating patients, either predefined or variable elec-
trode geometry is used. Optimal pulse parameters are pre-
determined for predefined electrode geometry, while they
must be calculated for each specific case for variable elec-
trode geometry. The position and number of electrodes are
also determined for each patient. It is currently assumed that
above a certain experimentally determined value of electric
field, all cells are permeabilized/destroyed and under it they
are unaffected. In this paper, mathematical models of sur-
vival in which the probability of cell death is continuously
distributed from 0 to 100 % are proposed and evaluated.
Experiments were performed on cell suspensions using
electrical parameters similar to standard electrochemother-
apy and irreversible electroporation parameters. The pro-
portion of surviving cells was determined using clonogenic
assay for assessing the ability of a cell to grow into a colony.
Various mathematical models (first-order kinetics, Hu¨l-
sheger, Peleg-Fermi, Weibull, logistic, adapted Gompertz,
Geeraerd) were fitted to experimental data using a non-linear
least-squares method. The fit was evaluated by calculating
goodness of fit and by observing the trend of values of
models’ parameters. The most appropriate models of cell
survival as a function of treatment time were the adapted
Gompertz and the Geeraerd models and, as a function of the
electric field, the logistic, adapted Gompertz and Peleg-
Fermi models. The next steps to be performed are validation
of the most appropriate models on tissues and determination
of the models’ predictive power.
Keywords Clonogenic assay  Cell death probability 
Treatment planning  Electrochemotherapy  Predictive
models  Non-thermal irreversible electroporation
Introduction
Electroporation is a phenomenon that occurs when short
high voltage pulses are applied to cells and tissues. This
exposure of cells to electric pulses results in pores being
formed in the cell membrane. Membranes become per-
meable to molecules that cannot otherwise pass in or out of
the cell (Kotnik et al. 2012; Weaver 1993). If the cell is
able to recover, it is considered reversible electroporation.
If the damage to the cell is too extensive and the cell dies, it
is considered irreversible electroporation. The existence of
the pores has been shown by molecular dynamics (Dele-
motte and Tarek 2012) and calculated by various theoret-
ical models (Neu and Neu 2009; Weaver and Chizmadzhev
1996). Electroporation is already being used in medicine,
e.g., electrochemotherapy (Edhemovic´ et al. 2014), non-
thermal irreversible electroporation as a method of tissue
ablation (Cannon et al. 2013; Davalos et al. 2005; Garcia
et al. 2014; Long et al. 2014; Neal et al. 2013), gene
therapy (Daud et al. 2008; Heller and Heller 2010), DNA
vaccination (Calvet et al. 2014), and transdermal drug
delivery (Denet et al. 2004; Yarmush et al. 2014), as well
as in biotechnology (Kotnik et al. 2015) and food pro-
cessing (Mahnicˇ-Kalamiza et al. 2014; Sack et al. 2010). It
has been shown that a sufficient electric field (E-field) is
the most important factor—all the cells in the tumor have
to be permeabilized (in electrochemotherapy) (Miklavcˇicˇ
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et al. 1998) or irreversibly electroporated (in irreversible
electroporation) to eradicate the tumor. E-field distribution
also corresponds to tissue necrosis (Long et al. 2014;
Miklavcˇicˇ et al. 2000).
When performing electrochemotherapy, irreversible
electroporation or gene therapy, fixed electrode configu-
rations with predefined pulse parameters can be used
(Heller et al. 2010; Mir et al. 2006). Alternatively, variable
electrode configurations can be used when the target tumor
is outside the standard parameters (Linnert et al. 2012;
Miklavcˇicˇ et al. 2012). When using variable electrode
configurations, a plan is needed of the electrodes’ position
and the parameters of electric pulses that offer sufficient E-
field in the tissue (Campana et al. 2013; Miklavcˇicˇ et al.
2010; Neal et al. 2015; Sˇel et al. 2007; Zˇupanicˇ et al. 2012).
Treatment planning of electroporation-based medical
applications has already been successfully used on col-
orectal liver metastases in humans (Edhemovic´ et al. 2014),
and on spontaneous malignant intracranial glioma in dogs
(Garcia et al. 2011a, b). It is currently assumed in treatment
plans that above an experimentally determined threshold
value of E-field, all cells are permeabilized or destroyed
and below this threshold cells are not affected or do not
die—i.e., we assume a step-like response. In reality,
though, the transition from non-electroporated to electro-
porated state and from reversibly to irreversibly electro-
porated state is continuous. Mathematical models of cell
permeabilization and survival can be implemented in order
to present treatment plan in a clearer way and to obtain a
better prediction of the tissue damaged (Dermol and Mik-
lavcˇicˇ 2014; Garcia et al. 2014). In addition, mathematical
models allow us to interpolate the predicted survival of the
cells and predict survival for other parameters than those
used for curve fitting. The mathematical models of survival
have to be adaptable and describe the experimental data
well (high goodness of fit). Goodness of fit is not only an
important criterion but trends of the optimized values of the
parameters and the predictive power of the model are also
important. In an ideal case, the models would include all
the parameters important for cell death due to electropo-
ration, but would have the lowest possible number of
parameters.
There are only a few reports describing the probability
of cell permeabilization (Dermol and Miklavcˇicˇ 2014) and
cell survival after irreversible electroporation (Garcia et al.
2014; Golberg and Rubinsky 2010) using mathematical
models. The first attempt using mathematical model of
survival to describe cell death after irreversible electropo-
ration was made by (Golberg and Rubinsky 2010). They
successfully fitted the Peleg-Fermi model to experimental
data of prostate cancer cells’ death described in (Canatella
et al. 2001). Later, (Garcia et al. 2014) simulated irre-
versible electroporation on liver tissue and characterized
cell death using the Arrhenius rate equation for thermal
injury and the Peleg-Fermi model for electrical injury. The
authors determined that using commercially available
bipolar electrodes (AngioDynamics, Queensbury, USA)
and standard irreversible electroporation parameters (90
pulses, 100 ls duration, 1 Hz, 3000 V) most cell death is a
consequence of electrical damage. In that study, the vol-
ume of the thermally destroyed tissue did not surpass 6 %
of the whole destroyed volume and was concentrated in the
immediate vicinity of the electrodes.
Until now, the Peleg-Fermi model has been the only
mathematical model used for describing cell death as a
consequence of irreversible electroporation in medicine.
However, mathematical modeling of cell death has a long
history in the field of microbiology, e.g., food sterilization
(Peleg 2006). Most models from the field of microbiology
describe thermal microbial inactivation; an independent
variable is treatment time (t). We used these models (first-
order kinetics, Weibull, logistic, adapted Gompertz, Geer-
aerd) in original and in transformed forms. In the original
forms, the models remained unchanged, treatment time was
an independent variable, and E-field was a parameter. In
the transformed forms, E-field became the independent
variable. There was no need to transform the Hu¨lsheger
model and the Peleg-Fermi model, since the independent
variables were E-field and treatment time (Hu¨lsheger et al.
1981) or E-field and the number of pulses (Peleg 1995). In
existing studies, mathematical models have not yet been
used as a function of the E-field. Since E-field is a domi-
nant parameter for predicting the effect of the electropo-
ration, we were interested in obtaining models as a function
of E-field. We also provide an explanation of the reasoning
for the transformation for each of the transformed models.
In (Canatella et al. 2001), the authors exposed prostate
cancer cells to 1–10 exponentially decaying pulses in the
range of 0.1–3.3 kV/cm, with time constants in the range of
50 ls–20 ms. In our experiments, up to 90 square pulses,
0–4.0 kV/cm, 50–200 ls were applied, which are typically
used in electrochemotherapy and irreversible electropora-
tion treatments. Clonogenic assay was used as a measure of
the ability of the cells to reproduce (Franken et al. 2006).
Our study is the first attempt to compare different
mathematical models describing the survival of animal
cells due to electroporation. We present the results
obtained with electrical parameters similar to those typi-
cally used in electrochemotherapy and in irreversible
electroporation clinical treatments. We evaluate the trends/
meaning of the parameters of the mathematical models,
determine whether and which models could be used for
describing cell death, and which models should be vali-
dated in the treatment planning and treatment response
prognostics of electrochemotherapy and irreversible
electroporation.
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Materials and Methods
Cell Preparation and Electroporation
Chinesehamster ovary cells (CHO-K1;EuropeanCollectionof
Cell Cultures, Great Britain) were grown in 25-mm2 culture
flasks (TPP, Switzerland) for 2–3 days in an incubator (Kam-
bicˇ, Slovenia) at 37 C and humidified 5 % CO2 in HAM-F12
growth media (PAA, Austria) supplemented with 10 % fetal
bovine serum (Sigma Aldrich, Germany), L-glutamine (Stem-
Cell, Canada) and antibiotics penicillin/streptomycin (PAA,
Austria), and gentamycin (Sigma Aldrich, Germany). The cell
suspensionwas prepared on the day of experiments. Cells were
centrifuged and resuspended in potassium phosphate electro-
poration buffer (10 mM K2HPO4/KH2PO4 in a ratio 40.5:9.5,
1 mM MgCl2, 250 mM sucrose, pH 7.4, 1.62 mS/cm,
260 mOsm) at a concentration 106 cells/ml.
A drop of cell suspension (100 ll) was pipetted between
two parallel stainless steel electrodes (Fig. 1) with the dis-
tance between them set at 2 mm. The surface of the elec-
trodes was much larger than the contact surface between the
cell suspension and the electrodes. All the cells were thus
exposed to approximately the same electric field, which was
estimated as the voltage applied divided by the distance
between the electrodes. Pulses were delivered using a
Betatech electroporator (Electro cell B10 HVLV, Betatech,
France) and monitored with an oscilloscope LeCroy Wave-
Surfer 422, 200 MHz and a current probe AP015 (both
LeCroy, USA). The parameters of the applied electric pulses
are summarized inTable 1. The electrodeswerewashedwith
sterile 0.9 % NaCl and dried with sterile gauze between
samples. After pulse application, 80 ll of cell suspension
was transferred into a microcentrifuge tube in which there
was already 920 ll of HAM-F12. In the control, sample cells
were put between the electrodes and no pulses were deliv-
ered. Control was performed at the beginning and at the end
of each experiment to monitor whether the survival or
number of cells in the suspension during an experiment had
decreased. After all the samples had been exposed to electric
pulses (10–20 min), cells were diluted in 0.9 % NaCl and
plated in triplicates in 6-well plates (TPP, Switzerland) in
3 ml of HAM-F12. Different numbers of cells were plated,
shown in Table 2 for parameters with different lengths of
pulses and in Table 3 for parameters with different numbers
of pulses (Franken et al. 2006). In preliminary experiments,
we determined how many cells have to be seeded in order to
obtain around 100 colonies per well. When more intense
treatments (600 V, 50–90 pulses and 800 V, 30–90 pulses)
were applied, often no cells survived but, because of
experimental conditions, we could not seed more cells than
the given number. Cells were grown for 6 days at 37 C and
5 % CO2.
After 6 days, HAM-F12 was removed and cells were
fixed with 1 ml of 70 % ethanol (Lekarna Ljubljana,
Slovenia) per well. Cells were left in ethanol for at least
10 min,which rendered all cells dead. Colonieswere colored
with 200 ll of crystal violet (0.5 %w/v in distilledwater) per
well. Excessive crystal violet was washed away with pipe
water. Colonies that had more than 50 cells were counted.
The proportion of surviving cells (S) was calculated as
S ¼ number of colonies after the treatment
number of seeded cells  PE ; ð1Þ
where plating efficiency (PE) is defined as
PE ¼ number of colonies formed in the control
number of colonies seeded in the control
: ð2Þ
The number of colonies formed in the control was cal-
culated as an average of the triplicates of the colonies formed
in the controls at the beginning and at the end of the exper-
iment. The number of colonies seeded in control samples was
100. There was no difference between the two controls, so we
could pool the results. At least four independent experiments
were performed for each pulse parameter, and mean and
standard deviation were then calculated.
In order to determine whether our pulses were indeed
not causing significant heating, we measured the temper-
ature of the cell suspension before any pulses were applied
and within 5 s after the application of 90 pulses, 4.0 kV/
cm, i.e., the most intense exposure. Because of the limi-
tations of the temperature probe, the temperature could not
be measured during the pulse application. We used the
fiber optic sensor system ProSens (opSens, Canada) with a
Fig. 1 Stainless steel parallel plate electrodes with a droplet of cell
suspension between the electrodes (upper image). Inter-electrode
distance is 2 mm
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fiber optic temperature sensor, which was inserted in the
cell suspension between the electrodes. In addition, a
numerical model of the cell suspension droplet between the
electrodes was made and temperature distribution after
90 pulses of 4.0 kV/cm was calculated (Appendix).
Fitting of the Mathematical Models of Survival
to the Experimental Results
Different mathematical models of survival were fitted to the
experimental data: (i) the first-order kinetics model (Bige-
low 1921), (ii) the Hu¨lsheger model (Hu¨lsheger et al. 1981),
(iii) the Peleg-Fermi model (Peleg 1995), (iv) the Weibull
model (van Boekel 2002), (v) the logistic model (Cole et al.
1993), (vi) the adapted Gompertz model (Linton, 1994), and
(vii) the Geeraerd model (Geeraerd et al. 2000). The method
of non-linear least squares was applied using Matlab
R2011b (Mathworks, USA) and Curve fitting toolbox.
Optimal values of the parameters of the mathematical
models and R2 values were determined. R2 or the coefficient
of determination is a statistical measure for the goodness of
fit, i.e., it is a correlation between the predicted and
experimentally determined values. Its values can be
between 0 and 1 and the closer its value is to 1, the better the
fit is. Natural logarithms of mathematical models were fitted
to natural logarithms of the experimental data. This pre-
vented the residuals at higher proportions of surviving cells
from influencing the R2 value the most. Treatment time t
was understood as the time of exposure of cells to the
electric field (E-field). It was calculated as
t ¼ NT ; ð3Þ
where N means number of the applied pulses and T the
duration of one pulse.
The first-order kinetics model has a long history
(Bigelow 1921):
SðtÞ ¼ expðktÞ: ð4Þ
Here, t denotes the time of exposure of bacteria to high
temperature and k is the first-order parameter, i.e., the
speed of decrease of the number of bacteria as a function of
the duration of their exposure to heat.
Hu¨lsheger studied the effect of E-field on E. coli and
derived an exponential empirical model (Hu¨lsheger et al.
1981):
Sðt;EÞ ¼ t
tc
 ðEEcÞ
k
; ð5Þ
Table 1 Experimental
parameters of electric pulses,
pulse repetition frequency 1 Hz
Voltage/V Electric field/kV/cm Number of pulses/- Pulse duration/ls
Varying pulse length 0–800, step 100 0–4, step 0.5 8 50, 100 or 200
Varying pulse number 0–800, step 200 0–4, step 1 30, 50, 70 or 90 100
Table 2 Number of plated cells
in experiments with different
lengths of the pulses, 8 pulses,
1 Hz pulse repetition frequency
Voltage/V Electric field/kV/cm Number of plated cells/-
For 50 ls For 100 ls For 200 ls
0 0 100 100 100
100 0.5 100 100 100
200 1.0 120 120 120
300 1.5 150 150 150
400 2.0 200 200 200
500 2.5 200 400 400
600 3.0 400 1000 1000
700 3.5 1000 2500 2500
800 4.0 2500 10,000 25,000
Table 3 Number of plated cells
in experiments with different
numbers of the pulses, 100 ls,
1 Hz pulse repetition frequency
Voltage/V Electric field/kV/cm Number of plated cells/-
For 30 pulses For 50 pulses For 70 pulses For 90 pulses
0 0 100 100 100 100
200 1.0 120 150 200 200
400 2.0 1000 2500 25,000 25,000
600 3.0 25,000 25,000 25,000 25,000
800 4.0 25,000 25,000 25,000 25,000
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where k is a constant, which depends on the type of
microorganism, Ec is the critical value of E-field below
which there will be no inactivation (100 % survival), and tc
is the extrapolated critical value of t below which there will
also be no inactivation.
The Peleg-Fermi model (Peleg 1995) has already been
used for modeling irreversible electroporation (Garcia et al.
2014; Golberg and Rubinsky 2010) and is defined as
S E;Nð Þ ¼ 1
1þ exp EEc Nð Þ
k Nð Þ
  ; ð6Þ
EcðNÞ ¼ Ec0 expðk1NÞ; ð7Þ
kðNÞ ¼ k0 expðk2NÞ; ð8Þ
where Ec means critical E-field, N is the number of applied
pulses, k is the kinetic constant that defines the slope of the
curve, Ec0 is the intersection of Ec(N) with the y axis, k0 is a
constant in kV/cm, k1 and k2 are non-dimensional constants
that depend on the parameters of the pulses and on the
cells.
The Weibull model describes the time to failure of
electronic devices after they have suffered some stress. The
Weibull model is based on the observation that cells die at
different times, which are statistically distributed. Cell
death due to electroporation can also be described using the
Weibull model (van Boekel 2002). We made a parallel: cell
death as a function of E-field is also statistically dis-
tributed. In addition, no-one has so far observed any cor-
relation between biological parameters and the parameters
of the Weibull model. We thus transformed the Weibull
model as a function of treatment time to a function of E-
field. In previous studies, the independent variable was
treatment time (time of exposure to high temperature or E-
field). The Weibull model as a function of t is
S tð Þ ¼ exp  t
b
 n 
; ð9Þ
where t denotes time of exposure, b is a scale parameter,
and n is a shape parameter. We can transform the Weibull
model and obtain a model as a function of E:
S Eð Þ ¼ exp  E
b
 n 
; ð10Þ
where all the parameters have the same meaning as in (9).
The logistic model can be used for describing distribu-
tions with a sharp peak and long tails (Cole et al. 1993).
The logistic model is defined as
S tð Þ ¼ 10
xa
1þexp 4rðslog10ðtÞxa
 
 !
; ð11Þ
where parameter a denotes the common logarithm of the
upper asymptote (survival around t = 0), x the common
logarithm of the lower asymptote (survival when t ? ?),
r the maximum slope, and s the position of the maximum
slope. We measured the proportion of surviving cells. After
a short treatment time, most of the cells are still alive,
survival is 1. Therefore,
a ¼ log upper asymptoteð Þ ¼ log 1 ¼ 0: ð12Þ
This allows us to simplify the Eq. (11) by assuming
a = 0:
S tð Þ ¼ 10
x
1þexp 4rðslog10ðtÞx
 
 !
; ð13Þ
where all the parameters have the same meaning as in (11).
A cumulative distribution of cell death was obtained in
the experimental results. This means that the experimental
data point of proportion of destroyed cells includes also
cells that would already die at shorter treatment times or
lower E-field values. A derivative of the cumulative cell
death distribution shows how cell death is spread over
different treatment times or E-field values; it shows cell
death distribution. Because our experimental data was
discontinuous, we obtained the derivative by calculating
the difference in survival between two consecutive data
points. We thus obtained the proportion of cells that die in
a certain range of treatment time or E-field values, for
example from 3000 to 5000 ls or from 1 to 2 kV/cm.
Shorter treatment times or lower E-field values do not kill
cells in that range. In dependence on the logarithm of the
treatment time, the derivative of the cumulative cell death
distribution (the derivative of experimental results) has a
sharp peak and two long tails. A similar shape of cell death
distribution is obtained as a function of E-field (without the
logarithm). As already mentioned, the logistic model is
suitable for distributions with a sharp peak and long tails.
This was our basis for the transformation from treatment
time as the independent variable to E-field as the inde-
pendent variable. The model is
S Eð Þ ¼ 10
x
1þexp 4rðsEÞxð Þ
 
; ð14Þ
where r and s have the same meaning as in (11) and x
denotes survival when E ? ?.
The Gompertz model is usually used for describing
growth of a tumor but in an adapted form it has also been
used for cell survival (Linton 1994):
S tð Þ ¼ exp Aee B0þB1 tð Þ  AeeB0
 
: ð15Þ
A denotes the natural logarithm of the lower asymptote, B0
is the length of the upper asymptote, and B1 is connected to
the speed of cell death. B1’s absolute value determines the
speed, the minus sign means a decrease in the number of
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cells and plus means an increase. The adapted Gompertz
model is purely empirical and was chosen because it offers
an excellent goodness of fit. High R2 is also obtained if the
independent variable is E-field instead of treatment time.
This was the reason for the transformation from treatment
time as the independent variable to E-field as the inde-
pendent variable. We transformed the adapted Gompertz
model to a model as a function of E:
SðEÞ ¼ expðAee B0þB1Eð Þ  AeeB0 Þ; ð16Þ
where all the parameters mean the same as in (15).
Geeraerd defined a model that describes exponential
decay of the number of surviving cells and a lower
asymptote that models the remaining resistant cells
(Geeraerd et al. 2000; Santillana Farakos et al. 2013):
S tð Þ ¼ Y0  Nresð ÞexpðktÞ þ Nres: ð17Þ
Y0 means the number of cells at the beginning of experi-
ments, Nres is the lower asymptote, and k is the specific
inactivation rate (the slope of the exponentially decaying
part of the curve). In our study, the number of cells was
substituted by the proportion of cells in order to scale the
model to our experimental data. At the beginning of our
experiments, the proportion of survival was always 1. We
simplified the Geeraerd model into
S tð Þ ¼ 1 Nresð ÞexpðktÞ þ Nres; ð18Þ
where all the parameters have the same meaning as in (17).
Results
Experimental Results
Figure 2 shows the experimental results—Fig. 2a for dif-
ferent pulse lengths and Fig. 2b for different numbers of
pulses. Experimental results are shown in a semi-loga-
rithmic scale, which enables low proportions of surviving
cells to be visualized. It can be observed in Fig. 2a that
longer pulses of the same electric field (E-field) cause
lower survival. However, with 8, 200 ls pulses of 4.0 kV/
cm, survival is still higher than with 50 or more 100 ls
pulses of 4.0 kV/cm (Fig. 2b). When the E-field increases
from 1.0 to 2.0 kV/cm, the survival after 50 pulses applied
drops by two decades, while after 70 and 90 pulses it drops
by three decades. In Fig. 2b, it can be seen that the
experimental values of survival are very similar for 50, 70,
and 90 pulses of 3.0 kV/cm and 4.0 kV/cm.
Results of the Mathematical Modeling
The results of the mathematical modeling are presented in
two ways. First, Tables 4, 5, 6, and 7 summarize the optimal
values of the parameters and R2 values for all the mathe-
matical models described in the Materials and Methods
section. Figures 3, 4, 5, and 6 show plotted optimized
mathematical models. When the results of the fitting are
presented in linear scale, the curves go straight and exactly
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Fig. 2 Experimental results of the clonogenic assay for different
pulse lengths (a) and for different numbers of pulses (b) as a function
of the applied electric field (E). Mean ± one standard deviation is
shown, pulse repetition frequency 1 Hz. If mean minus standard
deviation is lower than 0, it cannot be presented in a semi-logarithmic
scale and there is no error bar. The survival is lower when longer
pulses are applied and the electric field is held fixed. However, higher
number of pulses decreases the survival considerably. With 8, 200 ls
pulses of 4 kV/cm, the survival is still higher than with 50 or more
100 ls pulses, 4 kV/cm
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through the experimental results. In semi-logarithmic scale,
deviations are more easily noticed. When fitting survival
models to experimental results, it is advisable also to look at
the data in semi-logarithmic scale. All our results are
therefore presented in semi-logarithmic scale. When com-
paring the values of our optimized parameters with the val-
ues in other studies, it must be borne inmind that on the x axis
there are t in ls or E-field in kV/cm.
Mathematical Models Describing Cell Survival
as a Function of Treatment Time
A good fit could not be achieved using the Hu¨lsheger
model (5) because there were problems with the initial
value of the parameters and local minima. The results are
thus not shown and we do not discuss them.
In Fig. 3, (3.0 kV/cm, 100 ls, 1 Hz) it can be observed
that the Weibull model (9), the logistic (13), the adapted
Gompertz (15), and the Geeraerd models (18) are all
similarly shaped and go very close to the experimental
points. From the point of goodness of fit, they can be seen
as equally good. The first-order kinetics model (4) is only
able to describe a straight line in semi-logarithmic scale
(Fig. 3, gray dashed line). It is unadaptable and offers low
R2 (0.47–0.90). Because of very low goodness of fit, the
meaning of its parameters is not relevant.
Table 4 gives the optimized values of the parameters of
the mathematical models as a function of treatment time. In
the Weibull model (9), the values of n and b decrease with
a higher applied E-field. In the logistic model (13), the
value of the parameter x decreases with higher E. The
values of parameter s are very similar. The values of r
increase with longer pulses, as expected (higher value,
steeper slope). In the adapted Gompertz model (15), the
values of parameter A decrease, which means a lower
asymptote is reached. The values of parameters B0 and B1
also decrease, which means faster cell death with longer
pulses applied. In the Geeraerd model (18), Nres corre-
sponds to the remaining surviving cells and decreases with
higher E (similar to parameter A in the Gompertz model).
Parameter k corresponds to the speed of decrease and also
increases, both as expected.
Mathematical Models Describing Cell Survival
as a Function of Electric Field
In Fig. 4 (8, 100 ls pulses, 1 Hz), it can be observed that
all models look very similar. The difference is in their
behavior at high E-fields, i.e., in extrapolation of the data.
In terms of goodness of fit, all four models on Fig. 4
(Peleg-Fermi (6), Weibull (10), logistic (14) and Gompertz
(16)) can be considered equal.
In Fig. 5 (90, 100 ls pulses, 1 Hz), however, the dif-
ferences among the models are more pronounced. They no
longer overlap as shown in Fig. 4. The Peleg-Fermi (6) and
Weibull models (10) go close but not exactly through the
Table 4 Calculated optimal values of parameters of mathematical models as a function of treatment time and R2 value for different electric field
values
Mathematical models Parameters Optimized values of parameters and R2 value
For 2.0 kV/cm (400 V) For 3.0 kV/cm (600 V) For 4.0 kV/cm (800 V)
First-order kinetics model (4) k 0.0008805 0.001382 0.001582
R2 0.9096 0.8237 0.4747
Weibull model (9) b 908 112 3.178
n 0.8915 0.5490 0.3105
R2 0.9135 0.9442 0.9225
Logistic model (13) x –3.925 –6.026 –20.760
r –5.059 –4.240 –2.815
s 3.659 3.532 4.078
R2 0.9346 0.9607 0.9260
Adapted Gompertz model (15) A –8.18 –14.15 –16.05
B0 1.419 0.3732 1.8e-6
B1 –0.0004339 –0.0004419 –0.001291
R2 0.9389 0.9661 0.8539
Geeraerd model (18) Nres 0.0005619 4.157e-5 4.014e-5
k 0.001004 0.002011 0.007824
R2 0.9390 0.9788 0.8411
In all the experiments, pulses of 100 ls duration with pulse repetition frequency 1 Hz were applied
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experimental points (R2 between 0.90 and 0.91), since they
cannot model the lower asymptote but only a shoulder and
then a constant decrease of cell survival (on a semi-loga-
rithmic scale). The logistic and the adapted Gompertz
models, on the other hand, go exactly through the experi-
mental points (R2[ 0.99) and also look very similar. From
the point of view of the adaptability of the models, the
logistic and Gompertz models are better than the Weibull
(10) and Peleg-Fermi models (6).
Table 5 shows the results of fitting mathematical models
as a function of E-field for different pulse lengths. The
results of fitting the Peleg-Fermi model (6), the Weibull
model (10), the logistic model (14), and the adapted
Gompertz model (16) as a function of E-field are presented.
For each model, the optimal values of the parameters and
R2 value for three different pulse durations (50, 100 and
200 ls) are shown.
Table 6 presents the results of fitting mathematical
models as a function of E-field for different numbers of
pulses. Optimal values of parameters and R2 values for
each fit are shown. The pulse length was held fixed at
100 ls. It can be seen that R2 values are relatively high for
Table 5 Calculated optimal
values of parameters of
mathematical models as a
function of electric field and R2
for different lengths of the
pulses
Mathematical models Parameters Optimal values of parameters and R2 value
For 50 ls For 100 ls For 200 ls
Peleg-Fermi model (6) Ec/kV/cm 2.766 2.344 2.001
k/kV/cm 0.4160 0.2677 0.2871
R2 0.9968 0.9975 0.9836
Weibull model (10) b 2.992 2.408 1.936
n 2.831 3.645 2.695
R2 0.9900 0.9964 0.9615
Logistic model (14) x –1.555 –3.780 –2.961
r –0.963 –1.888 –2.082
s 3.383 3.537 2.916
R2 0.9966 0.9951 0.9809
Adapted Gompertz model (16) A –5.348 –19.080 –7.692
B0 3.528 2.683 4.149
B1 –1.013 –0.6438 –1.505
R2 0.9987 0.9991 0.9961
In all the experiments, 8 pulses with pulse repetition frequency 1 Hz were applied
Table 6 Optimized values of parameters of mathematical models as a function of E and R2 for different numbers of the pulses; the column 8
pulses is the same as the column 100 ls in Table 5
Mathematical models Parameters and R2 Optimal values of parameters and R2 value
For 8 pulses For 30 pulses For 50 pulses For 70 pulses For 90 pulses
Peleg-Fermi model (6) Ec (kV/cm) 2.3440 0.9720 0.9517 0.4298 0.4853
k (kV/cm) 0.2677 0.4260 0.2446 0.2833 0.2852
R2 0.9975 0.8959 0.9637 0.9085 0.9148
Weibull model (10) b 2.336 1.030 0.731 0.388 0.416
n 3.410 1.439 1.480 1.076 1.098
R2 0.9989 0.9652 0.9408 0.9004 0.9039
Logistic model (14) x –3.78 –2.93 –4.99 –4.58 –4.63
r –1.888 –1.474 –3.308 –5.029 –4.483
s 3.537 2.260 2.243 1.754 1.863
R2 0.9951 0.9918 0.9989 0.9825 0.9995
Adapted Gompertz model (16) A –19.08 –7.23 –11.74 –10.82 –10.96
B0 2.683 2.439 3.849 3.372 3.348
B1 –0.643 –1.221 –1.894 –2.221 –2.037
R2 0.9991 0.9987 0.9999 0.9865 0.9999
In all the experiments, pulses of 100 ls duration with pulse repetition frequency 1 Hz were applied
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all the fits in Tables 5 and 6. The trends of the models are
therefore analyzed more carefully for each of the models
separately in the following paragraphs.
The plotted optimized Peleg-Fermi model (6) is pre-
sented in Fig. 6a. The Peleg-Fermi model (6) has an
additional two models, which describe Ec0 (7) and k (8) as
functions of the number of pulses (N). Optimal parameters
of these two models (7), (8) are plotted in Fig. 6b. In
Fig. 6a, it can be seen that for higher numbers of pulses (50
or more), the model does not go exactly through the
experimental points. For 8 and for 30 pulses, the Peleg-
Fermi model describes the data very well, since there are
no problems with modeling the lower asymptote. In
Fig. 6b, it can be seen that Eq. (7) fits the experimental
points well (black circles). However, Eq. (8) does not fit
the data well (white squares on Fig. 6b), R2 = 0.049.
Equation (8) suggests an exponential dependence of k on
the number of pulses, while in our data the value of k is
almost constant.
Table 7 presents additional results of fitting the Peleg-
Fermi model, in which optimal values of the parameters
and R2 value for each fit of Eqs. (7) and (8) are shown. As
already observed in Fig. 6b, Eq. (8) does not describe our
data well. It can be observed that the goodness of fit is
relatively high for the Peleg-Fermi model ([0.89) for dif-
ferent durations (Table 4), as well for different numbers of
pulses (Table 5).
The Weibull model as a function of E-field (10) has a
similar shape as the Peleg-Fermi model (6) (Fig. 5). The
Weibull model cannot describe a sigmoid shape in semi-
logarithmic scale, so a deviation at higher E-field of more
than 8 pulses is noticeable (compare gray solid lines in
Figs. 4 and 5). The meaning of the parameters of the
Weibull model has not yet been established (10) and there
is also no trend in the value of parameter n in our results.
The value of parameter b decreases with longer pulses
(Table 5) and with a higher number of pulses applied
(Table 6).
The logistic (14) model is more adaptable and has a
concave (Fig. 4) or sigmoid shape (Fig. 5) in semi-loga-
rithmic scale. When fitting the logistic model (14) to the
results of different pulse lengths (Table 5), r decreases
(faster death). Parameter s denotes where on the x axis the
decrease is fastest. It is similar for all pulse lengths
(Table 5). When only 8 pulses of different lengths are
applied (Table 5), the asymptote is not reached (Fig. 1a).
Although the model predicts an asymptote, it is outside the
Table 7 Calculated optimal values of parameters of additional Peleg-
Fermi mathematical models (7), (8) for Ec and k as functions of N
Mathematical models Parameters Optimal values
of parameters
and R2 value
Peleg-Fermi mathematical
model for Ec(N) (7)
Eco (kV/cm) 2.734
k1 0.02506
R2 0.9237
Peleg-Fermi mathematical
model for k(N) (8)
k0 (kV/cm) 0.3259
k2 0.001598
R2 0.04916
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Fig. 3 Mathematical models (lines) and experimental results (sym-
bols) showing cell survival as a function of the treatment time (3 kV/
cm, 100 ls, 1 Hz). On y axis, there is the proportion of the surviving
cells (S) in logarithmic scale. For each fit, R2 value is shown. Except
for the first-order kinetics model (4), all the models offer a good fit
(R2[ 0.94). We found the adapted Gompertz (15) and the Geeraerd
model (18) to be the most suitable
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Fig. 4 Mathematical models (lines) and experimental results (sym-
bols) showing cell survival as a function of electric field (8 pulses,
100 ls, 1 Hz). On y axis, there is the proportion of the surviving cells
(S) in logarithmic scale. For each fit, R2 value is shown. All the
models as a function of electric field offer a similarly good fit
(R2[ 0.99). We found the adapted Gompertz (16), the Peleg-Fermi
model (6)–(8), and maybe the logistic (14) model to be the most
suitable
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range in which our models are valid. In this case, the value
of x is not relevant since the models are not meant for
extrapolation of the data. When fitting the logistic model to
the results of different numbers of pulses, the parameters
cannot be so easily explained. Parameter x is similar with
more pulses applied (Table 6) since we reach a similar
lower asymptote (Fig. 1b). Parameter r is similar for 70
and 90 pulses and on average higher than for 30 and 50
pulses. This means faster cell death when 70 or 90 pulses
are applied. Parameter s mostly decreases with a higher
number of pulses applied (Table 6), which means that cells
die at lower E-fields when more pulses are applied.
When applying the adapted Gompertz model (16) to the
results of different pulse lengths, the values of parameter
A are quite different (Table 5) because the lower asymptote
was not reached in the experiments (Fig. 2a). Parameter
A also does not have a trend with different numbers of
pulses applied (Table 6), but the reason could be that with
50, 70, or 90 pulses, there is a similar proportion of sur-
viving cells at higher E-field (around 10-5). Parameters B0
and B1 in Table 5 have similar values since the experi-
mental values for different lengths of the applied pulses are
similar. The value of B0 is similar for different numbers of
pulses (Table 6) since it denotes the length of the upper
asymptote, which is similar for all lengths of pulses
(Fig. 5). B1 decreases with more pulses (Table 6), which
means faster death with more pulses applied.
Discussion
Several mathematical models are able to describe experi-
mental results. The most appropriate models as a function
of treatment time are the adapted Gompertz (15) and the
Geeraerd models (18). The logistic model (13) can be used
but a clearer meaning of its parameters needs to be estab-
lished. The most appropriate models as a function of
electric field (E-field) were the Peleg-Fermi (6), the logistic
(14), and the adapted Gompertz models (16). Mathematical
models of cell survival could thus be integrated into
treatment planning of electrochemotherapy and irreversible
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Fig. 5 Mathematical models (lines) and experimental results (sym-
bols) showing cell survival as a function of electric field (90 pulses,
100 ls, 1 Hz). On y axis, there is the proportion of the surviving cells
in logarithmic scale. For each fit, R2 value is shown. Experimental
values at 3 kV/cm and at 4 kV/cm (the lower asymptote) are on the
limit of our detection. We found the adapted Gompertz (16), the
Peleg-Fermi model (6)–(8), and maybe the logistic (14) model to be
the most suitable
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Fig. 6 The Peleg-Fermi model (6) for different numbers of pulses
applied. For each fit, R2 value is shown. a Symbols are the
experimental values for 1 Hz, 100 ls, lines show the Peleg-Fermi
model (6). b Symbols are the optimized values of Ec and k, lines show
the optimized mathematical models (7) and (8). On y axis, there are
the values of Ec and k in kV/cm. Since the Peleg-Fermi model (6)
incorporates dependence on E as well as on N (7), (8) it already
connects two treatment parameters (electric field and number of the
pulses) and can therefore be used more easily than other models
investigated in this study
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electroporation as a method of tissue ablation. It must be
emphasized that the models should not be extrapolated,
since they predict different behaviors at very high E-fields
or very long treatment time. Some of them keep on
decreasing and some of them reach a stable value on a
semi-logarithmic scale.
Experimental Considerations
The electrical parameters chosen for the experiments were
similar to electrochemotherapy and irreversible electropo-
ration electrical parameters typically used in vivo. For
electrochemotherapy parameters, we used a fixed number
of pulses (8) and we varied the length of the pulses. In
electrochemotherapy treatments, 100 ls pulses are usually
used but to evaluate the trend of the parameters of the
mathematical models we also applied 50 ls and 200 ls
pulses (results on Fig. 2a). For irreversible electroporation
parameters, we tried to cover the parameter space as
equally as possible. In an orthogonal space, where on one
axis there was number of the pulses (N) and on the other E-
field, we equidistantly sampled it by increasing the voltage
by 200 V and the number of pulses by 30 (results on
Fig. 2b).
An important aspect of irreversible electroporation
experiments is the effect of increased temperature. Because
of high voltage, many pulses, and high current, the tem-
perature in the tissue or (as in our case) in the cell sus-
pension can be increased considerably by Joule heating
(Zˇupanicˇ and Miklavcˇicˇ 2011). Heating can change the
conductivity of the cells, as well as damage them (Neal
et al. 2012). Cell death could therefore be a thermal and not
electrical effect (Garcia et al. 2014). The temperature of the
suspension was therefore measured before and within 5 s
after the end of application of 90 pulses, 4.0 kV/cm (the
most severe electrical parameters employed in our study).
Even with the most severe electrical parameters, the tem-
perature within 5 s after the end of pulse application did
not surpass 40 C. This proved that, under our experi-
mental conditions, cell death can indeed be considered
solely as a consequence of irreversible electroporation.
The percentage of surviving cells was first evaluated
using tetrazolium based assay (MTS assay). The MTS
assay, however, proved not suitable for distinguishing
between low proportions of surviving cells and it cannot be
used to quantify the number of living cells exactly. The
MTS assay is based on measurements of absorbance, which
is then correlated to the number of metabolically active
cells. After reaching 2 % of the surviving/metabolically
active cells, the number did not drop, no matter how much
higher an E-field or how many more pulses we applied.
Since irreversible electroporation can be used successfully
to treat tumors, a lower percentage of surviving cells
should be achievable. In addition, metabolic activity and
the ability to divide do not necessarily correlate. We
therefore decided to use clonogenic assay, which requires
more time than the MTS assay but enables exact quantifi-
cation of the number of clonogenic cells. With more severe
treatments, we could detect as low as 1 surviving cell in
25,000 (4 9 10-5 survival). In some experiments, the
survival was lower than 4 9 10-5 because the final pro-
portion of surviving cells was calculated as a mean over at
least four repetitions. Often no cells survived (0 survival)
with severe treatments. In calculating the mean, the 0
survival caused the final proportion of the survival to be
lower than 4 9 10-5. The detection limit of our clonogenic
assay was thus reached at approximately 4 9 10-5. The
lower asymptote that can be observed in Fig. 2b for 50, 70,
and 90 pulses at 3.0 and 4.0 kV/cm could be a consequence
of the detection limit. For more precise (and lower), pro-
portions of surviving cells at high E-field values and many
pulses, more cells should be seeded, which can be achieved
using a denser cell suspension. However, more precise
results with denser cell suspension are perhaps not even
needed. In vivo, the last few clonogenic cells seem to be
eradicated by the immune system when performing elec-
trochemotherapy (Calvet et al. 2014; Mir et al. 1992; Sersˇa
et al. 1997), as well as irreversible electroporation (Neal
et al. 2013). The proportion of cells needed to kill to cause
a complete response and destroy the whole tumor should be
determined in future studies.
In our experimental results, we determined that the
transition area between maximum and minimum survival
gets narrower, i.e., the death of cells is quicker with higher
numbers of pulses applied (Fig. 1b). This is in agreement
with the theoretical predictions made (Garcia et al. 2014)
using the Peleg-Fermi model. The authors predicted that
the transition zone between electroporated and non-elec-
troporated tissue becomes sharper when more pulses are
applied.
There are also other parameters of the electric pulses,
and biological parameters, which could affect the survival
of cells. For example, the pulse repetition frequency in our
experiments was always 1 Hz and when calculating the
treatment time as t ¼ NxT ; we ignored the effect of pulse
repetition frequency. There are contradicting studies that
report on its effect on cell survival (Pakhomova et al. 2013;
Pucihar et al. 2002; Silve et al. 2014). The effect of pulse
repetition frequency on the shape of survival curves needs
also to be investigated in future studies. It must be
emphasized that even if t1 ¼ t2 ¼ N1T1 ¼ N2T2 his cannot
be necessarily understood as equal if T1 6¼ T2 and N1 6¼ N2:
Different repetition frequencies affect cell permeabiliza-
tion, and cell survival and temperature increase differently.
We therefore present and discuss the results of different
numbers and different lengths of applied pulses separately.
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The value of E-field applied in the tissue is needed for
correct prediction of surviving cells. At the moment, the
most reliable method of determining E-field in tissues is
numerical modeling. However, in future, the E-field in
tissue could be monitored using current density imaging
and magnetic resonance electrical impedance tomography
(Kranjc et al. 2012, 2015). Cell survival in tissue could be
correlated even better by taking into account conductivity
changes (Kranjc et al. 2014) measured during application
of the pulses.
One possible problem with prediction of cell death in
tissues is the use of mathematical models fitted in vitro in
an in vivo environment. Tissues, unlike cell suspensions,
are heterogeneous; there are connections between cells;
cells are irregularly shaped; extracellular fluid is more
conductive than the pulsing buffer used in our study; and
there is an immune system present. Before starting clinical
studies, the parameters of electric pulses are first tested on
cell lines. In the past, good correlation was found between
the behavior of cells in vitro and in vivo. We expect sur-
vival curves in tissues to have a similar shape as in our
in vitro study. The question is whether there will be a lower
asymptote present or survival as a function of treatment
time or E-field will keep decreasing. Our models can
describe both options. The optimal values of the parameters
depend on the sensitivity of the cells to the electric pulses
and will probably be different. If the threshold values of the
E-field for reversible and irreversible electroporation for
different tissues are compared, different values can be
found. For example, in vivo the threshold values of the E-
field for muscle (8 9 100 ls pulses) for reversible elec-
troporation have been determined to be 0.08 kV/cm and
0.2 kV/cm (parallel and perpendicular directions, respec-
tively) and for irreversible electroporation to be 0.4 kV/cm
(the same for parallel and perpendicular directions of
muscle fibers) (Cˇorovic´ et al. 2010, 2012). In vivo the
threshold for irreversible electroporation of healthy pros-
tate tissue has been determined to be 1 kV/cm (90 9 70 ls
pulses) (Neal et al. 2014), and for healthy brain tissue
0.5 kV/cm (90 9 50 ls pulses) (Garcia et al. 2010). For
healthy liver tissue, the threshold for reversible electropo-
ration has been reported to be 0.36 kV/cm and for irre-
versible electroporation 0.64 kV/cm (Miklavcˇicˇ et al.
2000). The thresholds thus seem to be different for dif-
ferent tissues (Jiang et al. 2015). In vitro the thresholds are
usually higher and different for different cell lines: for
reversible electroporation around 0.4 kV/cm and for irre-
versible electroporation around 1.0 kV/cm for 8 9 100 ls
pulses (Cˇemazˇar et al. 1998). The curves in vivo can
therefore be expected to have a similar shape but they will
be scaled according to the thresholds for different types of
tissue.
Mathematical Modeling
It was mentioned in the Introduction section that predictive
power is one of the three most important criteria for
choosing the model (in addition to goodness of fit and
trends of values of the optimized parameters of the mod-
els). In our current study, however, predictive power was
not assessed. For assessing predictive power, our optimized
models must be validated on the samples for which the
survival will be predicted. In our case, the models will be
used in predicting death of tissues in electrochemotherapy
and irreversible electroporation. Validation of the models
on tissues is beyond the scope of this paper but must be
done before implementing the models in actual treatment
planning of electroporation-based treatments. The reader
should also note that all the models approach 0 survival
asymptotically but can never actually reach 0 survival. As
already discussed, it is still not known how many cells must
be killed to achieve a complete response of the tumor.
Based on the fact that the immune system seems to erad-
icate the last remaining tumor cells, it seems that our
models adequately describe 0 to 100 % survival. It remains
to be established, however, what percentage of cells actu-
ally needs to be killed by irreversible electroporation.
Mathematical Models Describing Cell Survival
as a Function of Treatment Time
We fitted the first-order kinetics (4), the Weibull (9), the
logistic (13), the adapted Gompertz (15), and the Geeraerd
(18) models to the experimental data as a function of
treatment time. At 1.0 kV/cm (200 V), the percentage of
surviving cells decreased to 68 % for 90 pulses, 100 ls,
1 Hz. The results of fitting the models to 200 V are thus not
presented, since the decrease in survival was too small to
be relevant for describing cell death due to electroporation.
It can be seen in Fig. 3 that, except for the first-order
kinetics model (4), all the models describe the experi-
mental points well. From the point of goodness of fit, the
Weibull (9), the logistic (13), the adapted Gompertz (15),
and the Geeraerd model (18) are equal. The next criterion
is the trend of parameters which is to be discussed for each
model separately in the next paragraph.
The first-order kinetics model (4) has a very low R2
(Table 4) and it is not suitable for describing cell death. It
is still very often used for describing microbial inactiva-
tion. (Peleg 2006) stated that the first-order kinetics model
is popular because any data can be described with it if the
data are sampled too sparsely. The second reason for its
popularity is its long history. In the Weibull model (9), the
parameters have a trend. However, in many studies, it has
been shown that parameter n is not connected to any
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biological or other parameter (A´lvarez et al. 2003; Mafart
et al. 2002; Stone et al. 2009; van Boekel 2002). It only
describes the shape of the curve (concave, convex, linear).
The Weibull model is often used because it is highly
adaptable and can describe different shapes. Because the
Weibull model was used in many previous studies, but the
meaning of the parameters was not established in any of
them, the Weibull model is most likely not suitable for
predicting cell death after electroporation. The logistic
model (14) has a high R2 and most of its parameters can be
connected to some biological parameter. It may be suitable
for predicting cell death due to electroporation but the
meaning of its parameters must be more clearly defined. In
the adapted Gompertz model (16), both parameters B0 and
B1 behave as expected (shorter upper asymptote and stee-
per decline). The Geeraerd model was defined for the
shapes of curves just like ours—first the number of the
cells exponentially decreases and, after a certain treatment
time, it reaches a lower asymptote. The R2 value was high
and there was a trend of the values of the parameters.
It can be concluded that, as a function of treatment time,
adapted Gompertz and Geeraerd models are suitable, while
the logistic model has potential but should be tested with
more electrical parameters.
Mathematical Models Describing Cell Survival
as a Function of Electric Field
It can be seen in Fig. 4 that if there is no lower asymptote
present, all the models describe the data well and have a
similar R2 value. In Fig. 5, a lower asymptote is present and
the goodness of fit is different for different models. Looking
at Figs. 4 and 5, it can be said that the logistic (14) and the
adapted Gompertz models (16) are most suitable. In the
Weibull model (10) (Tables 5, 6), there is no trend in the
values of the optimized parameters. The Weibull model is
not suitable for the use in treatment planning. The adapted
Gompertz model (16) has high R2 and the values of its
parameters can be explained. The adapted Gompertz model
is thus suitable for describing cell death after electroporation.
The logistic model (14) is highly adaptable. Because of
the detection limit, not all values of the parameters behave
as expected. Until the detection limit is reached (Fig. 2a),
all the parameters can be explained (Table 5). It can
therefore be said that the logistic model is probably suitable
but it should be tested on a larger dataset.
We mentioned before that the Peleg-Fermi model (6)
does not well describe cell death for higher numbers of the
pulses. The reason is that it is not suitable for describing
lower asymptotes. However, it is very likely that the lower
asymptote is a consequence of the detection limit of the
clonogenic assay. In this case, it is not problematic that the
lower asymptote cannot be described. If it is discovered
in vivo that there is a lower asymptote present, the use-
fulness of the Peleg-Fermi model will have to be evaluated
separately for in vivo data. When the Peleg-Fermi model
(6) was fitted to our in vitro experimental results, the E-
field was the independent variable and the number of the
pulses or their length was the parameters. Unfortunately,
with different lengths of applied pulses, we could not
model the change of k(N) and Ec(N), since there is no
model to connect k and Ec with the length of the applied
pulses. With different numbers of applied pulses (Table 6),
we could also evaluate models for Ec(N) (7) and k(N) (8)
(Table 7). The value of Ec decreases with a higher number
of pulses (Table 6), is in agreement with our understanding
of Ec as a critical E-field (Pucihar et al. 2011) and can be
described using the proposed model (7). Ec changes less
with a higher number of pulses. An even higher number of
pulses applied would probably not lower the critical elec-
tric field but most likely only increase the heating. Values
of k are approximately similar for all different numbers of
applied pulses and they cannot be described using the
proposed model (8). One reason may be the sensitivity of
the clonogenic assay, as mentioned before. With more
pulses, there could be even lower proportions of surviving
cells, the model would be steeper and the value of
parameter k would decrease. In (Golberg and Rubinsky
2010), the model was fitted to experimental data of up to 10
pulses applied, while in our study we fitted it to up to 90
pulses applied. Equation (8) may be exponential for up to
10 pulses applied but for more pulses it seems more like a
constant. Equation (8) should be verified on tissues to see
whether there is an exponential dependency. We assume
that the Peleg-Fermi model (6), (7) will be suitable for use
in treatment planning of electrochemotherapy and irre-
versible electroporation, while the dependency of param-
eter k on the number of pulses (8) remains questionable.
We next compared the values of our optimized param-
eters to the values reported in the literature. Our values of
Ec and k are lower than in (Golberg and Rubinsky 2010)
and optimized to describe the experimental results for 8–90
pulses. The authors in (Golberg and Rubinsky 2010) opti-
mized their parameters to 1–10 pulses, whereby the
decrease of the number of cells in dependency on the E-
field is slower and smaller than for more pulses. This could
explain the lower values of k and Ec as well as the non-
exponential dependence of Eq. (8). The Peleg-Fermi model
(6) seems the most promising of all the models analyzed in
this study, since it also includes dependency on the number
of pulses.
It can be concluded that the Peleg-Fermi (6), the adapted
Gompertz (16), and probably also the logistic model (14)
can all be used for describing cell death due to electropo-
ration and could all be used in treatment planning of
electrochemotherapy and irreversible electroporation.
J. Dermol, D. Miklavcˇicˇ: Mathematical Models Describing Chinese Hamster Ovary Cell Death… 877
123
Results and Discussion - Paper 2
74
Since the Peleg-Fermi model incorporates dependence on
E-field as well as on the number of pulses it already con-
nects two electrical parameters and can therefore be used
more easily, while such connections still have to be
determined for other models.
Conclusion
Mathematical models can describe cell death after elec-
troporation. Hopefully, they can also be used in treatment
planning of electrochemotherapy and irreversible electro-
poration as a method of tissue ablation. Mathematical
models suitable for treatment planning have to describe the
data well, have predictive power, and their parameters have
to have a trend. Using the probability of cell death, the
treatment plan can be made more reliable and also more
comprehensive. Instead of displaying the electric field
around the electrodes, the probability of tissue destruction
around the electrodes can be shown. In this study, it was
shown that not only the Peleg-Fermi but also other models
are suitable for describing in vitro experimental results.
However, it still needs to be determined whether the pro-
posed mathematical models also have predictive and not
just descriptive power. Our results are valid only for one
cell line in suspension under our experimental conditions.
The question is whether mathematical models could also be
translated to tissues and more complex geometries. This
validation should be done on tissues since the models will
be used on tissues. Applying mathematical models of sur-
vival to tissues is thus the next step.
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Appendix: Numerical Model of Temperature
Distribution
We calculated temperature distribution to determine that 90,
100 ls pulses of 4 kV/cm and 1 Hz repetition frequency do
not induce significant Joule heating. A numerical model of a
drop of cell suspension between parallel plate electrodes was
made in ComsolMultiphysics (v4.4, Comsol, Sweden) using
Electric Currents, Heat Transfer, and Multiphysics modules
in time-dependent analysis. Electrodes were modeled as two
blocks of 20 9 10 9 1 mm and a drop of cell suspension
was modeled as a block of 7 9 7 9 2 mm. Two boundaries,
one on each electrode, were modeled as terminals, with
?400 V and-400 V in the first 90 s of the simulation, while
the other boundaries were electrically insulated. Similar as in
(Garcia et al. 2011a, b), only one pulse was applied for 90 s,
but we multiplied the Joule heating by the duty cycle (du-
ration/period) to adjust the amount of delivered energy. We
ran the simulation for an additional 5 s after the pulse
application to validate the model with our temperature
measurements, since measurements of temperature were
made within 5 s after the pulse application.
The change of conductivity due to cell electroporation
was disregarded in the model, since our cell suspension
was dilute. The values of parameters used in the simulation
are shown in Table 8. The properties of the cell suspension
(except for electrical conductivity, which is characteristic
of our electroporation buffer) are the same as for water.
The model was validated with current and temperature
measurements at 90, 100 ls pulses, 4 kV/cm, 1 Hz repe-
tition frequency. The predicted current (3.3 A) was in the
same range as the measured current (from 2.9 to 3.5 A).
Temperature measured within 5 s after the pulse applica-
tion was 37.0 C, while the predicted temperature 5 s after
Table 8 Parameters, used in our numerical model, with their symbols, values, and units
Name of the parameter Symbol Value Units
Electrical conductivity rs 0.162[S/m] 9 (1 ? 0.02 9 (T[degC]-20)) S/m
re 1.73913[MS/m] 9 (1 ? 0.00094 9 (T[degC]-20))
Heat capacity at constant pressure Cps 4200 J/(kg K)
Cpe 500
Density qs 1000 kg/m
3
qe 8000
Thermal conductivity ks 0.58 W/(m K)
ke 15
Relative permittivity es 80 –
ee 1
Subscript s denotes cell suspension and subscript e denotes electrodes
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the pulse application was 37.6 C. The model thus ade-
quately described our experiments.
The temperature distribution on the surface of the cell
suspension and on the electrodes, and a slice through the
drop of cell suspension after 90 pulses, is shown in Fig. 7.
Since the temperature of the cell suspension does not
exceed 42 C, under our experimental conditions cell death
can indeed be ascribed to electroporation.
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Abstract
Various models have been developed to describe microbial inactivation by pulsed
electric field treatment, and they have just recently been used for describing
eukaryotic cell death due to irreversible electroporation. In microbial inactivation,
the mathematical models of cell death enable the adaptation of the pulse param-
eters to achieve sufficient microbial reduction at the lowest energy input while
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preserving flavor and sensitive compounds in the food. For precise prediction, the
geometry of the treatment chamber, the fluid flow, the temperature, and the
electric field distribution should also be taken into account. In electroporation-
based medical treatments, currently, a deterministic critical value of electric field
is used to delineate between the destroyed and the unaffected tissue. Conse-
quently, tumor cells which have higher electroporation threshold than the exper-
imentally determined may remain viable and cause incomplete tumor elimination.
On the contrary, the more sensitive surrounding tissue could be damaged. Math-
ematical models of cell death help to achieve sufficient cell death while minimiz-
ing the damage to the surrounding vital structures. In this chapter, different
models are described which were already used for describing microbial inactiva-
tion in liquid foods or eukaryotic cell death (the first order, the Hülsheger, the
Peleg-Fermi, the Weibull, the logistic, the Adapted/Modified Gompertz, the
Geeraerd, the quadratic, the Peleg-Penchina model). The cell death models
have already been used for predicting survival in realistic setups like the treatment
chamber in microbial inactivation and different electrode geometries and tissues
in irreversible electroporation treatments. In conclusion, cell death models are
useful in predicting the treatment outcome. Unfortunately, since the mechanisms
of cell death due to electroporation are not yet fully elucidated, the models are
empiric. There is no direct connection between the parameters of the models and
the biological/electrical parameters. Thus, it is unclear which model is the most
appropriate to use. The models have to be optimized for each specific cell type
and electric pulses separately. The transferability from the in vitro to the in vivo
level is questionable.
Keywords
Microbial inactivation • Predictive models • Numerical modeling • Treatment
planning • Food pasteurization
Introduction
Mathematical modeling is becoming indispensable in the field of life sciences. It
enables description and prediction of a response of a biological system knowing the
excitation and other parameters, and gives insights into the mechanisms of phenom-
ena. The number of biological experiments can be decreased which decreases the
time and costs needed to obtain results. In the field of electroporation, models exist
on different levels – molecules, lipid bilayers, cells, and tissues. Cell death or
inactivation models are used for the description of microbial inactivation and
recently also eukaryotic cell death in irreversible electroporation as nonthermal
soft tissue ablation. In this chapter, the statistical models of cell death are described
on the level of cells and tissues.
Currently, there is no complete explanation of cell death due to electroporation
(“▶Cell Death Due to Electroporation”), neither for prokaryotic nor eukaryotic
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cells. The cell death is believed to be caused by the following mechanisms. First,
high electric pulses can cause membrane destruction and necrotic cell death. Second,
there is the apoptotic cell death, reasons for which are not yet clear. Third, in vivo,
last of the clonogenic cells are destroyed by the immune system (“▶ Immunological
Response During Electroporation”). Thus, the currently used cell death models are
empirical and were developed on the basis of the best fit to the experimental results.
Microbial Inactivation
In liquid food pasteurization by pulsed electric fields (PEF), short high-voltage
electric pulses are applied to decrease the number of microbes and quality-degrading
enzymes, and extending the shelf-life while retaining flavor and nutrients (Lelieveld
et al. 2007; Sun 2014). In the literature on cell death models, the expressions
bacterial and microbial cell death are both used. The microbe is a short expression
for microorganisms not visible with a naked eye which includes besides bacteria also
protozoa, fungi, and viruses. Thus, bacteria are a subgroup of microorganisms. Since
cell death models have been used for describing cell death of various microorgan-
isms (i.e., bacteria, yeast), expression microbial cell death models is used through
this chapter. Mathematical modeling of microbial cell death (“▶Modeling Microbial
Inactivation by Pulsed Electric Field”) is necessary to adapt the pulse parameters and
achieve sufficient decrease of microorganisms at a minimum energy input while
preserving the sensitive compounds in the food (Huang et al. 2012). In the food
industry, at least five log reductions of bacteria are required for food pasteurization.
Applying too gentle pulses may cause food spoilage and health-related problems
while applying too severe pulses may cause Joule heating and decrease the quality of
food. The cell death models have been used on a variety of liquid food (e.g., fruit
juices, milk, water, liquid egg yolks) or models of such liquids. When predicting the
microbial inactivation by the PEF treatment, the geometry of the treatment chamber
is modeled, and the electric field, the temperature distribution, and fluid flow are
(numerically) calculated (Gerlach et al. 2008). Microbial cell death prediction can be
included using the cell death models as a function of the electric field, treatment time,
the number of the applied pulses, and/or the pulse repetition frequency (Huang et al.
2013). The inactivation of the quality-degrading enzymes and the degradation of the
health-related compounds can also be modeled with similar models as the inactiva-
tion of microorganisms due to their similar kinetics.
Electroporation-Based Medical Treatments
When treating eukaryotic cells with electroporation, currently, the three main appli-
cations are the electrochemotherapy, the irreversible electroporation (“▶Tissue
Ablation by Irreversible Electroporation”), and the gene electrotransfer for gene
therapy and DNA vaccination (Yarmush et al. 2014). When treating tumors with
electrochemotherapy, pulses of standard parameters and fixed electrode
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configurations can be used. However, if the tumor is larger than 2 cm and/or has an
irregular shape, a variable electrode configuration should be used. For the irrevers-
ible electroporation treatments (Jiang et al. 2015), protocols are already set up in the
commercially available electroporators, but the ablated volumes do not always
correlate to the predicted ones (Bhutiani et al. 2016). In the electrochemotherapy,
irreversible electroporation, and also in gene electrotransfer treatments, the need for
patient-specific treatment planning (“▶Treatment Planning for Electroche-
motherapy and Irreversible Electroporation of Deep-Seated Tumors”) is on the
rise. The number, the geometry of the electrodes, and the parameters of the electric
pulses must be optimized considering the specifics of the cause and the treatment
(Županič et al. 2012). In electrochemotherapy, all tumor cells must be reversibly
permeabilized, while the surrounding tissue, especially critical structures, should be
undamaged. In irreversible electroporation, the tumor must be irreversibly
electroporated without significant thermal damage, while the surrounding tissue,
especially critical structures like nerves and vessels, should remain largely
undamaged. In gene electrotransfer, cells must be reversibly permeabilized, and
their viability must remain high. Currently, an experimentally determined critical
electric field is used to predict and delineate between the alive and the irreversibly
electroporated tissue – the response is modeled by a step function (Fig. 1). The
assumption of a step function is, however, too simplistic even for cell suspensions of
the same cell line (Canatella et al. 2001; Dermol and Miklavčič 2015) since cells
among other differ in size and position in a cell cycle. In tissues, especially in tumors,
this inhomogeneity is amplified since cells additionally differ in shape and tissues are
comprised of different cell types. In a tumor, in addition to the tumor cells, stromal
cells are present in the microenvironment. Therefore, in reality, the transition from
alive to irreversibly electroporated state is continuous and distributed over a range of
electric field values. The width of this range, as well as the threshold voltage, also
depend on the number and length of the applied pulses (Canatella et al. 2001; Garcia
et al. 2014).
When predicting the survival with the fixed threshold, the cells which have higher
critical threshold than the experimentally determined can survive and cause incom-
plete tumor elimination or its later recurrence. On the other hand, applying more
severe electric pulses than necessary can cause tissue necrosis, excessive Joule
heating, and thermal damage. By using cell death models to predict the treated
volume, the efficiency of the electroporation-based medical treatments and therapies
can be increased. Cell death models allow interpolation and predict survival at
parameters which were not experimentally determined. The last few of the
clonogenic cells are eradicated by the immune system (“▶ Immune Response
After Electroporation and Electrochemotherapy”) (Yarmush et al. 2014) which
should be considered when determining the tolerated percentage of the survived
cells in electroporation-based treatments. A complete eradication of all tumor cells
may not be needed.
In electrochemotherapy and gene electrotransfer, using cell death models is not
enough to correctly predict the treatment outcome. In the electrochemotherapy
treatments, the application of electric pulses increases the permeability of the cell
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membrane to the chemotherapeutics. Two commonly used chemotherapeutics are
cisplatin and bleomycin. Cell death is mostly caused by the cytotoxic effects of
chemotherapeutics, although, in the vicinity of the electrodes, cells can be irrevers-
ibly electroporated. To correctly predict the affected regions, a model of permeability
to cytotoxic drugs and their transport across the membrane as a function of electric
pulses should be included in the treatment planning of electrochemotherapy (Dermol
and Miklavčič 2014). Namely, when the number of the molecules of chemothera-
peutic entering each cell can be calculated, it can be predicted whether the cell will
die or not. In the gene electrotherapy, electric pulses increase the permeability of the
cell membrane to the DNA. The exact mechanisms of gene electrotherapy are
complex and also depend on genes. The presumed steps in the process are electroper-
meabilization of the cell membrane, electrophoretic migration of the DNA towards
membrane, DNA/membrane interaction, DNA translocation across the membrane,
intracellular migration of DNA through the cytoplasm, DNA passage through the
nuclear envelope, and gene expression (Rosazza et al. 2016). To correctly predict
where the transfection will occur, each step should be modeled.
Fig. 1 The comparison of the currently used and the proposed way of modeling cell death. The red
line shows the currently used step response where below a critical electric field all cells are regarded
alive and above all dead. The gray and dark lines show the suggested cell death models which
predict a gradual decrease in cell survival. Black circles are the experimentally determined values. It
is clear that the experimental values are better described with different cell death models than with a
step response
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Models Used to Describe Cell Death in Suspension
Ideally, cell death model would include all the parameters, important for cell death.
A problem arises since the exact mechanisms of cell death due to electroporation are
not completely known. Cell death depends on many parameters, among others on the
electric field; the duration and the number of the applied pulses; the pulse repetition
frequency; the properties of the cells; their size, shape, orientation in the electric
field; their concentration in the treated medium; the properties of the treated medium
or food; pH; temperature; configuration of the electrodes or the treatment chamber;
and the concentration of the chemotherapeutics (in electrochemotherapy). The most
important parameters for cell death should be identified and included in the model. It
should also be determined which parameters can be excluded to simplify the models
and the fitting. In summary, the cell death model due to electroporation should
describe the experimental results well, include all the important electrical and
biological parameters, have high predictive power, and a minimum number of
parameters to be optimized.
Various models have been developed and used to describe microbial cell death
due to pulsed electric field (PEF) treatment in liquid food pasteurization (Álvarez
et al. 2003; Peleg 2006; San Martín et al. 2007; Huang et al. 2012). Only recently,
interest to develop and use such models has been expressed in tissue ablation due to
irreversible electroporation, i.e., IRE treatment. Most of the models used, however,
are empirical, and their parameters have no physical meaning and even have no
parameters that could be explicitly linked to treatment parameters such as electric
field, pulse duration, the number of pulses, and pulse shape. There is also no solid
link demonstrated between cell membrane permeabilization and cell death.
In microbial cell death models, the independent variable is usually the treatment
time which is easily determined in the case of thermal, irradiation, high pressure,
ultrasound, or other continuous treatment. The treatment time of the PEF treatment is
more difficult to determine since multiple short pulses are applied at different pulse
repetition frequencies. Nevertheless, the treatment time (t) is usually calculated by
multiplying the number of pulses with the duration of one pulse (t ¼ NT ), where
N denotes the number of the pulses and T the duration of one pulse. This way of
calculating the treatment time assumes that only the product of N and T affects the
survival but not the duration or the number of the pulses by itself. The effect of the
pulse repetition frequency is also neglected. In microbial cell death models, the
electric field, the number of pulses, or their repetition frequency were used as
independent variables. With the exception of the quadratic model, however, no
model so far included more than two independent variables.
The electric field is the most important parameter in electroporation-based treat-
ments (Miklavčič et al. 2006). The survival curves as a function of the electric field
are usually composed of three parts: a shoulder (upper asymptote) which is then
followed by a steep decline in cell number and eventually, a tail (lower asymptote) is
reached. The tail can be a caused by either a resistant subpopulation of cells or the
reached limit of the survival assay. Several different curves can describe the survival
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data. When presenting the survival curves and the cell death models, they should be
plotted on a semilogarithmic scale. There, deviations and small percentages of
survival are more easily noticed. The quality of the fit should be evaluated using
various statistical measures: the goodness-of-fit (R2), the root-mean-square error
(RMSE), and/or accuracy parameter (Af). R
2 is a statistical measure of how close
the regression line is to the experimental data; RMSE is a measure of the average
deviation between the observed and predicted data; and Af measures the accuracy of
the estimates obtained by the models. Other criteria for evaluating the suitability of a
model are the number of the models’ parameters (which should be low), the
inclusion of more independent variables, and a high predictive power. In continua-
tion, models which were already used for describing microbial or eukaryotic cell
death are described.
The First-Order Kinetics Model
The first-order kinetics model was developed almost a century ago (Huang et al.
2012). It derives from the assumption that all cells in a population are equally
sensitive to the treatment. When used in PEF treatments, it describes cell death as
a function of the treatment time:
S tð Þ ¼ exp ktð Þ; (1)
where S denotes the survival, t the treatment time, and k is a first-order parameter,
i.e., the speed of the decrease. The model predicts that the viability decreases
immediately – there is no shoulder at short treatment time. The first-order kinetic
model did not provide a good fit to electroporation treatment of eukaryotic cells
(Dermol and Miklavčič 2015). It has also been observed that it does not describe all
microbial inactivation data well. It was stated that the model describes the data
sufficiently well only when the data is sampled too scarcely (Peleg 2006). The
deviations from the first-order kinetics model could among others be explained by
the statistical distribution of cell radii (Lebovka and Vorobiev 2004).
The first-order parameter k was found to be temperature dependent which could
be modeled in thermal treatments as well as in PEF treatments. In PEF treatments,
the temperature of the sample increases due to the Joule heating and consequently
the electrical conductivity of the sample is also increased. The parameter k could be
modeled by Arrhenius equation as:
k ¼ ktexp  EA
RT
 
(2)
Where kt is the rate constant at the reference temperature, EA the activation energy,
R is the gas constant, and T is the sample temperature in Kelvins.
Traditionally, the sensitivity of microorganisms to static treatments is described
using the decimal reduction time (Dt). It denotes the treatment time needed to obtain
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one decimal reduction of the cell population, i.e., 10 % of the initial population
survives. It is defined as Dt ¼ 2:303k since the first-order kinetics model is based on
natural and the decimal reduction time on the decimal logarithm.
If the treated cell population consists of two populations of which each has its
first-order dynamics, the biphasic model can be used:
S tð Þ ¼ f ek1t þ 1 fð Þek2t; (3)
where f denotes the proportion of the first subpopulation in the whole population,
and k1 and k2 are the first order parameters of the first and the second subpopulation,
respectively. In case there are more subpopulations, the decrease of each subpopu-
lation can be modeled with its own exponential factor which is then added to the
(Eq. 3).
The Hülsheger Model
Hülsheger studied the effect of electric field on the inactivation of E. coli (Huang
et al. 2012). He derived an empirical formula which has two independent variables –
the treatment time (t) and the electric field (E). As a function of the electric field, the
survival showed a linear decline when the electric field exceeded a certain critical
electric field (Ec) which was modeled as:
S Eð Þ ¼ exp bE E Ecð Þð Þ; (4)
where S is the survival, bE is the regression coefficient, and Ec is the critical value of
electric field below which there will be no inactivation (i.e., the lowest electric field
that causes inactivation). When E < Ec, the model predicts the survival above one
which is incorrect and the survival must be fixed at one.
As a function of the treatment time, the results were modeled as:
S tð Þ ¼ exp btln t
tc
  
; (5)
where S is the survival, bt is the regression coefficient, and tc is the extrapolated
critical value of treatment time below which there will be no inactivation (i.e., the
shortest treatment time which causes inactivation). For treatment times shorter than
the critical treatment time, the model predicts the survival to be more than 1. Thus,
also here, for t < tc the survival should be fixed at one.
Both models Eqs. 4 and 5 were joined in:
S t,Eð Þ ¼ t
tc
 EEck
(6)
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where k is the independent inactivation constant, and other parameters have the same
meaning as in Eqs. 4 and 5. The parameters tc, Ec, and k were proposed to be
microorganism dependent within a certain range of experimental parameters.
Although the Hülsheger model includes two independent variables, it cannot
universally describe the experimentally determined cell death. With the Hülsheger
model, some microbial cell death results were possible to model, and some were not
(Huang et al. 2012), while only one study unsuccessfully fit it to the eukaryotic cell
death data (Dermol and Miklavčič 2015).
The Peleg-Fermi Model
The Peleg-Fermi model has been successfully fit to various microbial inactivation
data (Huang et al. 2012) and was also the first to be used for describing eukaryotic
cell death due to electroporation (Golberg and Rubinsky 2010). It derives from the
Fermi’s equation which is used to describe the behavior of materials at their glass
transition temperature. The Peleg-Fermi model is one of the most promising since it
describes the data well and includes two independent variables – electric field (E)
and the number of the applied pulses (N ):
S E,Nð Þ ¼ 1
1þ exp E Ec Nð Þ
k Nð Þ
  (7)
Ec Nð Þ ¼ Ec0exp k1Nð Þ (8)
k Nð Þ ¼ k0exp k2Nð Þ (9)
where Ec(N ) is the critical electric field where the survival drops to 50 %, k(N ) is the
kinetic constant describing the slope of the curve, Ec0 is the intersection of Ec(N )
with the y-axis, k0 (in the same units as the electric field), k1 and k2 are constants
which change depending on the parameters of the pulses and the properties of the
cells. The critical electric field depends on the number and length of the applied
pulses (Pucihar et al. 2011). For values below the critical electric field, the Peleg-
Fermi model predicts survival to be 100 %. The Peleg-Fermi model described
various experimental data well, although the k(N ) and Ec(N ) did not always change
exponentially as a function of the pulse number (Dermol and Miklavčič 2015;
Sharabi et al. 2016). Unfortunately, the pulse length and the pulse repetition fre-
quency are not included in the model, and the dependency on them is included
indirectly via the parameters of the model. An example of fitting the Peleg-Fermi
model to the eukaryotic cell death due to irreversible electroporation in vitro is
shown in Fig. 2.
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Fig. 2 The Peleg-Fermi model, fit to eukaryotic cell death data in a wide range of pulse number and
electric field values. (a) symbols show the experimental values for 100 μs, 1 Hz repetition frequency
at different pulse numbers (8, 30, 50, 70, and 90), lines show the fitted Peleg-Fermi model (Eq. 7).
(b) symbols are the optimized values of Ec and k for different pulse numbers, lines show the fitted
models for Ec(N ) and k(N ) (Eqs. 8 and 9) (Reprinted from Journal of Membrane Biology, Vol
248/Issue 5, Dermol J, MiklavčičD, Mathematical Models Describing Chinese Hamster Ovary Cell
Death Due to Electroporation In Vitro, Pages 865–881, Copyright 2015 Springer Science + Busi-
ness Media New York)
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The Weibull Model
The Weibull model was originally used to describe the time to failure of electronic
devices after stress was imposed on them. A parallel can be made when stress, for
example, thermal, high pressure, or PEF treatment, is applied to biological cells.
Time to cell death after the stress can be described using the Weibull model (San
Martín et al. 2007). The Weibull model was successfully used to describe microbial
(Huang et al. 2012) and eukaryotic cell death (Dermol and Miklavčič 2015) using
various pulse parameters. Although the Weibull model is very adaptable, no clear
connection between the electrical/biological parameters and the optimized parame-
ters of the model was made. In some cases, the scale parameter b was exponentially
dependent on the electric field. The model is:
S xð Þ ¼ exp  x
b
 n 
; (10)
where x denotes the treatment time or the electric field, b is the scale (in the same
units as x), and n is the shape parameter. The scale parameter determines the
characteristic time or the characteristic electric field at which 63 % of the cells die.
With different values of the shape parameter, the shape of the survival curve varies
between the convex (n < 1), linear (n = 1), and concave curve (n > 1) in semi-
logarithmic scale.
The Logistic Model
The logistic model can be used for describing distributions with a sharp peak and
long tails (Cole et al. 1993). When taking into account that survival of cells before
the treatment is 100 %, the logistic model can be written as either Eq. 11 or 12,
depending on what is chosen as the independent variable. The equations are:
S Eð Þ ¼ 10^ ω
1þ exp 4σ τ  Eð Þω1ð Þ
 
(11)
S tð Þ ¼ 10^ ω
1þ exp 4σ τ  log10tð Þω1ð Þ
 
(12)
where E denotes the electric field, t the treatment time, ω the common logarithm of
the lower asymptote, σ the maximum slope, and τ the position of the maximum
slope. Survival curves show the cumulative cell death as a function of the indepen-
dent variable, i.e., applied electric field or treatment time. Thus, each data point
includes cells which died due to the corresponding or less severe parameter. The cell
death distribution is obtained as a derivative of the cumulative distribution. Only cell
death due to the corresponding parameter is plotted. In electroporation treatments,
the distribution of cell death with a sharp peak and long tails is obtained when the
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independent variable is either the electric field or the common logarithm of the
treatment time. The logistic model was successfully fit to inactivation of microor-
ganisms by PEF treatment (Huang et al. 2012) and to eukaryotic cell death (Dermol
and Miklavčič 2015).
The Adapted/Modified Gompertz Model
The Gompertz model is usually used for describing the growth of a tumor, but in
modified form, it can also describe cell death. Originally, it was used for describing
bacterial (Linton et al. 1995) cell death due to thermal treatment, but later it was
extended to describing bacterial cell death due to pulsed electric field treatment and
eukaryotic (Dermol and Miklavčič 2015) cell death due to electroporation. The
model is written as:
S xð Þ ¼ exp A exp e B0þB1xð Þ
 
 A exp eB0 
 
(13)
where x denotes either the treatment time or the electric field, A is the natural
logarithm of the survival in the stationary phase (the natural logarithm of the tail),
B0 is the length of the shoulder, and B1 the speed of the increase (when it is positive)
or decrease (when it is negative) in cell number.
The Geeraerd Model
The Geeraerd model (Geeraerd et al. 2000) describes the exponential decrease of
cells including a tail which models the resistant cell subpopulation. Assuming the
initial survival is 100 %, the Geeraerd model can be written as:
S tð Þ ¼ 1 Nresð Þexp ktð Þ þ Nres (14)
Where Nres represents the tail and k is the inactivation rate. Since the model does not
also include a shoulder, it cannot be used universally for all cell death results. The
Geeraerd model was so far successfully fit to experimental data of microbial
inactivation after mild heat treatment and eukaryotic cell death due to
electroporation.
The Quadratic Model
The quadratic model is currently the only model which can model dependency on
two or more independent variables. As the independent variable x, various param-
eters have been used – the electric field, the treatment time, the pulse repetition
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frequency, the pH, and the concentration of some compound. The model is written
as:
S xð Þ ¼ k1 þ k2xþ k3x2 (15)
where the parameter k1 is the central point of the system, k2 is the coefficient of the
linear effect, and k3 of the quadratic effect of the independent variable. It is also
possible to fit more parameters at once by joining several quadratic models into one:
S x1, x2ð Þ ¼ k1 þ k2x1 þ k3x12 þ k4x2 þ k5x22 þ k6x1x2 (16)
where x1 and x2 denote two independent variables which were marked as the x in the
(Eq. 15), k1 is the central point of the system, k2 and k4 represent the linear, k3 and k5
the quadratic, and k6 the interactive effects of the independent variables. If some of
the terms are nonsignificant under certain experimental conditions, they can be
omitted from the model. By quadratic model fitting, the interaction between different
experimental parameters can be determined. The quadratic model was successfully
fit to microbial inactivation results as well as to the inactivation of the enzymes and
health-related compounds like vitamins (Huang et al. 2012).
The Peleg-Penchina Model
The Peleg-Penchina model is also an empirical model but can describe only the
convex curves (Peleg and Penchina 2000; Álvarez et al. 2003) in the semilogarith-
mic scale. It is written as:
S tð Þ ¼ 10 ^ m ln 1þ ktð Þð Þ (17)
where t is the treatment time of the PEF treatment; m and k are the parameters of the
model, which have to be optimized; and ln denotes the natural logarithm. Together
with the Eq. 17, the authors introduced a way of describing bacterial survival when
the intensity of the lethal agent (e.g., temperature, chemical agent, PEF treatment)
varies either between treatments or during one treatment.
As long as the mechanisms of cell death due to electroporation (PEF treatment)
are not known, it is difficult to decide which model is superior to others, and they can
all be regarded as equivalent. An example of fitting several cell death models to
eukaryotic and bacterial cell death results is shown in Fig. 3.
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Fig. 3 (a) Different cell death models as a function of the electric field (the Peleg-Fermi, the
Weibull, the Logistic, the Adapted Gompertz model) were fitted to the experimental data of
eukaryotic cell death when 90, 100 μs pulses were applied to the cell suspension. Symbols show
the experimental values and lines the models. It can be seen that several models describe the
experimental data well Observed values are marked by circles, model 1 by a bold line, model 2 by a
dotted line, model 3 by a thin line, and model 4 by a dashed line. (Reprinted from Journal of
Membrane Biology, Vol 248/Issue 5, Dermol J, Miklavčič D, Mathematical Models Describing
Chinese Hamster Ovary Cell Death Due to Electroporation In Vitro, Pages 865–881, Copyright
2015 Springer Science + Business Media New York 2015). (b) Different cell death models as a
function of the treatment time were fitted to the survival of E. coli after pulsed electric field
treatment. Model 1 is the biphasic model, model 2 is the sigmoidal equation, model 3 is the Weibull
model, and model 4 is the Peleg-Penchina model. A good fit was obtained with all tested models
(Reprinted from Innovative Food Science & Emerging Technologies, Vol 4/edition number
4, Alvarez I, Virto R, Raso J, Condon S, Comparing predicting models for the Escherichia coli
inactivation by pulsed electric fields, Pages No 195–202, Copyright (2003), with permission from
Elsevier)
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Models Used to Describe Cell Death In Vitro on Attached Cells
and Cells in 3D Tissue-Like Structure
In liquid food pasteurization, the microorganisms are suspended in the food. How-
ever, they can also grow in layers, for example, on surgical meshes. Surgical mesh is
thin mesh which supports or reinforces damaged tissue. The cell death models were
applied to PEF treatments of medical mesh implants, on which 2D layers of bacteria
can form as a biofilm (“▶Electroporation of Biofilms”) (Khan et al. 2016). The
authors successfully described the data using the Weibull model.
The cell death models have not yet been applied to the attached or 3D eukaryotic
cell models. The optimization of the models in vitro would need to be done anew
since the critical electric fields are different for the attached than for the suspended
cells due to a different shape, density, and connections between cells (Pucihar et al.
2006; Towhidi et al. 2008).
Models of Cell Death Used in the Treatment Chamber and In Vivo
Microorganisms grow in suspensions and 2D layers. Thus, there are no reports on
using the mathematical models to describe PEF inactivation of microorganisms
in vivo. There is, however, an example of modeling the treatment chamber (“▶Opti-
mization of Pulsed Electric Field Treatment Chamber”) with included suspension of
bacteria. Huang et al. predicted the inactivation of bacteria in watermelon juice by
first building a 2D numerical model of the treatment chamber and using the
Hülsheger model to describe the inactivation (Huang et al. 2013). Authors obtained
very good predictions. Cells respond to the electric field to which they are exposed.
In treatment chambers (as well as in tissue when performing the IRE treatment), the
electric field can be highly inhomogeneous. In future, to obtain the optimal condi-
tions for microbial inactivation, first optimization of the treatment chambers’ geom-
etry and the parameters of electric pulses should be done.
There are just a few reports of using cell death models to describe and predict the
extent of eukaryotic cell death due to electroporation in vivo. Golberg and Rubinsky
were first to suggest using statistical cell death models in vivo (Golberg and
Rubinsky 2010). They fit the Peleg-Fermi model to the results of an in vitro study
of electroporation of prostate cell line. Then, the fitted Peleg-Fermi model was
theoretically applied to the 2D case of tissue electroporation using needle electrodes.
The spatial distribution of probability of cell death the authors obtained is shown in
Fig. 4. It was shown that there exists an area where the cell death probability ranges
from 0 % to 100 % and the deterministic critical electric field is not an optimal
choice for predicting the electroporation-based medical treatment outcome.
A theoretical study of commercially available bipolar electrodes used in irrevers-
ible electroporation treatments was done by Garcia et al. (2014). The authors
determined the extent of the cell death caused by the heating and by the electropo-
ration when standard IRE pulses were applied. The thermal damage was evaluated
using the Arrhenius integral and the electrical damage using the Peleg-Fermi model.
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The electrical damage due to electroporation around the bipolar electrodes is shown
in Fig. 5. Different combinations of pulse number and electric field lead to different
probabilities of cell death as shown in Fig. 6.
A study in vivo was performed by Sharabi et al., who analyzed the brain
electroporation using the Peleg-Fermi model to describe cell death as well as the
disruption of the blood–brain barrier (Sharabi et al. 2016). The authors concluded
that the Peleg-Fermi model could be successfully used to describe the electropora-
tion of rat brain, although they found that the Ec(N ) was better described using power
than an exponential function, especially in the range of a high number of pulses
(more than 90). As shown in (Eq. 8), Ec(N ) in the Peleg-Fermi model can be
expressed as Ec Nð Þ ¼ Ec0exp k1Nð Þ . Sharabi et al. obtained better fit using the
equation:
Ec Nð Þ ¼ Ec0Nk1 ; (18)
where Ec0 denotes the critical electric field, N the number of the applied pulses, and
k1 is a constant.
In electroporation-based medical treatments, the desired use of the models is in
tissues in vivo. It is questionable to what extent the in vitro optimized models can be
used in vivo. The thresholds for cell death due to electroporation in vivo (Jiang et al.
2015) seem to be different than in vitro (Dermol and Miklavčič 2015). In vivo, the
Fig. 4 The Peleg-Fermi model was fit to the 2D model of prostate tissue treated by irreversible
electroporation using needle electrodes. The legend on the right shows the probability of cell death.
Around the electrodes exists an area where the probability of cell death is between 0 % and 100 %,
thus the deterministic critical electric field is not sufficient for predicting cell death in vivo. (a–c)
show the predicted cell death when a different number of 100 μs pulses of the same voltage (1.5
arbitrary unit) are applied: (a) 10 pulses, (b) 50 pulses, (c) 100 pulses (Reprinted from BioMedical
Engineering OnLine, Vol 9, Golberg A, Rubinsky B, A statistical model for multidimensional
irreversible electroporation cell death in tissue, Page No 13, Copyright 2010 Golberg and Rubinsky;
licensee BioMed Central Ltd.)
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cells are connected, they are of different size and shape, their density varies, there are
different types of cells in each tissue, and the immune system is present. It seems that
the cell death models optimized in vitro may not be directly transferable in vivo but
would need to be optimized separately.
Fig. 5 The probability of cell death due to electroporation around the commercially available
bipolar electrodes at different pulse numbers (a – 30, b – 50, c – 70, and d – 90) when applying
100 μs pulses of 3000 Vat 1 Hz. The transition zone where the cell death decreases from 100 % to
0 % becomes sharper with increasing pulse number (Reprinted from PLoS ONE, Vol 9/Issue
8, Garcia PA, Davalos RV, Miklavčič D, A Numerical Investigation of the Electric and Thermal
Cell Kill Distributions in Electroporation-Based Therapies in Tissue, Pages No e103083, Copyright
2014 Garcia et al.)
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Conclusions
Using cell death models in treatment planning could increase the efficiency of PEF
microbial inactivation and electroporation-based medical treatments. However, cur-
rently, it is unclear which model is the most appropriate since they are all empirical,
and mostly, there is no clear relation between the electrical/biological parameters and
parameters of the cell death models. Although the cell death models describe data
well, they must be optimized for each cell type/tissue and different electric pulses
separately. A direct translation of in vitro optimized models to an in vivo environ-
ment is questionable. In future, cell death models should be based on mechanisms of
cell death due to electroporation, include all and only the relevant treatment param-
eters, and describe and predict the cell death accurately.
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Fig. 6 The probability of cell death due to electroporation as a function of pulse number and
electric field. The cell death is predicted by the Peleg-Fermi model optimized for the prostate cancer
cell death. The contours show the predicted cell death (denoted with numbers in bold) using various
combinations of electric field and pulse number. To achieve 99.9 % cell death a certain minimal
electric field and a number of pulses should be applied (Reprinted from PLoS ONE, Vol 9/Issue
8, Garcia PA, Davalos RV, MiklavčičD, A Numerical Investigation of the Electric and Thermal Cell
Kill Distributions in Electroporation-Based Therapies in Tissue, Pages No e103083, Copyright
2014 Garcia et al.)
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Available online 21 March 2018In electroporation-basedmedical treatments, excitable tissues are treated, either intentionally (irreversible elec-
troporation of brain cancer, gene electrotransfer or ablation of the heart muscle, gene electrotransfer of skeletal
muscles), or unintentionally (excitable tissues near the target area). We investigated how excitable and non-ex-
citable cells respond to electric pulses, and if electroporation could be an effective treatment of the tumours of the
central nervous system. For three non-excitable and one excitable cell line, we determined a strength-duration
curve for a single pulse of 10 ns–10 ms. The threshold for depolarization decreased with longer pulses and was
higher for excitable cells. We modelled the response with the Lapicque curve and the Hodgkin-Huxley model.
At 1 μs a plateau of excitabilitywas reachedwhich could explainwhyhigh-frequency irreversible electroporation
(H-FIRE) electroporates but does not excite cells. We exposed cells to standard electrochemotherapy parameters
(8 × 100 μs pulses, 1 Hz, different voltages). Cells behaved similarly which indicates that electroporation most
probably occurs at the level of lipid bilayer, independently of the voltage-gated channels. These results could
be used for optimization of electric pulses to achievemaximal permeabilization andminimal excitation/pain sen-
sation. In the future, it should be establishedwhether the in vitro depolarization correlates to nerve/muscle stim-
ulation and pain sensation in vivo.
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Lapicque curve1. Introduction
Short, high-voltage pulses increase the permeability of cell mem-
branes to different molecules (reversible electroporation) or cause cell
death (irreversible electroporation) [1–3]. Electroporation is used in
biotechnology, food-processing [4–6] and medicine [7], e.g. gene
electrotransfer [8–10], DNA vaccination [11–14], transdermal drug de-
livery [15,16], IRE as a soft tissue ablation technique [17–20] and
electrochemotherapy [21–24].
In medical applications of electroporation, different types of tissues
and tumours are treated, among them, also excitable tissues, e.g. critical
structures like nerves and spine. Non-excitable as well as excitable cellssible electroporation; CHO cells,
medium; DMEM, Dulbecco's
tial indicator; YP, YO-PRO-1®.
rmol-Černe),
sek@fe.uni-lj.si (M. Reberšek),
ormos@ensil.unilim.fr
ue), rodney.oconnor@emse.frcan be depolarized, i.e. their transmembrane potential increases. How-
ever, only excitable cells can produce action potentials due to their ex-
pression of a high density of voltage-gated channels which enables
electrical communication between cells [25]. Types of excitable cells in-
clude neurones, muscle, endocrine and egg cells.
In the literature, there are several examples of electrochemotherapy,
irreversible electroporation and gene electrotransfer of excitable tissues
by electric pulses. Brain cancer is treated with irreversible electropora-
tion, and electric pulses can transiently disturb the blood-brain-barrier
and allow chemotherapeutics to enter the brain [26–31]. Treating pros-
tate cancer can affect the neurovascular bundle [32,33], treating bone
metastases can affect nerves [21,34], treating tumours in the spine can
affect the spinal cord [34]. When treating tumours in other parts of
the body, electrodes will invariably be in the vicinity of the nerves or
muscles where the electric field is high enough for excitation or even
permeabilization. Electric pulses are also used for ablation ofmyocardial
tissue to treat atrial fibrillation [35–37]. Muscles are a popular target for
gene electrotransfer as they are easily accessible and transfected
[38,39]. Among them, the heart can be electroporated to treat ischemia
[40,41]. Other examples of the application of electric pulses to excitable
cells include electroporation of neurons as a labelling technique which
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nsPEF on intracellular calcium and release of catecholamine in endo-
crine cells [47–49].
Several studies showed that the effect of electric pulses on the func-
tionality of excitable tissueswas only short-term. After irreversible elec-
troporation the nerves of different animal models recovered electro-
physiologically, histologically and functionally [34,50–52] or at least
showed a potential for regeneration [53]. After electroporation of indi-
vidual rat neocortex neurons, in vitro and in vivo, themembrane poten-
tial, the action potential waveform and passive membrane properties
remained unchanged [54]. After pulmonary vein ablation with electro-
poration, the histology and functionality of phrenic nerve remained un-
changed [55]. There was no histological damage on nerves in the
neurovascular bundle when treating prostate with irreversible electro-
poration [51].
One of the main drawbacks to the treatment of tissues with pulsed
electric fields is the discomfort and pain associated with repeated elec-
trical stimulation [56–59], the need to administer muscle relaxants and
anaesthesia [60] and synchronization with the electrocardiogram [61–
63]. The neurons responsible for pain sensation (nociceptors) can be
stimulated by electric pulses [64,65]. An important advance of the treat-
mentwould be to determine a point atwhichmaximumpermeability of
themembrane could be achievedwhileminimizing excitation of the ex-
posed excitable cells. In electrochemotherapy, for example, this would
translate to maximumdrug delivery to tumour cells withminimum tis-
sue damage to surrounding regions, reduced pain experienced by the
patient, and minimal use of muscle relaxants. One suggested option is
applying short bipolar pulses which do not cause muscle contraction
but come at the expense of delivering higher energy than with longer
monopolar pulses [66].
Questions that need to be answered include, (i) whether excitable
and non-excitable tissues respond similarly to electroporation pulses,
(ii) can electroporation be an effective treatment of cancers of the cen-
tral nervous system, (iii) are the properties of surrounding excitable tis-
sues significantly altered or damaged due to the treatment. In our paper,
we evaluated the depolarization and membrane permeability of four
cell lines, one excitable and three non-excitable. For each cell line, we
determined the strength-duration curve to one pulse of durations be-
tween 10 ns and 10 ms. Additionally, response of excitable cell line
was modelled with the Lapicque curve and the Hodgkin-Huxley
model. Lapicque curve is an empirical description of the strength-dura-
tion curve and the Hodgkin-Huxley model is a set of differential equa-
tions, describing the dynamics of voltage-gated channels when they
are exposed to electric stimulus. Our study shows that higher electric
fields are needed for depolarization of excitable cell line than for depo-
larization of non-excitable cell lines. We compared the depolarization
results with previously experimentally determined electroporation re-
sults modelled with the Saulis model [67]. We explain the lack of exci-
tation after electroporation with short 1 μs pulses as well as high
frequency short bipolar pulses (H-FIRE). This lack of excitability with
short bipolar pulses can be explained by reaching a plateau of excitation
and electroporation around 1 μs. We also determined the permeability
curve to pulses of standard electrochemotherapy parameters (8 × 100
μs, 1 Hz at different electric field amplitudes). All four cell lines were
permeabilized at approximately the same electric field, and the perme-
abilization curveswere similarly shapedwhich indicates that electropo-
ration is independent of voltage-gated channels.
2. Materials and methods
2.1. Cell culture/preparation
Four cell lines of different excitability were used (Fig. 1). CHO Chi-
nese hamster ovary cells (European Collection of Authenticated Cell
Cultures ECACC, CHO-K1, cat. no. 85051005, obtained directly from
the repository), U-87 MG human glioblastoma cells (ECACC, PublicHealth England, cat. no. 89081402), and HT22 immortalizedmouse hip-
pocampal neurons (The Salk Institute, La Jolla, CA)were grown in anhu-
midified environment at 37 °C at 5% CO2. CHO cells were grown in the
Ham-F12 (Sigma-Aldrich, Germany), U-87MG inMEM (Sigma-Aldrich,
Germany) and HT22 cells in DMEM (Sigma-Aldrich, Germany) growth
medium. All growth media were supplemented with 10% fetal bovine
serum, L-glutamine and antibiotics. Cells were grown either on Poly-Ly-
sine (Sigma-Aldrich, Germany) coated 22 mm glass coverslips which
were put inside a plastic ring or on 40 mm Petri dishes (TPP, Austria).
The HT22 cell line was differentiated by 48 h incubation in the
Neurobasal medium (Gibco, USA) supplemented with 0.5 mM L-gluta-
mine and B-27 serum-free supplement as advised by the manufacturer.
In this time, the cells stopped dividing and changed their morphology
(Fig. 1c vs d). We tested the excitability by chemically exciting the
cells by varying the concentration of extracellular potassium ions and
comparing the response to a 1 ms pulse at 0.6 kV/cm.
2.2. Cell labelling – depolarization and membrane permeability
In the depolarization experiments, we labelled the cells with the
plasma membrane potential indicator fluorescent dye (PMPI) of the
FLIPR Membrane Potential Assays Kit (Molecular Devices, USA). For
30 min before the experiments, cells were incubated at 37 °C and 5%
CO2 in Live Cell Imaging Solution (Fischer Scientific, France) supple-
mented with 1 mg/ml 20% D-glucose (Gibco, France) and 0.5 μl/ml
PMPI. PMPI consists of a two-part system which includes a fluorescent
anionic voltage-sensor and a quencher. When the interior of the cell
has a relatively negative charge (in the state of resting potential or repo-
larization), the anion dye remains bound to the external surface of the
plasma membrane. In this state, the quencher in the extracellular fluid
preventsfluorescence excitation. During depolarization the voltage sen-
sor translocates to the interior of the plasmamembrane. This transloca-
tion is reversible as we observe cells return to their base-level
fluorescence approximately 30min after exposure to pulse. An increase
in fluorescence is observed because the quenching agent is restricted to
the extracellular environment. The time-constant of sensor transloca-
tion is in the range of seconds [68].
To determine whether cells were excitable, cells were exposed to
different extracellular concentrations of potassium ions (2.5 mM,
25 mM, 50 mM, 75 mM, 100 mM, 140 mM), while the NaCl (140 mM
in the original Live Cell Imaging Solution) was substituted for KCl in
an equimolar manner. The buffer was changed every 5 min, and the
cells were continuously imaged. Increased concentration of extracellu-
lar K+ ions increases the equilibrium potential of K+ and causes depo-
larization. Chemical depolarization is slow and does not cause action
potential but accommodation. In electrical depolarization experiments,
images were acquired every 30 s for 15–30 min, and pulse was deliv-
ered 5 min after the beginning of imaging.
In permeability experiments, we labelled the cells with the YO-PRO-
1® (YP) (Molecular Probes, USA). Right before the experiments, the
growth medium was changed with the Live Cell Imaging Solution sup-
plemented with 1 mg/ml 20% D-glucose (Gibco, France) and 1 μM YP.
Images were acquired every 3 s for 6 min, and 8 × 100 μs pulses were
delivered 30 s after the beginning of the imaging.
2.3. Exposure of cells to electric pulses
Three different pulse generatorswere used, each for a different pulse
duration range. For 10 ns pulses, we used a commercially available
nsPEF (nanosecond pulsed electric fields) generator (FPG 10-1NM-T,
FID Technology, Germany) where the electric field was numerically de-
termined [69] (Fig. 3a). For pulse exposures of 550 ns–1 μs, we used a
laboratory prototype pulse generator (University of Ljubljana) based
on H-bridge digital amplifier with 1 kV MOSFETs (DE275-102N06A,
IXYS, USA) [70] (Fig. 3b). For pulse exposures of 10 μs–10 ms we used
a commercially available BetaTech electroporator (Electro cell B10,103
Fig. 1. Phase-contrast images of all four cell lines used in experiments. a - CHO, b - U-87 MG, c - undifferentiated HT22 and d - differentiated HT22.
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age and current by oscilloscope (DPO 4104, Tektronix, USA or
Wavesurfer 422, 200 MHz, LeCroy, USA), voltage probe (tap-off 245
NMFFP-100, Barth Electronics Technology, USA for 10 ns pulses or dif-
ferential probe ADP305, LeCroy, USA for longer pulses) and a current
probe (CP030, LeCroy, USA or Pearson current monitor model 2877,
Pearson Electronics, Inc., USA). We used different systems as not all
pulse generators were available in both laboratories.
For 10 ns pulses, we used two stainless-steel needle electrodes with
a 1.2mm gap (Fig. 2a) [69]. For pulses longer than 10 ns we used either
stainless-steel wire electrodes with a 4 mm inter-electrode distance or
Pt/Ir wire electrodes with 1 mm, 2.2 mm or 5 mm inter-electrode dis-
tance (Fig. 2b) [70], depending on the electric field needed and the
power limitations of the generators. The electric field in the middle be-
tween the electrodes was nearly homogeneous and could beFig. 2. Photos of the electrodes, used in our experiments. a - electrodes used for delivering 10 n
inter-electrode distance.
104approximated as the applied voltage divided by the distance between
the electrodes [70].
In depolarization experiments, we delivered one pulse, and we var-
ied the pulse duration (10 ns, 550 ns, 1 μs, 10 μs, 100 μs, 1 ms, 10 ms),
and voltage to determine the minimum electric field intensity required
to cause a change in membrane potential (depolarization) that was sta-
tistically different from control conditions. This minimum electric field
intensity was considered to be the depolarization threshold. In mem-
brane permeability experiments, we delivered 8 × 100 μs pulses at
1 Hz repetition frequency.
2.4. Fluorescence microscopy and measurement
Imaging was performed on two different fluorescent microscopy
systems due to different availability of pulse generators in the twos with 1.2 mm gap, b - electrodes used for delivering pulses longer than 10 ns with 5 mm
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Fig. 3. Traces of pulses applied in the experiments. a - traces of 10 ns pulses generated by a commercial 10 ns nsPEF generator [69], b - a trace of 1 μs pulse generated by a prototype
generator from University of Ljubljana [70]. Voltage V/kV or V/V is presented as a function of time t/ns or t/μs, a and b, respectively.
106 J. Dermol-Černe et al. / Bioelectrochemistry 122 (2018) 103–114
Results and Discussion - Paper 3laboratories where the work was done. However, by repeating several
samples on both systems, we determined that the difference in systems
did not influence the results. Either a DMI6000 inverted microscope
(Leica Microsystems, Germany) with EMCCD camera (EMCCD Evolve
512, Roper, USA) or an AxioVert 200 inverted microscope (Zeiss, Ger-
many) with VisiCam 1280 CCD camera (Visitron, Germany) and either
a 100× oil immersion or 40× dry objective for PMPI and 20× dry objec-
tive for YP were used for experiments. Samples were excited with ap-
propriate wavelengths using the Spectra 7 light engine (Lumencor
USA) or a monochromator (High-Speed Polychromator, Visitron Sys-
tems GmbH, Germany) and the emission lightwas selected through ap-
propriate filters. Images were acquired using MetaFluor and
MetaMorph PC software (both Molecular Devices, USA).
2.5. Image analysis
First, the backgroundwas subtracted, each cell was selected by using
freehand tool, and its mean fluorescence was determined. Indepolarization experiments, we determined the maximal fluorescence
in the first 2.5 min and normalized it to the base line (the value of fluo-
rescence prior exposure to pulses). In permeability experiments, the
cells do not take up any YP without the electric pulses applied. Thus,
we reported the values either raw or normalized to the fluorescence
at maximal pulse parameters (8 × 100 μs, 1.2 kV/cm, 1 Hz repetition
frequency).
2.6. Statistical analysis
The threshold of depolarization was determined using ANOVA tests.
The threshold was determined as the lowest field intensity required to
produce a statistically significant membrane depolarization. The statis-
tical parameters are given in the Appendix, Table A1. The threshold of
electroporation (the fluorescence that was significantly different from
the control) and the comparisons of the change inmaximalfluorescence
between all four cell lines were determined using t-test (p b 0.05) in
SigmaPlot v.11 (Systat Software, San Jose, CA).3. Calculation/models
3.1. Cell excitability
Cell excitability models described the depolarization/action potential thresholds of the excitable differentiated HT22 cell line as the models we
used are valid for excitable cells. We modelled the strength-duration curve with two models – the Lapicque curve [71] which is one of the most
often used experimentally tested theoretical model and the Hodgkin-Huxley model [72] which is a phenomenological description of the activity
of voltage-gated channels.
The Lapicque curve is in the form:
I ¼ b 1þ c
T
 
; ð1Þ
where b denotes the rheobase, c the chronaxie and T the duration of the stimulus. Since we were controlling the electric field to which cells were
exposed, we substituted the current (I) with the electric field (E). For the rheobase value we took the depolarization threshold at applied 10 ms,
i.e. 0.28 kV/cm. The chronaxie should thus be the pulse duration at twice the rheobase, i.e. around 6 μs. However, with these parameters, the
curve fits the data poorly, and thus we determined the parameter c to be 1.88 μs. A non-physiological value of parameter indicates that the Lapicque
curve is not an optimal choice for description of our data.
One of the classical models describing neuronal excitation is the Hodgkin-Huxley (HH) model. We numerically calculated the strength-
duration curve via the HH model as described in [71]. For several pulse durations, we calculated the corresponding critical transcellular volt-
age which triggers the action potential (Fig. 4). The K, Na, and leakage current were modelled separately for the anodic and cathodic pole of
the cell and coupled via the equivalent circuit (Fig. 1A in [71]). Cells were modelled as idealized planar cells with two uniformly polarized
flat surfaces. The corresponding external electric field was calculated by dividing the transcellular voltage with the diameter of the cell. We
modelled monopolar as well as bipolar pulses. The bipolar pulse consisted of a positive pulse immediately followed by a negative pulse. The
duration of the bipolar pulse is the duration of a separate positive or negative pulse– the whole duration was thus twice this value. The cell
excitability calculations were performed in Matlab, R2017a (Mathworks, USA). Shape of the strength-duration curve depends on the time
constant of the membrane (Fig. 3 in [71]).105
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Permeabilization consisted of two sets of experiments – thosewith the application of one pulse (results previously published in [67]) and the ap-
plication of 8 pulses (data acquired in this study).
When one pulsewas applied, twomodels were used – a time-dependent Schwann equation or theory of kinetics of pore formation. First, we used
the time-dependent Schwann equation for prolate ellipsoidal cells [73,74]:
ΔVcrit ¼ E
R1
2−R2
2
R1−
R2
2
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
R1
2−R2
2
q log
R1 þ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
R1
2−R2
2
q
R2
0
@
1
A
R2 cos φð Þffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
R1
2 sin2φþ R22 cos2φ
q 1− exp −
t
τ
  
; ð2Þ
where the time constant of the membrane was 0.87 μs (τ) as determined in [67] and R1 = 27 μm± 7 μm and R2 = 10 μm± 5 μmwhich we deter-
mined from131 differentiatedHT22 cells on phase-contrast images. The critical threshold of electroporation (Vcrit) 1.776 Vwas obtained by the least-
square method, but the fit was poor (R2 = 0.53) Parameter t denotes time and φ the angle between the electric field and position on the plasma
membrane. Because we were interested in the maximal transmembrane voltage, we assumed φ= 0 (prolate ellipsoid oriented in the direction of
the electric field. Electric field (E) was expressed and we calculated the critical applied electric field for electroporation.
Second, we used the expression for a fraction of electroporated cells as derived by [75].We used the optimized parameters for attached cells in a
monolayer from (Eq. (5) and Fig. 5 in this [67]):
Fp E; tp
  ¼ 1− exp −kf Eð Þtp
  ð3aÞ0 5 10 15 20 25 30
t/min
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Fig. 5. Time-dynamics of electrical and chemical depolarization of all four cell lines. a) Chemical depolarization for all four cell lines. The K+ concentration was increased every 5 min. The
arrows mark which K+ concentration cells were exposed to from that time point further. b) Electrical depolarization when 1 pulse of 1 ms and 0.6 kV/cm was applied. In a and b the
increase over base level (Δf/f0)/arbitrary units is presented as a function of time t/min with shown 1 standard deviation.
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kbT
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exp πCmr2
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εm
−1
 
2kbT
K1ER cos θð Þ 1− exp −tpK2τ
  
þ Δφ
 2
2
664
3
775dθ; ð3bÞ
where Fp denotes the fraction of electroporated cells (0.7), tp the duration of the pulse, ν the frequency of lateralfluctuations of the lipids (1011 s−1),R
is byfitting determined cell radius (15.9 μm) [67], a the area per lipidmolecule (0.6 nm2),ΔW0 the energy barrier for pore formation (46.4 kbT), kb the
Boltzmann constant, T the temperature in kelvins, r the radius of the pore (0.32 nm), Cm the capacity of themembrane (1 μF/cm2), εw (78) and εm (4)
the relative permittivity of the water in the pore and membrane, respectively, K1 (1.24) and K2 (2.56) two numerical parameters, τ the membrane
time constant (0.87 μs), Δφ resting membrane voltage (−25 mV). The values were used as optimized by experimental data on attached CHO cells
and electroporation was determined by Fura-2AM [67].
When 8 pulses were applied, the normalized fluorescence curve was obtained by:
f n Eð Þ ¼
f Eð Þ− f E ¼ 0 kV=cmð Þ
f E ¼ 1:2 kV
cm
 
− f E ¼ 0 kV=cmð Þ
ð4Þ
where fn(E) denotes the normalized fluorescence, f(E) the raw fluorescence and E the applied electric field. The normalized fluorescence curve was
then fitted using a symmetric sigmoid to obtain permeabilization curve [76]:
p Eð Þ ¼ 1
1þ exp − E−E50%
b
  ð5Þ
where p denotes the normalized permeabilization, E the applied electric field, E50% the electric field where 50% of the final fluorescence was reached
and b the width of the curve. Permeabilization curve is based on normalized fluorescence of the population and not the exact percentage of perme-
abilized cells.
The rawvalues of YO-PRO-1-® fluorescencewere described using a first-order uptakemodel, which gave information on the resealing speed [77].
The model was:
f tð Þ ¼ S 1− exp − t
τ
  
ð6Þ
where S is the reached plateau, t is the time, f is the raw fluorescence and τ is the time constant of the resealingwhen 63% of the permeable structures
in themembrane are resealed. A higher value of τmeans slower resealing than lower value of τ. For curve fitting, we usedMatlab R2015 (Mathworks,
USA) and the Curve Fitting Toolbox. The goodness of the fit was evaluated using R-squared value, whose value closer to 1 indicates better fit.10
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pulse of duration T/s. Depolarization was determined using the PMPI dye and the
electroporation by the Fura-2AM dye. Lines correspond to models and symbols to
experimental values. External electric field E/(kV/cm) is presented as a function of pulse
duration T/s.4. Results
Results are divided into two sections – cell depolarization and
plasma membrane permeabilization after one pulse and plasma mem-
brane permeabilization after pulses of standard electrochemotherapy
parameters. Results in the cell depolarization section were obtained
with the PMPI dye. Results in the plasma membrane permeabilization
section were obtained with the YO-PRO-1® dye.
4.1. Cell depolarization and plasma membrane permeabilization after one
pulse
Fig. 5 shows the response of excitable andnon-excitable cells to elec-
trochemical and electrical depolarization. In Fig. 5a, the differential be-
havior of cells to depolarization by increasing extracellular K+
concentrations is shown. In Fig. 5b, the results to electrical depolariza-
tion after 1 pulse of 1ms (themost relevant point for neurostimulation)
at 0.6 kV/cm is shown. We compared the intensity of the response and
thus exposed all four cell lines to electric pulses of the same parameters.
The increase in fluorescence was observed when the pulse was applied
at threshold or above-threshold electric fields. We also tested several
different pulse durations and electric fields. Depolarization curves for
other pulse durations were similar in shape and values as the curves
after excitation with 1 ms pulse.
Fig. 6 shows the strength-duration depolarization curve (right y-
axis) and strength-duration permeabilization curve (left y-axis). Both
aspects (depolarization and membrane permeabilization) were experi-
mentally determined aswell asmodelled. The experimental depolariza-
tion threshold was determined from the membrane depolarization
curves, for each pulse duration and cell line separately. It is shown ingrey symbols – x denotes the CHO cells, Δ the U-87 MG cells,□ the un-
differentiated HT22 cells and ○ the differentiated HT22 cells. The exact
values are stated in Table 1. We can see that with increasing pulse107
Table 1
The depolarization thresholds for all tested pulse durations and cell lines. The results are
the same as in the Fig. 6. The asterisk (*) denotes that the threshold is only estimated
due to the variability of the data.
Electric field (kV/cm) 10 ns 550 ns 1 μs 10 μs 100 μs 1 ms 10 ms
CHO 44 2.0 1.2 0.45 0.30 0.15 0.10
U-87 MG 34 2.2 1.4 0.60 0.35 0.20 0.12
Undifferentiated HT22 34 2.0 1.4 0.70 0.50 0.35 0.24
Differentiated HT22 52 2.0 1.7* 0.90 0.60 0.40 0.28
Table 2
Parameters of the fitted symmetric sigmoid to the normalized data of YO-PRO-1® uptake.
8 × 100 μs pulseswere delivered at repetition frequency1Hz. The numbers denote the op-
timal value and the corresponding 95% confidence intervals.
Cell line E50% (kV/cm) b (kV/cm) R-squared
CHO 0.80 ± 0.06 0.15 ± 0.11 0.98
U-87 MG 0.81 ± 0.10 0.13 ± 0.09 0.99
HT22 undifferentiated 0.94 ± 0.07 0.12 ± 0.06 0.99
HT22 differentiated 0.91 ± 0.07 0.12 ± 0.06 0.99
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durations, the threshold for depolarization was the highest for the dif-
ferentiated HT22 cell line. The statistical parameters of the analysis of
the experimental depolarization threshold are shown in the Appendix
in Table A1. The depolarization strength-duration curve was modelled
using the Lapicque curve and the Hodgkin-Huxley model. The models
are only valid for excitable cell lineswhich have voltage-gated channels.
In excitable cells we obtained excitability strength-duration curve and
in non-excitable cell lineswe obtained depolarization strength-duration
curve. The modelled curves are presented with grey lines – in dash-dot
line is the Lapicque curve, in solid line is the Hodgkin-Huxley model for
the unipolar pulses and in dashed line is the Hodgkin-Huxleymodel for
bipolar pulses. The Hodgkin-Huxley model predicts a plateau at around
1 μs and is also slightly better at describing the data than the Lapicque
curve.
Experimental electroporation thresholds are shown in filled black
circles [67]. By the Saulis model modelled electroporation threshold is
presented in black lines. The dashed line is the Schwann's equation.
Bothmodels follow a similar dynamics up to 1ms, but for longer pulses,
the Saulismodel predicts lower electroporation thresholds andmatches
the experimental data better. In the Schwann model, the threshold of
electroporation was assumed to be constant for all pulse lengths, al-
though it is possible that it changed. The Saulis model was obtained
by fitting the model to the experimental results [67] and thus followed
the experimental data better than the Schwann equation. Depolariza-
tion and electroporation thresholds follow a similar dependency, al-
though the electroporation thresholds are slightly higher than the
depolarization thresholds. The same dependency indicates that electro-
poration and depolarization behave similarly as a function of the ap-
plied electric field.
4.2. Plasma membrane permeability after pulses of standard
electrochemotherapy parameters
In plasma membrane permeability experiments, we delivered
8 × 100 μs pulses of different voltage at 1 Hz repetition frequency.
These parameters are the standard electrochemotherapy parameters
and were used to evaluate the possibility of using electrochemotherapy0 0.2 0.4 0.6 0.8 1.0 1.2
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Fig. 7.Normalized fluorescence (a) and permeabilization curve (b) of all four cell lines to YO-PR
0.4 kV/cm (U-87 MG and CHO) or 0.6 kV/cm (undifferentiated and differentiated HT22 cells)
sigmoid. Normalized fluorescence fn/− is presented as a function of applied electric field E/(kV
108as treatment of excitable tissues or in the vicinity of excitable tissues.
The normalized plasma membrane permeabilization curve (Eq. 4) to
YO-PRO-1® is for all four cell lines shown in Fig. 7. The threshold of elec-
troporation of the U-87 MG and CHO cells was 0.4 kV/cm while of the
undifferentiated and differentiated HT22 cells it was 0.6 kV/cm. The
threshold was determined as electric field intensity where the fluores-
cence 6.5 min after pulse application was significantly higher than the
fluorescence of the control. With the increase of the electric field, the
permeabilization also increased in a similar way for all four cell lines.
The permeabilization curve could be described using a symmetric sig-
moid (Eq. 5), which is shown in Fig. 7b. The symmetric sigmoid param-
eters (Table 2) show that all four cell lines reached 50%
permeabilization between 0.8 and 0.9 kV/cm (E50%).
An example of the time dynamics of the uptake at applied 8 × 100 μs
at 1.2 kV/cm is shown in Fig. 8a. From the time-lapse of the YO-PRO-1®
uptake, we obtained the maximal fluorescence. The maximal fluores-
cence (Fig. 8b) was the highest for the U-87 MG cells and the lowest
for the CHO cells (CHO vs U-87 MG is just significant at p = 0.0468,
CHO vs. undifferentiated HT22 p = 0.0002, CHO vs. differentiated
HT22p=0.0008.). Therewere no significant differences in themaximal
fluorescence between the differentiated and undifferentiated HT22s
while for all other pairwise comparisons the difference was significant
(t-test, p b 0.05). We obtained the resealing constant (τ) (Fig. 8c) by
fitting a first-order uptake model (Eq. 6). The value of time constant τ
(Fig. 8c) corresponds to the time when 63% of the pores in the mem-
brane resealed. The resealingwas the fastest for the U-87MG cells, sim-
ilar for the undifferentiated HT22s and CHO and slower for the
differentiated HT22 cells. Statistical significance of the fit is obtained
by comparing the error bars which represent a statistical error of 5%.
5. Discussion
Our study we aimed at comparing the depolarization thresholds be-
tween excitable and non-excitable cells, to determine if excitable and
non-excitable cells respond similarly to electroporation pulses, and to
determine if electroporation can be an effective treatment of cancers
of the central nervous system. For each cell line, we determined the
strength-duration curve to one pulse of lengths between 10 ns and0 0.2 0.4 0.6 0.8 1.0 1.2
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the Lapicque curve and the Hodgkin-Huxley model. We compared the
excitability results with permeabilization to 1 pulse of durations be-
tween 150 ns and 100 ms, previously experimentally determined and
modelled using the Saulis model [67]. We also determined the perme-
ability curve to 8 × 100 μs pulses, delivered at 1 Hz and different electric
field intensities. For the assessment of cell depolarization we used the
PMPI dye. For the assessment of the plasma membrane perme-
abilization we used the YO-PRO-1® (YP) dye. Thus, we assume all re-
sults obtained with the dye PMPI to be depolarization due to voltage-
gated channels opening or formation of the pores in the membrane.
We assume all results obtained with the YP to be due to influx of YP
through the voltage-gated channels or through permeable plasma
membrane. Ourmethodology does not allow us tomake distinction be-
tween molecules entering through voltage-gated channels or through
pores/defects in the cell membrane.
The dye PMPI of the FLIPRR Membrane Potential Assay Kit is a valu-
able tool for the measurement of membrane potential [78] and ion
channel pharmacology [79,80]. Although electrophysiology is consid-
ered the gold standard for measurement of membrane potential, PMPI
has several advantages, namely the ease of use, the ability to monitor
long-term changes in multiple cells simultaneously. Furthermore,
PMPI has been compared directly to electrophysiology data with a
good agreement [68]. The quencher in the PMPI usually remains in the
extracellular fluid due to its large size and continues to quench the fluo-
rescence in the extracellular environment. However, when the plasma
membrane is permeabilized, the quencher could potentially enter the
cell through pores formed in the membrane and decrease the fluores-
cence in the cell. When we delivered pulses well above the depolariza-
tion threshold, we observed a decrease in a fluorescent signal which
could be indicative of cell electroporation. In the future, it should be
established to what extent the PMPI dye could also serve as cell mem-
brane permeabilization indicator.
The results of electrochemical depolarization show that with in-
creasing K+ concentration, the fluorescence and thus the transmem-
brane voltage are increasing which is in agreement with theory.
However, it was unexpected that the highestfluorescencewas achieved
with CHO cells and notwith the differentiated HT22 cells. Excitable cells
typically have a higher density of voltage-gated channels, and thus
more ions should enter the cell when these channels are open. Results
for electrical depolarization to 1 ms and 0.6 kV/cm show similar trends
– the highest change in fluorescence was measured with the CHO cells,
and the response of the differentiated and non-differentiated HT22 cells
was similar (Fig. 5) which was surprising. CHO cells are non-excitable
cells and would be expected to have a low background of voltage-gated ion channels; however, some reports indicate that these cells ex-
press voltage-gated Na+ channels [81] and a lack delayed rectifier K+
currents [82]. This would explain why CHO cells exhibited more signif-
icant and prolonged depolarization in our experiments compared to
other cells evaluated. Future investigations should examine the influ-
ence of voltage-gated Na+ channel inhibitors on CHO depolarization.
This finding highlights the importance of considering the endogenous
complement of voltage-gated ion channels expressed in a given cell
line It is also commensurate with our recent results using PMPI voltage
imaging to demonstrate the numerous ion channels present and impli-
cated in the depolarization of U-87MGcells by short electric pulses [83].
Another difference between the CHO cells and other three cell lines is
their pattern of growth. CHO cells tend to form colonies and are in
close contact to one another which causes electric field shielding and
lower induced transmembrane voltage [84]. Cells of U-87 MG and
HT22 cell lines were grown to be more isolated (Fig. 1).
Our strength-duration curve was determined for pulse lengths be-
tween 10 ns and 10 ms. As expected, the electric field needed to depo-
larize cells decreased with increasing pulse duration [71,85,86]. In
[86], the strength-duration curve was measured for frog muscles be-
tween 1 ns and 100 ms. The authors determined that the thresholds
for pulses of 100 μs or shorter followed a linear curve (in log-log
scale) which confirmed that the signal was due to the opening of the
ionic channels and not due to electroporation. Our results had roughly
the same dependency but the linear curve followed a linear dynamics
for pulses shorter than 1 μs. The differentiated HT22 cells are excitable
[87] and because of similar shape of the strength-duration curve to
the curve by Rogers et al. [86] we can assume that for short pulses we
also measured predominantly opening of the voltage-gated channels
and notmembrane electroporation. The other three cell lines are not ex-
citable, and the depolarization threshold only shows when the trans-
membrane voltage was significantly increased above the resting
voltage. The reasons for the discrepancy between the data by Rogers
et al. and our study could be that they used exponential pulses instead
of square pulses used in our study, and determined the threshold by ob-
serving the twitching of the muscle while we used a fluorescent dye.
For the depolarization of the differentiated HT22 cells, higher
electric field intensity was needed at most pulse lengths. These re-
sults are expected due to the more negative resting membrane volt-
age of differentiated non-dividing cells [88] for which a higher
change in membrane potential is needed to reach the threshold of
depolarization. However, at pulse lengths of 10 ns the difference
in the critical membrane voltage between the differentiated HT22
cells and non-excitable cells was up to 0.6 V (approximating cells
as prolate spheroids with R1 = 27 μm and R2 = 10 μm), which109
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age (around 50 mV difference between the excitable and non-excit-
able cells). The endogenous voltage-gated channels present in the
plasma membrane of the CHO cells could explain this observation.
First, we tried modelling the depolarization data with Lapicque's
curve which is similar to the Bleiss curve used in [86] but is valid for
square pulses.We could not describe the shape of the strength-duration
curve well, and the optimized value of the chronaxie was higher than
predicted from the value of the rheobase. Thus, we decided to fit the
Hodgkin-Huxley model, a more complex model, which takes into ac-
count the dynamics of the voltage-gated channels. The Hodgkin-Huxley
model in [71] couples the voltage on the anodal and cathodal pole of the
cell via the equivalent circuit. We modelled the cell as an idealized pla-
nar structure which does not accurately describe cell shape but it does
give a general idea of the shape of strength-duration curve. Even
when calculating the strength-duration curve for a spherical cell, the
shape of the strength-duration curve remained the same, it only slightly
moved along the y-axis (Fig. 7 in [71]).The shape of the strength-dura-
tion curve is not linear. The Hodgkin-Huxley model qualitatively
followed the data well for pulses shorter than 10 μs, but for longer
pulses, the predicted depolarization threshold decreased more than
the experimentally determined one. The reasons for deviation at long
pulses could be the following. First, we were also electroporating cells
enough for the dye to enter the cell but not the quencher. Second, our
systemwas not sufficiently sensitive to determine very low depolariza-
tion thresholds. Third, for exact determination of the depolarization
thresholds or action potential (for the differentiatedHT22 cells) electro-
physiological measurements are necessary. Fourth, also other channels
contributed to the dependency of depolarization observed in our exper-
iments but were not included in the model.
In [52] the authors achieved excitation of a peripheral nerve with a
nanosecond pulse without electroporation. The presence of action po-
tential without electroporation is in agreement with our modelling
since the thresholds for depolarizationwere lower than electroporation
thresholds. Additionally, the nerves' refractory properties were not
affected.
We found the plateau of depolarization thresholds at 1 μs intriguing
and decided to try the samemodel on bipolar pulses. The results of this
model offered an interesting perspective on the potential mechanism of
theH-FIRE protocol [66]. In Fig. 6, we can see that around 1 μs there is an
overlap of the depolarization thresholds determined by the Hodgkin-
Huxley model and of the Saulis permeabilization model. This overlap
could explain why with 1 μs bipolar pulses, electroporation was ob-
servedwhile muscle contractionswere not [66]. In ourmodel, with cur-
rently chosen parameters the threshold for electroporation was still
higher than for an action potential, but the parameters of the Hodg-
kin-Huxley model were not optimized to describe our data, and we
used the same values as in [71]. Optimizing the values of the Hodgkin-
Huxley model could bring curves closer together. The Hodgkin-Huxley
model and permeabilization model also indicate that short monopolar
pulses could be better at not exciting the tissues since the threshold
for action potential was calculated to be higher than that of the bipolar
pulses. A similar explanation why the H-FIRE pulses do not excite the
cells was offered in [89] by numerical modelling of the response of
nerves to bipolar pulses. These authors showed that byusing short bipo-
lar pulses, it was possible to ablate a tissue regionwithout triggering ac-
tion potentials in the nearby nerve. The reason proposed being that the
stimulation threshold rises faster than the irreversible electroporation
threshold. Further experiments are now needed to test these hypothe-
ses, comparing the thresholds for action potentials and electroporation
in excitable tissues with monopolar versus bipolar pulses in the 1 μs
range.
The repolarization time of all four cell lines was in the range of mi-
nutes. The values for CHO, U-87 MG and non-differentiated HT22s are
in agreement with the current knowledge existing as these cell lines
do not have IK voltage-gated potassium channels, responsible for fast110repolarization. The values of repolarization of differentiated HT22 cells
are much longer than traditionally observed during neural depolariza-
tion,which is in the range ofmilliseconds. There are several possible ex-
planations for this discrepancy. First, as the assessment method, we
used PMPI dye entering the cell and then being pumped out. PMPI dye
has a time constant of several seconds [90] and can be understood as a
low-pass filter. Second, our experiments were performed at room tem-
peraturewhich slows down the speed of theNa/K pump. Third, it is pos-
sible that delivery of a single pulse led to a burst of action potentials and
thus a prolonged depolarization. Fourth, that cells were depolarized as
well as electroporated. Fifth, electroporation causes leakage of ATP
[91] which is necessary for driving the pumps, and lack of ATP could
slow them down. Sixth, due to high induced transmembrane voltage
ion channels could be damaged [92,93].
The time required for reaching the peak fluorescence in depolariza-
tion experiments coincidedwith the resealing time observed in the per-
meabilization experiments. It is possible that during depolarization and
permeabilization experiments, PMPI and YP were entering through the
voltage-gated channels [94] as well as through pores formed in the
plasma membrane. Even when using channel inhibitors, a total inhibi-
tion of depolarization could not be achievedwhich indicates that during
depolarization ions also enter through pores [83].
An interesting studywhere also a fluorescent dyewas used to assess
depolarization/action potential and plasma membrane electroporation
of hippocampal neurons was recently performed by Pakhomov et al.
[95]. They determined that the activation of voltage-gated sodiumchan-
nels enhanced the depolarizing effect of electroporation. The authors
used the Fluo-Volt dye which enables imaging of fast changes in the
range of ms. On the other hand, the PMPI dye enables imaging in the
range of seconds to minutes, and it enables to capture slow, persistent
changes in the transmembrane potential in the non-excitable cells.
In the next part of our study, we exposed cells to 8 × 100 μs pulses,
which are typically used in electrochemotherapy treatments. All four
cell lines reached the threshold of electroporation at approximately
the same value - between 0.4 and 0.6 kV/cm. The permeabilization
curve of all four lines could be described using a symmetric sigmoid. Al-
though the differentiation causes a drop in the resting membrane po-
tential [88], the lower, i.e. more negative resting membrane potential
did not affect the threshold of electroporation as it was similar for excit-
able and non-excitable cells. The permeabilization curves then followed
similar dependency (Fig. 7b) and reached 50% of the maximal fluores-
cence around 0.9 kV/cm.We can conclude that irrespective of the excit-
ability, all four cell lines responded similarly to electroporation pulses.
The results are in agreement with electroporation being a physical
means of disturbing plasma membrane in the lipid domain of the
membrane. If the voltage-gated ion channels contributed to the YP up-
take, it was much lower than the uptake through the permeabilized
membrane.
The fluorescence reached was the highest for the U-87 MG cell line
and the lowest for the CHO cell line while the fluorescence of the differ-
entiated and undifferentiated HT22 cells was between the levels of the
CHO and U-87MG cells. Since the cells were grown attached in amono-
layer, the lowest fluorescence of the CHO cell line can be explained by
the tendency of CHO cells to grow in colonies in proximity which de-
creases the area of the plasma membrane available for dye uptake. An-
other reason could be that the proximity of cells decreases the induced
transmembrane potential due to shielding [76,84,96] although it is un-
expected that the proximity did not affect the threshold of electropora-
tion. YP starts to emit fluorescent light after binding to nucleic acids.
Thus different concentration of intracellular nucleic acids could also af-
fect the fluorescence.
From the time-lapse images of the YP uptake, the resealing speed
could be determined. The values of resealing constants were in the
same range as in [77] although the electroporation buffer we used in
this study was not tested previously. The cancerous U-87 MG cell line
resealed much faster than the other (normal) three cell lines which is
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resealed 2–3 times faster than normal ones due to lower tension levels
in their lipid membranes.
6. Conclusions
In summary, the depolarization threshold was higher for the excit-
able cells than for the non-excitable cells. The strength-duration curve
of excitable cells was described with the Lapicque curve and the Hodg-
kin-Huxley model. However, neither of the models described the be-
haviour at all pulse durations. The Hodgkin-Huxley model gave insight
into the ability of the H-FIRE to permeabilize but not excite the tissue.
All four cell lines responded similarly to pulses of standard
electrochemotherapy parameters. The shape of the permeability curve
was similar to curves already published in the literature [98]. Thus, elec-
troporation is a feasible means of treating excitable and non-excitable
cells with pulses of similar parameters. Furthermore, our results show
the potential of achieving permeabilization and minimizing or avoiding
excitation/pain sensation which needs to be explored in more detail. In
future studies, it should be established, however, to what extent in vitro
depolarization and excitability correlate to the actual excitation and
pain sensation in vivo.
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Table A1
Statistical parameters of the strength-duration curve statistical analysis by ANOVA for the
CHO cell line (Table A1a), the U-87 MG cell line (Table A1b) the undifferentiated HT22
(Table A1c) and the differentiated HT22 cell line (Table A1d). F(x,y) means the F-test
value, where x, y are the degrees of freedom of the between-group comparison and the
within-group comparison. Where Fw is indicated, the assumption of homogeneity of var-
iance was not met; therefore, aWelch's adjustment for the ANOVAwas calculated and re-
ported. The statistical significance provides the p-valueswhich are compared to our alpha
criterion ofα=0.05. The effect size column provides an indication of the variability in re-
sponse that can be attributed to the PEF. As an example,Ω2 = 0.47means that 47% of the
change in membrane potential can be attributed to the PEF.
Table A1aCHO F p111Ω20 ns F(2, 17) = 9.00 p b 0.01 0.47
50 ns F(3, 15) = 4.56 p = 0.02 0.36
μs F(3, 16) = 91.52 p b 0.01 0.93
0 μs FW(3, 6.08) = 14.12 p b 0.01 0.67
00 μs F(4, 19) = 10.35 p b 0.01 0.61
ms FW(3, 5.55) = 53.76 p b 0.01 0.89
0 ms F(3, 13) = 10.80 p b 0.01 0.63Table A1bU-87 MG F p Ω20 ns F(4, 19) = 2.90 p b 0.01 0.80
50 ns F(3, 15) = 3.60 p = 0.04 0.29
μs F(3, 16) = 4.32 p = 0.02 0.33
0 μs FW(4, 9.27) = 43.54 p b 0.01 0.63
00 μs F(3, 21) = 47.64 p b 0.01 0.85
ms FW(4, 6.62) = 13.96 p b 0.01 0.71
0 ms F(3, 19) = 10.66 p b 0.01 0.56Table A1cUndifferentiated HT22 F p Ω20 ns FW(3, 3.06) = 21.88 p = 0.01 0.81
50 ns F(2, 9) = 12.96 p b 0.01 0.67
μs F(3, 9) = 11.14 p b 0.01 0.70
0 μs F(4, 10) = 5.24 p = 0.02 0.53
00 μs F(2, 12) = 3.79 p = 0.05 0.27
ms F(3, 10) = 9.06 p b 0.01 0.63
0 ms F(4, 13) = 4.15 p = 0.02 0.41Table A1dDifferentiated HT22 F p Ω20 ns FW(3, 11.76) = 13.41 p b 0.01 0.60
50 ns F(2, 10) = 5.20 p = 0.03 0.39
μs F(2, 16) = 4.56 p = 0.03 0.29
0 μs F(6, 21) = 3.97 p b 0.01 0.39
00 μs F(4, 16) = 6.13 p b 0.01 0.49
ms F(3, 19) = 8.80 p b 0.01 0.50
0 ms F(4, 20) = 6.02 p b 0.01 0.451References
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Abstract
Electroporation-induced cell sensitization was described as the occurrence of a delayed
hypersensitivity to electric pulses caused by pretreating cells with electric pulses. It was
achieved by increasing the duration of the electroporation treatment at the same cumulative
energy input. It could be exploited in electroporation-based treatments such as electroche-
motherapy and tissue ablation with irreversible electroporation. The mechanisms responsi-
ble for cell sensitization, however, have not yet been identified. We investigated cell
sensitization dynamics in five different electroporation buffers. We split a pulse train into two
trains varying the delay between them and measured the propidium uptake by fluorescence
microscopy. By fitting the first-order model to the experimental results, we determined the
uptake due to each train (i.e. the first and the second) and the corresponding resealing con-
stant. Cell sensitization was observed in the growth medium but not in other tested buffers.
The effect of pulse repetition frequency, cell size change, cytoskeleton disruption and cal-
cium influx do not adequately explain cell sensitization. Based on our results, we can con-
clude that cell sensitization is a sum of several processes and is buffer dependent. Further
research is needed to determine its generality and to identify underlying mechanisms.
Introduction
Electroporation is a phenomenon resulting in a transient increase in membrane permeability,
which occurs when short high voltage pulses are applied to cells and tissues [1,2]. If cells can
recover, we consider this reversible electroporation. If the damage is too extensive and they die,
we consider this irreversible electroporation (IRE). Electroporation is used in medicine, e.g.
electrochemotherapy (ECT) [3–6], non-thermal IRE as a method of tissue ablation [7–9], gene
therapy [10,11], DNA vaccination [12,13] and transdermal drug delivery [14–16], as well as in
biotechnology [17], and food processing [18–20].
For tumor eradication, ECT, IRE, and gene therapy are successfully used. However, it was
shown that electroporation of tumors larger than 2 cm in diameter is not as successful as of
smaller tumors [21]. When treating tumors with IRE, a high number of pulses is delivered,
which can cause significant Joule heating and thermal damage and complicate the treatment
[22,23]. Provided the effect of the electric pulses be enhanced, we can treat larger tumors with
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fewer pulses of lower voltage. Pulse effect amplification can be achieved using molecules that
enhance cell sensitivity to electric pulses, e.g. DMSO or surfactant C12E8 [8].
Lately, several reports on a so-called phenomenon of cell sensitization have been published
[24–29]. By increasing the duration of an electroporation treatment (e.g. by decreasing the
pulse repetition frequency or by splitting the delivered pulse train in more trains with delays
between them), a decrease in cell viability and a much higher uptake of molecules were
achieved. When applying conventional 100 μs pulses, 5 minute delay between the two trains
was suggested [25], but also shorter delays led to cell sensitization [27,30]. Cell sensitization
has been observed as decreased membrane integrity, increased mass transport across the mem-
brane, and decreased cell viability. Similarly as with square pulses, it has been shown that
exposing cells to AC electric fields increased their sensitivity to subsequent millisecond square
pulses [31].
Cell sensitization could be beneficially used in the electroporation-based treatments. It is
possible that it is already influencing the outcome of the IRE and the ECT. Namely, in the IRE,
90 pulses synchronized with a heartbeat are delivered between each pair of electrodes [8]. Usu-
ally, four electrodes are inserted, and IRE can last up to 9 minutes (four electrodes equals six
pairs, 6x90 pulses at around 1 Hz take 9 minutes). In ECT, eight pulses at 1 Hz or 5 kHz are
applied [32]. When using hexagonal electrodes, pulses are effectively delivered between 7 elec-
trodes (12 pairs) [33]. Between each electrode pair, four pulses are delivered, and the procedure
is repeated with four pulses of reverse polarity (twelve pairs, 8x12 pulses at around 1 Hz take
1.5 minute). If we consider the switching time [34], both treatments already fall within the time
range for cell sensitization. The mechanisms of the delayed cell sensitization are not yet
known. The proposed mechanisms are: 1) calcium uptake [24,25], 2) ATP leakage [24,25], 3)
reactive oxygen species formation [24,25], 4) cell swelling [24,25], 5) cytoskeleton disruption
[28], 6) reduced pore edge line tension which lowers the electroporation threshold [26,27], 7)
extended pore opening times [26,27], and 8) the decrease of high conductance membrane state
which allows for the creation of additional defects [35].
We would like to emphasize the difference in the definition of the cell sensitization in the
already published studies and our paper. So far, cell sensitization has been defined as an
increase in total molecular uptake or decrease in cell survival after applying a split dose as
opposed to a single dose. The contribution of separate pulse trains to the final uptake and sur-
vival has not been investigated although, in our opinion, it is very important for the applicabil-
ity of cell sensitization. When applying a single dose, we can reach saturation in mass transport
[36,37]. Pulses at the end of the train contribute to the uptake less than pulses at the beginning
[35,38]. With splitting the dose in half, we avoid saturation which is then mistakenly regarded
as cell sensitization although cells respond to the first and the second pulse train in a similar
way. In our experiments, we distinguished contributions of the first and the second pulse train.
We considered the cells sensitized when the uptake due to the second pulse train was higher
than the uptake due to the first train, irrespective of the final fluorescence level.
In preliminary experiments, we tested cell sensitization in a standard low-conductivity elec-
troporation buffer. Surprisingly, splitting the dose in half lowered the final fluorescence. We
were intrigued and decided to test propidium uptake in the growth medium, where cell sensiti-
zation has been previously observed [24,25,27]. There, splitting the dose in half increased the
final fluorescence. We repeated experiments in three more electroporation buffers to investi-
gate the effect of electrical conductivity, calcium influx, and sucrose concentration; splitting the
dose in half again did not increase the final propidium uptake. Then, we analyzed the contribu-
tions of the separate pulse trains to the final fluorescence. The response of cells to pulse split-
ting in different electroporation buffers was complex and varied among others in the increased
or decreased sensitivity to the second pulse train, in the resealing speed, and in the efficiency of
Cell Electrosensitization in Different Electroporation Buffers
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split versus single dose. Although cell sensitization has already been defined as a phenomenon
and models have been constructed describing it [39], further research is needed to determine
its generality and the involved mechanisms.
Materials and Methods
Cell preparation
Chinese hamster ovary cells (European Collection of Authenticated Cell Cultures ECACC,
cells CHO-K1, cat. no. 85051005, obtained directly from the repository) were grown in 25 cm2
culture flasks (TPP, Switzerland) for 2–3 days in an incubator (Kambič, Slovenia) at 37°C and
humidified 5% CO2 in HAM-F12 growth medium (PAA, Austria). The growth medium was
supplemented with 10% fetal bovine serum (Sigma-Aldrich, Germany), L-glutamine (StemCell,
Canada) and antibiotics penicillin/streptomycin (PAA, Austria) and gentamycin (Sigma-
Aldrich, Germany). On the day of the experiments, the cell suspension was prepared. Cells
were detached by 2.5 ml of 10x trypsin-EDTA (PAA, Austria), diluted 1:9 in Hank’s basal salt
solution (StemCell, Canada). After 1.5 minute the trypsin was inactivated by 2.5 ml of the
growth medium. Cells were transferred to 50 ml centrifuge tube and centrifuged 5 minutes at
180g and 24°C. Then, cells were resuspended in the growth medium at 6x104 cells/ml. 500 μl of
cell suspension was added per well in 24-well plate. The plates were moved to the incubator for
15–40 minutes until cells attached to the bottom of the well but maintained their spherical
shape [40].
Before the experiments, cells were washed with a fresh electroporation buffer and 500 μl of
the new electroporation buffer was added to each well. For fluorescence measurements, the
electroporation buffer included 150 μM propidium iodide (Life Technologies, USA). The com-
position of the tested electroporation buffers is given in Table 1. The electrical conductivity was
measured with conductometers MA 5959 (Metrel, Slovenia) or S230 SevenCompact (Mettler
Toledo, Switzerland) at 37°C and the osmolality by freezing point depression with Knauer
cryoscopic unit (model 7312400000, Knauer, Germany). MgCl2, NaCl, K2HPO4, CaCl2,
HEPES, and sucrose were from Sigma-Aldrich, Germany, and KH2PO4 fromMerck, Germany
Electroporation and image acquisition
We used Pt/Ir wire electrodes with 0.8 mm diameter and 4 mm inter-electrode distance posi-
tioned at the bottom of the plate as shown in Fig 1. The plate was put under the microscope
with a heated stage (37°C). Square pulses (300V or 0.75 kV/cm, 100 μs, 10 Hz) were applied
using the βtech electroporator (Electro cell B10, Betatech, France) and monitored with an oscil-
loscope WaveSurfer 422, 200 MHz and a current probe AP015 (Teledyne LeCroy, Chestnut
Table 1. Composition of electroporation buffers.
Electroporation
buffer
Composition Electrical
conductivity [mS/cm]
Osmolality [mOsm/kg]
The growth medium
HAM-F12
Inorganic salts, amino acids, vitamins and other components (PAA Austria,
cat. no. E15-016), 10% fetal bovine serum, L-glutamine, and antibiotics
17.14 260–320 (based on the
producer’s data sheet)
The low-conductivity
buffer
10 mM KH2PO4/K2HPO4 in ratio 40.5:9.5, 1 mMMgCl2, 250 mM sucrose 1.78 292
The hyperosmotic
buffer
10 mM KH2PO4/K2HPO4, 1 mMMgCl2, 400 mM sucrose 1.76 475
The high-conductivity
buffer
10 mM KH2PO4/K2HPO4 in ratio 40.5:9.5, 1 mMMgCl2, 150 mM NaCl 19.12 300
The buffer with calcium 10 mM HEPES, 250 mM sucrose, 0.7 mMMgCl2, 0.3 mM CaCl2 0.38 281
doi:10.1371/journal.pone.0159434.t001
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Ridge, NY). In fluorescence measurements, we exposed cells to either half dose (four 100 μs
pulses), single dose (eight 100 μs pulses) or split dose (4+4, 100 μs pulses with 1, 2 or 3 minute
delay) (Fig 2). In the cell size measurements, we exposed cells only to the half dose (four 100 μs
pulses). 300 V was chosen based on the preliminary experiments, where most of the cells were
permeabilized, but the survival was not affected. 3 minutes was chosen as the delay that pro-
duced cell sensitization in other studies [30] and where the measured final fluorescence value
of the split dose was higher (the growth medium) or lower (the low-conductivity buffer) than
of the single dose.
Cells were observed by the inverted microscope AxioVert 200 (Zeiss, Germany) under 20x
objective for fluorescence (535 nm excitation, 617 nm emission) and 40x for cell size measure-
ments. Images were acquired using the VisiCam 1280 camera (Visitron, Germany) and the
MetaMorph PC software (Molecular Devices, USA) in a time lapse: one image every 8 or 10 s
for 8 minutes (fluorescence measurements) or 2 s for 3 minutes (cell size measurements). We
chose a field of view in the middle between the electrodes where the electric field distribution
was approximately homogeneous, and electric field was calculated as a ratio of the applied volt-
age to inter-electrode distance [41]. The numbers of the experiments and the analyzed cells for
each protocol are shown in Table 2. The exposure time in fluorescence measurements was dif-
ferent across tested buffers, and the absolute values of fluorescence should not be directly
compared.
Images were analyzed using the ImageJ software (http://imagej.nih.gov/ij/). On fluorescent
images, each cell was manually outlined, and its average fluorescence intensity through the
whole stack was automatically measured. Fluorescence intensity before the pulse application
was subtracted to compensate for the background fluorescence. In preliminary experiments, it
was determined that in all tested buffers, there was no measurable spontaneous propidium
uptake on the same time scale without applying electric pulses. For cell size measurements, the
threshold was applied to the bright-field images, cells were automatically outlined, and their
Fig 1. Photo of the electrodes attached to the bottom of the 24-well plate. The plate was put under a
microscope. The images were acquired from between the electrodes where the electric field was
approximately homogeneous and could be calculated as the ratio of the applied voltage and inter-electrode
distance.
doi:10.1371/journal.pone.0159434.g001
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area in each image was measured. The measured area was normalized to the size of the area
before pulse application to determine a relative change in the cross-section. In each time step,
the average value and the standard error were determined.
Fig 2. Scheme of the used protocols. In the half dose, four 100 μs pulses, and in the single dose, eight
100 μs pulses were applied. In the split dose, two trains of four 100 μs pulses were applied and the delay
between the end of the first and the beginning of the second train was 1, 2 or 3 min. In all experiments, 300 V
or 0.75 kV/cm were applied. The repetition frequency was 10 Hz.
doi:10.1371/journal.pone.0159434.g002
Table 2. Number of experiments and analyzed cells in each experiment.
Type of experiment No. of experiments No. of analyzed cells
Fluorescence measurement The growth medium 4 pulses 3 19
8 pulses 5 34
4+4 pulses, 1 min delay 6 31
4+4 pulses, 2 min delay 6 37
4+4 pulses, 3 min delay 7 40
The low-conductivity buffer 4 pulses 5 34
8 pulses 6 45
4+4 pulses, 1 min delay 6 38
4+4 pulses, 2 min delay 8 55
4+4 pulses, 3 min delay 7 48
The hyperosmotic buffer 4 pulses 4 21
8 pulses 3 20
4+4 pulses, 3 min delay 4 23
The high-conductivity buffer 8 pulses 3 24
4+4 pulses, 3 min delay 3 23
The buffer with calcium 8 pulses 3 21
4+4 pulses, 3 min delay 3 25
Cell size measurement The growth medium 4 19
The low-conductivity buffer 7 25
doi:10.1371/journal.pone.0159434.t002
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The model fitting
The quantitative results of the uptake were acquired by fitting a first-order model [42]:
f tð Þ ¼ C 1 exp  t
t
  
ð1Þ
to the experimental results using the Curve fitting toolbox and Matlab R2011b (Mathworks,
USA). S signifies the plateau of the fluorescence; τ is the relaxation time of propidium uptake
when the cells reach 63% of the final fluorescence. The time course of propidium uptake
reflects the resealing process of the membrane and τ can also be understood as a resealing con-
stant [42]. The derivation is in the S1 Appendix.
The model:
f tð Þ ¼ S1 1 exp 
t
t1
  
þ S2 1 exp 
t  tdelay
t2
  
 t > tdelay
 
þ kt ð2Þ
was fitted to the split dose results. Parameter tdelay is the inter-train delay, k is the slope of the
linear part of the propidium uptake. An example of the fitted curve and the parameters is
shown in Fig 3. The first order kinetics model described the majority of our data sufficiently
well (R2>0.97), but it predicted that after the exponential closing of the pores the transport will
stop, and the fluorescence will not increase. In our experimental results, the shape of the propi-
dium uptake curves indicated that there was an additional process present that caused the lin-
ear uptake. We modeled it with a linear uptake process (‘kt’) which we assumed present from
the beginning of the treatment. Since we do not know what exactly caused the linear uptake, it
seemed inappropriate to ascribe it only to one of the trains.
We fitted Eq 1 to the half and the single dose and Eq 2 to the split dose results. The optimal
values of the parameters and the R2 (the coefficient of determination) value are presented in
Table 3. In the split dose protocols, we normalized the S2 and τ2 values to the average S1 or τ1
value in the same buffer (unless stated differently in Table 3). If S2/S1>1, cells were assumed
sensitized, if S2/S1<1, they were assumed desensitized, and if S2/S11 the trains were assumed
equally effective. Ratio τ2/τ1 gave information whether the resealing after the second train was
faster (τ2/τ1<1) or slower (τ2/τ1>1) than after the first train or similar to the first train (τ2/
τ11). The values of parameters S1 and τ1 should be the same for all first trains (half and split
dose) in each buffer. The difference in their values was due to the biological variability and the
Fig 3. An example of fitted first-order models to the results of propidium uptake in the growth
medium.Meaning of S1, S2, τ1 τ2, tdelay and the increase due to ‘kt’ are shown.
doi:10.1371/journal.pone.0159434.g003
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Table 3. The optimal values of parameters and the R2 of fitted Eqs 1 and 2. A–The growth medium, B–the low-conductivity buffer, C–the hyperosmotic
buffer, D–the high-conductivity buffer, E–the buffer with calcium. Values in bold and the symbol next to them emphasize if the cells were desensitized (S2/
average(S1)<1, symbol #), sensitized (S2/average(S1)>1, symbol ") or if the trains were equally effective (S2/average(S1)1, symbol). The numbers
after ± sign define 95% confidence interval. The graphical representation of S2/average(S1) and τ2/average(τ1), based on experimental uptake results in Fig 4,
is in Fig 5.
A–The growth medium
Half dose Single dose 1 min delay 2 min delay 3 min delay
S1 215.5 ± 7.5 354.8 ± 9.9 179.6 ± 14.2 197.4 ± 17.2 204.2 ± 8.2
S2 / / 265.9± 13.9 226.9 ± 12.5 207.6 ± 8.8
τ1 65.91 ± 4.17 63.45± 3.33 44.02± 6.16 69.47± 10.07 46.13 ± 3.44
τ2 / / 48.37 ± 1.58 47.01± 3.25 37.76 ± 2.98
k 0.06664 ± 0.02 0.06825 ± 0.0267 0.1831 ± 0.0124 0.1234 ± 0.0339 0.1024 ± 0.0372
S2/average(S1) / / 1.34 ± 0.18 " 1.14 ± 0.15" 1.04 ± 0.13
τ2/average(τ1)
/ / 0.86 ± 0.20 0.83 ± 0.20 0.67 ± 0.16
R2 0.9954 0.9961 0.9998 0.9993 0.9991
B–The low-conductivity buffer
Half dose Single dose 1 min delay 2 min delay 3 min delay
S1 516.9 ± 3.9 965.7 ± 1.7 516.9 ± 3.9
a 516.9 ± 3.9a 445.4 ± 19.4
S2 / / 413.1 ± 4.9 269 ± 12.4 229.2 ± 10.7
τ1 91.6 ± 2.66 82.78 ± 0.6 91.6 ± 2.66
a 91.6 ± 2.66a 86.7 ± 4.97
τ2 / / 51.58 ± 3.15 65.11 ± 3.40 44.95 ± 3.65
k 0 0 0 0.0985 ± 0.0293 0.1512 ± 0.0556
S2/average(S1) / / 0.86 ± 0.04 # 0.56 ± 0.03# 0.48 ± 0.03#
τ2/average(τ1) / / 0.58 ± 0.05 0.73 ± 0.06 0.50 ± 0.05
R2 0.9962 0.9997 0.9980 0.9994 0.9996
C–The hyperosmotic buffer
Half dose Single dose 3 min delay
S1 191 ± 2.4 387.7 ± 4.5 155.8 ± 27.3
S2 / / 86.76 ± 10.28
τ1 161.1 ± 5.3 117.8 ± 4.5 124.8 ± 21.2
τ2 / / 69.63 ± 12.46
k 0 0 0.01741 ± 0.0662
S2/average(S1) / / 0.50 ± 0.08 #
τ2/average(τ1) / / 0.49 ± 0.10
R2 0.9977 0.9958 0.9992
D–The high-conductivity buffer
Single dose 3 min delay
S1 681.2 ± 9.1 369.8 ± 31.4
S2 / 379.8 ± 8.6
τ1 57.54 ± 1.54 122.2 ± 11.7
τ2 / 36.68 ± 1.34
k 0.4366 ± 0.0255 0.2719 ± 0.0623
S2/average(S1) / 1.03 ± 0.09
τ2/average(τ1) / 0.30 ± 0.10
R2 0.9992 0.9999
E–The buffer with calcium
Single doseb 3 min delay
S1 1129 ± 432 365.6 ± 22.4
S2 / 386.1 ± 22
τ1 144 ± 55.9 79.36 ± 11
(Continued)
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error of curve fitting. The error of curve fitting was more noticeable if the delay between two
pulse trains was short and the first-order shape of the uptake curve was not very clear. There-
fore, in order to decrease the error we presented results by normalizing the S2 and τ2 to the
average values of S1 and τ1 for each buffer separately. In the cell (de)sensitization definition, ‘kt’
was not included, since we assumed this additional process present from the beginning of the
measurement.
Results
First, experiments were performed with a fixed inter-train delay (3 min) in five electroporation
buffers. Results are presented in Cell sensitization in different buffers section. Second, different
inter-train delays were tested in the growth medium and the low-conductivity buffer. These
two buffers were chosen as a representative for the cell sensitization and cell desensitization
effect. Results are presented in Cell sensitization with different delays section. The time dynam-
ics of propidium uptake in the growth medium, the low-conductivity, the hyperosmotic, the
high-conductivity buffer, and the buffer with calcium are shown in Fig 4A, 4B, 4C, 4D and 4E,
respectively. The observations on higher or lower uptake as a response to the first or second
train are based on fitting Eqs 1 and 2 to the experimental results. One of the fitted curves is
plotted in Fig 3 where the parameters S1, S2, tdelay, τ1, and τ2 are shown. In Table 3, the optimal
values of parameters and the calculated ratios of S2/S1 and τ2/τ1 are presented. If S2/S1>1, cells
were assumed sensitized, if S2/S1<1, they were assumed desensitized, and if S2/S11 the trains
were assumed equally effective. The final level of fluorescence was irrelevant in our definition
of cell sensitization. In Fig 5A, there is the graphical representation of the ratios in the growth
medium, the low-conductivity, the hyperosmotic, the high-conductivity buffer, and the buffer
with calcium at fixed 3 minute inter-train delay. In Fig 5B, ratios for the growth medium, and
in Fig 5C for the low-conductivity buffer at different delays are shown.
Cell sensitization in different buffers
In the growth medium, the total uptake after a split dose protocol (i.e. 4+4 pulses) was higher
than after a single dose protocol (i.e. eight pulses) at 1 minute delay (Fig 4A). The second train
contributed more to the total fluorescence (Fig 5A), i.e. cell sensitization was present. The
value of k was similar for the single and the half dose, but it was much higher for the split dose.
There was a gradual uptake of propidium even 8 minutes after the pulses (k> 0).
In the low-conductivity buffer, the split dose protocol resulted in lower final fluorescence
than the single dose protocol (Fig 4B). In the split dose protocol, the uptake due to the second
train was lower than due to the first train (Fig 5A), i.e. cell sensitization was not present. On
Table 3. (Continued)
τ2 / 69.86 ± 5.54
k 0 0
S2/average(S1) / 1.06 ± 0.88
τ2/average(τ1) / 0.88 ± 0.14
R2 0.9705 0.9974
a The values for the S1 and τ1 were taken from the results of fitting Eq 2 to the results of the half dose (2
nd column) where the plateau of fluorescence was
already reached, and the first order shape was clear.
b Here, the first order model was not appropriate since the 95% confidence interval was very large. These parameters do not influence the results of the
analysis since the ratios were not calculated from the single dose parameters.
doi:10.1371/journal.pone.0159434.t003
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the contrary, cell desensitization was present. The value of k was 0 for single, half dose and 1
minute delay.
In the hyperosmotic buffer, the cells were exposed to half, single and split dose with 3 min-
ute delay (Fig 4C). The split dose was less effective than the single dose. The uptake due to the
second pulse train was lower than the uptake due to the first train (Fig 5C), i.e. cell desensitiza-
tion was present. The parameter k was more than 0 only in the split dose protocol, and it was
Fig 4. Measured fluorescence due to the propidium uptake in the growthmedium and four different
electroporation buffers. Propidium uptake was detected by fluorescence microscopy. On the y-axis, there are the
average experimental values in arbitrary units ± standard error. On the x-axis, there is the time in seconds. (a), the
growth medium; (b), the low-conductivity; (c) the hyperosmotic; (d), the high-conductivity buffer, (e) the buffer with
calcium. The exposure times were different among the electroporation buffers.
doi:10.1371/journal.pone.0159434.g004
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10-times smaller than in the low-conductivity buffer (the same exposure time allows us to
make the comparison).
In the high-conductivity buffer, the cells were exposed to the single and split dose with 3
minute delay (Fig 4D). The uptake due to the second train was similar to the uptake due to the
first train (Fig 5C), i.e. cell sensitization was not present. The uptake due to the split dose was
Fig 5. Graphical representation of the ratio of parameters S2/S1 and τ2/τ1. A first order model (Eqs 1 and
2) was fitted to the experimental results. S2 and τ2 were normalized to the average value of S1 or τ1,
calculated from parameters of the half dose and the split doses with different delays. (a) The ratios at 3
minute delay between the trains in all buffers. (b) The ratios in the growth medium at 1, 2 or 3 minute delay. (c)
The ratios in the low-conductivity buffer at 1, 2 and 3 minute delay. The bars at 3 minute delay in (b) and (c)
represent the same results as the growth medium and the low-conductivity buffer bars in (c) to enable easier
comparison of the ratios between the buffers. Error bars represent the 95% confidence interval.
doi:10.1371/journal.pone.0159434.g005
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twice the uptake due to the half dose (determined by extrapolation). The k after the single dose
was higher than after the split dose.
In the buffer with added calcium, the final uptake due to the single dose was higher than
due to the split dose (Fig 4E). However, the uptake due to the second train was similar to the
uptake due to the first train, i.e. cell sensitization was not present (Fig 5A). The value of k was 0
for the split and single dose.
The values of τ after the second pulse train were lower than after the first pulse train in the
growth medium and all electroporation buffers, i.e. the resealing after the second pulse train
was faster than after the first train (Table 3). The values of τ after the first train were the lowest
in the growth medium (44–69 s-1) and then they increased in the order: the buffer with added
calcium (69–79 s-1), the low-conductivity (86–91 s-1), the high-conductivity (122 s-1), and the
hyperosmotic buffer (124–161 s-1).
In the growth medium and the low-conductivity buffer, we also determined the cell size
change after four 100 μs pulses (the half dose) (Fig 6). Cell size change was proposed as a possible
mechanism of cell sensitization [24]. In the growth medium, the cell cross-section did not change
much. In the low-conductivity buffer, it decreased. In the low-conductivity buffer, the dynamics
of cell size change was different from the dynamics of the fluorescence change due to the second
train (Fig 4C). The uptake due to the second train was lower at 3 than at 2 minute delay while the
cell cross-section did not change from the first minute until the end of the measurement.
Cell sensitization with different delays
In the growth medium and the low-conductivity buffer, additional experiments with 1 and 2
minutes delay between the trains were performed (Fig 4A and 4B). In the growth medium, the
cell sensitization decreased with increasing inter-train delay (Fig 5B). At 3 minute delay, there
was no cell sensitization; the fluorescence was a sum of the separate contributions of the pulse
trains. The parameter k decreased with an increasing inter-train delay as well. In the low-con-
ductivity buffer, we observed cell ‘desensitization’ (S2/S1<1) which increased with increasing
delay. The value of k was zero for single, half dose, and 1 minute delay.
Fig 6. Cell size change dynamics in the growthmedium and the low-conductivity buffer. Symbols
denote the average ± standard error. The relative change was determined as a ratio of the cell cross-section
after and before the pulses. The upper magenta curve–the growth medium; the lower black curve–the low-
conductivity buffer.
doi:10.1371/journal.pone.0159434.g006
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Discussion
Cell sensitization was not present in all tested electroporation buffers as determined by the pro-
pidium uptake measurements. In the growth medium, the split dose was more efficient than
the single dose at all delays, but the cells were sensitized by the first train only at 1 min. In
other buffers, the split dose was similarly (the high-conductivity buffer, and the buffer with cal-
cium), or less effective (the low-conductivity, and the hyperosmotic buffer) than the single
dose. In these buffers, thus cell sensitization was not present. After pulse application, different
processes are triggered in the cells or on their membranes. These processes apparently depend
also on the electroporation buffer composition and influence the response of the cells to the
electric pulses. The sum of these processes determines whether the cells will be sensitized,
desensitized or the trains will be equally effective. In our study, if S2/S1>1, cells were assumed
sensitized, if S2/S1<1, they were assumed desensitized, and if S2/S11 the trains were assumed
equally effective. Cell sensitization, assessed by the uptake of different molecules or by survival
after a single or a split dose protocol, was observed when applying pulses in the growth
medium [24,25,28,30], in electroporation buffers [24,25,43], in three-dimensional cell cultures
[29], and in vivo [26,27]. Our results in the growth medium are in agreement with them, but
the results in the other buffers are not.
With our definition of cell sensitization (higher uptake due to the second than due to the
first pulse train), the sensitizing effect was observed only at 1 minute delay in the growth
medium (Fig 5B). However, the final level of fluorescence in the growth medium was still
higher when applying the split dose than when the single dose with all delays tested (1, 2 or 3
min). In previously published studies, the higher final fluorescence of the split than of the single
dose was already considered cell sensitization. There, cells were assumed sensitized if the split
dose caused higher uptake or lower survival than the single dose. With their definition, in our
experiments in the growth medium, all delays would be considered as cell sensitizing although
the second pulse train did not cause higher uptake than the first pulse train, i.e. the cells were
not sensitized during the inter-train delay.
Pulse splitting in different buffers
In the growth medium, cell sensitization was present, and the split dose was more effective
(Figs 4A and 5A) than the single dose. The reason could be higher membrane damage due to
the first pulse train than in other tested buffers which rendered cells more sensitive to the sub-
sequent pulses. With increasing delay, the damage was repaired, and cell sensitization ceased.
In other studies [24–27,30], the cell sensitization was present at longer delays. The possible
explanations are: 1) They assessed cell sensitization as the efficiency of the split vs single dose.
In our experiments, the final value of the fluorescence was higher when applying the split dose,
although separate contributions to the final fluorescence of the two trains were equal. 2) They
damaged the membrane more by applying more pulses of higher electric field. Since higher
electric fields cause higher cell sensitization [30], they could also cause longer cell sensitization.
3) Our experiments were performed at 37°C where the membrane resealing is faster [44] while
their experiments were performed at room temperature.
In the low-conductivity buffer, there were protecting processes happening which take more
than 3 minutes to finish since the effect of ‘desensitization’ was still present with 3 minutes
delay. The time dynamics of propidium uptake was different than in the growth medium
which indicates that different mechanisms are involved. In the hyperosmotic buffer, the second
train of the split dose was even less effective than in the low-conductivity buffer. Since one of
the differences between these buffers was sucrose concentration, we can assume that it has an
important role, as discussed in the following paragraphs. In the high-conductivity buffer, split
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and single dose caused similar final fluorescence (Fig 4G). Although sucrose inhibited cell sen-
sitization, its absence did not cause it.
Time constant τ describes the time dynamics of the membrane resealing. Membrane reseal-
ing is affected by several parameters. It was slower when the membrane was oxidized [45] and
faster at higher temperatures [44], lower sucrose concentration [46], and in the presence of low
Ca2+ concentrations [42]. The cell membrane resealing depended on calcium, which had to be
present in low concentrations when the cells were damaged either chemically, mechanically or
electrically [42,47–49]. The increased intracellular calcium concentration after electroporation
served as a stress indicator that triggered the membrane resealing process in the form of endo-
[49], and exocytosis [47,48]. In the growth medium and the buffer with calcium, there were
low concentrations of Ca2+ present and τ was lower than in other buffers (faster resealing),
probably due to Ca2+ facilitated membrane resealing. Even when calcium was not added, it was
still present during electroporation. First, calcium is present in the intracellular storages [50].
Second, even if it is not added to the buffer, there is some free calcium which comes from the
glass or impurities in the chemicals, as measured in [45] for the low-conductivity buffer. Inter-
estingly, in [47], the resealing after a second membrane disruption was much faster than after
the first one. Authors suggested that initial wound was healed by exocytosis of the vesicles
from the endocytic compartment while the second wound resealed faster since Golgi apparatus
(responsible for a formation of new vesicles) had already been activated by an increased Ca2+
influx. The role of Golgi apparatus is in agreement with our results since the resealing constant
τ after the second pulse train was lower (faster resealing) than after the first one in all electropo-
ration buffers (Table 3). Parameter τ decreased with increasing delay since there was more
time for the activation of the Golgi apparatus. The resealing speed after the half and the single
dose was very similar in all tested buffers, contrary to what was observed by Rols and Teissié
[51]. However, they applied more pulses (10 or 20 as opposed to 4 or 8 in our study) of higher
intensity (1.2 kV/cm as opposed to 0.75 kV/cm in our study) which caused more pronounced
membrane damage and difference in the resealing speed.
Parameter k describes the additional uptake process on a longer time scale. A higher value
of k indicates either higher final fluorescence or faster resealing since k ¼ St, as derived in the S1
Appendix. Thus, k depends on the final fluorescence and inversely depends of the resealing
time constant. In the growth medium, this additional process was always present. The value of
k decreased with an increasing delay, which suggests that either 1) the fluorescence due to the
additional process was decreasing or 2) its resealing speed was increasing. The decrease in the
final fluorescence could be caused by the decreasing membrane permeabilization between the
trains. The second train caused less damage, and the additional uptake was lower than at
shorter delays. In the low-conductivity buffer, the additional process of linear propidium
uptake was not always present. The trend of k was different than in the growth medium. With
increasing delay, the final fluorescence of the additional process was increasing since slower
resealing is not likely (longer delay should decrease the resealing time). When the additional
process was not present, it finished too fast or was too small to be observed. With longer delays,
the additional process was visible because it was not finished yet. Parameter k does not reflect
the binding delay of propidium after it enters the cells since it binds in microseconds [52].
In [43] pulses were split into two trains, and propidium or Yo-Pro-1 uptakes were measured.
Interestingly, under the same pulse parameters, there was a large cell sensitization effect present
with propidium, but much smaller with Yo-Pro-1 [53]. Apparently, different dyes give different
uptake results under the same conditions. Although pulses in the nanosecond range were applied,
the observation is interesting also for the microsecond pulses since there are reports on cell sensi-
tization with nanosecond [24] as well as with microsecond [25–27,30] pulses.
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Possible mechanisms of cell (de)sensitization
Increasing sucrose concentration caused among others an increase in osmotic pressure which
decreased the size or density of the permeabilizing structures in the membrane, slower mem-
brane resealing [46] and stabilization of cell membrane [54]. Similarly, trehalose (a disaccha-
ride similar to the sucrose) had a protective and stabilizing role [55,56]. Our results are in
agreement with slower membrane resealing observation since τ increased with increasing
sucrose concentration. Higher sucrose concentration also caused lower fluorescence due to the
second pulse train—the cells were protected by a still unknown mechanism which is also in
agreement with the protective role of the sucrose. When the sucrose was replaced by NaCl, the
pulse trains were equally effective. Sucrose inhibits cell sensitization, but its absence does not
facilitate it.
The electrical conductivity of the growth medium and the high-conductivity buffer was in
the same range. In the high-conductivity buffer, there was no cell sensitization, while in the
growth medium, cell sensitization was observed. Since a similar electrical conductivity induces
a different cell response, it is considered not to be responsible for cell sensitization.
In [35], authors ascribed cell sensitization to the higher efficiency of lower pulse repetition
frequencies. Applying pulses on a permeabilized cell membrane is less effective because the
existing conducting structures prevent the establishment of an additional transmembrane
potential, which they call ‘cell desensitization'. (The expression was used in a different sense
than in our paper.) Assuming that cell sensitization is a consequence of repetition frequency
effect, one cannot explain such different behaviors in different buffers. Their explanation of cell
sensitization effect is thus unlikely.
Extended pore opening times have also been proposed among possible mechanisms [26,27].
The duration of all the protocols was the same; the membrane resealing was in the same time
range. Thus, the pore opening times were also of approximately the same duration. The
extended pore opening time does not explain cell sensitization.
Cell size change after electroporation occurs due to the colloid osmotic pressure [57,58].
Electric pulses of different parameters cause different extent of cell permeability, and the cell
membrane becomes permeable to small molecules but not to large ones. The colloid osmotic
pressure drives the influx of water and small solutes in the cell, and the cell swells [2]. Mole-
cules, larger than the pores, balance colloid osmolality and stop cell swelling [58]. Increased/
decreased cell size could cause higher/lower induced transmembrane voltage according to the
Schwann equation. Cell size was measured via visible cross-section. In the growth medium, the
cell size did not increase and thus cannot be the reason for cell sensitization. In the low-con-
ductivity buffer, the cells shrunk. Cell desensitization could in part be explained by cell shrink-
ing and lower induced transmembrane voltage. However, cell shrinking cannot be the only
reason since the time dynamics of the uptake due to the second train and the cross-section
change were different.
Cell sensitization has been observed in several cell lines and in vivo. In our experiments, we
used Chinese hamster ovary cells. Since in this cell line cell sensitization either was [25] or was
not present, it does not depend only on the cell line. It is possible that even in the growth
medium cell sensitization would not be present in certain cell lines; however this remains to be
further investigated.
The cytoskeleton is damaged by electric pulses [59–61] and there were different observa-
tions made (e.g. damaged cytoskeleton does not influence electroporation [62,63], it increases
permeabilization [28], it increases the survival [62], it changes the resealing dynamics [61]).
Cytoskeleton disruption has also been connected to cell swelling [60]. In [28], the disruption of
the cytoskeleton rendered cells more sensitive to electric pulses. However, the repair of the
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cytoskeleton is in the range of hours [59], but the cell sensitization dynamics in our experi-
ments was in the range of minutes. The cytoskeleton disruption is not a likely explanation for
cell sensitization.
The concentration of calcium we used in our buffer with calcium was similar as in the
HAM-F12 growth medium. In the buffer with calcium, cells were more sensitive to the second
pulse train than in the low-conductivity buffer. However, this was due to the lack of sucrose in
the buffer with calcium. In the high-conductivity buffer where there is no calcium, the ratio S2/
S1 was 1.03 and in the buffer with calcium, it was 1.06. In both buffers, the first and the second
pulse train were equally effective. It is possible that higher calcium concentrations would cause
cell sensitization but they could also lower cell viability [64]. Namely, electroporation with 1
mM calcium already decreased survival of various cell lines to 20–40% [65].
In the literature, also other explanations for cell sensitization were suggested: ATP leakage,
membrane oxidation, and reduced membrane line tension. The investigation of these factors is
beyond the scope of our current study. Our study opens many more questions which deserve
being investigated in future: the mechanism of sucrose’s protection of the membrane, the effect
of different pulse parameters (duration and the number of pulses, electric field).
Modeling of cell electroporation is very useful since it allows us to describe cell responses,
make predictions about effects of electric pulses on the cells, decrease the number of experi-
ments needed, and help us to understand what is happening [37,39,66–68]. However, until also
biological effects are included in the models, they will have a limited power and will not cor-
rectly predict the outcome in certain cases.
Cell sensitization has also been observed in vivo by the delayed tumor growth, enhancement
of tumor necrosis and perfusion defects [26,27]. The growth medium is an approximation of
the in vivo extracellular fluid. The mechanism(s) for cell sensitization in vitro and in vivo could
be similar. There are, however, many more factors in vivo–cell crowding, blood supply,
immune system, electric field shielding.
Conclusions
Cell sensitization seems to be a buffer dependent phenomenon. In the growth medium, still
unknown processes were triggered by the pulse application and rendered cells more susceptible to
electric pulses. In the low-conductivity and hyperosmotic buffer, a protective effect of the sucrose
and cell shrinking caused cell ‘desensitization’. In the high-conductivity buffer, there was no cell
‘desensitization’, probably due to the lack of sucrose. There was also no cell sensitization present
since the cell ‘sensitizing’ processes from the growth medium were missing. The exact mechanism
of cell sensitization has still to be determined; however we believe we shed additional light on the
existing hypotheses and discarded some of them. The effect of pulse repetition frequency [35], cell
size change, cytoskeleton disruption [24] and calcium influx [24] seem unlikely explanations.
Based on our results, there are different sensitizing and desensitizing mechanisms present and
competing at the same time, and the outcome depends on their overall contributions.
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S1 Appendix: Derivation of the first-order uptake equation 
We can follow a similar derivation as (Shirakashi et al. 2002) and assume that after a pulse application cell 
permeabilization decreases exponentially with time: 
𝑃𝑃(𝑡𝑡) = 𝑃𝑃0 exp �− 𝑡𝑡𝜏𝜏 �, (1) 
where P(t) means the permeability at time t, P0 is the initial permeability at the end of the pulse and τ is the 
resealing constant. Flux through the electroporated membrane can be written as in (Miklavčič and Towhidi 
2010): 
𝑗𝑗(𝑡𝑡) = 𝑃𝑃0 exp �− 𝑡𝑡𝜏𝜏 � (𝑐𝑐𝑒𝑒 − 𝑐𝑐𝑖𝑖) ≈ 𝑃𝑃0 exp �− 𝑡𝑡𝜏𝜏 � 𝑐𝑐𝑒𝑒 , (2) 
where ci means the internal and ce the external concentration. We assume that all propidium in the cell binds 
to nucleic acids immediately and that the intracellular propidium concentration is 0 mM. Namely, in 
(Pucihar et al. 2008) it has been shown that the propidium signal starts to increase microseconds after the 
pulse start. In our experiments, we measured the uptake in the range of seconds, and we could neglect the 
time delay of propidium binding. Since in our experiments, we did not reach propidium saturation (the 
fluorescence value of the treated cells was below the maximal measured fluorescence of electroporated 
cells) we can assume that there was no unbound propidium in cells and thus the internal propidium 
concentration was 0 mM. The number of molecules N that enter the cells can be obtained by integration of j 
over time and permeabilized area ((Miklavčič and Towhidi 2010), Equation 9): 
𝑁𝑁(𝑡𝑡) = 𝑃𝑃0𝜏𝜏𝑐𝑐𝑒𝑒𝐴𝐴𝑁𝑁𝐴𝐴(1 − exp �− 𝑡𝑡𝜏𝜏 �), (3) 
where A is the permeabilized area and NA the Avogadro constant. By uniting τ, ce, P0, A and NA into a 
constant C we obtain a first-order model: 
𝑁𝑁(𝑡𝑡) = 𝐶𝐶 �1 − exp �− 𝑡𝑡
𝜏𝜏
 ��. (4) 
The fluorescence of propidium is linearly dependent on the number of the bound molecules below the 
saturation level (Kennedy et al. 2008). The constant C does not have any meaning; it is only a multiplicative 
factor and describes the plateau of the reached fluorescence. Thus, the fluorescence can be written as: 
𝑓𝑓(𝑡𝑡) = 𝑆𝑆(1 − exp �− 𝑡𝑡
𝜏𝜏
 �), (5) 
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where f signifies the fluorescence in dependence on time and S is constant. The expression (5) can be 
directly applied to our measurements. 
The shape of the propidium uptake curves indicated that there is an additional process present that causes 
the linear uptake seen after the first order process is finished. If we assume that this process is also first-
order and that its time constant is much larger than our observation time, we can use linear expansion and 
include the first two terms: 
exp(𝑡𝑡) = 1 + 𝑡𝑡1! + 𝑡𝑡22! + ⋯ = �𝑡𝑡𝑛𝑛𝑛𝑛!∞
𝑛𝑛=0
. (6) 
We obtain an approximation of Equation (5): 
𝑓𝑓(𝑡𝑡) = 𝑆𝑆 �1 − exp �− 𝑡𝑡
𝜏𝜏
 �� ≅ 𝑆𝑆
𝜏𝜏
𝑡𝑡 = 𝑘𝑘𝑡𝑡, (7) 
where k equals the plateau of the process divided by the resealing constant. 
1. Shirakashi R, Köstner CM, Müller KJ, Kürschner M, Zimmermann U, Sukhorukov VL. Intracellular Delivery of Trehalose
into Mammalian Cells by Electropermeabilization. J Membr Biol. 2002;189: 45–54. doi:10.1007/s00232-002-1003-y 
2. Miklavčič D, Towhidi L. Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells.
Radiol Oncol. 2010;44. doi:10.2478/v10019-010-0002-3 
3. Pucihar G, Kotnik T, Miklavčič D, Teissié J. Kinetics of Transmembrane Transport of Small Molecules into
Electropermeabilized Cells. Biophys J. 2008;95: 2837–2848. doi:10.1529/biophysj.108.135541 
4. Kennedy SM, Ji Z, Hedstrom JC, Booske JH, Hagness SC. Quantification of electroporative uptake kinetics and electric
field heterogeneity effects in cells. Biophys J. 2008;94: 5018–5027. doi:10.1529/biophysj.106.103218 
136
Results and Discussion - Paper 5 
Paper 5 
Title: From cell to tissue properties – modelling skin electroporation with pore and local transport 
region formation 
Authors: Janja Dermol-Černe, Damijan Miklavčič  
Publication: IEEE Transactions on Biomedical Engineering, vol. 65, no. 2, pp. 458-468, Feb. 2018. 
DOI: 10.1109/TBME.2017.2773126 
Impact factor: 3.577 (2016), 3.407 (5-year) 
Quartile: Q1 (Biomedical Engineering) 
Rank: 12/77 (Biomedical Engineering) 
137
458 IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. 65, NO. 2, FEBRUARY 2018
From Cell to Tissue Properties—Modeling Skin
Electroporation With Pore and Local Transport
Region Formation
Janja Dermol-Cˇerne and Damijan Miklavcˇicˇ
Abstract—Current models of tissue electroporation either
describe tissue with its bulk properties or include cell level
properties, but model only a few cells of simple shapes in
low-volume fractions or are in two dimensions. We con-
structed a three-dimensional model of realistically shaped
cells in realistic volume fractions. By using a ‘unit cell’
model, the equivalent dielectric properties of whole tis-
sue could be calculated. We calculated the dielectric prop-
erties of electroporated skin. We modeled electroporation
of single cells by pore formation on keratinocytes and on
the papillary dermis which gave dielectric properties of the
electroporated epidermis and papillary dermis. During skin
electroporation, local transport regions are formed in the
stratum corneum. We modeled local transport regions and
increase in their radii or density which affected the dielec-
tric properties of the stratum corneum. The final model of
skin electroporation accurately describes measured electric
current and voltage drop on the skin during electroporation
with long low-voltage pulses. The model also accurately de-
scribes voltage drop on the skin during electroporation with
short high-voltage pulses. However, our results indicate that
during application of short high-voltage pulses additional
processes may occur which increase the electric current.
Our model connects the processes occurring at the level of
cell membranes (pore formation), at the level of a skin layer
(formation of local transport region in the stratum corneum)
with the tissue (skin layers) and even level of organs (skin).
Using a similar approach, electroporation of any tissue can
be modeled, if the morphology of the tissue is known.
Index Terms—Franz diffusion cell, local transport region,
multiscale approach, numerical modeling, pore formation,
skin electroporation.
I. INTRODUCTION
E LECTROPORATION is a physical way of disturbing cellmembrane with the application of short, high-voltage
pulses leading to increase in its permeability to different
molecules (reversible electroporation) and to achieve cell death
(IRE - irreversible electroporation) [1], [2]. Electroporation or
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pulsed electric field treatment is used in biotechnology [3], food-
processing [4], [5] and medicine [6], e.g., gene electrotransfer
[7], [8], DNA vaccination [9], [10], transdermal drug delivery
[11], [12], IRE as an ablation technique [13], [14] and elec-
trochemotherapy [15], [16].
Transdermal drug delivery is easy to conduct, non-invasive,
quick and it avoids gastro-intestinal degradation. Skin is also
a barrier not many drugs can penetrate, and various enhance-
ment methods are used to improve drug delivery, electropo-
ration being one of them [12]. However, skin electroporation
is a complex phenomenon and still not well understood. It is
believed that electric pulses cause the formation of regions of
an increased electrical conductivity through which the trans-
port occurs – i.e., local transport regions (LTRs). The density
of the LTRs increases with increasing voltage while their size
increases with increasing pulse duration [17]–[22].
Models of tissue electroporation enhance our understanding
as they offer a concise description using mathematical and
physical laws. The current tissue models are of two types – they
model tissue as a bulk [23]–[26] while only few model tissues’
microscopic structure [27]–[31]. The bulk tissue models
describe the electric field distribution as a function of tissue
properties, applied voltage and the geometry of the electrodes
but assume that the tissue is homogeneous. For each tissue type,
the critical electric field for electroporation or cell death must be
experimentally determined or described with statistical models
[32]–[34]. The models with included microstructure are in 2D or
3D. The 2D models include sampling the tissue with Cartesian
transport lattices [30], [31], [35], describing it with the equiva-
lent circuit [36], [37], or modeling it with the Voronoi network
[29]. The 2D models disregard the geometry of the cells and
cannot model different cell density which significantly alters
the equivalent dielectric properties, the induced transmembrane
voltage and electroporation [38]. In 3D, tissue was modeled as an
infinite lattice [39], [40] or randomly distributed spherical cells
of different sizes [28]. The volume fraction maximally achiev-
able by face-centered cube or hexagonal close-packed lattices
is 77% which is lower than the volume fractions we encounter
in most tissues (e.g., 83% in the epidermis, 91% in the stratum
corneum, 85% in the muscle tissue, 80% in the hypodermis
[41]). Furthermore, cells were not of realistic shapes although it
was shown that cell shapes also affects the dielectric properties
[42]. An improvement was a model of spinach leaf which also
0018-9294 © 2017 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
See http://www.ieee.org/publications standards/publications/rights/index.html for more information.
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included the size and shape of the cells; however, only a small
part was modeled [27], and a generalization to the whole leaf
is questionable. The model by Huclova et al. [42] also models
single cells but offers a more realistic description since cells can
be of different shapes, sizes, and densities. Moreover, also tissue
heterogeneity and anisotropy can be described which most of
the current models cannot. The dielectric properties of cells are
generalized to tissues as their equivalent dielectric properties.
Numerical calculation is reduced to tissue level, and much larger
geometry than a single cell can be modeled. The latter model
describes the behaviour of cells in the linear range but has a po-
tential to include also nonlinear behaviour, i.e., electroporation.
In the field of skin electroporation, only a few models exist
[20], [43]–[48] and they mostly belong to the group of bulk
tissue models and for the values of dielectric properties of sep-
arate layers take rough approximations or even model several
layers with the same values. The values of the dielectric proper-
ties of the electroporated layers are also rough approximations
[44]. Some models include the formation of the local transport
regions [43], [46], [48] but are focused only on the stratum
corneum and do not include pore formation in the membranes
of the cells in lower layers. In the equivalent circuit of the skin
[47], the information on the geometry of the cells is lost, and
the resistance of the elements is determined by experimental
measurements which vary between systems.
Our aim was thus to start from the microscopic scale to obtain
a bulk model of skin electroporation. We started with the model
by Huclova et al. [41] which has several advantages (possibil-
ity to model real shapes and densities of cells, heterogeneity
and anisotropy). We modeled the change in dielectric parame-
ters of skin during electroporation and validated our model with
current-voltage measurements. We modeled pore formation in
cell membranes and local transport region formation in the stra-
tum corneum. We modeled the skin’s dielectric properties after
two protocols which varied in voltage and pulse duration – long
low-voltage pulses (LV protocol) and short high-voltage pulses
(HV protocol) [49]. We achieved good agreement with measure-
ments of LV protocol by including LTR formation in the stratum
corneum, change in electrical conductivity of the deeper skin
layers due to cell membrane electroporation and electrode po-
larisation. During HV protocol the modeled voltage drop on the
skin matched the measurements well; however, the current devi-
ated for 50%. Also, the modeled density of the LTRs in the HV
protocol was much higher than the experimentally determined
values, which indicates that during the HV protocol additional
processes may occur which are not yet identified and were thus
not included in our model. The advantage of our approach is
that it is not limited only to skin electroporation, but electropo-
ration of any tissue can be modeled provided the geometric and
dielectric properties of cells constituting the tissue are known.
II. METHODS
A. Experimental Work
For fitting and validation of our model, we used experimental
results from [49]. In short, 350 μm thick dermatomed porcine
ear skin was put between the donor and receiver chamber of the
Franz diffusion cell. Porcine ear skin is similar to the human
skin regarding layers’ thickness, number of hairs, their size and
extension depth [50]. Two Pt electrodes were positioned 0.2 cm
above and 0.5 cm below the skin. Long low-voltage (3 × 45 V
pulses of 250 ms duration, 100 ms pause – LV protocol) or
short high-voltage pulses (3 × 500 V pulses of 500 μs dura-
tion, 500 μs pause – HV protocol) were delivered to the skin.
The delivered voltage, the voltage on the skin and current were
measured.
According to the model [41], the dermatomed skin consists
of four layers: the stratum corneum, the epidermis, the papillary
dermis, and the upper vessel plexus.
B. Construction of the Model
The model of the skin before electroporation was constructed
according to [41]. The modeling in our study aimed to add elec-
troporation to the model by Huclova et al. The main steps in
our ‘upgraded’ model are described by Fig. 1. We manually
changed (i.e., optimized) the parameters in the local transport
region model and the electroporation in a unit cell model. We
obtained equivalent dielectric properties of separate layers and
introduced them into the Franz diffusion cell model. We applied
voltage to the Franz diffusion cell model and calculated the
electric current and the voltage drop on the skin. We compared
the simulated values with the measured ones and changed the
parameters in the local transport region model and electropora-
tion in a unit cell model until the measured and simulated values
matched. Values of dielectric and geometric parameters, used in
the final model, are referred to as ‘optimized values’ although
they could be only a local optimal values and not global.
The numerical calculations were done in Comsol Multi-
physics (v5.3, Stockholm, Sweden) in 3D unless noted oth-
erwise. All models were remeshed until there was a negligible
difference in the modeled voltage drop on the skin with further
remeshing. In all models, electric currents physics was used
which calculates the electric potential in a subdomain by
−∇ (σ∇V)−∇jωε∇V = 0 (1)
where σ denotes the electric conductivity, ε the relative permit-
tivity of the subdomain. jω in the frequency domain is equivalent
to time differentiation in the time domain. Cell membrane was
modeled by boundary condition distributed impedance, given by
n · J = 1
dm
(σm + jωε) (V − Vref ) (2)
where dm denotes the membrane thickness, ε its dielectric
permittivity, σm its electrical conductivity, Vref is the electric
potential on the exterior side of the boundary, n is the unit vector
normal to the boundary surface, J is the electric current density.
1) The Model of Dielectric Properties Without Electro-
poration: We constructed the model as described in [41]. For
more detail on initial geometric and dielectric properties of the
cells and settings of the numerical solver, we refer the reader to
[41]. The authors modeled full thickness skin and also included
layers which were not included in the dermatomed skin from
our experiments. Initially, we modeled all layers for validation
of our model, but for modeling electroporation, only the stratum
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Fig. 1. Optimization scheme used in obtaining the parameters of the skin electroporation model. The parameters of the local transport region
model and the electroporation in a unit cell model were changed and introduced into the Franz diffusion cell model. In the Franz diffusion cell model,
we simulated the current through the Franz diffusion cell and voltage drop on the skin. Results of the simulation were compared to the results of the
experiments. We varied the parameters of the models until the simulated and measured values matched.
corneum, epidermis, papillary dermis, and upper vessel plexus
were modeled. Briefly, the skin was divided into separate layers,
based on their morphology. In each layer, a typical biological cell
(i.e., corneocyte, keratinocyte,) or a typical structure (i.e., blood
vessels, collagen fibres) were identified. For the calculation of
equivalent dielectric properties, either analytical or numerical
method was applied. When the particles were embedded in the
extracellular fluid in a low volume fraction (<80%) the ana-
lytical Hanai-Bruggeman equation was used in Matlab R2015b
(Mathworks, USA) which was calculated much faster than the
numerical method. The papillary dermis was modeled as 40 μm
spheres in 0.74 volume fraction and the upper vessel plexus
as x-axis oriented cylinders with diameter 50 μm in volume
fraction 0.3. Layers of higher volume fractions were modeled
numerically. A unit cell was constructed for each cell layer. A
biological cell in a unit cell was modeled via the ‘superformula’,
imported into the Comsol and scaled to achieve the correct sizes
and volume fractions. These were (in x-, y- and z-direction with
corresponding volume fraction) for the corneocyte: (40 μm,
40 μm, 0.8 μm, 0.85) and the keratinocyte: (5.97 μm, 5.97 μm,
11.95 μm, 0.8). Several unit cells together could describe the
morphology of the entire layer. Stratum corneum was modeled
with corneocyte, epidermis with keratinocyte and subcutaneous
tissue with adipocyte. In Fig. 2, the corneocyte, the keratinocyte
and the papillary dermis (used with the Krassowska asymptotic
equation) are shown. The opposite boundaries of the unit cell
were exposed to a sinusoidal voltage, and via the admittance, the
frequency dependent dielectric properties were calculated (ε∗).
Other outer boundaries were set to insulation. The process was
repeated in all three axes to obtain the dielectric tensor (ε∗).
From ε∗, the electrical conductivity and relative permittivity
were calculated and inserted in the Franz diffusion cell model
as properties of separate layers. We used the frequency domain
study, the direct PARDISO solver and the physics controlled
mesh with finer or extra fine element size.
2) The Model of Dielectric Properties With Electropora-
tion: We added skin electroporation to the model by Huclova
et al. [41]. We modeled pore formation on the level of single
cells as well as local transport region formation in stratum
Fig. 2. The geometry of the (a) corneocyte, (b) keratinocyte. Due to the
symmetry, only one-eighth was modeled. (c) Spheres in papillary dermis
were arranged in the face-centered cubic arrangement and could not be
described by including only one cell in the unit cell. Thus, for unit cell,
we used a geometry which could periodically describe the geometry of
the papillary dermis.
corneum. The pore formation was modeled on the keratinocytes
and papillary dermis. The local transport region formation was
modeled in the stratum corneum. The upper vessel plexus was
assumed not be electroporated.
a) The Model of Pore Formation: Pore formation
was included with Krassowska’s asymptotic equation [51], [52].
We modeled pore formation on the keratinocytes [Fig. 2(b)] and
spheres in the papillary dermis, [Fig. 2(c)]. The Krassowska’s
asymptotic equation cannot be analytically modeled, and thus
we used the papillary dermis unit cell [Fig. 2(c)] and not the
Hanai-Bruggeman equation. Papillary dermis was modeled as
spheres in the face-centered cubic arrangement in volume frac-
tion 0.74. To include Krassowska’s asymptotic equation, we
used the Weak Form Boundary Partial Differential Equation
interface with
dN
dt
= αe
(
I T V
V e p
)2 (
1− N
N0
e
−q
(
I T V
V e p
)2 )
, (3)
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TABLE I
PARAMETERS USED IN UNIT CELL MODEL WITH KRASSOWSKA’S
ASYMPTOTIC EQUATION, THEIR MEANING, VALUE, AND REFERENCE
Symbol Meaning Value Reference
εe Dielectric permittivity of extracellular space
(-)
80 [41]
σe Electrical conductivity of extracellular space
(S/m)
0.53 [41]
εm Dielectric permittivity of cell membrane (-) 9.4 [41]
σm 0 Initial electrical conductivity of cell
membrane (S/m)
10−6 [41]
εi Dielectric permittivity of the intracellular
space (-)
50 [41]
σi Electrical conductivity of intracellular space
(S/m)
0.12 [41]
dm Thickness of the cell membrane (nm) 7 [41]
Vep Electroporation threshold (mV) 258 [52]
α Electroporation parameter (m−2s−1) 109 [52]
q Electroporation constant 2.46 [52]
N0 Equilibrium pore density (m−2) 1.5 × 109 [52]
Rp Pore radius (nm) 0.75 [52]
Vrest Resting membrane voltage (mV) −50 [52]
σp Pore electrical conductivity (S/m) σ e −σ iln( σ eσ i )
[52]
σm Electrical conductivity of the electroporated
cell membrane (S/m)
σm 0 +
σep
[52]
where N denotes the density of the pores in the membrane,
and N0 in the unelectroporated membrane, ITV the induced
transmembrane voltage, α, q, Vep describe the characteristics of
the electroporation process [51], [52], and t is time. The pore
formation caused an increase in electrical conductivity of the
cell membrane:
σep = N
2πr2pσpdm
πrp + 2dm
, (4)
where rp and σp were the radius and the internal electrical
conductivity of a single pore, respectively, and dm is the cell
membrane thickness. The values of the parameters are in Table I.
Increasing voltages were applied to the opposite boundaries of
the unit cell in the z-direction. With increasing voltages, the
density of the pores increased and consequently the induced
transmembrane voltage. Dielectric tensor was calculated via the
applied voltage and the current flowing through the unit cell.
In the experiments, the pulses were applied in the z-direction,
and pore formation was therefore primarily in the z-direction.
Electrical conductivity in x- and y-directions and the relative
permittivity in all three directions (x, y, z) were assumed un-
changed and set to the unelectroporated values. We used the
time domain study, the direct PARDISO solver and the physics
controlled mesh with finer or extra fine element size.
b) The Model of the Local Transport Region For-
mation: The effect of electric pulses on the stratum corneum
was modeled via local transport region (LTR) formation. The
LTR was modeled as a cylinder in a unit cell (Fig. 3). We chose
the size of the LTR as stated it [49] and adapted the density by
changing the width and depth of the unit cell. In LV protocol,
the LTR’s diameter was chosen according to [49] and in HV
protocol its density was adapted. Also here, we applied voltage
on opposite boundaries in x- or z-direction, and via the electric
Fig. 3. Geometry of the local transport region (LTR) embedded in the
stratum corneum (SC). The cylinder is the LTR. The outer region is the
SC, unaffected by electric pulses. The image represents the size and
density of the LTR at the end of low-voltage protocol at t = 1 s (aLV was
443 μm and rLV was 90 μm).
TABLE II
GEOMETRIC AND DIELECTRIC PROPERTIES OF THE LOCAL TRANSPORT
REGION AND THE UNELECTROPORATED STRATUM CORNEUM, THEIR
MEANING, VALUE AND REFERENCE
Symbol Meaning Value Reference/method
εLT R
(x, y, z)
Dielectric permittivity
of the LTR (-)
x and y:
6.97 × 104 ,
z: 5.46 × 102
Calculated with a unit
cell with
unelectroporated
corneocyte
σLT R
(isotropic)
Electrical conductivity
of the LTR (S/m)
0.7 Optimized∗
εS C
(x, y, z)
Dielectric permittivity
of the SC (-)
x and y:
6.97 × 104 ,
z: 5.46 × 102
Calculated with a unit
cell with
unelectroporated
corneocyte
σS C
(x, y, z)
Electrical conductivity
of the SC (S/m)
x and y:
1.38 × 10−2 ,
z: 2.29 × 10−4
Calculated with a unit
cell with
unelectroporated
corneocyte
rLV Radius of the LTR
during LV protocol
Fig. 5(a) [49]
rH V Radius of the LTR
during HV protocol (μm)
10 [49]
aLV Length of the unit cell
during LV protocol (μm)
443 [49]
aH V Length of the unit cell
during LV protocol (μm)
177, 130,
100, 80, 60,
40, 30 (density in
Fig. 6(a))
Optimized∗
hLT R Height of the LTR (μm) 20 The same as the SC
height
hS C Height of the SC (μm) 20 [41], [49], [50]
SC denotes stratum corneum and LTR local transport region.
∗Optimization was done by comparing measured and simulated current and voltage drop
on the skin.
current calculated the dielectric tensor. Due to the symmetry,
the properties in the x- and y-axis were the same. The geometric
and dielectric properties of the stratum corneum and the LTR
are in Table II. The dielectric properties of the electroporated
stratum corneum were calculated under DC conditions since the
applied pulses in LV and HV protocol were relatively long and
the capacitive properties could be neglected. The size of the local
transport region was taken from [49] and slightly adapted as we
took into account that between pulses the LTRs could partially
reseal which allowed a better description of our experimental
data. We used frequency domain study, the direct PARDISO
solver and the physics-controlled mesh with extra fine element
size.
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Fig. 4. Geometry of the Franz diffusion cell with marked boundary
conditions and geometry. (a) the whole model, (b) zoomed to the area
between the electrodes and (c) zoomed to the skin.
c) The Model of Franz Diffusion Cell: The Franz
diffusion cell model was built according to the measurements
and the data in [49]. In Comsol, we used 2D axisymmetric geom-
etry. Although the properties of the skin were anisotropic, there
was only 3% difference in the 2D and 3D calculation. However,
the 3D calculation took approximately 6 hours and the 2D 1
minute. The boundary conditions and the geometric parameters
of the Franz diffusion cell model are marked in Fig. 4. Between
the electrodes, there was skin, immersed in phosphate buffer. On
top of the electrodes, we applied the measured square voltage
pulses. The other boundaries of the electrodes were assigned
contact impedance to model the impedance of the double layer,
formed at the electrode-liquid interface:
n · J1 = 1
ρ
(V1 − V2) (5a)
n · J1 = 1
ρ
(V1 − V2) (5b)
where ρ denotes the surface resistance and V1 and V2 are the
voltages on each side of the boundary, n is the unit vector normal
to the boundary surface, J is the electric current density. Prop-
erties of the stratum corneum were obtained from the model
of the local transport region, properties of the epidermis from
the unit cell of the keratinocyte and applied Krassowska’s equa-
tion, properties of the papillary dermis from the unit cell of
the spheres in the papillary dermis and applied Krassowska’s
asymptotic equation. We used the physics-controlled mesh with
normal element size, time domain study and a direct MUMPS
solver.
III. RESULTS
After choosing the size [49] [LV protocol – Fig. 5(a)] and
adapting the density [HV protocol – Fig. 6(a)] of the local trans-
port regions (LTRs) we obtained the corresponding equivalent
electrical conductivity [Fig. 5(b) LV protocol and Fig. 6(b) HV
protocol] and relative permittivity [Fig. 5(c) LV protocol and
Fig. 6(c) HV protocol]. Fig. 5 thus shows results for the LV pro-
tocol – in Fig. 5(a) we can see how the radius of the LTR changed
during the treatment, in Fig. 5(b) the change in the equivalent
electrical conductivity and Fig. 5(c) in equivalent relative per-
mittivity in all three directions (x, y, and z). Fig. 6 shows results
for the HV protocol – on Fig. 6(a) we can see how the density of
LTRs changed during the treatment, in Fig. 6(b) the change in
the equivalent electrical conductivity and Fig. 6(c) in equivalent
relative permittivity in all three directions (x, y, and z).
Fig. 7 shows the electrical conductivity of lower layers (papil-
lary dermis and epidermis) as calculated using the Krassowska’s
asymptotic equation. The electrical conductivity varies with dif-
ferent voltages on the boundary of the unit cell. Optimized val-
ues of the electrical conductivity were inserted in the Franz,
diffusion model. Figs. 8 and 9 show the final results of our
model – the simulated values of the voltage on the skin and
the current and are compared with the measured values. In the
LV protocol (Fig. 8) the simulated and measured values of the
voltage drop on the skin [Fig. 8(a)] and the current [Fig. 8(b)]
matched well while in the HV protocol [Fig. 9] the voltage drop
on the skin corresponded well [Fig. 9(a)], but the current did
not [Fig. 9(b)]. The simulated current underestimated the actual
measurement for approximately 50%.
IV. DISCUSSION
A. Experimental Considerations
In the stratum corneum (SC), the local transport regions
(LTRs) were formed. In the epidermis (E) and papillary dermis
(PD), cell electroporation occurred as SC resistance decreased
due to LTR formation, and consequently, electric field increased
also in the lower layers. Electric pulses increase the permeability
of blood vessels and induce vascular lock [55], [56]. However,
we assumed there was no electroporation in the upper vessel
plexus (UVP) as it is a layer of blood vessels and even if we
assumed electroporation to occur there is a lack of experimental
data on its dielectric properties after electroporation.
Change in dielectric properties of tissues can be used to de-
scribe and understand processes happening during electropo-
ration. For assessing skin permeability, electric measurements
were used before [17], [57]–[60]. Dielectric properties can be
measured by dielectric spectroscopy [61], current-voltage mea-
surements during electroporation [62], electric impedance to-
mography [63], and magnetic resonance electric impedance to-
mography [64]. The efficiency of electroporation can be moni-
tored by measurements of the change in electrical conductivity
[25], [65], [66]. When measuring dielectric properties of tissues,
secondary effects can affect measurements – such as swelling
of cells [67], forming of edema [65], loss of ions from the cells
[62], vascular lock [55]. Thus, for the validation of our model,
we used current-voltage measurements during pulse application
when the secondary effects can still be largely neglected.
Skin hydration and the electrical conductivity of the liquid in
which the skin is immersed was shown to have a large effect on
skin impedance [68]. In our experiments, the dermatomed skin
was well hydrated as it was immersed in phosphate buffer. We
took hydration into account by increasing the electrical conduc-
tivity of LTRs to 0.7 S/m. This conductivity is in the same range
as in [43] but is much higher than the electrical conductivity of
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Fig. 5. Dynamics of local transport region (LTR) during low-voltage (LV) protocol. (a) LTR size and the corresponding voltage on the skin, (b)
electrical conductivity and (c) relative permittivity change. The obtained values were then taken as equivalent dielectric properties of the whole
stratum corneum. The axes correspond to the coordinate system in Fig. 3.
Fig. 6. Dynamics of local transport region (LTR) during high-voltage (HV) protocol. (a) LTR density and the corresponding voltage on the skin,
(b) electrical conductivity and (c) relative permittivity change. The obtained values were then taken as equivalent dielectric properties of the whole
stratum corneum. Please, notice the time-scale which is only 300 μs although the whole treatment took 2.5 ms. We assumed that all changes in
the LTR density occur during the first pulse and afterwards there was no resealing or increasing of the LTR density. The axes correspond to the
coordinate system in Fig. 3.
Fig. 7. Electrical conductivity as a function of voltage, applied to a unit
cell of a keratinocyte or papillary dermis. Even before pulse formation,
the unit cell has a certain conductivity which then increases as a function
of applied voltage.
melted lipids (0.05 S/m [49]) which is relevant in the case of
dry skin.
We assumed that the relative permittivity of the epidermis,
papillary dermis and upper vessel plexus do not change due to
electroporation since the applied pulses were long and the capac-
itive component of the layers at low frequencies is approximated
with an open circuit. The change in relative permittivity of the
stratum corneum was based on the change in the geometry of
the LTR.
The buffer used in the donor compartment was phosphate
buffer, and in the receiver, it was phosphate buffered saline.
They varied in the ionic composition and pH, but their electrical
conductivity was the same (1 S/m). For our model, only the
dielectric properties were important, and we modeled liquid in
the donor and receiver compartment as the same buffer.
B. Pore Formation in Keratinocytes and Papillary Dermis
The Krassowska’s asymptotic equation describes how the
density of the pores changes as a function of applied voltage and
time. It is a simplification of a theory of pore formation as it as-
sumes all pores in the cell membrane are of the same size which
is a justified approximation only for short nanosecond pulses.
During longer pulses, the pores start to grow. For inclusion of an
increase in pore radius, creation of stable macropores should be
modeled [69], but the inclusion is computationally demanding.
Therefore, we decided to calculate the change of electrical con-
ductivity in the first few nanoseconds by Krassowska’s asymp-
totic equation. As the sampling period of the current and voltage
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Fig. 8. Measured and simulated (a) voltage on the skin and (b) current
through the system during LV protocol.
Fig. 9. Measured and simulated (a) voltage on the skin and (b) current
through the system during HV protocol.
measurements was much longer than nanoseconds, we assumed
that the electrical conductivity of the papillary dermis and the
epidermis changed immediately when the pulse was applied.
We calculated the dielectric properties at t = 0 s by the Kras-
sowska’s asymptotic equation. To avoid modeling pore growth,
we simplified our model and adapted the bulk electrical con-
ductivity of separate layers at the end of pulse application. The
dielectric properties during pulse application were determined
by interpolation between t = 0 s and t = 1 s (LV protocol) or
t = 2.5 ms (HV protocol). The changes in electrical conduc-
tivity of lower layers (papillary dermis and epidermis) had to
be included; otherwise we could not describe the experimental
measurements.
The initial electrical conductivity of the epidermis and pap-
illary dermis was for the LV protocol approximated with
Krassowska’s equation when 0.07 V or 0.08 V were applied to
the unit cell which corresponds to 69 mV or 71 mV of induced
transmembrane voltage for corneocyte and papillary dermis, re-
spectively. The initial electrical conductivity of the epidermis
and papillary dermis was for the HV protocol approximated
with Krassowska’s equation when 3 V were applied to the unit
cell which corresponds to 1.14 V or 1.24 V of induced mem-
brane voltage for corneocyte and papillary dermis, respectively.
The initial theoretical voltage drop at t = 0 s on the epidermis
and papillary dermis was determined by treating skin as a volt-
age divider (right part of Fig. 10) on which there was a 30 V
[LV protocol – initial peak of Fig. 8(a)] or 180 V [HV protocol
– initial peak on Fig. 9(a)] voltage drop. Taking into account the
geometry (thickness of layers, area 0.785 cm2 [49], size of unit
cells and corresponding number of unit cells in z-direction) and
Fig. 10. The equivalent circuit of the Franz diffusion cell. The electrode
polarisation is represented only by resistance. Since we are delivering
relatively long pulses, the capacitance due to a double layer which is in
parallel with Relectrodes , could be approximated as an open circuit and
thus neglected. Rsk in is represented by separate resistances of each
layer. The voltage drop on the skin is thus distributed among RSC , RE ,
RPD and RUVP , according to the thickness and electric conductivity of
each layer.
initial electrical conductivity of each layer before electropora-
tion in z-direction (SC: 2.29 × 10−4 S/m, E: 6.36 × 10−2 S/m,
PD: 7.19 × 10−2 S/m, UVP: 3.85 × 10−1 S/m) we calculated
the resistance of each layer and a corresponding voltage drop
on each layer. This calculated voltage drop was then used in the
Krassowska’s asymptotic model.
With HV protocol, the initial theoretical voltage drop on the
epidermis and papillary dermis was 0.4 V, but a good agreement
between measurements and model was achieved with 3 V. The
initial electrical conductivity was thus higher than theoretically
predicted. Higher initial electrical conductivity indicates that
some defects were formed in the stratum corneum quickly and
lower layers were exposed to a higher voltage than predicted.
In HV pulses, the change in electrical conductivity was the
largest during the first pulse, and it changed only slightly dur-
ing the following two pulses. Between pulses, there was some
decrease in electrical conductivity present which indicates re-
sealing of the cell membranes as defects in the stratum corneum
were reported to reseal on a timescale of ms - hours [22].
C. Local Transport Region Formation in the Stratum
Corneum
It was shown that short high-voltage pulses increase the den-
sity of the local transport regions (LTRs) while low-voltage
long pulses increase the size of LTRs by Joule heating and lipid
melting around the pre-existing defects [17]–[22]. The radius
of the LTR during LV protocol increased from 10 μm to 90 μm
and was taken from [49] and the values are within the ranges
reported by [21], [22]. We assumed that LTRs reseal to some
extent between pulses [Fig. 6(a)] although as with the HV pro-
tocol, it is possible that cells in the lower layers resealed as well.
Since the pause during LV protocol was longer than during HV
protocol (100 ms vs 500 μs), we modeled LTR resealing instead
of corneocyte or papillary dermis resealing. The time course
of recovery in skin electroporation ranges from a few ms up to
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several hours [22]. Thus, we assumed that it is possible that LTR
radii slightly decrease during the pause between pulses. Still, this
is only an assumption – the increase in the resistance of the skin
could as well be a consequence of resealing of the pores in the
membranes of the cells in the lower layers. We have added the
resealing in our model, and by doing so, we were able to describe
the measurements of voltage and current more accurately.
The increase in electrical conductivity of SC during HV pro-
tocol was modeled by an increase in density of the LTRs while
their radii stayed the same (10 μm). The modeled density of the
LTR-s was high (up to 1200 LTRs/mm2) in comparison to previ-
ously published studies ([43] and the references therein) (up to
9 LTR/mm2). We tried decreasing the density of the LTRs down
to the reported values, but the modeled voltage on the skin was
2-times higher than measured which indicates that with lower
LTR density the predicted electrical conductivity of the skin is
too low. Even with increasing the electrical conductivity of epi-
dermis and papillary dermis to 1 S/m (electrical conductivity of
the phosphate buffer), the voltage on the skin did not decrease
enough to obtain voltage on the skin that would correspond to
the measured values. This indicates that LTR density is most
probably higher than expected.
D. Measurements and Simulation in the Franz Diffusion
Cell
An equivalent circuit can represent the Franz diffusion cell
(Fig. 10), where Relectrodes , RP BS and Rskin denote the resis-
tance of the double layer on the electrodes, phosphate buffer
and skin, respectively. Udel is the voltage, delivered to the elec-
trodes, and Uskin the voltage, measured on the skin. The double
layer acts as an additional resistance in parallel to capacitance
[53]. Since our pulses were relatively long, we assumed the ca-
pacitance as an open circuit, and only the resistance Relectrodes
was included in the equivalent circuit (Fig. 10). This additional
resistance caused a drop of voltage on the electrodes, and the
sample received less voltage than what was delivered to elec-
trodes. In the case of LV protocol, the voltage drop on electrodes
was significant in comparison to the applied voltage and voltage
drop on the skin (around 1 V on the electrodes with delivered
45 V and 12–30 V on the skin). In the case of HV protocol,
the voltage drop on the electrodes did not influence the results
but was included for consistency. Relectrodes , RP BS , Udel , and
Uskin were known, which means that according to the voltage
divider, Rskin is already determined:
Rskin =
Uskin (Relectrodes + RP BS )
Udel − Uskin (6)
The simulated voltage drop on the skin and current through
the system after the LV protocol corresponded well with the
measurements (Fig. 8). The fitting was obtained by adapting
the electrical conductivities of separate layers until a good
agreement was obtained between simulated and measured
values. Taking into account that in LV protocol, the simulated
and measured current match [Fig. 8(b)], our model was thus
additionally validated.
Fig. 11. Position of the measuring Cu electrodes. When in parallel, the
electrodes were not directly one on top of another as they would squeeze
the skin and change the thickness of the skin. When the electrodes were
crossed, there was a preferential path for electric current.
In HV protocol, however, when we achieved a good agree-
ment between simulated and measured voltage drop on the skin,
the simulated and measured current did not match [Fig. 9(b)].
One possibility is additional processes, e.g., introduced by mea-
suring Cu electrodes. Namely, when measuring the voltage drop
on the skin, the Cu electrodes were in contact with skin. The elec-
trodes were put on the skin between the donor and receiver part
of the Franz diffusion chamber in two possible configurations:
parallel and crossed (Fig. 11) (M. Rebersˇek, personal commu-
nication). Unfortunately, the exact position of the measuring
electrodes was not noted during experiments and is thus not
known. Crossed configuration introduced a preferential path for
electric current since Cu is much more conductive than PBS or
skin. It possible that there was localised heating and discharges
present which caused the current to increase significantly, lo-
cally thus contributing to the overall current measured, but not
causing a detectable voltage drop.
The shape of the voltage and current measurements reflects
the different phenomena occurring during electroporation. The
initial voltage drop and increase in current in the first few mil-
liseconds is due to LTR formation in the stratum corneum. The
emergence of LTRs increases the electric conductivity, but with
increasing the radius of the LTRs, the effect slowly reaches a
plateau. With decreasing resistance of the SC, the electric field
increases in the lower layers of the skin. The prolonged decrease
in voltage and increase in current is due to a slow but constant
increase in the electric conductivity of lower layers due to pore
formation in the cell membranes of the cells in the lower layers,
i.e., electroporation.
From Table III we can see that HV protocol increased the
electrical conductivity of all layers more than the LV protocol.
In LV protocol, the delivered voltage was 45 V, and on the skin,
it was 12 V–30 V (26%–66% of the delivered voltage). In HV
protocol, the delivered voltage was 500 V, and on the skin, it
was 100 V–180 V (20%–36% of the delivered voltage), which
is much less than what was delivered to the skin in the LV
protocol.
When electrodes are immersed in liquid, a double layer is
formed at the electrode-liquid interface. The surface resistance
due to the double layer changes with current density, electrode
material, ions in the liquid. Interestingly, although it can sig-
nificantly change the voltage the cells and tissues are exposed
to, it is included only in a few models [70]. We used the values
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TABLE III
GEOMETRIC AND DIELECTRIC PARAMETERS OF THE FRANZ DIFFUSION CELL
MODEL, THEIR MEANING, VALUE AND REFERENCE
Parameter Meaning Value Reference/
Method
w Radius of the skin sample (cm) 0.5 [49]
hsc Height of SC (μm) 20 [41], [49], [50]
he Height of E (μm) 100 [41]
hpd Height of PD (μm) 140 [41]
huv p Height of UVP (μm) 80 [41]
dd Distance between electrode in the
donor solution and skin (cm)
0.2 [49]
dr Distance between electrode in the
receiver solution and skin (cm)
0.5 [49]
T Temperature of the FDC (°C) 37 [49]
wpla te Radius of the plate on the electrode
(mm)
3.5 [49]
wel Radius of the electrode (mm) 0.5 [49]
h Height of the FDC (cm) 5.255 Measured
ρs Surface resistance (Ωcm2) 3.03 [53]
εP B S Dielectric permittivity of the
PBS(-)
80 [52]
σP B S Electric conductivity of the PBS
(S/m)
1 [49]
σel Electric conductivity of the Pt
electrodes (S/m)
9.43 × 106 [54]
εS C , LV
(x, y, z)
Dielectric permittivity of the SC
after LV protocol (-)
Fig. 5(c) Optimized∗
σS C , LV
(x, y, z)
Electric conductivity of the SC
after LV protocol (S/m)
Fig. 5(b) Optimized∗
εS C , H V
(x, y, z)
Dielectric permittivity of the SC
after HV protocol (-)
Fig. 6(c) Optimized∗
σS C H V
(x, y, z)
Electrical conductivity of the SC
after HV protocol (S/m)
Fig. 6(b) Optimized∗
εE
(x, y, z)
Dielectric permittivity of the E (-) x and y:
4.83 × 103 , z:
1.52 × 104
The unit-cell
model with
keratinocyte
σE , LV
(x, y, z)
Electrical conductivity of the E
after LV protocol (S/m)
x and y:
5.82 × 10−2 ,
z: 6.36 × 10−2
at t = 0 and
7.69 × 10−2
at t = 1 s
Optimized∗
σE , H V
(x, y, z)
Electrical conductivity of the E
after HV protocol (S/m)
x and y:
5.82 × 10−2 ,
z: 0.12 at
t = 0 and
0.17 at
t = 2.5 ms
Optimized∗
εP D
(isotropic)
Dielectric permittivity of the PD (-) 1.62× 104 The Hanai-
Bruggeman
equation
σP D , LV
(isotropic)
Electrical conductivity of the PD
after LV protocol (S/m)
0.086 at
t = 0, 0.096
at t = 1 s
Optimized∗
σP D , H V
(isotropic)
Electrical conductivity of the PD
after HV protocol (S/m)
0.13 at t = 0,
0.18 at
t = 2.5 ms
Optimized∗
εU V P
(x, y, z)
Dielectric permittivity of the
UVP (-)
x: 4.92 × 104 ,
y and z:
6.40 × 104 ,
The Hanai-
Bruggeman
equation
σU V P
(x, y, z)
Electrical conductivity of the UVP
(S/m)
0.42, 0.39,
0.39
The Hanai-
Bruggeman
equation
(x, y and z) denote the anisotropic properties in x-, y- and z-direction. SC denotes stratum
corneum, E epidermis, PD papillary dermis, UVP upper vessel plexus, PBS phosphate
buffer, and FDC the Franz diffusion cell. Dielectric permittivity of material was not relevant
as it did not influence the results since the pulses were relatively long.
∗Optimization was done by comparing measured and simulated current and voltage drop
on the skin.
from a study [53] where they used Pt electrodes. However, they
measured resistance in saline instead of phosphate buffer, and
their electrodes were smaller, which could affect the results.
More concerning is that they delivered much lower voltage than
the voltage delivered in our experiments. The chemistry of high
voltage pulses delivered to an electrolyte is still not well under-
stood [71], with few studies focusing on the release of metal
from electrodes [72] and possible reactions happening on or
near the electrodes [73], [74].
The drawback of our model is that there are several com-
binations of parameters which can offer good agreement with
the current and voltage measurements – e.g., we could change
the dynamics of local transport region formation and describe
the exponential decrease of voltage drop on the skin with dif-
ferent dynamics of change of electrical conductivity of lower
layers. We could compensate for the different geometry of the
LTRs with a different electric conductivity of the LTR. The
model, obtained in this study, is not trying to replicate the ex-
perimental results precisely but serves as a proof of principle
how cell level electroporation can be expanded to tissue level
electroporation. For a more precise determination of parame-
ters, more experiments and electrical measurements are needed
as the values of several parameters are currently only estimated
(for example, dielectric properties of separate layers during
electroporation).
The advantage of using our model is that we can use it to
describe any tissue with any resolution we want, we can include
blood vessels, lymphatic system, different types of cells in a tis-
sue etc. The only requirement is that the geometric and dielectric
properties of the tissues’ microstructure are known. When gen-
eralizing the properties to a tissue level, the computations are
quick and enable inclusion of other physical phenomena – for
example, heating or chemical reactions.
V. CONCLUSION
Our model connects the processes occurring at the level of
cell membranes (pore formation), and at the level of a skin layer
(formation of local transport region in the stratum corneum),
with the level of tissue (skin layers) and even level of organs
(skin). It enables description and prediction of changes in dielec-
tric properties of tissue while taking into account microstruc-
ture and processes on a much smaller scale and simultaneously
keeping the computational times reasonable. Not just skin but
any other tissue could be described similarly, as long as its mi-
crostructure is known. Our model thus offers a step forward in
modeling of electroporation at different spatial scales.
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Abstract 
In electrochemotherapy two conditions have to be met to be successful – the electric field of sufficient 
amplitude and sufficient uptake of chemotherapeutics in the tumor. Current treatment plans only take into 
account critical electric field to achieve cell membrane permeabilization. However, permeabilization alone 
does not guarantee uptake of chemotherapeutics and consequently successful treatment. In our study, we 
described the transport of cisplatin in vivo based on experiments performed in vitro. In vitro, a spectrum of 
parameters can be explored without ethical issues. In the experimental part of our study, we performed in 
vitro and in vivo experiments. Mouse melanoma B16-F1 cell suspension and inoculated B16-F10 tumors 
were exposed to electric pulses in the presence of chemotherapeutic cisplatin. The uptake of cisplatin was 
measured by inductively coupled plasma mass spectrometry. In the modeling part of our study, we modeled 
the transport with the dual-porosity model which is based on the diffusion equation, connects pore 
formation with membrane permeability, and includes transport between several compartments. In our case, 
there were three compartments - tumor cells, interstitial fraction and peritumoral region. Our hypothesis 
was that in vitro permeability coefficient can be introduced in vivo, as long as tumor physiology is taken 
into account. A transformation from in vitro to in vivo was possible by introducing a transformation 
coefficient which takes into account in vivo characteristics, i.e., smaller available area of the plasma 
membrane for transport due to cell density, and presence of cell-matrix in vivo, reducing drug mobility. Our 
model offers a step forward to connecting transport models at the cell level to the tissue level.  
Keywords: electrochemotherapy, drug delivery, transport, modelling, dual-porosity model 
1. Introduction 
When biological cells are exposed to short high-voltage pulses, the permeability of the cell membrane 
increases, presumably due to pore formation following electroporation. As a result, membrane-impermeant 
molecules can pass the membrane [1–4], presumably through newly formed pores. If cells recover, it is 
called reversible electroporation. If the damage is too severe and cells die, it is called irreversible 
electroporation. Electroporation is used in biotechnology [5], food processing [6,7] and medicine [8,9], e.g. 
electrochemotherapy [10], gene electrotransfer [11,12], irreversible electroporation as an ablation technique 
[13,14] and transdermal drug delivery [15,16]. 
In electrochemotherapy transport of chemotherapeutics is critical for a successful treatment. In standard 
electrochemotherapy treatment, after intravenous or intratumoral injection of chemotherapeutic delivered 
electric pulses enhance the uptake of chemotherapeutics into tumor cells [17–19]. In electrochemotherapy, 
chemotherapeutics cisplatin and bleomycin are commonly used as described in the Standard Operating 
Procedures [18]. Starting in the late 1980s [20–22] with preclinical experiments, followed by clinical 
studies [23,24], intratumoral injection of cisplatin was introduced into the Standard Operating Procedures of 
the electrochemotherapy [18] and is now a well-established therapy in clinics across Europe [10]. Because 
the mass of cisplatin can be determined relatively easy, we used cisplatin in our study. Cisplatin enters cells 
by passive (diffusion) as well as active (endocytosis, pinocytosis, macrocytosis, membrane transporters) 
mechanisms [25–27]. Tumor cells can become resistant to cisplatin due to several mechanisms; modified 
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transport or detoxification, or increased DNA damage repair [27]. However, if the mechanism of resistance 
depends on membrane restriction of cisplatin uptake or increased pumping out of the cell, the resistant and 
non-resistant cells responded similarly to electroporation in vitro [28]. The situation in vivo was different, 
as electroporation was more effective on parental than cisplatin-resistant tumors, and it can only be 
hypothesized that additional factors could be present. Cisplatin is known to have negative side effects, 
among them nephrotoxicity, ototoxicity, nausea, depending on the cisplatin concentration and 
administration of the drug [29]. When injected, it accumulates in different organs (blood, liver, kidneys, and 
brain) [30]. Thus, electrochemotherapy offers a possibility to deliver lower dose than in chemotherapy 
while increasing local effectiveness. When treating patients with electrochemotherapy, we can follow 
standard operating procedures where electrode geometry, parameters of electric pulses and 
chemotherapeutic dose are predefined [18]. When tumors are outside the standard parameters, we can use 
variable electrode configuration [31]. With variable electrode configuration, we need a treatment plan 
where the position of the electrodes and electric pulse parameters are optimized to offer sufficient tumor 
coverage with above-threshold electric field [32–36]. Current treatment planning procedure could be 
upgraded by introducing a model of transport to the treatment plan. In this case, the spatially and temporally 
dependent number of intracellular cisplatin molecules could be predicted. Number of bleomycin molecules 
which must enter the cell to cause cell death has already been determined to be a few thousand [37]. If a 
similar dependency, i.e., a necessary number of molecules for cell death, would also be revealed for 
cisplatin, treatment efficacy could be more precisely predicted. 
Usually, experiments are first performed in vitro and then translated to the in vivo environment. However, it 
is difficult to compare the transport during electroporation in vivo and in vitro. In in vitro experiments with 
single cell suspensions, the solute surrounds the cells, and the transport of solute occurs via diffusion. 
Solute can pass cell membrane where the membrane is permeabilized. The transport in the extracellular 
space is not limited. If there is enough of solute in the extracellular space, the transport stops when a cell 
membrane reseals after electroporation. The transport through the membrane can be directly linked to the 
cell membrane permeability [38]. In vivo, the initial solute concentration varies spatially. All the solute 
available can enter cells before the membrane reseals and although cell membrane is still permeable, it does 
not enter cells anymore, i.e., the extracellular compartment can be locally depleted. The transport of solute 
occurs via diffusion and convection [39]. Cells are close together which decreases the possible area for the 
uptake and decreases the induced transmembrane voltage due to electric field shielding [40]. Already in 
spheroids, it was shown that transport of small molecules was spatially heterogeneous, cells inside the 
spheroid contained less of solute than cells at the rim of the spheroid due to established concentration 
gradient [39,41]. Electric pulses cause vasoconstriction [42] which limits the transport of solute in or out of 
a tumor and prolongs the exposure of the tumor to chemotherapeutic. In a tumor, increased interstitial 
pressure, heterogeneous perfusion, defective lymphatic circulation, binding of the drug to non-target 
molecules and metabolism additionally affect the transport [43–45]. 
Modeling is advantageous since it decreases the number of necessary experiments and facilitates 
understanding of the underlying processes. Several models of the increased uptake of molecules after 
electroporation exist. For example, statistical models which describe the data well but do not include 
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specific transport mechanisms [46], the kinetic scheme of electroporation [47,48], (electro)diffusion 
through a permeable membrane or a single pore [49–53] and pharmacokinetic models [54,55]. We decided 
to use the dual-porosity model [38,56] which is based on the diffusion equation, connects pore formation 
with membrane permeability, and includes transport between several compartments – in our case between 
intracellular space, interstitial tumor fraction and peritumoral environment, and can also include thermal 
relations [57].  
In our study, we focused on the electrochemotherapy and modeling of the drug transport after delivery of 
electric pulses, i.e., electroporation. Our hypothesis was that in vitro membrane permeability coefficients 
can be used to predict the transport of cisplatin in in vivo experiments. We used cisplatin as its intracellular 
mass can be determined via measuring the mass of Pt by inductively coupled plasma mass spectrometry 
[58] which is a very sensitive and precise method. We exposed suspension of mouse melanoma cells to 
electric pulses in the presence of chemotherapeutic cisplatin and measured the intracellular mass of Pt. We 
used the dual-porosity model to calculate the in vitro permeability coefficient as a function of pulse number 
and electric field. We performed in vivo experiments on mouse melanoma tumors and measured the 
intracellular and extracellular Pt mass, the mass of Pt in the serum, the mass of Pt bound to DNA and 
components other than DNA (i.e., proteins and lipids). We built a 3D numerical model of a tumor and by 
using the in vitro permeability coefficient predicted the mass of Pt in a tumor. A transformation from in 
vitro to in vivo was possible by introducing a transformation coefficient which takes into account the 
smaller available area of cell membrane for transport due to cell density, and presence of cell-matrix in 
vivo. Our model can describe the amount of intracellular Pt and Pt in the interstitial fraction after 
electroporation. We offer a step forward in connecting the transport at the cell level (in vitro) with the tissue 
level (in vivo) which could be eventually used in treatment planning. 
2. Materials and Methods 
2.1. In vitro experiments 
2.1.1 Cell preparation 
Mouse skin melanoma cell line B16-F1 was grown until 80% confluency in an incubator (Kambič, 
Slovenia) at 37°C and humidified 5% CO2 in Dulbecco's Modified Eagle’s Medium (DMEM, cat. no. 
D5671, 13.77 mS/cm 317-351 mOs/kg). The cell line was tested to be mycobacterium free. DMEM was 
supplemented with 10% fetal bovine serum (cat. no. F7524), 2 mM L-glutamine (cat. no. G7513) and 
antibiotics (50 μg/mL gentamycin (cat. no. G1397), 1 U/mL penicillin-streptomycin (cat. no. P11-010, 
PAA, Austria)) and was in this composition also used as electroporation buffer and for dilution of the 
samples.  
The cell suspension was prepared by detaching the cells by 10x trypsin-EDTA (cat. no T4174), diluted 1:9 
in Hank’s basal salt solution (cat. no. H4641). Trypsin was inactivated with the DMEM containing 10% 
fetal bovine serum. For electroporation, cells were centrifuged (5 min, 180g, 21°C) and resuspended in 
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DMEM containing 10% fetal bovine serum at concentration 2.2x107 cells/mL. The chemicals were from 
Sigma Aldrich, Germany, unless noted otherwise.  
2.1.2. Cell electroporation 
The 3.3 mM stock cisplatin (Accord Healthcare, Poland) was diluted in 0.9% NaCl and prepared fresh for 
each experiment. Right before experiments, 120 μL of cell suspension was mixed with required quantity of 
cisplatin to achieve the desired concentration (usually 100 μM, unless noted otherwise). 60 μL of the cell 
suspension was transferred between the 2 mm stainless-steel electrodes [59], and pulses were delivered with 
a commercially available BetaTech electroporator (Electro cell B10, BetaTech, France). We varied the 
pulse number (1, 4, 8, 16, 32, 64) and the electric field (0.4 kV/cm, 0.6 kV/cm, 0.8 kV/cm, 1.0 kV/cm, 
1.2 kV/cm) while pulse duration was 100 μs and repetition frequency 1 Hz. The remaining 60 μl was used 
as a control and was transferred between the electrodes, but no pulses were delivered. 50 μl of the treated 
and control sample was transferred to 15 mL centrifuge tubes. 10 min after pulse delivery (unless noted 
otherwise), the samples were diluted 40x in full DMEM and vortexed. Samples were then centrifuged (5 
min, 900g, 21 °C) and the supernatant was separated from the pellet. Until the Pt mass measurements the 
samples were stored at -20 °C.  
The following parameters were tested during establishement of our protocol: 1) the effect of extracellular 
cisplatin (1 μM, 5 μM, 10 μM, 20 μM, 50 μM, 100 μM, 200 μM, 330 μM) on the intracellular Pt mass, 2) 
time interval (5 min, 10 min or 20 min) between pulse delivery and dilution on the intracellular Pt mass, 3) 
the binding of cisplatin to proteins from fetal bovine serum by using DMEM with or without fetal bovine 
serum as the electroporation buffer, 4) we also determined the resealing time by adding 100 μM cisplatin 2 
min, 5 min, 10 min and 20 min after pulse delivery. In the experiments mentioned in this paragraph, 
8x100 μs pulses at 1.0 kV/cm and 1 Hz repetition frequency were delivered. 
2.1.3. Cell death - Irreversible electroporation 
Survival after electroporation (without cisplatin) was assessed with two different assays. Short-term 
irreversible electroporation was measured 1h after the treatment on flow cytometer by the propidium iodide 
uptake. The long-term irreversible electroporation was measured 24h after the treatment by a metabolic 
assay. Cells were prepared the same way as described under Cell preparation. Electroporation was 
performed as described in Cell electroporation section, but we added 0.9% NaCl instead of cisplatin.  
2.2.3.1.  Short-term irreversible electroporation 
After application of electric pulses, cells were incubated at 37 °C for 30 min. During these 30 min cells 
resealed. We added propidium iodide (Life Technologies, USA) in final concentration 136 μM. As 
reversibly electroporated cells were already resealed, only irreversibly electroporated cells stained. After 5 
min in the propidium iodide, we measured fluorescence on the flow cytometer (Attune NxT; Life 
Technologies, USA). Cells were excited with a blue laser at 488 nm, the emitted fluorescence was detected 
through a 574/26 nm band-pass filter, and 20.000 events were acquired. Two distinct peaks were formed on 
the histogram of fluorescence and percentage of dead cells was determined with Attune NxT software (Life 
Technologies, USA).  
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2.2.3.2. Long-term irreversible electroporation 
Long-term death was assessed 24h after electroporation with the MTS test (CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (MTS), Promega, USA). 20.000 cells per well were transferred into in a 
96-well plate in triplicates and then incubated for 24 hr. 20 μL of the MTS was added per well, and after 
2 hours at 37 °C, the absorbance at 490 nm was measured with a spectrofluorometer (Tecan Infinite 200; 
Tecan, Austria). 
2.2.4. Statistical Analysis 
The statistical analysis was performed in SigmaPlot (v11.0, Systat Software, USA). We performed the t-test 
when the normality test passed, or the Mann-Whitney rank sum test when the normality test failed. 
2.2. In vivo experiments 
2.2.1. Animals  
Eight-week-old female C57Bl/6 mice (Envigo Laboratories, Udine, Italy) were used in experiments. At the 
beginning of the experiments, their body weight was between 18 and 20 g. All procedures were performed 
in compliance with the guidelines for animal experiments of the EU Directives, the permission of the 
Ministry of Agriculture and the Environment of the Republic of Slovenia (Permission No. U34401-
1/2015/16), which was provided based on the approval of the National Ethics Committee for Experiments 
on Laboratory Animals. Mice were kept in a specific pathogen-free environment with 12-hour light/dark 
cycles at 20–24 °C with 55% ± 10% relative humidity and given food and water ad libitum. 
2.2.2. Treatment and sample collection protocol 
One day before the experiment, mice were shaved on their right flanks. Tumors were induced in the right 
flanks of the non-anesthetized mice with subcutaneous inoculations of 106 B16-F10 melanoma cell 
suspensions in 100 μL of a physiological solution prepared from cell culture in vitro. The treatment was 
performed when tumors reached volumes of 35–40 mm3, which was 6-7 days after inoculation. Tumor 
volume was measured using a Vernier Caliper. The tumor volume was calculated using the following 
formula: 
V=π×e1×e2×e3÷6;         (1) 
where e1, e2, and e3 are three orthogonal diameters of the tumor [60]. During the treatment, mice were under 
isoflurane (Izofluran Torrex para 250 ml, Chiesi Slovenia, Ljubljana, Slovenia) anesthesia. To obtain 
precise application of electroporation mice were initially anesthetized with inhalation anesthesia in the 
induction chamber with 2% (v/v) of isoflurane in pure oxygen and afterward, the mouse muzzle was placed 
under inhalation tube to keep mice anesthetized during the experiment. In experiments from [60], mice 
were randomly divided into three experimental groups, consisting of three animals per group. The three 
groups were: 1) control group, where we intratumorally injected 80 μL of physiological solution, 2) 
cisplatin group, where we injected 80 μL of cisplatin (40 μg of cisplatin) and 3) cisplatin and 
electroporation group, i.e. electrochemotherapy, where we injected 80 μL of cisplatin (40 μg of cisplatin) 
and after 2 minutes delivered electric pulses. Pt mass in these three groups was determined 60 minutes after 
injection as described in [60].  
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In the scope of this paper, additional two groups were used with three mice per group. The treatment 
consisted of an intratumoral injection of 80 μL cisplatin (40 µg of cisplatin). After two minutes, tumors 
were excised, removed from the overlaying skin and weighted. The blood was collected from the 
intraorbital sinus using glass capillary tubes. In the first group, we measured Pt in a whole tumor, and in the 
second group, Pt in several tumor compartments (serum, single cell suspension, extracellular matrix, DNA) 
[60]. For total tumor Pt content detection, tumors were frozen at -20 °C until the analysis. 
2.3. Platinum measurements 
For Pt determination inductively coupled plasma mass spectrometry (ICP-MS) was used. 
2.3.1. Sample digestion  
All dilutions of the samples were made with ultrapure water (18.2 MΩ cm) obtained from a Direct-Q 5 
Ultrapure water system (Merck Millipore, USA). Nitric acid (65 % HNO3) and hydrogen peroxide (30 % 
H2O2) were obtained by Merck Millipore, USA. 
Samples of cell pellet were digested with 200 µL of concentrated nitric acid, 200 µL of concentrated 
hydrogen peroxide and heated overnight at 90°C in the heating oven (Binder GmbH, Tuttlingen, Germany). 
After the digestion, the samples were filled up to 5 mL with MilliQ water and measured by ICP-MS.  
Samples of supernatant fluid were digested with one mL of concentrated nitric acid, one mL of 
concentrated hydrogen peroxide and heated overnight at 90°C in the heating oven. After the digestion, the 
samples were filled up to 10 mL with MilliQ water and 2.5-times diluted before ICP-MS measurements. 
Samples from the in vivo experiments were digested at 90 °C for approximately 36 h in 0.2 to 2.0 mL of a 
mixture of concentrated nitric acid and hydrogen peroxide (1:1). After obtaining clear solutions, samples 
were adequately diluted with MilliQ water before ICP-MS measurements. 
2.3.2. Inductively coupled plasma – mass spectrometry measurements 
Mass concentrations of Pt in the digested samples were determined by the use of mass spectrometry with 
inductively coupled plasma (ICP-MS) against an external calibration curve using Ir as an internal standard. 
Calibration standard solutions of Pt were prepared from Pt stock solution (1000 µg Pt/mL in 8 % HCl), 
obtained from Merck (Darmstadt, Germany), and diluted in 2.6 % nitric acid. Experimental conditions for 
the ICP-MS instrument (Agilent 7900 ICP-MS instrument, Agilent Technologies, Tokyo, Japan), 
summarized in Table 1, were optimized for plasma robustness and adequate sensitivity.  
For evaluation of the accuracy of the analytical method (digestion procedure and ICP-MS analysis), the 
same quantity of cell pellet was spiked with 20 µL of 500 ng/mL ionic Pt solution to reach final Pt 
concentration of 10 ng/sample, while the supernatant fluid was spiked with 20 µL of 50 µg/mL ionic Pt 
solution to reach final Pt concentration of 1000 ng/sample. Spiked samples were digested in the same way 
as described before. Recoveries (the ratio between the measured and expected Pt concentrations) were 101 
± 2 % (N=4) and 98 ± 1 % (N=4) for spiked cell pellets and spiked supernatant fluids, respectively.  
Parameter Type/Value 
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Sample introduction  
Nebulizer Micromist 
Spray chamber Scott 
Skimmer and sampler cone Ni 
Plasma condition  
Forward power 1550 W 
Plasma gas flow 15.0 L min-1 
Carrier gas flow 1.05 L min-1 
Nebulizer pump 0.1 rps 
Sample depth 8.0 mm 
He gas flow 0 mL min-1 
Energy discrimination 5.0 V 
Data acquisition parameters  
Isotopes monitored 195Pt 
Isotopes of internal standards 193Ir 
 
2.4. Modelling  
2.4.1. In vitro 
From the in vitro results, we calculated the coefficient membrane permeability to Pt (P). In vitro, the model 
of transport was relatively simple – the initial concentration of the extracellular cisplatin was the same for 
all the cells, there was enough of cisplatin so that we could consider the extracellular cisplatin concentration 
constant. The whole membrane was surrounded by cisplatin which could enter from all sides, depending on 
the permeability of the membrane. By changing the pulse number and voltage, we obtained the permeability 
coefficient as a function of pulse number and electric field intensity. Permeability coefficient was a direct 
measure of membrane permeability.  
The resealing time constant was determined by describing the resealing data with a curve: 
𝑓𝑓(𝑡𝑡) = 𝐶𝐶 exp �− 𝑡𝑡
𝜏𝜏
�         (2) 
Where C denotes the intracellular Pt mass if cisplatin is present at the moment of pulse delivery, τ is the 
resealing time constant or time when 63% of the pores/defects are resealed [61], and t is the time elapsed 
since the end of pulse delivery.  
In vitro, we used the dual-porosity model [38] to calculate the permeability coefficient. In Matlab (R2017a, 
Mathworks Inc., USA) we calculated the permeability coefficient (P) at t = 0 s which corresponds to P0 by 
solving the differential equation: 
𝜕𝜕𝑐𝑐𝑖𝑖𝑖𝑖𝑖𝑖
𝜕𝜕𝑡𝑡
= 𝑃𝑃0exp (− 𝑡𝑡𝜏𝜏 ) 3𝑅𝑅 (𝑐𝑐𝑖𝑖𝑛𝑛𝑡𝑡 − 𝑐𝑐𝑒𝑒𝑒𝑒𝑡𝑡)        (3) 
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for the external concentration cext (100 μM), the resealing constant τ (2.29 min), in vitro cell radius R 
(8.1 μm) [62], and initial conditions cint(t=0s)=0 μM. The permeability coefficient was a function of time as 
the permeability decreased with time due to membrane resealing. 
2.4.2. In vivo 
Model of a tumor was constructed in Comsol Multiphysics® (v5.3, Comsol AB, Stockholm, Sweden). The 
tumor was modeled as a sphere with radius 2.03 mm which corresponds to 35 mm3, i.e., the average volume 
of a tumor when in vivo treatment was performed. Due to symmetry, we modeled only 1/8 of the tumor, 
i.e., one octant of the sphere. We used physics-controlled mesh with extra fine element size and confirmed 
that with decreasing element size, the calculated intra- and extracellular Pt mass did not change 
significantly. In Comsol, two equations were coupled and calculated in a whole tumor. In the intracellular 
space: 
𝜕𝜕𝑐𝑐𝑖𝑖𝑖𝑖𝑖𝑖
𝜕𝜕𝑡𝑡
=  −3𝑃𝑃(𝑡𝑡)
𝑅𝑅
(𝑐𝑐𝑖𝑖𝑛𝑛𝑡𝑡 − 𝑐𝑐𝑒𝑒𝑒𝑒𝑡𝑡)𝑘𝑘        (4) 
And in the extracellular space: 
𝜕𝜕𝑐𝑐𝑒𝑒𝑒𝑒𝑖𝑖
𝜕𝜕𝑡𝑡
= 𝐷𝐷𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐∇2𝑐𝑐𝑒𝑒𝑒𝑒𝑡𝑡 + 3𝑃𝑃(𝑡𝑡)𝑅𝑅 (1−𝑓𝑓)𝑓𝑓 (𝑐𝑐𝑖𝑖𝑛𝑛𝑡𝑡 − 𝑐𝑐𝑒𝑒𝑒𝑒𝑡𝑡)𝑘𝑘       (5) 
Where cint and cext denote the intracellular and extracellular concentration, respectively, Dcddp is the 
diffusion coefficient of cisplatin in the extracellular tumor space, P is the permeability coefficient, time-
dependent due to membrane resealing, R is the cell radius in vivo (6.25 μm) [63], f is the fraction of cells in 
a tumor (37%) [63,64], and k is the transformation coefficient which transforms the data from the in vitro to 
the in vivo conditions. The initial conditions were cint(t=0)=0 mM and cext(t=0)=1.6 mM. P was determined 
from the in vitro experiments. The boundary conditions for the intracellular concentration were no flux on 
all boundaries and for extracellular concentration, no flux in the inner boundaries of a tumor and cext(r=2.03 
mm)=0 mM at external boundaries.  
In a model, we varied parameters k and Dcddp and calculated the intracellular and extracellular Pt mass for 
each combination of k and Dcddp when k was between 0 and 1 in steps of 0.2 and Dcddp was between 2 x10-8 
cm2/s and 8x10-5 cm2/s in steps of 0.2 decades. Then, we determined a global minimum and sampled the 
space around it with higher resolution by changing k from 0.3 to 0.5 by 0.1 and Dcddp from 1.5x10-6 cm2/s to 
2.5 x10-6 cm2/s by 0.1 decades. The final values of the parameters k and Dcddp were chosen as the values 
with which we achieved the best agreement with a measured mass of Pt in vivo and were the global 
minimum. 
3. Results 
3.1. In vitro experiments 
First, we performed experiments to determine the effect of extracellular cisplatin concentration, incubation 
time, fetal bovine serum, and the resealing time on the Pt uptake. From Fig. 1 we can see that the 
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intracellular Pt mass was linearly dependent on the extracellular cisplatin concentration in control as well as 
in the electroporated cells. Thus, we decided to perform all subsequent experiments with 100 μM 
extracellular cisplatin and scaled our results to any concentration in the tested range. In Fig. 2 we can see 
that 5 min after pulse delivery we reach a plateau in the intracellular Pt mass. We thus decided to perform 
all subsequent experiments with 10 min incubation time after electroporation. Next, we tested whether the 
presence of serum in the electroporation medium affects cellular uptake of Pt (Fig 3). There was no 
statistical difference between the uptake with or without serum. In Fig. 4 we can see how the membranes 
resealed after pulse application. When describing the data with a first-order dynamics (Eq. (1)), we 
determined that the resealing time constant was 2.29 min. 10 min after pulse delivery was cell membrane 
resealed which corroborates results shown in Fig. 2. 
Fig. 1: Effect of extracellular cisplatin (Cext) concentration on intracellular Pt mass when 8x100 μs 
pulses of 1 kV/cm were delivered at repetition frequency 1 Hz. The results could be described with a linear 
function y = kcextwith k and R2 of 0.2672 and 0.99 for the treated and 0.0228 and 0.92 for the control 
cells, respectively. Mean ± standard deviation. Each data point was repeated 3-5 times. Except for 1 μM 
extracellular cisplatin where the measured values were below the detection threshold of 0.005 ng and we 
could not evaluate statistical significance, all electroporated samples were statistically different from the 
corresponding control samples (P<=0.03). 
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Fig. 2: Effect of incubation time after pulse application on the intracellular Pt mass when 8x100 μs 
pulses of 1 kV/cm were delivered at repetition frequency 1 Hz and 100 μM extracellular cisplatin. Already 5 
min after pulse delivery a plateau was reached. Mean ± standard deviation. Each data point was repeated 
3-6 times. All treated samples were statistically different from the corresponding control (P<=0.001).
There was a significant difference between 2 min and 5 min exposure of treated samples (P=0.02), other 
comparisons were not significant. 
Fig. 3: Effect of the presence of serum in the electroporation medium on intracellular Pt mass. There 
was no statistical difference in pulsed (P=0.652) and control (P=0.430) cells when serum was or was not 
present (t-test). Mean ± standard deviation. Each data point was repeated 3-5 times. 
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Fig. 4: Membrane resealing after 8x100 μs pulses of 1 kV/cm were delivered at repetition frequency 1 Hz 
and 100 μM cisplatin (mean ± standard deviation). Membrane resealed with a first-order dynamics with a 
time constant 2.29 min which is shown in red. Each data point was repeated 4-6 times. 2 and 5 min data 
point was statistically significantly different between electroporated and corresponding control samples 
(P<=0.001 for 2 min and P=0.045 for 5 min). There was also a statistical difference between 2 min and 5 
min electroporated samples (P=0.002). All other comparisons were not significant. 
In Fig. 5 intracellular Pt mass is shown as a function of pulse number and electric field intensity. We can 
see that the highest uptake was achieved with eight pulses of 1.2 kV/cm (35 ng of Pt per sample). With 
higher pulse number or higher electric field, the intracellular Pt mass decreased, most likely due to 
increased cell death. To explore hypothesis of cell death contribution, we also performed experiments 
evaluating cell death. Results are shown in Fig. 6 - in Fig. 6a is the short-term cell death measured by flow 
cytometry one hour after the treatment and in Fig. 6b is the metabolic activity measured by MTS assay 24 
hours after the treatment. We can see that the results obtained with both assays correlate well. Survival 
starts to decrease at electric fields above 0.6 kV/cm for any pulse number tested. With 1, 4 or 8 pulses even 
at the highest electric fields, the survival was not yet affected. For calculating the permeability coefficients, 
we have to take into account cell death and correct the permeability coefficient.  
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Fig. 5: Effect of number of pulses and the electric field on the intracellular Pt mass. 8x100 μs pulses of 1 
kV/cm were delivered at repetition frequency 1 Hz (mean ± standard deviation). Each data point was 
repeated 3-5 times. Data points were compared to the control. Comparison was not significant for 0.4 
kV/cm and 1, 4 or 32 pulses; for 0.6 kV/cm and 1, 4, 8 or 64 pulses, for 0.8 kV/cm and 1 or 4 pulses. All 
other data points were statistically significant (P<=0.05).
Fig. 6: Decrease in cell survival due to irreversible electroporation. (a) Survival determined by flow 
cytometry, one hour after electroporation and (b) by the MTS survival assay, 24 h after electroporation 
(mean ± standard deviation). The legend is valid for both figures. Each data point was repeated 3-6 times. 
In (a) the statistically significant points in comparison to the control were 0.8 kV/cm and 32 or 64 pulses, 1 
kV/cm at 8, 16, 32 or 64 pulses and 1.2 kV/cm at 16, 32 or 64 pulses (P<=0.03). In (b) the statistically 
significant points in comparison to the control were 0.4 kV/cm at 8, 32 and 64 pulses, 0.8 kV/cm at 64 
pulses, 1 kV/cm at 1, 32 or 64 pulses, 1.2 kV/cm at 8, 32 and 64 pulses (P<=0.03). 
Due to increased cell membrane permeability, different molecules and ions can enter the cell in different 
concentrations, depending on their size, molecular weight and charge. Small molecules (several hundredths 
of Da) were shown to enter cells in 90-100% of their extracellular concentration [58]. In our experiments, 
we calculated intracellular cisplatin concentration in comparison to extracellular cisplatin concentration 
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(Fig. 7). We reached 80% of the extracellular concentration when 8 pulses of 1.2 kV/cm were applied (Fig. 
7a). Lower cell membrane permeability or cell death decreased this percentage in case of other pulse 
parameters. We took cell death into account by normalizing the intracellular concentration to the survival as 
determined by flow cytometry and obtained graph in Fig. 7b. There we can see that we obtain uptake higher 
than 100% and is increasing with increasing electric field and pulse number.  
Fig. 7: The fraction of the extracellular Pt concentration, present in the intracellular compartment 
(mean ± standard deviation). a) Cell death was not taken into account, and the intracellular Pt 
concentration was almost 80% of the extracellular cisplatin concentration. b) Results of the uptake were 
corrected for cell death as determined by flow cytometry one hour after the treatment. The intracellular Pt 
concentration was almost 140% of the extracellular cisplatin concentration. The legend is valid for both 
figures. 
3.2. In vivo experiments 
We measured the intra- and extracellular Pt mass and by taking into account the size of cells and their 
volume fraction also calculated the intracellular and extracellular cisplatin concentration. The concentration 
is just an approximation since the concentration in the tissue/tumor is most likely inhomogeneous. Results 
are shown in Table 2. 
Table 2: Intra- and extracellular Pt mass and the corresponding cisplatin concentration, based on the 
measured volume of each tumor at t=2 min after injection of cisplatin (initial conditions, time when electric 
pulses are applied) and at t=60 min after the therapy (cisplatin + electroporation). From the results at 60 min 
we subtracted the Pt in the control samples (without electroporation) to focus only on the transport due to 
electroporation. 
t = 0 min 
(Mean ± St. dev). 
t = 60 min [60] 
(Mean ± St. dev.) 
Intracellular Pt mass 17 ng ± 12 ng 67 ng ± 18 ng 
Extracellular Pt mass 6431 ng ± 4681 ng 666 ng ± 104 ng 
Intracellular cisplatin concentration 7 μM ± 5.5 μM 25 μM ± 10 μM 
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Extracellular cisplatin concentration 1600 μM ± 1200 μM 144 μM ±110 μM 
3.3. Modeling 
By using the dual-porosity model, we calculated the in vitro permeability coefficient. We also took into 
account that the permeability coefficient changes with time due to cell membrane resealing. We assumed 
that during resealing, the permeability of the plasma membrane decreases exponentially with time, which 
has been confirmed experimentally and by modeling in several studies [61,66,67]. Thus, the permeability 
coefficient also decreases exponentially with time. The resealing coefficient was obtained by fitting Eq. (2) 
to results, shown in Fig. 4 and optimizing the τ to obtain the highest R2 value of the model. In Fig. 8a we 
can see the permeability coefficient P0 at t=0 s, i.e., when electric pulses were applied and the cell 
membrane was fully permeabilized and in Fig. 8b, how the permeability coefficient changed with time. 
Fig. 8: The permeability coefficient at pulse application determined by the dual-porosity model [32] for 
all conditions, where survival was 100%. a) Permeability coefficient at t=0, i.e., just after exposure to 
electric pulses. b) Permeability coefficient as a function of time when 8x100 μs pulses were delivered at 
0.4 kV/cm and 1 Hz repetition frequency on a semi-logarithmic scale. This was the permeability coefficient 
which was used in the in vivo model. 
For the in vivo conditions, we modeled transport in a tumor modeled by a sphere consisting of intra- (tumor 
cells) and extracellular (interstitial fraction) space. In each compartment, the transport was described by the 
dual-porosity model. We determined the optimal diffusion coefficient to be 2.1x10-6 cm2/s and the optimal 
transformation coefficient to be 0.3. We obtained temporal and spatial dynamics of Pt uptake in the intra- 
and extracellular environment. To compare results of the simulation with experimental results [60], we 
extracted from the model results one hour after pulse delivery. In the model, the Pt mass achieved plateau 
sooner since cell membrane resealed in 10 min (Fig. 4) but we simulated one hour more to be in the same 
time point as when tumors were excised. 
The concentration of Pt in a tumor one hour after electroporation as calculated by the model was 
inhomogeneous with higher concentration in the center of a tumor and gradually decreasing to the rim of a 
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tumor, where concentration was 0 mM (Fig. 9). Therefore, we compared the mass of Pt which was 
calculated as an integral over the corresponding volume fraction to the measured Pt mass in the in vivo 
experiments.  
 
Fig 9: Modelled spatial dependency of Pt concentration 1 hour after pulse delivery in mol/m3. (a) Intra- 
and (b) extracellular Pt concentration. Spatial distribution is inhomogeneous in both cases. 
Table 3: Experimentally determined and modelled mass of Pt in the intracellular and extracellular space of 
a tumor 1 hour after the treatment with electrochemotherapy [54]. 
 Experiments [60] Model 
Intracellular Pt mass 67 ng 65 ng 
Extracellular Pt mass 666 ng 664 ng 
4. Discussion 
Our aim was to model the transport of chemotherapeutics in tumors based on experiments obtained on cell 
suspension. On cell suspension, experiments are easier to perform, there are no ethical issues, and a large 
spectrum of parameters can be explored. Our goal was to include a model of transport in treatment planning 
of electroporation-based medical treatments. In treatment planning of electrochemotherapy, a critical 
experimentally determined electric field of permeabilization [68,69] or statistical models [59,70] are used to 
determine which area will be permeabilized/affected and which not. Permeabilization alone, however, does 
not guarantee treatment efficacy [10]. For successful electrochemotherapy, a sufficient amount of 
chemotherapeutics has to enter tumor cells and bind to DNA (the main target of cisplatin) or target other 
molecules in the cell to prevent future cell division and cause cell death. Current treatment plans of 
electrochemotherapy lack a model of transport and drug uptake in a tumor and the cells. A number of 
internalized bleomycin has been correlated with the biological effect – few thousand bleomycin molecules 
cause mitotic death while several million molecules cause cell death similar to apoptosis [37,71]. A similar 
analysis could also be done for cisplatin. 
In our paper, we connected the in vitro experiments with the in vivo experiments by the dual-porosity 
model. We accurately calculated the Pt mass in the intra- and extracellular tumor space by using in vitro 
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permeability coefficients. Our model could be used to predict treatment efficacy from a number of 
molecules delivered to cells as a function of the electric field in tissue. 
4.1. Experimental part 
In vitro, we used mouse melanoma B16-F1 cells and in vivo, tumor from mouse melanoma B16-F10 cells. 
B16-F1 and B16-F10 cells vary only in their metastatic potential. [72] In vitro, increased uptake of 
molecules after to electroporation is relatively easy to determine using fluorescent dyes and techniques like 
fluorescent microscopy, flow cytometry, spectrofluorometry [73]. In vivo, the increased uptake of 
molecules after electroporation is challenging to assess. 57Co-bleomycin [74], 111In-bleomycin [75], 99mTc-
DTPA [76], 51Cr-EDTA [77], gadolinium [78], lucifer yellow [79] and cisplatin [20,21,28,80–84] were 
used previously. Cisplatin is Pt-based chemotherapeutic. We can calculate the concentration of cisplatin by 
measuring Pt mass in a known volume. The mass of Pt can be measured precisely even for very low 
amounts by inductively coupled plasma mass spectrometry. As Pt mass is easily determined in vitro as well 
as in vivo, we used cisplatin in our study. Another possibility for Pt detection is attaching a contrasting 
agent as a ligand to the Pt. 
Before exploring the parameter space by changing the number of applied electric pulses and electric field, 
we tested 1) at what extracellular cisplatin concentration we should perform the experiments, 2) if we could 
use the fetal bovine serum, 3) how long should we incubate cells after pulse delivery and 4) what was the 
effect of membrane resealing on intracellular Pt mass. 1) We determined that with increasing extracellular 
cisplatin concentration, also intracellular Pt mass increased. The dependency was linear which indicates that 
the increased uptake of molecules after electroporation was mostly diffusive and not electrophoretic or 
endocytic which is in accordance with an already published study [85]. We decided to perform experiments 
at 100 μM and because of the linear dependency results could be scaled to any concentration in the tested 
range. 100 μM concentration was used because it is in a similar range as in other in vitro studies [22,86–88] 
and higher cisplatin concentration caused higher intracellular Pt mass which enabled to more accurately 
distinguish between intracellular masses at similar pulse parameters. 2) Fetal bovine serum added to the 
growth medium consists mostly of proteins. Cisplatin unspecifically binds to proteins [58] and also to 
collagen [89] which represents 5-10% of the matrix. The time dynamics of cisplatin binding to proteins is in 
a range of hours [58,90,91]. Cisplatin, bound to proteins, is biologically inactive [92]. In vitro the binding 
of cisplatin to proteins in the fetal bovine serum in the first 10 minutes was negligible (Fig. 3). Because 
cisplatin was observed to bind to proteins in a time-range of hours-days, we did not include cisplatin 
binding in the tumor model. 3) When we tested the influence of incubation time after electric pulse 
application, we determined that a plateau is reached after 5 minutes (Fig. 2). Thus we decided to perform all 
our experiments 10 min after pulse application when the uptake due to electroporation ends. The reason for 
reaching a plateau could be that the increased uptake of molecules after electroporation is much faster than 
the passive diffusion or active mechanisms which exist in the cells. Namely, it was shown that without 
electroporation, intracellular cisplatin concentration increases in a time-range of hours, in vitro as well as in 
vivo [30,93] The additional mechanisms could contribute to a higher transport and increase in the uptake on 
a longer timescale. To focus only on the modeling uptake due to electroporation, we subtracted the mass of 
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the Pt in the control samples from the mass of Pt in treated samples when calculating the permeability 
coefficient and comparing the results of our model with the experiments. 
Electrochemotherapy is usually performed with 8x100 μs pulses. However, we wanted our model to be 
valid in a larger parameter space, which would enable its use also with other pulse parameters. Thus, we 
applied from 1 to 64 pulses. With increasing pulse number and electric field the intracellular Pt mass 
increased with a peak at eight 100 μs pulses of 1.2 kV/cm (Fig. 5). We calculated the volume of all cells (≈2 
mm3) in a sample and using the measured Pt mass in the cells calculated the intracellular Pt concentration. 
We determined that the intracellular Pt concentration is up to 80% of the extracellular cisplatin 
concentration (Fig. 7a). The high percentage is in agreement with the mass of the cisplatin (300 g/mol) [65]. 
With some parameters of electric pulses, we were already irreversibly electroporating cells (Fig. 6) which 
also affected the uptake. The uptake was decreased as can be observed in the shape of the curves in Fig. 5, 
i.e., we reach maximum at lower pulse number (eight pulses at 1.2 kV/cm or 16 pulses at 1.0 kV/cm) and 
then with increasing pulse number the uptake decreases. We normalized the percentage of intracellular 
cisplatin concentration to survival and obtained values higher than 100% (Fig. 7b) which indicates that 
either 1) cisplatin binds to DNA and concentration gradient increases, 2) cell death was not the only reason 
for decreased uptake, 3) some other cell death assay would be more suitable, 4) active mechanisms 
additionally transport cisplatin into cells. We determined that eight pulses are the optimal number to be 
delivered which is consistent with the standard electrochemotherapy protocol [18]. For our in vivo model, 
we only used the permeability coefficient when the survival was 100%. 
In the in vivo experiments, we injected 26 μg of Pt by intratumoral injection of 80 μl of cisplatin in 35 mm3 
tumors. The volume of injection was twice the volume of a tumor because we reused the data from [60] to 
follow the 3Rs of the animal experiments [94]. Most of the injected Pt was not measured. When a tumor 
was excised 2 min after cisplatin injection, we determined that 27 % of the injected Pt was still present in a 
tumor and the serum. A part of cisplatin was lost due to lower tumor volume than injection volume and due 
to washout of cisplatin from the tumor. When a tumor was excised after 1 hour, we determined that in a 
tumor and serum there was 2% of the injected Pt in the control samples (cisplatin injection, no 
electroporation) and 7 % in the treated (cisplatin injection and electroporation) samples. Thus, in vivo, the 
majority of cisplatin was unaccounted for. Part of cisplatin was lost due to the used methodology (when the 
tumor was mechanically disintegrated and during blood collection). Part of cisplatin could accumulate in 
different organs and cause unwanted side effects [95].  
4.2. Modelling part 
Our model is based on a hypothesis that cell permeability in vitro and in vivo is similar when cells are 
exposed to the same induced transmembrane voltage. However, the transport in vivo is decreased in 
comparison to the transport in vitro due to the hindered transport of molecules in the in vivo environment 
due to the cell matrix, the lower diffusion coefficient of molecules in the interstitial space and close cell 
contacts. The transformation of the transport model from the in vitro to the in vivo environment is 
challenging. We can use the in vitro permeability coefficient in the in vivo model, as long as we take into 
account the geometric characteristics of tissue (cell volume fraction, cell matrix volume fraction, cell size). 
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We took the characteristics into account by decreasing the transport by the transformation coefficient. In 
our model, we assume that the transformation coefficient is a function of tissue morphology and decreases 
with increasing cell volume fraction and matrix volume fraction. It remains to be tested if the 
transformation coefficient can be used over several values of parameters and if transformation coefficient is 
a function of experimental conditions (e.g., tumor cell volume fraction) [63].  
Our initial conditions of the in vivo model were homogeneously distributed 1.6 mM cisplatin in the tumor 
interstitial fraction. Initial cisplatin concentration was determined from experiments by excising tumors 2 
min after cisplatin injection when usually electric pulses were applied. According to our calculations, the 
initial cisplatin concentration in a tumor (1.6 mM) was similar to the concentration injected (1.65 mM), 
which means that by injecting cisplatin we washed out the interstitial fluid and replaced it with cisplatin. 
Thus, part of cisplatin volume was lost due to washout from the tumor, but the remaining cisplatin was not 
diluted in the interstitial fraction, and it remained in (almost) initial concentration. Initial cisplatin 
distribution was determined from the literature [21,96]. Solutes are washed out relatively quickly from 
small tumors and with some delay from larger tumors [96]. In [21] it was determined that 
electrochemotherapy treatment was most efficient when electric pulses were delivered 0-5 min after 
intratumoral cisplatin injection. This time scale indicates that in the first 5 minutes after intratumoral 
injection the cisplatin distribution in a tumor is approximately homogeneous and not yet washed out of a 
tumor. 0-5 minutes was a similar time range as used in our experiments (2 min) implying that 
approximating the initial cisplatin distribution in the model as homogeneous is justified. In future, for 
experimental determination of initial cisplatin distribution, a technique like imaging mass cytometry could 
be used [89]. 60 minutes after the treatment, the cisplatin concentration was the highest in the center of the 
tumor, which corresponds to previously published data – in [79] a fluorescent dye was injected, and in the 
tissue sections it can be seen that the highest concentration of the dye was in the middle of the sample. 
We modeled the tumor as a symmetrical sphere, thus decreasing the complexity of the model and time of 
calculation, which was justifiable because mouse melanomas used in our experiments were spherical due to 
a localized injection during inoculation. However, our model also supports also other geometries, the only 
adaptations required would be those of the geometry and the mesh. 
The volume fraction of cells in a tumor was calculated by the method presented in [64] - the surface 
fraction of cells determined on a slice is a good approximation of volume fraction. We used experimental 
data [63] where the volume fraction of cells and cell matrix and cell size in B16-F1 mouse melanoma 
tumors were assessed. We calculated cell volume fraction of 37% in tumors. Since a tumor has a high 
cellular fraction in comparison to our in vitro results, we took that into account. The high volume fraction of 
cells decreased the induced transmembrane voltage due to electric field shielding [40]. Considering the 
calculations in [97,98] we can determine that the induced transmembrane voltage in cells in vivo is 76-88% 
of the one induced on a single spherical cell. The average radius of cells in vivo was determined to be 6.25 
μm [63] which is less than the average in vitro radius of 8.1±1.1 μm [62] which means that according to 
Schwann equation, the induced transmembrane on the cells in vivo is 77% of the in vitro induced 
transmembrane voltage. Taking into account the decrease in induced transmembrane voltage due to cell 
proximity and smaller cells in vivo, under the same external electric field, the induced transmembrane 
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voltage is approximately 60% of the one induced on cells in vitro. The voltage-to-distance ratio delivered to 
a tumor by parallel plate electrodes was 1.3 kV/cm. It was numerically determined that the electric field in a 
tumor was inhomogeneous [36], and in the center of a tumor, it was 0.6 kV/cm. Taking into account the 
lower induced transmembrane voltage on the cells in vivo, the conditions in vivo correspond to when 0.34-
0.4 kV/cm is delivered in vitro. Thus, the in vitro permeability coefficient when eight 100 μs, 0.4 kV/cm at 
1 Hz was used in the tumor model. We also took into account cell resealing after pulse application and the 
decrease in cell permeability coefficient. From the in vitro results, we determined the time constant of 
resealing was 2.29 min which is in agreement with the in vivo data (Fig. 2 in [21]). When eight pulses at 0.4 
kV/cm were delivered the survival was still 100% (Fig. 6) and thus there was no need for permeability 
coefficient correction. The calculated value of 0.4 kV/cm is in agreement with the literature where 0.4 
kV/cm is usually assumed to be a threshold of electroporation for a tumor [79,99]. 
In tumors, the transport differs from normal tissues, as tumors have an abnormal vasculature and increased 
interstitial pressure which facilitates cisplatin loss [100,101]. In the interstitial space, two mechanisms of 
transport are present – diffusion and convection. The diffusion in tissues is lower than in water as tissue 
structures obstruct the transport. In the literature, values of diffusion coefficient for cisplatin or similar 
molecules are reported in the range of 0.1-0.7x10-6 cm2/s [102–104] which is less than the value we 
determined in our model (2.1x10-6 cm2/s). Electric pulses cause a vascular lock which is present in the time 
range of hours, although blood flow is to some extent restored in first 15 minutes [42]. It is possible that the 
diffusion constant in our study is higher because a part of the transport out of a tumor was due to 
convection, while we limited our analysis to diffusion. However, convection introduces a new unknown 
parameter (velocity) in the model, and here we decided to model the transport as only diffusive. Also, 
vasoconstriction due to electric pulses decreases convective transport from the tumor. In future, the 
convective transport could be included, but experimental data are first needed. 
All models include simplifications. The following are simplifications we made in our model. We assumed 
that the electric field in a tumor was homogeneous although in reality, it is inhomogeneous [36,79]. We 
approximated initial cisplatin distribution in the tumor as homogeneous and the cisplatin concentration at 
the external border of a tumor to be 0 mM, although in reality there is a smooth transition in the 
concentration between intra- and extratumoral cisplatin. Our model was tested on one type of a tumor, and 
more in vivo experiments are needed, preferably with several different tumor types to increase the validity 
of the model. Our current hypothesis is that different tumor types will differ in the diffusion coefficient for 
cisplatin and the transformation coefficient in the interstitial tumor fraction depending on the volume 
fraction of cells in the tumor, both decreasing with the increased volume fraction of cells in the tumor. 
Additionally, different sizes and volume fractions of cells in different tumors affect the induced 
transmembrane voltage [97,98]. Permeability coefficient for different tumor types should be calculated 
from the experiments on corresponding cell types in vitro as different cells exhibit different sensitivity to 
electric pulses [105]. We have applied electric pulses in vivo at only one pulse number and electric field. 
Thus our model is valid at 1.3 kV/cm voltage over the distance, 8x100 μs pulses between the electrodes and 
should in future be tested with more parameters in vivo. Our model is valid for transport of small molecules 
in the range of several hundred Da. For gene electrotherapy where large plasmids have to pass the cell 
169
Results and Discussion - Paper 6 
 
membrane, a different approach would need to be used as the mechanisms governing the transport of large 
molecules [106] are different from mechanisms governing the transport of small molecules [50,54,85]. 
Also, the mobility of large molecules such as plasmids in the tissue is smaller than the mobility of small 
molecules like cisplatin [43]. We assumed that the resealing time in vitro and in vivo is similar, as was 
suggested by comparing our in vitro data to the in vivo already published study [21]. The difference in the 
resealing would influence the time dependency of the permeability coefficient. The size of the cells in vitro 
is statistically distributed [54] which could in future be included in the calculation of the permeability 
coefficient.  
There are several possible upgrades to our model. We could include kinetics of the binding of cisplatin to 
the DNA and resulting cell death as was previously described at a cell level [107–110]. We modeled 
intratumoral cisplatin delivery as suggested in Standard Operating procedures of electrochemotherapy [18]. 
However, for our model to be useful for intravenous (i.v.) drug delivery, additional steps would have to be 
performed to determine the initial spatial drug concentration in the tumor. In the i.v. delivery the drug has to 
overcome several obstacles before entering the tumor – it has to extravasate from the blood vessels, reach 
the tumor, overcome the increased interstitial pressure and distribute throughout the interstitial tumor 
fraction [100]. With our model, we could predict not only the intracellular cisplatin concentration but also 
cell death as a function of the electric field in the tissue and injected cisplatin dose. We would need to 
additionally determine the sufficient amount of molecules in the cell to achieve cell death, and then predict 
the apoptotic or necrotic area of the tumor.  
5. Conclusion 
Electrochemotherapy is a combination of delivering chemotherapeutics and electric pulses to efficiently 
treat tumors. To predict the treatment outcome or optimize the position of the electrodes, we first calculate 
the electric field distribution. We use the critical electric field for reversible electroporation to determine 
reversibly electroporated area, i.e., the area where electrochemotherapy would be efficient. In the paper, we 
introduced a model of drug transport that described the transport of cisplatin after intratumoral injection and 
application of electric pulses in subcutaneous melanoma tumor. We modeled the transport of 
chemotherapeutic between several compartments – tumor cells, interstitial tumor fraction, and peritumoral 
environment using the dual-porosity model. We described the uptake of cisplatin in vivo by using the 
permeability coefficient from in vitro experiments. By optimizing the parameters of the treatment in vitro, a 
large spectrum of parameters could be easily tested, and a number of experiments on animals could be 
reduced. We offer a step forward in bridging the models at the cell level (in vitro) and the models at the 
tissue level (in vivo). By incorporating the analysis of transport into treatment planning of 
electrochemotherapy, the precision of the outcome could be increased taking into account the cell-level 
mechanisms of electroporation. 
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Conclusions and future work 
In the scope of this doctoral dissertation, we have modeled electroporation at the level of single cells and 
the level of tissues. At the level of single cells, experiments are relatively easy to perform, and a large 
spectrum of parameters can be explored without ethical issues which are present in animal experiments 
(Workman et al. 2010). However, not many models include single-cell properties in the bulk tissue models. 
Our aim was to use results of cell level in vitro experiments to establish models which can be then used to 
model electroporation in vivo.  
First, we have employed mathematical models of cell membrane permeability and cell death to describe 
results of in vitro experiments on cell suspensions and cell monolayers. We concluded that several models 
describe the experimental data well. Our optimized Peleg-Fermi model of cell death was already used on 
tissues with good accuracy of prediction (Kranjc et al. 2017). In the survival models, the models approach 
survival zero but never reach it. It remains to be established how low the survival has to be to achieve a 
complete response. The last few remaining cells in electrochemotherapy as well as in ablation with 
irreversible electroporation are shown to be eradicated by the immune system (Neal et al. 2013; Serša et al. 
2015). 
We analyzed the time-dynamics of the dye uptake into cells after electroporation. We could describe the 
uptake with the first-order model which corresponded to the dynamics of pore resealing in the cell 
membrane. In several studies, speed of resealing was assessed and it was determined that it was in the range 
of minutes in the in vitro as well as in the in vivo experiments, which was in agreement with our 
experimental data (Kinosita and Tsong 1977; Saulis et al. 1991; Čemažar et al. 1998; Shirakashi et al. 2004; 
Kandušer et al. 2006; Demiryurek et al. 2015). 
In electroporation of excitable tissues, we can trigger action potential and thus muscle contraction and pain. 
We determined experimental strength-duration curve for excitable and non-excitable cell lines and modeled 
it with the phenomenological Lapicque curve and the Hodgkin-Huxley model. In future, it should be 
established to what extent the in vitro determined strength-duration curve correlates to the in vivo muscle 
contractions and pain sensation. When using strength-duration curves to predict action potential in excitable 
cells, we have to take into account that for a while after the pulses cells are not able to trigger an action 
potential. In future, a model describing the time between delivered electric pulses and action potential could 
be determined. There are even studies which showed that high-voltage electric pulses could cause damage 
to membrane proteins like voltage-gated channels (Chen et al. 2006b; Azan et al. 2017). The protein 
conformational changes that open and close the channel gate take place on the order of a hundred times per 
second, i.e., in the range of milliseconds (Gadsby 2009). It is interesting that nanosecond pulses are even 
able to trigger an action potential (Pakhomov et al. 2017) as they are much shorter than the time needed for 
conformational changes of voltage-gated channels. The models of excitability were determined 
phenomenologically in the range of physiologically possible transmembrane voltages. However, 
electroporation increases the transmembrane voltage more which is thus outside the range of the 
physiological values. It should be established to what extent the current excitability models are valid in the 
range of high transmembrane voltages (several hundreds of millivolts).  
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Second, we have modeled the change in dielectric properties of tissues by modeling pore formation in cell 
membranes and local transport region formation in the stratum corneum. In future, a similar model could 
also be built for other tissues and validated with current-voltage measurements. For example, this could be 
done for electroporation of liver metastases or muscles. A possible upgrade of the model is to model also 
change in pore radii during pulses. Namely, with the asymptotic equation of pore formation, we assume that 
all pores are of the same radii and only their density changes. We could use a method described in (Smith et 
al. 2004) and model also change in pore radii. In this way, the change in of dielectric properties of skin 
layers would not be determined based on the best agreement with the measurements, but it would be based 
on mechanisms of electroporation. We achieved good agreement with current-voltage measurements when 
long low-voltage pulses were applied. However, when short high-voltage pulses were applied the modeled 
current deviated 50% from the measured one. In experiments, additional current component appeared which 
could not be explained by the formation of the local transport regions. Even if we assumed that the whole 
stratum corneum was one big local transport region or that the whole stratum corneum was substituted with 
the electroporation buffer, the simulated current through the skin was lower than the measured one, and 
simulated voltage drop on skin was too low as the conductivity of skin was too high. When measuring 
voltage drop on the skin two thin copper wires were used, one on each side of the skin. Copper wires 
created a preferential high-conductivity path for the electric current because they were much more 
conductive than the electroporation buffer or the skin. Thus, electric current could locally increase and 
contribute to the measured current, but it would not affect voltage drop on the skin. In future, also 
electrochemistry happening during electroporation should be evaluated. During electroporation pH changes, 
metal is released from the electrodes. We can see bubble formation, which could be a consequence of local 
water evaporation or chemical reactions and formation of different gases. We could also include thermal 
effects. Because of Joule heating the temperature increases and consequently, electric conductivity also 
increases. In our model, heating was included indirectly, through the increase of radii of local transport 
regions, which occurs due to lipid melting in the stratum corneum. In future, also melting of lipids could be 
included in our model of local transport region formation (Becker and Kuznetsov 2007; Becker 2012; 
Becker et al. 2014). Currently, we have taken the values of radii of local transport regions directly from 
(Zorec et al. 2013a), we have only added a slight decrease in radii during the pause between pulses, which 
described the experimental data better.  
In the model, we have estimated the induced transmembrane voltage by treating the skin as a voltage 
divider and taking into account the thickness of one layer and size of cells in that layer. However, the 
induced transmembrane voltage is decreased due to close cell connections and electric field shielding. It is 
possible that we overestimated the change in conductivity of lower layers and underestimated the 
conductivity of local transport regions or their size and density. The change in the electric conductivity of 
skin layers influences the electric field distribution and vice versa which could also introduce errors in our 
modeling.  
Third, we have modeled transport of small molecule in tumor during electroporation. Our model is valid for 
small molecules in the range of cisplatin size (300 g/mol). It was shown that larger molecules pass cell 
membrane with more difficulty than small molecules when electric pulses of the same parameters are 
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applied (Maček Lebar et al. 1998). The first reason could be lower diffusion coefficient of larger molecules 
in the tumor interstitial fraction than of smaller molecules. Also, larger molecules enter cells predominantly 
by electrophoresis while small molecules enter cells predominantly by diffusion (Pucihar et al. 2008). 
Larger molecules, i.e., DNA, enter cells in several steps (Rosazza et al. 2016). Currently, in the model, we 
assume that all the transport is due to diffusion, which is not necessarily always valid. Due to increased 
interstitial pressure in the tumor (Baxter and Jain 1989; Boucher et al. 1990; Pušenjak and Miklavčič 2000), 
convection mediated washout of drugs from the tumors is elevated. In the case of systemic drug 
administration, this translates to the hindered entrance of drugs into the tumor. In the case of intratumoral 
drug administration, which was employed in our in vivo experiments, this translates to increase in the 
washout of the drug from the tumor. We found several velocities of the convective transport in the literature 
(Ning et al. 1999). However, they did not correspond to our measurements of intracellular platinum mass 
before pulse application and one hour after it. By inserting existing velocities from the literature in our 
numerical model, all cisplatin was washed out in a few minutes. In future, the convective transport in the 
mouse melanoma tumor needs to be evaluated. Our model was tested on only one tumor type. It is known 
that different tumors have a different cell and matrix volume fractions (Mesojednik et al. 2007). Different 
volume fractions influenced the diffusion coefficient of molecules in the tumor and the surface of the cell 
membranes, available for the transport. In future, or model could be tested with different tumor types. We 
could evaluate if transformation coefficient could be predicted from the tumor morphology. I believe that 
such a transformation should exist – higher cell and matrix volume fractions in tumor should be reflected in 
lower mobility of chemotherapeutic in the tumor and the cells and consequently, in lower transformation 
coefficient. Another question is whether transformation coefficient depends on parameters of electric 
pulses. Currently, we have tested our model at single pulse parameters in vivo. More experiments are 
needed to test our model in wider parameter space and determine the functional dependency of the 
transformation coefficient. 
When delivering chemotherapeutic intratumorally, we avoid several steps in chemotherapeutic transport, 
when it is delivered systemically. In systemic administration, the drug must first enter the bloodstream and 
distribute through the vascular compartment, transport across the microvascular wall and then through the 
interstitial fraction (Jain 1999; Jang et al. 2003). In a tumor, increased interstitial pressure decreases drug 
transport into the tumor and facilitates drug washout from the tumor. In our model, we took into account 
intratumoral delivery of cisplatin where we made a justified assumption of initial homogeneous distribution 
of cisplatin in high concentration. If chemotherapeutic were delivered systemically, we would need to 
additionally calculate initial conditions of cisplatin concentration in a tumor.  
In the in vitro experiments, all cisplatin was accounted for. In the in vivo experiments, we injected 26 μg of 
platinum by intratumoral injection of 80 μl in 35 mm3 tumors. The volume of injection was two-times the 
volume of a tumor because we reused the data from (Uršič et al. 2018). Most of the injected platinum was 
not measured. When a tumor was excised 2 min after cisplatin injection, we determined that 27 % of the 
injected platinum was still present in a tumor and the serum. A part of cisplatin was lost due to lower tumor 
volume than injection volume and due to washout of cisplatin from the tumor. When a tumor was excised 
after 1 hour, we determined that in a tumor and serum there was 2% of the injected platinum (control 
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samples - cisplatin injection, no electroporation) and 7 % in the treated (cisplatin injection and 
electroporation) samples. Thus, in vivo, the majority of cisplatin was unaccounted for. Part of cisplatin was 
lost when the tumor was mechanically disintegrated and during blood collection. Part of cisplatin could 
accumulate in different organs and cause unwanted side effects (Sancho-Martínez et al. 2012). In future, it 
should be established if injecting a lower volume of cisplatin could maintain high treatment efficacy while 
decreasing unwanted side effects. In the literature, it was observed that changing the volume of injection did 
not affect treatment efficacy (Wang 2006; Frandsen et al. 2017) which was also in agreement with our 
results. Namely, although almost 70% of the injected cisplatin volume was lost already when injecting 
cisplatin, the remaining cisplatin in the tumor was in high concentration, and consequently, the 
concentration gradient was high.  
Number of bleomycin molecules necessary to cause cell death was determined in (Tounekti et al. 1993; 
Tounekti et al. 2001). A similar analysis should also be done for cisplatin as it would allow us to optimize 
treatment parameters to achieve a high enough intracellular cisplatin concentration. The inductively coupled 
plasma – mass spectrometry enables precise measurements of platinum mass in the cells. We could also 
perform experiments evaluating cell death (e.g., by the clonogenic assay) at the same pulse parameters used 
in the measurements of the platinum uptake. Then, we could link the survival and transport and determine 
the necessary number of cisplatin molecules to cause cell death. Namely, the complete tumor eradication is 
our final goal in electrochemotherapy, and our model of the cisplatin transport is a step forward in 
achieving more precise prediction of cell death. 
Electroporation results in an increase of membrane electric conductivity and permeability, which can be 
understood as two separate phenomena (Miklavčič and Towhidi 2010; Leguèbe et al. 2014). The initial idea 
was to connect membrane conductivity and permeability in one model. However, this idea was deemed 
difficult to achieve. Already in the initial experiments, we determined that when exposing cells to electric 
pulses in buffers which varied in their ionic composition but were of similar electric conductivity much 
different time dynamics of a dye uptake was measured (Dermol et al. 2016). It was observed as well that 
electroporation buffer conductivity did not affect cell sensitization (Gianulis et al. 2018). A similar electric 
conductivity of a buffer would indicate similar induced transmembrane voltage and thus similar pore 
density. In future, it would be interesting to determine what is the connection between cell membrane 
conductivity and permeability or if permeability is largely influenced by biological processes happening in 
a cell. The electric conductivity of cell membrane namely decreases relatively fast after pulse application, 
while the transport lasts for several minutes or even hours if cells are left to reseal at lower temperatures 
(Saulis et al. 1991). Another possible explanation of prolonged transport is the oxidative damage caused to 
the cell membrane by electric pulses (Benov et al. 1994; Gabriel and Teissié 1995; Maccarrone et al. 1995; 
Pakhomova et al. 2012). Oxidative damage disturbs the lipid bilayer and increases membrane permeability. 
One of the main problems when modeling electroporation is the lack of measurements and experimental 
data, e.g., electric conductivity of the local transport regions, the convective transport in the tumors, the 
initial drug distribution prior to electroporation treatment, electric conductivity of separate skin layers 
before and after electroporation, the change in local transport region radii as a function of pulse duration 
and electric field. The models describing electroporation are namely very complex and have a large number 
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of parameters whose values are only estimated. When establishing and optimizing models of 
electroporation, we can thus in many cases determine only local optimal values of parameters and not 
necessarily global optimal values, as we determined in (Dermol-Černe and Miklavčič 2018). 
In future, we aim to use the presented models in the treatment planning of electroporation-based treatments. 
When optimizing electrode geometry and pulse parameters, currently we aim to reach a high-enough 
experimentally determined critical electric field. We could first introduce the statistical models of cell death 
and permeability. Later, we could aim to achieve a high-enough intracellular cisplatin concentration or even 
number of molecules to cause cell death. We could decrease muscle contractions and pain which would 
shorten and simplify the treatment. We could add measurement of the electric field in the tissue (Kranjc et 
al. 2014; Kranjc et al. 2015) and change the pulse parameters in real-time while delivering electric pulses to 
more precisely know the expected outcome.  
In my opinion, natural sciences cannot exist without models which describe the processes, predict the 
behavior of biological systems, offer insights into biological processes and their connections, and decrease 
number of needed experiments. In this thesis, I have tried to unveil a small part of knowledge in the field of 
electroporation. With the knowledge I have gained in the process of model development, even more 
questions exist now than there did when I first started working on my Ph.D. and they should be answered in 
future. 
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Original Scientific Contributions 
Mathematical modeling of cell membrane permeability and cell death 
We used mathematical models to describe and predict cell membrane permeability and depolarization and 
cell death in vitro. First, we made an overview of the existing models. The existing models are mostly 
phenomenological and do not include any electroporation mechanisms. Only a few models of cell 
membrane permeability exist. On the contrary, there are many models of cell death because they are being 
used for prediction of the efficacy of pulsed electric field assisted food pasteurization and sterilization. The 
parameters of the models were optimized using experimental results. Cell membrane permeability and 
depolarization were assessed by fluorescent dyes, and spectrofluorometric measurements and fluorescent 
microscopy and cell death was assessed by metabolic activity test and clonogenic assay. The experiments 
were performed on attached monolayers and cell suspensions. Our in vitro data was described well with 
several different models. An easy transformation from cell level to tissue level was not possible – each 
model had to be optimized separately for each tissue type, and thus their predictive power was limited.  
The transition between single-cell models and the tissue models, where the realistic three-
dimensional skin model is presented with the model of electroporation of all components and 
essential layers of the skin 
Electroporation changes dielectric properties of tissues which can be assessed by different measuring 
methods. We built a three-dimensional skin model by taking into account geometry of single cells. Each 
cell was representative of the whole layer – corneocytes of the stratum corneum, keratinocytes of the 
epidermis and lipid spheres of the papillary dermis. We modeled dielectric properties of each layer 
analytically by the Hanai-Bruggeman formula or numerically, by a ‘unit cell’ to obtain a bulk skin model. 
We added electroporation with long low-voltage or short high-voltage pulses to our model. We modeled 
formation and growth of local transport regions in the stratum corneum. By asymptotic pore equation we 
modeled pore formation on membranes of the cells of the lower layers. We accurately described current-
voltage measurements of skin electroporation. Our method can be used to determine the change in dielectric 
properties due to electroporation of any tissue, as long as the geometric and the dielectric properties of cells 
constituting the tissue are known.  
Mathematical modeling of transport of small molecules (chemotherapeutic) across the cell 
membrane using the dual porosity model 
For efficient electrochemotherapy treatment, a sufficient uptake of chemotherapeutic in the tumor cells has 
to be achieved to cause cell death. We accurately described the uptake of cisplatin by the tumor cells in the 
mouse melanoma tumors. We performed experiments in vitro and measured the mass of the intracellular 
platinum by the inductively coupled plasma – mass spectrometry. With the dual porosity model, we 
calculated the permeability coefficient as a function of pulse number and electric field. We have built a 3D 
tumor model where we described the transport of cisplatin between several compartments - tumor cells, 
interstitial tumor fraction, and peritumoral environment. We determined that in vitro permeability 
coefficient could be used to model uptake of cisplatin in vivo. However, in vivo, the transport was slower 
due to close cell connections, smaller available membrane area for transport and presence of cell matrix. 
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These differences between in vivo and in vitro were taken into account by a transformation coefficient, 
which is most likely a function of tumor morphology. Our model can be in future used in treatment 
planning of electrochemotherapy.   
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